methadone has been researched along with buprenorphine in 1591 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 28 (1.76) | 18.7374 |
| 1990's | 98 (6.16) | 18.2507 |
| 2000's | 349 (21.94) | 29.6817 |
| 2010's | 682 (42.87) | 24.3611 |
| 2020's | 434 (27.28) | 2.80 |
| Authors | Studies |
|---|---|
| Maykut, MO | 1 |
| Griffith, JD; Jasinski, DR; Pevnick, JS | 1 |
| Camí, J; Fernández, T; Ollé, JM; Peri, JM; San, L; Torrens, M | 1 |
| Brooke, D; Fudala, PJ; Johnson, RE | 1 |
| Bigelow, GE; Liebson, IA; Preston, KL; Strain, EC | 2 |
| Kleber, HD; Kosten, TR; Morgan, C | 4 |
| Jain, RB | 1 |
| Weng, TS | 1 |
| Fudala, PJ; Johnson, RE | 1 |
| Lee, ML | 1 |
| Tiwari, RC | 1 |
| Gross, AJ | 1 |
| Follmann, D; Geller, N; Wu, M | 1 |
| Kosten, TR; Kreek, MJ; Morgan, C | 1 |
| Fudala, PJ; Jaffe, JH; Johnson, RE | 3 |
| Goldberg, SR; Grayson, NA; Jaffe, JH; Johnson, RE; Katz, JL; Rice, KC; Witkin, JM | 1 |
| Kapitsopoulos, G; Makhay, MM; Steigerwald, ES; Young, AM | 1 |
| Bonde, J; Christrup, LL; Jonsson, T | 1 |
| Bigelow, GE; Liebson, I; Preston, KL; Strain, EC | 1 |
| Dooley-Coufos, K; Kuehnle, J; Mello, NK; Mendelson, JH; Sintavanarong, P; Teoh, SK | 1 |
| Camí, J; Fernandez, T; Ollé, JM; Peri, JM; Sam, L; Torrens, M | 1 |
| Kapitsopoulos, G; Makhay, MM; Young, AM | 1 |
| Kosten, TR; Rosen, MI | 1 |
| Chariot, J; Nagain, C; Roze, C; Vaille, C | 1 |
| Cleary, J; Macenski, MJ; Thompson, T | 1 |
| Fraser, AD | 1 |
| Kosten, TA; Kosten, TR; Morgan, C | 1 |
| Charney, DS; Kleber, HD; Kosten, TR; Krystal, JH; Morgan, CH; Price, LH | 1 |
| Bickel, WK; Bigelow, GE; Jasinski, DR; Johnson, RE; Liebson, IA; Stitzer, ML | 2 |
| Foley, KM; Houde, RW; Inturrisi, CE; Moulin, DE; Nip, TJ; Reidenberg, B; Wallenstein, S; Weinberg, DS | 1 |
| de la Torre, R; Ollé, JM; Porta Serra, M; San, L; Tremoleda, J | 1 |
| Collins, CC; Fudala, PJ; Jaffe, JH; Johnson, RE | 1 |
| Kleber, HD; Kosten, TR; Morgan, CJ | 1 |
| Hynes, MD; Leander, JD; Reel, JK; Zimmerman, DM | 1 |
| Cleary, J; Ho, B; Nader, M; Thompson, T | 1 |
| Olley, JE; Tiong, GK | 1 |
| Kleber, HD; Kosten, TR | 1 |
| Bree, MP; Lukas, SE; Mello, NK; Mendelson, JH | 1 |
| Mello, NK; Mendelson, JH | 1 |
| Lukas, SE; Mello, NK; Mendelson, JH | 1 |
| Boren, JJ; Henningfield, JE; Jasinski, DR; Johnson, RE; Lange, WR; Lukas, SE | 1 |
| Bree, MP; Mello, NK; Mendelson, JH | 3 |
| Bläsig, J; Dum, J; Herz, A | 1 |
| Mastropaolo, J; Moerschbaecher, JM; Thompson, DM; Winsauer, PJ | 1 |
| Hall, LW; Nolan, AM | 1 |
| Allen, MC; Baldwin, D; Bullingham, RE; McQuay, HJ; Moore, RA; Symonds, HW | 1 |
| Jasinski, DR; Johnson, RE; Lukas, SE | 1 |
| de Klerk, G; Mattie, H; Spierdijk, J | 1 |
| Jasinski, DR | 1 |
| Wodak, A | 1 |
| Bigelow, GE; Preston, KL; Stitzer, ML; Walsh, SL | 1 |
| Bigelow, GE; June, HL; Preston, KL; Schuh, KJ; Stitzer, ML; Walsh, SL | 1 |
| Bigelow, GE; Liebson, IA; Stitzer, ML; Strain, EC | 3 |
| Follmann, D; Wu, M | 1 |
| Yang, G | 1 |
| Kosten, TR; Stine, SM | 1 |
| Janiri, L; Mannelli, P; Persico, AM; Serretti, A; Tempesta, E | 1 |
| Beauverie, P; Ghaleh, B; Jacquot, C; Khan, E; Poisson, N; van de Vyver, M | 1 |
| Reisinger, M | 2 |
| Auriacombe, M; O'Brien, CP; Tignol, J | 1 |
| Bloch-Lainé, JF; Carpentier, J; Hefez, S | 1 |
| Boissonnas, A | 2 |
| Gelbhart, P | 1 |
| Charpak, Y | 1 |
| Durand, H; Haas, C; Lowenstein, W | 1 |
| Morel, A | 1 |
| Déglon, JJ | 1 |
| Jutel, J | 1 |
| Cleary, J; Macenski, MJ; Schaal, DW; Thompson, T | 1 |
| Bigelow, GE; Cone, EJ; Preston, KL; Stitzer, ML; Walsh, SL | 1 |
| Bickel, WK; Higgins, ST; Hughes, JR | 1 |
| Kosten, T; Oliveto, A; Schottenfeld, R; Ziedonis, D | 1 |
| Castillo, C; de la Torre, R; Porta, M; San, L; Torrens, M | 1 |
| KOSTEN, TR | 1 |
| Gold, MS | 1 |
| Falcioni, J; Kosten, TR; Schottenfeld, R; Ziedonis, D | 1 |
| Galanter, M; Lifshutz, H; Marmor, M; Michaels, J; Perrone, R; Resnick, R | 1 |
| Charuvastra, VC; Compton, PA; Ling, W; Wesson, DR | 1 |
| Greenwood, J; Seivewright, NA | 1 |
| Charuvastra, C; Klett, CJ; Ling, W; Wesson, DR | 1 |
| Borgbjerg, FM; Eriksen, J; Groth Clausen, T | 1 |
| Charuvastra, VC; Compton, PA; Ling, W; Wesson, DR; Wilkins, J | 1 |
| Callaway, E | 1 |
| Fischman, MW; Foltin, RW | 1 |
| Blake, AD; Bot, G; Freeman, JC; Reisine, T | 1 |
| Connerney, I; Fischman, MW; Foltin, RW; Levin, FR | 1 |
| Batki, SL; Brown, J; Jones, RT; Mendelson, J; Welm, S | 1 |
| Brandt, MR; Cabansag, SR; France, CP | 1 |
| Kosten, TR; Oliveto, A; Pakes, JR; Schottenfeld, RS; Ziedonis, D | 1 |
| Braithwaite, RA; Jarvie, DR; Simpson, D; Stewart, MJ; Walker, S; Watson, IW; Widdop, B | 1 |
| Alvarez Requejo, A; Caro-Patón, T; Carvajal, A; García del Pozo, J; Martín Arias, LH; Martín de Diego, I; Rueda, AM | 1 |
| Kosten, TR; Pakes, JR; Schottenfeld, RS | 1 |
| Berthou, F; Carlhant, D; Dreano, Y; Iribarne, C; Lohezic, F; Picart, D; Riche, C | 1 |
| Avants, SK; DePhilippis, D; Kosten, TR; Margolin, A | 1 |
| Gygi, SP; Nagasawa, PR; Rollins, DE; Valdez, AS; Wilkins, DG | 1 |
| Berthou, F; Dréano, Y; Iribarne, C; Picart, D | 1 |
| Eder, H; Fischer, G; Gombas, W; Jagsch, R; Kasper, S; Stühlinger, G | 1 |
| Beauverie, P; Bouchez, J; Touzeau, D | 1 |
| Brunelle, E; Vignau, J | 1 |
| Broers, B; Voegeli, JP | 1 |
| Morgan, D; Picker, MJ | 1 |
| Kopferschmitt, J; Weber, JC | 1 |
| Afflelou, S; Auriacombe, M; Daulouède, JP; Lafitte, C; Lavignasse, P; Roux, D; Tignol, J | 1 |
| Wartenberg, AA | 1 |
| Ladewig, D; Petitjean, S | 1 |
| Aschauer, HN; Eder, H; Fischer, G; Gombas, W; Jagsch, R; Kasper, S; Stühlinger, G | 1 |
| Aschauer, HN; Eder, H; Fischer, G; Gombas, W; Jagsch, R; Kasper, S; Peternell, A; Pezawas, L; Stühlinger, G | 1 |
| Avants, SK; Margolin, A | 1 |
| Gong, ZH; Liu, JG; Qin, BY | 2 |
| Newman, RG | 4 |
| Chawarski, MC; Pakes, J; Pantalon, MV; Schottenfeld, RS | 1 |
| Gessa, GL; Maremmani, I; Pani, PP; Pirastu, R; Tagliamonte, A | 1 |
| Barrau, K; Haramburu, F; Lowenstein, W; Micallef, J; Sanmarco, JL; Thirion, X | 1 |
| Fiellin, DA; O'Connor, PG | 1 |
| Ottenjann, H | 1 |
| Bréchot, C; Carnot, F; Corréas, JM; Fontaine, H; Pol, S; Zylberberg, H | 1 |
| Bigelow, GE; Chutuape, MA; Johnson, RE; Stitzer, ML; Strain, EC; Walsh, SL | 1 |
| O'Connor, PG | 2 |
| Carrieri, MP; Gastaud, JA; Moatti, JP; Obadia, Y; Pradier, C; Reynaud-Maurupt, C | 1 |
| Vasseur, V | 1 |
| Auriacombe, M; Franques, P; Tignol, J | 1 |
| Barrau, K; Djezzar, S; Lagier, G; Lambert, H; Micallef, J; Sanmarco, JL; Thirion, X | 1 |
| Déglon, JJ; Ladewig, D; Livoti, S; Petitjean, S; Stohler, R; Uehlinger, C; Waldvogel, D | 1 |
| Bisaga, A; Popik, P; Radomska, M | 1 |
| Yui, K | 1 |
| Stimmel, B | 3 |
| Mo, Q; Robinson, SE; Schwartz, JP; Wu, VW; Yabe, T | 1 |
| Garzón, J; Gómez-Serranillos, P; Sánchez-Blázquez, P | 1 |
| Barrau, K; Djezzar, S; Lagier, G; Micallef, J; Sanmarco, JL; Thirion, X | 1 |
| Schnoll, SH | 2 |
| Barnett, PG; Bloch, DA; Rodgers, JH | 1 |
| Charuvastra, VC; Compton, P; Ling, W | 1 |
| Kosten, T; Rosenheck, R | 1 |
| Clark, HW | 1 |
| Adda, C; Ben Soussen, P; Gisselbrecht, M; Gourarier, L; Lepère, B; Lowenstein, W; Nordmann, F; Peyret, E; Sanchez, M | 1 |
| Chrostek Maj, J; Pach, J; Radomska, M | 1 |
| Graham, CW; O'Neal, KK; West, SL | 1 |
| Robinson, SE; Wallace, MJ | 1 |
| Barrau, K; Bellemin, B; Chuniaud-Louche, C; Micallef, J; San Marco, JL; Thirion, X | 1 |
| Espegren, O; Hole, R; Høiseth, T; Krook, AL; Lazaridis, KB; Moen, S; Sandvold, M; Waal, H; Welle-Strand, G | 1 |
| Grönbladh, L; Heilig, M; Nilsson, LH; Sternebring, B; Thulin, SO | 1 |
| French, MT | 1 |
| Sindelar, JL | 1 |
| Berglund, M; Jonsson, E; Thelander, S | 1 |
| Hall, WD; Wodak, AD | 1 |
| Dittert, S; Horak, M; Kagerer, S; Soyka, M | 1 |
| Camí, J; Farré, M; Mas, A; Moreno, V; Torrens, M | 1 |
| Pallenbach, E | 1 |
| Cone, EJ; Preston, KL | 1 |
| Beauverie, P; Bonnet, N; Fournier, G; Gaudoneix-Taïeb, M; Imbert, E; Poisson, N | 1 |
| Aubisson, S; Cneude, F; Gourarier, L; Lejeune, C; Piquet, M; Simmat-Durand, L | 1 |
| Bronner, C; Fontaa, V | 1 |
| Feingold, A; Kosten, TR; Oliveto, A; Schottenfeld, R | 1 |
| Merrill, JO | 1 |
| Ali, RL; Gowing, LR; White, JM | 1 |
| Andersen, HT | 1 |
| Butelman, E; Kreek, MJ; LaForge, KS | 1 |
| Blatier, C; Levasseur, L; Marzo, JN; Ross, N | 1 |
| Kreek, MJ; Vocci, FJ | 1 |
| Albert, PS; Follmann, DA; Suh, EB; Wang, SA | 1 |
| Borsutzky, M; Emrich, HM; Metzner, C; Paetzold, W; Passie, T; Rollnik, J; Schneider, U; Seifert, J; Wiese, B | 1 |
| Bachs, LC; Bramness, JG; Waal, H | 1 |
| Baud, FJ; Borron, SW; Monier, C; Risède, P | 1 |
| Daniels, AM; Ferner, RE | 1 |
| Auriacombe, M; Daulouede, JP; Loustauneau, A; Tignol, J | 1 |
| Breen, C; Davoli, M; Kimber, J; Mattick, RP | 5 |
| Chaisson, RE; Hoover, DR; Leslie, JM; Preston, KL; Tucker, MJ; Umbricht, A | 1 |
| Ali, R; Danz, C; Mattick, RP; O'Brien, S; White, JM; Wolk, S | 1 |
| Compton, M; Ling, W; Rawson, RA | 1 |
| Jaffe, JH; O'Keeffe, C | 1 |
| Ling, W; Wesson, DR | 1 |
| Ertl, M; Giacomuzzi, SM; Hinterhuber, H; Kemmler, G; Kurz, M; Riemer, Y; Rössler, H | 1 |
| Champion, R; Gray, J | 1 |
| Ahmadi, J | 1 |
| Bell, J; Breen, CL; Harris, SJ; Hawken, L; Lenné, M; Lintzeris, N; Mattick, RP; Mendoza, E; Ritter, AJ | 1 |
| Kleber, HD | 2 |
| Colker, AC | 1 |
| Feingold, A; Jatlow, P; Kosten, TR; Oliveto, AH; Schottenfeld, R | 1 |
| Cavacuiti, C; Selby, P | 1 |
| Jacquiez, O | 1 |
| Auriacombe, M; Daulouède, JP; Fatseas, M; Franques-Rénéric, P; Tignol, J | 1 |
| Ahmadi, J; Ahmadi, K; Ohaeri, J | 1 |
| Ali, R; Bell, J; Doran, CM; Mattick, RP; Shanahan, M; White, J | 1 |
| Heilig, M; Kakko, J | 1 |
| Ishøy, T; Iversen, C | 1 |
| Uchtenhagen, A | 2 |
| Ullmann, R | 1 |
| Benigeri, M; Brodeur, JM; Calderon, C; Gaigi, H; Guichard, A; Lert, F; Maguet, O; Richard, L; Soletti, J; Zunzunegui, MV | 1 |
| Caplehorn, J | 1 |
| Funada, M | 1 |
| Dietze, P; Lenné, MG; Redman, JR; Rumbold, GR; Triggs, TJ | 1 |
| Darke, S; Lynskey, M; Ross, J; Teesson, M | 1 |
| Krantz, MJ; Mehler, PS | 1 |
| Eder, H; Fischer, G; Opgenoorth, E; Ortner, R; Peternell, A; Schindler, SD | 1 |
| Amato, L; Davoli, M; Ferri, M; Gowing, L; Perucci, CA | 1 |
| Digiusto, E; Mattick, RP; O'Brien, S; Ritter, A; Shakeshaft, A | 1 |
| Adams, CE; Oldham, NS; Sheard, L; Tompkins, CN; Wright, NM | 1 |
| Böttiger, Y; Bulka, A; Kouya, PF; Svensson, JO; Wiesenfeld-Hallin, Z; Xu, XJ | 1 |
| Auriacombe, M; Daulouède, JP; Dubernet, J; Fatséas, M; Tignol, J | 1 |
| Bammer, G; Clark, N; Kutin, J; Lintzeris, N; Panjari, M; Ritter, A | 1 |
| Bertacca, S; Borella, F; Bubici, C; Bussandri, M; Gerra, G; Moi, G; Zaimovic, A | 1 |
| Belcheva, MM; Clark, AL; Coscia, CJ; Hou, Y; Tan, Y; Zahm, DS | 1 |
| Baud, FJ; Borron, SW; Giudicelli, CP; Pirnay, S; Ricordel, I; Tourneau, J | 1 |
| Cunningham-Rathner, J; Ling, W; Rawson, R | 1 |
| Crucilla, C; Hotchkiss, E; Murillo, R; Pickworth, WB; Schmittner, J | 1 |
| Bailey, KP | 1 |
| Des Jarlais, DC; Donghua, M; Hammett, TM; Ngu, D; Van, LK; Wei, L | 1 |
| Darke, S; Hetherington, K; Lynskey, M; Ross, J; Teesson, M | 1 |
| Albrecht, S; Bliesener, N; Klingmüller, D; Lichtermann, D; Schwager, A; Weckbecker, K | 1 |
| Johann, M; Klein, H; Loncarek, E; Unglaub, W; Wismath, M; Wodarz, N | 1 |
| Ebner, R; Schreiber, W; Zierer, C | 1 |
| Bell, J; Christie, MJ; Dean, AJ; Mattick, RP | 1 |
| Sanchez, M | 2 |
| Auquier, P; Bartolo, K; De Stopeleire, C; Jaquet, I; Labrune, N; Lançon, C | 1 |
| Asland, R; Espegren, O; Jakobsen, E; Kristensen, Ø; Lie, Ø; Seiler, S | 1 |
| Carroll, KM; Chawarski, MC; Kosten, TR; Pakes, JR; Pantalon, MV; Schottenfeld, RS | 1 |
| Fiellin, DA; Fudala, PJ; Metzger, DS; Sullivan, LE | 1 |
| Gospodarevskaya, E; Harris, AH; Ritter, AJ | 1 |
| Amin, J; Byrne, A; Dore, GJ; Hallinan, R | 1 |
| Ali, R; Bell, J; Breen, C; Digiusto, E; Kimber, J; Lintzeris, N; Mattick, RP; Saunders, JB | 1 |
| Bond, C; Inkster, K; Ludbrook, A; Matheson, C; Simoens, S | 1 |
| Jasinski, DR; Johnson, RE; Jones, HE; Milio, L | 1 |
| Abate, G; Bruno, CM; Calvagno, S; Cilio, D; Ignaccolo, L; Interlandi, D; Italiano, C; Malaguarnera, M; Mauceri, B; Neri, S; Noto, R; Prestianni, L; Pulvirenti, D; Ricchena, M; Tsami, A | 1 |
| Davies, D | 1 |
| Ryle, PR | 1 |
| Amato, L; Davoli, M; Faggiano, F; Ferri, M; Mattick, RP; Perucci, CA | 1 |
| Ertl, M; Giacomuzzi, SM; Kemmler, G; Riemer, Y; Vigl, A | 1 |
| Chisholm, CA; Choo, RE; Crocetti, M; Dudas, R; Harrow, C; Huestis, MA; Jansson, LM; Jasinski, DR; Johnson, RE; Jones, HE; Lantz, M; Lester, BM; Milio, L; O'Grady, KE | 1 |
| Gerada, C; Hunt, C; Kerr, B; Pringle, M; Sheridan, J; Strang, J | 1 |
| Ali, R; Bell, J; Digiusto, E; Doran, CM; Gilmour, S; Lintzeris, N; Mattick, RP; Saunders, JB; Shanahan, MD; White, J | 1 |
| Garcia, JA; Krantz, MJ; Mehler, PS | 1 |
| Byrne, A; Hallinan, R; Watson, R; Wodak, A | 1 |
| Kornør, H; Waal, H | 1 |
| Apelt, SM; Backmund, M; Bühringer, G; Gastpar, M; Gölz, J; Klotsche, J; Kraus, MR; Pittrow, D; Siegert, J; Soyka, M; Tretter, F; Wittchen, HU | 1 |
| Auriacombe, M; Encrenaz, G; Messiah, A; Rondeau, V | 1 |
| Comer, SD; Sullivan, MA; Walker, EA | 1 |
| Hock, B; Kagerer, S; Kuefner, H; Lehnert, R; Limmer, C; Soyka, M | 1 |
| Bearn, J; de Wet, CJ; Glasper, A; Gossop, M; Reed, LJ | 2 |
| Becker, H; Borsutzky, M; Emrich, H; Hauser, U; Metzner, C; Ohlmeier, M; Paetzold, W; Passie, T; Schneider, U; Seifert, J; Wiese, B | 1 |
| Croissant, B; Hermann, D; Klages, E; Mann, K; Welzel, H | 1 |
| Kamenczak, A; Pach, D; Piatek, P; Schmager, J | 1 |
| Aubisson, S; Gourarier, L; Lejeune, C; Simmat-Durand, L | 1 |
| McCance-Katz, EF | 2 |
| Ali, R; Cooke, R; Darke, S; Lynskey, M; Ritter, A; Ross, J; Teesson, M | 1 |
| Cioe, P; Friedmann, PD; Stein, MD | 1 |
| Eder, H; Fischer, G; Gombas, W; Jagsch, R; Moody, DE; Schindler, SD | 1 |
| Luty, J; O'Gara, C; Sessay, M | 1 |
| Bini, V; Diana, M; Fais, R; Falconieri, D; Messina, M; Pirastu, R; Spiga, S | 1 |
| Bigelow, GE; Johnson, RE; Marsch, LA; Mudric, T; Stephens, MA; Strain, EC | 1 |
| Ertl, M; Giacomuzzi, S; Kemmler, G; Riemer, Y | 1 |
| Bond, C; Ludbrook, A; Matheson, C; Simoens, S | 1 |
| Alford, DP; Compton, P; Samet, JH | 1 |
| Aschauer, H; Baewert, A; Fischer, G; Jagsch, R; Langer, M; Ortner, R; Rohrmeister, K | 1 |
| Blaney, S; Coffin, PO; Fuller, C; Miller, S; Vadnai, L; Vlahov, D | 1 |
| Ahmed, MS; Deshmukh, SV; Hankins, GD; Nanovskaya, TN; Zharikova, OL | 1 |
| Negus, SS | 1 |
| Calsyn, DA; Malcy, JA; Saxon, AJ | 1 |
| Becker, WC; Fiellin, DA | 1 |
| Herget, G | 1 |
| Barratt, DT; Coller, JK; Somogyi, AA | 1 |
| Clark, NC; Dietze, P; Lenné, MG; Redman, JR | 1 |
| Caplehorn, J; Deeks, JJ | 1 |
| Bell, J; Mutch, C | 1 |
| Altice, FL; Bruce, RD; Friedland, GH; Gourevitch, MN | 1 |
| Cubells, JF; Tang, YL; Zhao, C; Zhao, D | 1 |
| Guffens, JM | 1 |
| Cezard, C; Mathieu-Nolf, M; Nisse, P; Peucelle, D | 1 |
| Bond, A; Lintzeris, N; Mitchell, TB; Nestor, L; Strang, J | 1 |
| Penning, R; Soyka, M; Wittchen, U | 1 |
| Linardi, RL; Natalini, CC; Polydoro, Ada S | 1 |
| Nasir, R; Smither, G; Troon, S; Williams, N | 1 |
| Caldiroli, E; Lucchini, A; Nava, F; Premi, S | 1 |
| Cocchi, L; Corrado, F; Cozzolino, E; De Chiara, M; Guglielmino, L; Marzorati, P; Silenzio, R; Vigezzi, P | 1 |
| Adams, CE; Sheard, L; Tompkins, CN; Wright, NM | 1 |
| Fairbairn, N; Kerr, T; Maas, B; Montaner, J; Wood, E | 1 |
| Ng, BY; Peh, LH | 1 |
| Bigelow, GE; Brooner, RK; Johnson, RE; Lott, DC; Strain, EC | 1 |
| Ashe, RG; Lowry, J; Mawhinney, S | 1 |
| Haasen, C; van den Brink, W | 1 |
| Selzer, J | 1 |
| Conti, M; Gerra, G; Leonardi, C; Mandrioli, R; Mercolini, L; Raggi, MA | 1 |
| Cho, E; Dermatis, H; Galanter, M | 1 |
| Carrieri, MP; Dellamonica, P; Poizot-Martin, I; Préau, M; Protopopescu, C; Spire, B; Villes, V | 1 |
| Carnicelli, P; Dixon, M; Ferreira, TH; Luna, SP; Steagall, PV; Taylor, PM | 1 |
| Lum, PJ; Tulsky, JP | 1 |
| Fiellin, DA; Friedland, GH; Gourevitch, MN | 1 |
| Bruce, RD; Eldred, L; Fiellin, DA; Finkelstein, R; Haltiwanger, D; Lucas, GM; Sullivan, LE | 1 |
| Amass, L; Carrieri, MP; Lucas, GM; Vlahov, D; Wodak, A; Woody, GE | 1 |
| Apelt, SM; Lieb, M; Soyka, M; Wittchen, HU | 1 |
| Shen, HJ | 1 |
| Brambilla, F; Branchi, B; Gerra, G; Moi, G; Moroni, M; Raggi, MA; Zaimovic, A | 1 |
| Lofwall, MR; Rodriguez-Rosas, ME; Siluk, D; Strain, EC; Wainer, IW | 1 |
| Hesse, M | 1 |
| Amundsen, EJ; Kielland, KB; Ødegård, E | 1 |
| Darke, S; Havard, A; Mills, KL; Ross, J; Teesson, M; Williamson, A | 1 |
| Dietze, P; Dunlop, A; Lee, N; Nielsen, S; Taylor, D | 1 |
| Daley, M; Fuller, BE; McCarty, D; Rieckmann, T; Thomas, CP | 1 |
| Stancliff, S | 1 |
| Burls, A; Connock, M; Day, E; Frew, E; Fry-Smith, A; Jowett, S; Juarez-Garcia, A; Lintzeris, N; Liu, Z; Roberts, T; Taylor, RJ; Taylor, RS | 1 |
| Ege, P; Fanoe, S; Hvidt, C; Jensen, GB | 1 |
| Cordonnier, L; Noble, F; Roques, BP; Sanchez, M | 1 |
| Darke, S; Ross, J; Teesson, M | 1 |
| Dietze, P; Dunlop, A; Lee, N; Muhleisen, P; Nielsen, S; Taylor, D | 1 |
| Dejgaard, B | 1 |
| Delzenne, C; Doublet, A; Fontaine, B; Frimat, P; Labat, L; Lhermitte, M; Marek, MC; Tellier, D; Tonneau, M | 1 |
| Conigrave, KM; Haber, PS; Wallace, C; Watson, B; Whitfield, JB; Wurst, F | 1 |
| Brady, KT | 1 |
| Grönbladh, L; Heilig, M; Kakko, J; Nilsson, LH; Rawlings, B; Rück, C; Svanborg, KD; von Wachenfeldt, J | 1 |
| Bramness, JG; Kornør, H | 1 |
| Best, D; Manning, V; Mayet, S; Ridge, G; Sheridan, J; Strang, J | 1 |
| Bigelow, GE; Rosado, J; Strain, EC; Walsh, SL | 1 |
| Oyemade, A | 1 |
| Degenhardt, LJ; Gibson, AE | 1 |
| Alho, H; Fabritius, C; Kalska, H; Rapeli, P; Salaspuro, M; Wahlbeck, K | 1 |
| Baewert, A; Eder, H; Fischer, G; Gombas, W; Jagsch, R; Peternell-Moelzer, A; Schindler, SD | 1 |
| Arnsten, JH; Gourevitch, MN; Kunins, HV; Whitley, SD | 1 |
| Maremmani, I; Pacini, M; Pani, PP; Perugi, G | 1 |
| Friedmann, PD; Stein, MD | 1 |
| Blondell, RD; DeVaul, SK; Servoss, TJ; Simons, RL; Smith, SJ | 1 |
| Amass, L; Bower, EH; Branstetter, SA; Kamien, J | 1 |
| Bond, AJ; Lintzeris, N; Mitchell, TB; Nestor, L; Strang, J | 1 |
| Baldelli, F; Belfiori, B; Chiodera, A; Ciliegi, P; Francisci, D; Stagni, G; Tosti, A | 1 |
| Cicero, TJ; Inciardi, JA; Munoz, A; Surratt, H | 1 |
| Carrieri, MP; Lucas, GM; Spire, B | 1 |
| Hall, WD; Mattick, RP | 1 |
| Heger, B; Krook, AL; Nygaard, E; Stokka, D | 1 |
| Gardner, TJ; Kosten, TR | 1 |
| Grinshpoon, A; Ponizovsky, AM | 1 |
| Altice, FL; Bruce, RD; Copenhaver, MM | 1 |
| Davis, WR; Johnson, BD | 1 |
| Manning, V; Mayet, S; Ridge, G; Sheridan, J; Strang, J | 1 |
| Haraldsen, M | 2 |
| Binder, T; Vavrinková, B | 2 |
| Agho, K; Attia, J; Byrne, A; Hallinan, R; McMahon, CG; Tynan, P | 1 |
| Byrne, A; Wodak, A | 1 |
| Bond, CM; Matheson, C; Tinelli, M | 1 |
| Mendez, IA; Trujillo, KA | 1 |
| Bues-Charbit, M; Busuttil, M; Colombini, N; Dubuc, M; Einaudi, MA; Elias, R | 1 |
| Lawrinson, P; Le, PP; Roche, A; Terao, H | 1 |
| Bigelow, GE; Haigney, MC; Johnson, RE; Nuzzo, PA; Wedam, EF | 1 |
| Des Jarlais, DC; Lugoboni, F; Melara, B; Mezzelani, P; Pattaro, C; Quaglio, G | 1 |
| Day, E; George, S | 1 |
| Pritham, UA; Stetson, A; Troese, M | 1 |
| Agho, K; Attia, J; Byrne, A; Hallinan, R; McMahon, C; Tynan, P | 1 |
| Anchersen, K; Clausen, T; Waal, H | 1 |
| Lea, T; Nittis, M; Whitton, G; Winstock, AR | 1 |
| Ali, R; Degenhardt, L; Gibson, A; Mattick, RP; O'Brien, S; White, J | 1 |
| Fiellin, DA; Gunderson, EW | 1 |
| Koller, G; Kuefner, H; Soyka, M; Zingg, C | 1 |
| O'Brien, CP | 2 |
| Bruce, RD; Schleifer, RA | 1 |
| Arria, AM; Coyle, MG; Fischer, G; Heil, SH; Jones, HE; Kaltenbach, K; Martin, PR; O'Grady, KE; Selby, P; Stine, SM | 2 |
| Aitken, CK; Hellard, ME; Higgs, PG | 1 |
| Franchi, S; Gerra, G; Leccese, V; Panerai, AE; Sacerdote, P; Somaini, L | 1 |
| Cantwell, K; Dietze, P; Lee, N; Nielsen, S; Taylor, D | 1 |
| Apelt, SM; Backmund, M; Bühringer, G; Gastpar, M; Gölz, J; Kraus, MR; Rehm, J; Schäfer, M; Scherbaum, N; Siegert, J; Soyka, M; Tretter, F; Wittchen, HU | 1 |
| Heilig, M; Kakko, J; Sarman, I | 1 |
| Lea, T; Sheridan, J; Winstock, AR | 4 |
| Fischer, G; Jung, E; Winklbaur, B | 1 |
| Batey, R; Bell, JR; Mutch, C; Rea, F; Ryan, A | 1 |
| Amato, L; Davoli, M; Minozzi, S; Vecchi, S | 2 |
| Fiellin, DA; Sullivan, LE | 1 |
| Jones, HE | 3 |
| Casadonte, PP; Horton, T; Kolodner, GF; McMurphy, SM | 1 |
| Heil, SH; Jones, HE; Sigmon, SC; Wagner, M | 1 |
| Ali, R; Buavirat, A; Chiamwongpaet, S; Dvoryak, S; Habrat, B; Jie, S; Lawrinson, P; Mardiati, R; Mokri, A; Moskalewicz, J; Newcombe, D; Poznyak, V; Subata, E; Uchtenhagen, A; Utami, DS; Vial, R; Zhao, C | 1 |
| Do, LT; Esses, JL; Hanon, S; Rosman, J; Schweitzer, P | 1 |
| Choo, RE; Huestis, MA; Johnson, RE; Jones, HE; Kacinko, SL | 1 |
| Croissant, B; Diehl, A; Kniest, A; Loeber, S; Mann, K | 1 |
| Bailey, JE; Campagna, E; Dart, RC | 1 |
| Carrieri, MP; Dellamonica, P; Poizot-Martin, I; Ravaux, I; Roux, P; Spire, B; Villes, V | 1 |
| Ebner, N; Fischer, G; Jung, E; Kopf, N; Thau, K; Winklbaur, B | 1 |
| Leonardi, C; Lucchini, A; Manzato, E; Nava, F | 1 |
| Fiellin, DA; Jones, ES; Moore, BA; O'Connor, PG; Schottenfeld, RS; Sindelar, JL | 1 |
| Lee, SS; Merican, MI; Noordin, NM; Rahman, HA; Ramly, R | 1 |
| Hershberger, J; Joseph, H; Lee, JD; Magura, S; Marsch, L; Rosenblum, A; Shropshire, C | 1 |
| Bacosi, D; Baldelli, F; Belfiori, B; Chiodera, A; Ciliegi, P; Francisci, D; Tosti, A | 1 |
| Athanasos, P; Compton, P; Farquharson, AL; Hay, J; Psaltis, P | 1 |
| Tenore, PL | 1 |
| Gossop, M; Lintzeris, N; Ridge, G; Strang, J; Witton, J | 1 |
| Hennig-Fast, K; Kagerer, S; Koller, G; Kuefner, H; Lehnert, P; Lieb, M; Limmer, C; Soyka, M; Zingg, C | 1 |
| Ashrafioun, L; Blondell, RD | 1 |
| Coles, LD; Eddington, ND; Hassan, HE; Lee, IJ | 1 |
| Aasland, OG; Johannesen, A; Spilhaug, G | 1 |
| Shaygani, S; Waal, H | 1 |
| Dolan, K; Larney, S | 1 |
| Darke, S; Havard, A; Mills, K; Ross, J; Teesson, M; Williamson, A | 1 |
| Bruarøy, S; Elgen, I; Laegreid, LM; Reigstad, H; Sandtorv, L | 1 |
| Kreek, MJ; Piccolo, P; Talal, AH | 1 |
| Anderson, BJ; Craig, F; Michel, E; Zernikow, B | 1 |
| Bakstad, B; Ravndal, E; Sarfi, M; Welle-Strand, GK | 1 |
| Backmund, M; Gölz, J; Kraus, MR; Schäfer, A; Schäfer, M; Siegert, J; Soyka, M; Tretter, F; Wittchen, HU | 1 |
| Casuccio, A; Ferrera, P; Intravaia, G; Mangione, S; Mercadante, S; Villari, P | 1 |
| Chand, PK; Thirthalli, J | 1 |
| Berterame, S; Busse, A; Capovani, B; Gerra, G; Kleber, H; Maremmani, I; Saenz, E; Somaini, L; Tomas-Rossello, J | 1 |
| Keating, GM; Orman, JS | 1 |
| Coop, A; Eddington, ND; Hassan, HE; Myers, AL | 1 |
| Amato, L; Davoli, M; Minozzi, S | 1 |
| Alho, H; Fabritius, C; Kalska, H; Rapeli, P | 3 |
| Bath, N; Lea, T; Madden, A; Winstock, AR | 1 |
| Anchersen, K; Clausen, T; Gossop, M; Hansteen, V; Waal, H | 2 |
| Allard, L; Bogaert, J; Brohée, JP; De Wulf, I; Duquet, N; Karadag, EN; Lagrain, J; Ledoux, MY; Puttemans, MK; Remy, C; Saevels, J; Verrando, R | 1 |
| Magura, S | 1 |
| Hunault, C; Marzo, JN; Meroueh, F; Obradovic, I; Rotily, M; Varastet, M; Zin, A | 1 |
| Batey, R; Bell, JR; Butler, B; Lawrance, A; Salmelainen, P | 1 |
| Dahne, J; Johnson, R; Jones, HE; Lemoine, L; Milio, L; O'Grady, K; Ordean, A; Selby, P | 1 |
| Barnett, PG | 1 |
| Dodrill, CL; Kosten, TR; Stotts, AL | 1 |
| Dervaux, A; Kanit, M; Laqueille, X; Launay, C | 1 |
| Bell, J; Butler, B; Randall, D; Rubin, G; Trinh, L | 1 |
| Adams, CE; Bound, N; Hart, R; Rushforth, B; Sheard, L; Tompkins, CN; Wright, NM | 1 |
| Burns, L; Butler, T; Degenhardt, L; Hall, W; Law, M; Randall, D | 1 |
| Dickman, S; Nijhawan, A; Nunn, A; Rich, JD; Trimbur, C; Zaller, N | 1 |
| Ali, RL; Bell, JR; Degenhardt, L; Larance, BK; Lintzeris, N; Mattick, RP; Scheuer, N; Winstock, AR | 1 |
| Chast, F | 1 |
| Baud, FJ | 1 |
| Levine, M; Ruha, AM | 1 |
| Fang, WB; Lin, SN; Moody, DE; Omiecinski, CJ; Strom, SC; Weyant, DM | 1 |
| Bradbury, C; Dale-Perera, A; Eastwood, B; Farrell, M; Hammond, P; Knight, J; Marsden, J; Randhawa, K; Wright, C | 1 |
| Carrieri, MP; Cohen, J; Dellamonica, P; Poizot-Martin, I; Ravaux, I; Roux, P; Spire, B | 1 |
| Baud, FJ; Chevillard, L; Mégarbane, B; Risède, P | 1 |
| Eide-Olsen, B | 1 |
| Rosemann, T; Seidenberg, A; Senn, O | 1 |
| Chtenguelov, V; Schaub, M; Subata, E; Uchtenhagen, A; Weiler, G | 1 |
| Lea, T; Lintzeris, N; Winstock, AR | 2 |
| Bakstad, B; Martinsen, H; Røislien, J; Sarfi, M; Waal, H | 1 |
| Bachs, L; Bakke, E | 1 |
| Cribier, B; Guillaume, JC; Roth-Mall, B; Sfia, M; Tortel, MC | 1 |
| Altice, FL; Ball, SA; Bruce, RD; Herme, M; Schwarz, RK | 1 |
| Lea, T; Winstock, AR | 1 |
| Arends, MT; de Haan, HA; Klazinga, NS; van Everdingen, JJ; Westra, M | 1 |
| Meader, N | 1 |
| Larney, S | 1 |
| Day, E | 1 |
| Bramness, J; Gossop, M; Lobmaier, P; Waal, H | 1 |
| Altice, FL; Chen, S; Springer, SA | 1 |
| Capellà, D; Casas, M; Castells, X; Colom, J; Kosten, TR; Vidal, X | 1 |
| Baud, FJ; Buisine, A; Chevillard, L; Jacobs, F; Mégarbane, B; Résière, D; Vicaut, E | 1 |
| Ali, H; Ambekar, A; Degenhardt, L; Hickman, M; Mathers, BM; Mattick, RP; Myers, B; Strathdee, SA; Wiessing, L | 1 |
| Khachatrian, A | 1 |
| Lorenzetti, V; Lubman, DI; Velakoulis, D; Yücel, M | 1 |
| Ackermann, G; Waizmann, M | 1 |
| Borchgrevink, PC; Fredheim, OM; Høivik, T; Nordstrand, B; Nøstdahl, T; Rygnestad, T | 1 |
| Bean, HK; Gannon, R | 1 |
| Accornero, VH; Bandstra, ES; Mansoor, E; Morrow, CE | 1 |
| Howland, RH | 1 |
| De Pauw, M; Hoetelmans, R; Lefebvre, E; Sekar, V; Tomaka, F; van den Brink, W; Vangeneugden, T | 1 |
| Kashanpour, H; Lombardelli, T; Maisto, M; Moratti, E | 1 |
| Jansson, LM; Johnson, RE; Jones, HE; O'Grady, KE; Velez, M | 1 |
| Chiang, YC; Ho, IK; Hung, TW; Lee, CW; Yan, JY | 1 |
| Gruber, VA; McCance-Katz, EF | 1 |
| Bailey, EJ; Cicero, T; Dart, RC; Dasgupta, N; Inciardi, J; Parrino, M; Rosenblum, A | 1 |
| Mactier, H | 2 |
| Cohen, J | 1 |
| Davstad, I; Engdahl, B; Fugelstad, A; Leifman, A; Romelsjö, A; Stenbacka, M; Thiblin, I | 1 |
| Weich, L | 1 |
| Carrieri, MP; Shepard, D; Wolfe, D | 1 |
| Concheiro, M; Gray, TR; Huestis, MA; Shakleya, DM | 1 |
| Byun, J; Philipp, BL; Wachman, EM | 1 |
| Cunningham, CO; Giovanniello, A; Kunins, HV; Li, X; Sacajiu, G; Sohler, NL; Whitley, SD | 1 |
| Metzger, DS; Zhang, Y | 1 |
| Holland, R; Maskrey, V; Pinto, H; Rumball, D; Swift, L; Wagle, A | 1 |
| Carrieri, MP; Cohen, J; Dellamonica, P; Protopopescu, C; Ravaux, I; Rosenblum, A; Roux, P; Spire, B | 1 |
| Flassing, J | 1 |
| Blandthorn, J; Forster, DA; Love, V | 1 |
| Frei, M | 1 |
| Krupitsky, E; O'Brien, CP; Woody, GE; Zvartau, E | 1 |
| Amar, R; Casarella, J; Drexler, K; Fareed, A; Vayalapalli, S | 1 |
| Cornish, R; Hickman, M; Macleod, J; Strang, J; Vickerman, P | 1 |
| Martin, TC; Rocque, MA | 1 |
| Awgu, E; Magura, S; Rosenblum, A | 1 |
| Degenhardt, L; Dietze, P; Horyniak, D; Larance, B; Winstock, A | 1 |
| Concheiro, M; Huestis, MA; Shakleya, DM | 1 |
| Bignamini, E; Cappa, C; Compostino, R; De Vivo, E; Demarie, D; Ferro, S; Imazio, M; Marletta, G; Trinchero, R | 1 |
| Foster, DJ; Gordon, AL; Lopatko, OV; Somogyi, AA; White, JM | 1 |
| Bernard, JP; Christophersen, AS; Mørland, JG; Oiestad, EL; Vindenes, V; Waal, H; Yttredal, B | 1 |
| Ende, G; Frischknecht, U; Heinrich, M; Hermann, D; Hoerst, M; Kiefer, F; Mann, K; Tunc-Skarka, N; Vollmert, C; Vollstädt-Klein, S | 1 |
| Botsko, M; Chaudhry, AA; Egan, JE; Estrada, B; Fiellin, DA; Flanigan, TP; Lucas, GM; Mitty, J; Weiss, L; Woodson, T | 1 |
| Botsko, M; Egan, JE; Fiellin, DA; Finkelstein, R; Netherland, J; Weiss, L | 1 |
| Gilchrist, G; Lintzeris, N; Longman, C; Temple-Smith, M | 1 |
| Ali, R; Bell, J; Degenhardt, L; Larance, B; Lintzeris, N; Mattick, RP; O'Brien, S; Winstock, A | 1 |
| Benich, JJ | 1 |
| Arria, A; Aschauer, C; Bäwert, A; Fischer, G; Jagsch, R; Jones, H; Leitich, H; Rohrmeister, K; Unger, A; Winklbaur, B | 1 |
| Baxter, JD; Clark, RE; Hashemi, L; Leung, GY; Samnaliev, M | 1 |
| Konijnenberg, C; Melinder, A | 6 |
| Kasper, S; Kranzler, HR; Krystal, J; Möller, HJ; Soyka, M; van den Brink, W | 1 |
| Dodrill, CL; Helmer, DA; Kosten, TR | 1 |
| Berrebi, A; Chaumerliac, C; Damase-Michel, C; Garipuy, D; Hammou, Y; Lacroix, I; Lapeyre-Mestre, M; Montastruc, JL; Schmitt, L | 1 |
| Braunack-Mayer, A; Eliott, J; Scarborough, J | 1 |
| Adler, MW; Benamar, K; Cowan, A; Geller, EB; Palma, J | 1 |
| Christophersen, AS; Johansen, U; Oiestad, AM; Oiestad, EL | 1 |
| Chiang, YC; Chiou, LC; Ho, IK; Hung, TW; Lee, CW; Wang, HL; Yan, JY | 1 |
| Law, F; Melichar, J; O'Shea, J | 1 |
| Auriacombe, M; Denis, C; Fatseas, M; Franques-Rénéric, P; Massida, Z; Verger, M | 1 |
| de Castro, A; Gray, TR; Huestis, MA; Johnson, RE; Jones, HE; Shakleya, DM | 1 |
| Pawar, P | 1 |
| Abraham, AJ; Kovas, AE; McFarland, BH; Rieckmann, TR | 1 |
| Aschauer, C; Ebner, N; Fischer, G; Jagsch, R; Metz, V; Pribasnig, A; Würzl, J | 1 |
| Sarfi, M; Smith, L; Sundet, JM; Waal, H | 1 |
| Corletto, F; Vettorato, E | 1 |
| Ali, R; Bornemann, R; Farrell, MF; Gowing, L; Sullivan, LE | 1 |
| Gerra, G; Marcheselli, C; Raggi, MA; Saracino, MA; Somaini, L; Zanchini, S | 1 |
| Baldassarre, C; Curcio, F; Franco, T; Topa, M | 1 |
| Haberthür, A; Kagerer, S; Koller, G; Küfner, H; Lehnert, R; Limmer, C; Martin, G; Soyka, M | 1 |
| Wallace, M | 1 |
| Bart, G | 2 |
| Bauchner, H; Bonzagni, A; Byun, J; Newby, PK; Philipp, BL; Vreeland, J; Wachman, EM | 1 |
| McCarthy, JJ | 2 |
| Bio, LL; Poon, CY; Siu, A | 1 |
| Backmund, M; Bühringer, G; Klotsche, J; Rehm, J; Soyka, M; Träder, A; Wittchen, HU | 1 |
| Bukten, A; Clausen, T; Gossop, M; Havnes, I; Skurtveit, S; Stangeland, P; Waal, H | 1 |
| Knoppert, D | 1 |
| Curry, K; Day, CA; Demirkol, A; Haber, PS; Hines, S; Lintzeris, N; Tynan, M | 1 |
| Law, F; Melichar, J; O'Shea, J; Praveen, KT | 2 |
| Fagan, J; Kernan, K; Smyth, BP | 1 |
| Alves, P; Farrell, M; Hedrich, D; Mayet, S; Møller, L; Stöver, H | 1 |
| Gryczynski, J; Jaffe, JH; Kelly, SM; Mitchell, SG; Myers, CP; O'Grady, KE; Olsen, YK; Schwartz, RP | 2 |
| Lange, M; Müller, MJ; Paul, T; Seeliger, S | 1 |
| Huxtable, CA; MacIntyre, PE; Roberts, LJ; Somogyi, AA | 1 |
| Chen, JS | 1 |
| Eschenroeder, AC; Robinson, SE; Sanchez, ES; Sato-Bigbee, C; Vestal-Laborde, AA | 1 |
| Gevertz, SG; Newman, RG | 1 |
| Trautmann, S; Wittchen, HU | 1 |
| Bäwert, A; Coyle, M; Fischer, G; Jagsch, R; Martin, PR; Rohrmeister, K; Unger, A; Winklbaur, B | 1 |
| Coller, JK; Gelston, EA; James, HM; Lopatko, OV; Schmidt, H; Somogyi, AA; White, JM | 1 |
| Dick, AW; Farmer, C; Gordon, AJ; Schuster, J; Sorbero, M; Stein, BD | 1 |
| Castot, A; Corsenac, P; Delorme, B; Gadegbeku, B; Lagarde, E; Laumon, B; Moore, N; Orriols, L; Philip, P; Tricotel, A | 1 |
| Gordon, AJ; Harris, AH; Oliva, EM; Trafton, JA | 1 |
| Rushforth, BJ; Wright, NM | 1 |
| Adams, CE; Bound, N; Harrison, W; Hart, R; Rushforth, BJ; Sheard, L; Tompkins, CN; Wright, NM | 1 |
| Hendrickson, RG; McKeown, NJ | 1 |
| Frey, R; Kasper, S; Kowarik, A; Naderi-Heiden, A; Pjrek, E; Strnad, A; Winkler, D | 1 |
| Kemp, R; Smirnov, A | 1 |
| Birmes, P; Rodgers, R; Saint-Lèbes, J; Schmitt, L | 1 |
| Brown, BS; Katz, EC; Kelly, SM; King, S; Mitchell, SG; O'Grady, KE; Schwartz, RP | 1 |
| Flynn, PM; Friedmann, PD; Frisman, LK; Gordon, M; Hall, E; Hoskinson, R; Kinlock, T; Knight, K; Knudsen, HK; O'Connell, DJ; Sacks, S; Schwartz, R; Shafer, MS; Stein, LA; Welsh, WN | 1 |
| Albizu-García, CE; Caraballo, JN; Caraballo-Correa, G; Hernández-Viver, A; Román-Badenas, L | 1 |
| Brittain, J; Dickman, S; Glick, A; Harris, A; Hershberger, J; Lee, JD; Luther, C; Selling, D | 1 |
| Dickman, SL; Trigg, BG | 1 |
| Bhatia, KS; Lee, T; Mannelli, P; Peindl, KS; Wu, LT | 1 |
| Castro, AL; Silvestre, A; Tarelho, S; Teixeira, HM | 1 |
| Lagundoye, O; Lee, KH; Parks, RW; Pluck, G; Rele, R; Sarkar, S; Spence, SA | 1 |
| Black, KI; Haber, PS; Lintzeris, N; Stephens, C | 1 |
| Aschauer, C; Baewert, A; Jagsch, R; Kaiser, G; Metz, V; Thau, K; Unger, A; Weninger, M; Winklbaur, B | 1 |
| Coller, JK; Colvill, J; Farquharson, AL; James, HM; Michalakas, JR; Somogyi, AA; White, JM | 1 |
| Hayes, MJ; Paul, JA; Pritham, UA | 1 |
| Bäwert, A; Fischer, G; Höflich, AS; Jagsch, R; Langer, M; Unger, A; Winklbaur, B | 1 |
| Bisaga, A; Kosten, T; Nunes, EV; O'Connor, PG; Sigmon, SC; Woody, G | 1 |
| Golovanevskaya, M; Saucier, R; Vlasenko, L | 1 |
| Murnion, B | 1 |
| Chisolm, MS; Jansson, LM; Jones, HE; Terplan, M | 1 |
| Finnegan, LP; Jones, HE; Kaltenbach, K | 1 |
| Benvenuto, A; Howard, D; Johnston, A; Mandell, T; Metayer, J; Meyer, M; Plante, D | 1 |
| Bhupal, HK | 1 |
| Cheema, M; Fuentes, L; Roose, R | 1 |
| Farrell, M; Gowing, L; Wodak, A | 1 |
| Martin, PR; Young, JL | 1 |
| Amen, G; Casari, R; Chiamulera, C; Faccini, M; Lugoboni, F; Moro, L; Pajusco, B; Quaglio, G | 1 |
| Cockayne, L; McKeganey, N; Russell, C | 1 |
| Ferrara, MM | 1 |
| Hamilton, R; MacKinnon, JR; Mactier, H; McGlone, L | 1 |
| Darke, S; Kaye, S; McDonald, S; Torok, M | 2 |
| Bortolami, E; Murrell, JC; Slingsby, LS | 1 |
| Knudsen, HK; Roman, PM | 1 |
| Bakstad, B; Bjarkø, L; Jones, HE; Ravndal, E; Skurtveit, S; Waal, H; Welle-Strand, GK | 1 |
| Alvarado, MX; Juanós Iborra, M; Martin Fernandez, X; Rodriguez Morera, J | 1 |
| Bühringer, G; Haberthür, A; Klotsche, J; Rehm, J; Soyka, M; Träder, A; Wittchen, HU | 1 |
| Joseph, H; Woods, JS | 2 |
| Häkkinen, M; Launiainen, T; Ojanperä, I; Vuori, E | 1 |
| Ang, A; Bilangi, R; Bruce, RD; Cohen, A; Doraimani, G; Hasson, A; Hillhouse, M; Jacobs, P; Leimberger, J; Ling, W; Lokhnygina, Y; McCarthy, J; McLaughlin, P; Saxon, AJ; Tasissa, G; Thomas, C; Wiest, K; Woody, G | 1 |
| d'Argouges, F; Desjeux, G; Marsan, P; Thevenin-Garron, V | 1 |
| Gauda, EB; Jones, CH; Lewis, T; McLemore, GL | 1 |
| Bora, E; Lubman, DI; MacKenzie, T; Roffel, K; Verdejo-García, A; Vilar-López, R; Yücel, M | 1 |
| Bathen, J; Kristensen, Ø; Nordstrand, B; Skogvoll, E; Spigset, O; Stallvik, M | 1 |
| Allouche, S; Le Marec, T; Marie, N; Noble, F | 1 |
| Bandstra, ES | 1 |
| Arria, AM; Baewert, A; Coyle, MG; Fischer, G; Heil, SH; Jones, HE; Kaltenbach, K; Martin, PR; Selby, P; Stine, SM | 1 |
| Coyle, MG; Heil, SH; Jones, HE; Kaltenbach, K; Martin, PR; O'Grady, KE; Salisbury, AL; Stine, SM; Weninger, M | 1 |
| Coyle, MG; Heil, SH; Holbrook, AM; Jones, HE; Kaltenbach, K; Martin, PR; Salisbury, AL; Stine, SM | 1 |
| Arria, AM; Badger, GJ; Coyle, MG; Gaalema, DE; Heil, SH; Jones, HE; Kaltenbach, K; Martin, PR; Scott, TL; Stine, SM | 1 |
| Coyle, MG; Fischer, G; Graf-Rohrmeister, K; Jones, HE; Lester, BM; Lin, H; Salisbury, AL | 1 |
| Arria, AM; Benningfield, MM; Coyle, MG; Dietrich, MS; Fischer, G; Heil, SH; Jones, HE; Kaltenbach, K; Martin, PR; O'Grady, KE; Stine, SM | 1 |
| Baxter, JK; Coyle, MG; Heil, SH; Holbrook, AM; Jones, HE; Kaltenbach, K; Martin, PR; Stine, SM | 1 |
| Coyle, MG; Heil, SH; Holbrook, AM; Jones, HE; Kaltenbach, K; Martin, PR; McNicholas, LF; O'Grady, KE; Stine, SM | 1 |
| Cerić, I; Mehić-Basara, N | 1 |
| Banks, ML; Negus, SS | 1 |
| Fisk, A; Gordon, AL; Lopatko, OV; Pearson, V; Stacey, H; White, JM; Woods, A | 1 |
| Back, D; Buggisch, P; Burger, D; Buti, M; Craxí, A; Foster, G; Klinker, H; Larrey, D; Nikitin, I; Pol, S; Puoti, M; Romero-Gómez, M; Wedemeyer, H; Zeuzem, S | 1 |
| Bascaran, MT; Bobes, J; Bobes-Bascaran, MT; Garcia-Portilla, MP; Saiz, PA | 1 |
| Baewert, A; Fischer, G; Graf-Rohrmeister, K; Jagsch, R; Langer, M; Thau, K; Unger, A; Winklbaur-Hausknost, B | 1 |
| Friedmann, PD; Schwartz, RP | 1 |
| Bell, J | 2 |
| Lee-Parritz, A; Saia, K; Shainker, SA | 1 |
| Arria, AM; Coyle, MG; Heil, SH; Jones, HE; Kaltenbach, K; Martin, PR; O'Grady, KE; Selby, P; Stine, SM | 2 |
| Brekke, M; Clausen, T; Gossop, M; Lindbaek, M; Reinertsen, E; Skeie, I; Thoresen, M; Waal, H | 1 |
| Arnestad, M; Fjeld, B; Mørland, J; Strand, MC | 1 |
| Acquavita, SP; Chisolm, MS; Fitzsimons, H; Heil, SH; Jansson, LM; Jones, HE; Kaltenbach, K; Leoutsakos, JM; Martin, PR; Tuten, M; Wilson-Murphy, M; Winklbaur, B | 1 |
| Chavchanidze, M; Gamkrelidze, I; Nikolaishvili, N; Piralishvili, G | 3 |
| Stitzer, ML | 1 |
| White, J | 1 |
| D'Apolito, K | 1 |
| Bennett, L; Donaldson, LF; Green, A; Kaul, A; Melichar, JK; Mullings, EL; Munafò, MR; Nutt, DJ; O'Shea, J; Sharma, E | 1 |
| Chohan, G; Copello, A; Day, E; George, S; Grewal, P; Haque, S; Karia, M; Roche, J | 1 |
| Hulse, GK; Reece, AS | 1 |
| Azadfard, M; Blondell, RD; Giambrone, AK; Homish, GG; Jaanimägi, U; Kowalik, U; Lozano, JR; Neumann, AM | 1 |
| Gryczynski, J; Jaffe, JH; Mitchell, SG; O'Grady, KE; Olsen, Y; Schwartz, RP; Sharfstein, JM; Warren, G | 1 |
| Chen, CL; Chen, ST; Huang, CL; Lin, HR; Lua, AC | 1 |
| Genetti, B; Gomma, M; Gryczynski, J; Mollica, R; O'Grady, KE; Rimondo, C; Schwartz, RP; Serpelloni, G; Zermiani, M | 1 |
| Coyle, MG; Fischer, G; Heil, SH; Holbrook, AM; Jones, HE; Kaltenbach, K; Martin, PR; Stine, SM | 1 |
| Gaughwin, M; Huxtable, CA; Macintyre, PE; Russell, RA; Usher, KA | 1 |
| Moody, DE | 1 |
| Chiang, YC; Ho, IK; Hung, TW | 1 |
| Degenhardt, L; Gowing, LR; Hickman, M | 1 |
| Dehghani-Arani, F; Nadali, H; Rostami, R | 1 |
| Ambrose-Lanci, LM; Ang, A; Berrettini, WH; Bruce, RD; Clarke, TK; Crist, RC; Hillhouse, MP; Ling, W; Lohoff, FW; Saxon, AJ; Woody, G | 1 |
| Belkaï, E; Courtin, C; Crété, D; Marie-Claire, C; Noble, F | 1 |
| Altice, FL; Bruce, RD; Friedland, GH; Gourevitch, MN; Moody, DE | 1 |
| Doyon, S; Klein-Schwartz, W; Lee, S; Welsh, C | 1 |
| Bertollo, DN; Case, BG; DiRocco, D; Galanter, M; Hansen, HB; Siegel, CE | 1 |
| Konijnenberg, C; Melinder, A; Sarfi, M | 2 |
| Ang, A; Baker, R; Canamar, CP; Hillhouse, MP; Ling, W; Marino, EN; Martin, JA; Nielsen, S; Potter, JS; Saxon, AJ; Wiest, K | 1 |
| Duchene, DM; McCabe, BE; McLean, C; Mena, MP; Monroe, M; Santisteban, DA | 1 |
| Gryczynski, J; Jaffe, JH; Mitchell, SG; O'Grady, KE; Olsen, YK; Schwartz, RP; Sharfstein, JM; Warren, G | 1 |
| Chaulk, P; Han, J; Serio-Chapman, C; Sherman, SG; Welsh, C | 1 |
| Bramness, JG; Bukten, A; Clausen, T; Herskedal, A; Skurtveit, S | 1 |
| Brooks, DJ; Lingford-Hughes, AR; Myers, JF; Nutt, DJ; Reid, AG; Stokes, PR; Taylor, LG; Turkheimer, FE; Watson, BJ; Wilson, SJ | 1 |
| Badger, GJ; Gaalema, DE; Heil, SH; Johnston, AM; Metayer, JS | 1 |
| Abdul-Quader, AS; Arasteh, K; Des Jarlais, D; Feelemyer, J; Hagan, H | 1 |
| Attenburrow, PM; Hunt, JR; Murrell, JC; Slingsby, LS | 1 |
| Bounes, V; Jouanjus, E; Lapeyre-Mestre, M; Roussin, A | 1 |
| Bakstad, B; Bjarkø, L; Jansson, LM; Ravndal, E; Skurtveit, S; Welle-Strand, GK | 1 |
| Kamkamidze, G; Otiashvili, D; Piralishvili, G; Poole, S; Sikharulidze, Z; Woody, GE | 2 |
| Kowalski, G; Leppert, W | 1 |
| Barwatt, JW; Bates, ML; Eitan, S; Emery, MA; Hofford, RS; Wellman, PJ | 1 |
| Cohen, A; Hasson, A; Hillhouse, M; Hser, YI; Huang, D; Jacobs, P; Ling, W; McLaughlin, P; Saxon, AJ; Teruya, C; Thomas, C; Wiest, K | 1 |
| Barton, G; Holland, R; Maas, J; Maskrey, V; Pinto, H | 1 |
| Gill, LA; Rose, C; Stanhope, TJ | 1 |
| Grim, K; Harrison, TE; Wilder, RT | 1 |
| Sarfi, M; Sundet, JM; Waal, H | 1 |
| Blackinton Gale, R; Casarella, J; Drexler, K; Fareed, A; Patil, D; Scheinberg, K; Vayalapalli, S | 1 |
| Furu, K; Karlstad, Ø; Selmer, R; Skurtveit, S | 1 |
| Creanga, AA; Deppen, K; Hudak, ML; Jones, HE; Leffert, L; McClelland, C; Sahin, L; Starer, J; Terplan, M; Thorp, JM; Walsh, J | 1 |
| Arunogiri, S; Foo, L; Frei, M; Lubman, DI | 1 |
| Clausen, T; Havnes, IA; Middelthon, AL | 2 |
| Johnson, B; Richert, T | 6 |
| Cartier, C; Galland, P; Gibaja, V; Léglise, Y; Peyrière, H; Rousseau, A | 1 |
| Baroudi, M; Barro, J; Broers, B; Casillas, A; Favrod-Coune, T; Gaspoz, JM; Gétaz, L; Rieder, JP; Wolff, H | 1 |
| Clausen, T; Gossop, M; Riksheim, M | 1 |
| Holland, R; Kouimtsidis, C; Maskrey, V; Nagar, J; Notley, C | 1 |
| Gale, T; Holland, R; Kouimtsidis, C; Maskrey, V; Nagar, J; Notley, C; Robinson, A; Swift, L | 1 |
| Hisham Hashim, HM; Loh, HS; Ng, CG; Yee, A | 1 |
| Duffy, S; Glanville, JM; Godfrey, C; Hewitt, C; Martyn-St James, M; McCool, R; Neilson, M; Perry, AE | 1 |
| Amato, L; Bellisario, C; Davoli, M; Ferri, M; Minozzi, S | 1 |
| Austin, KL; Bohnert, AS; Park, TW; Pizer, SD; Saitz, R | 1 |
| Baneshi, MR; Esmaeili, HR; Nakhaee, N; Nikravesh, MR; Ziaddinni, H | 1 |
| Obot, IS | 1 |
| Hillemacher, T; Soyka, M | 1 |
| Ali, R; Degenhardt, L; Dietze, P; Jenkinson, R; Larance, B; Lintzeris, N; Mattick, R; White, N | 1 |
| Adams, M; Borys, S; Culleton, R; Dauber, S; Hall, G; Iheoma, J; McDonald, R; Morgenstern, J; Muench, F; Neighbors, CJ | 1 |
| Bidlack, JM | 1 |
| Sigmon, SC | 3 |
| Olsen, Y; Sharfstein, JM | 1 |
| Koller, G | 1 |
| Doyon, S; Klein-Schwartz, W; Lee, SC; Welsh, C | 1 |
| Ahmedzai, SH; Boland, JW; Foulds, GA; Pockley, AG | 1 |
| Abid, S; Beck, T; Besson, J; Hämmig, R; Kuntz, A; Stohler, R; Wiesbeck, G | 1 |
| Brandt, L; Druid, H; Kieler, H; Öhman, I; Seldén, T; Wikner, BN | 1 |
| Bruce, D; Chhatre, S; Hillhouse, M; Jacobs, P; Korthuis, PT; Ling, W; Metzger, D; Poole, S; Saxon, AJ; Sorensen, J; Woody, GE | 1 |
| Brooner, RK; Fingerhood, MI; King, VL; Rastegar, DA | 1 |
| Mozurkewich, EL; Rayburn, WF | 1 |
| Hsi, A; Leeman, L; Sutter, MB | 1 |
| Cottencin, O; Karila, L; Lejoyeux, M; Zarmdini, R | 1 |
| Black, DL; Caplan, YH; Cone, EJ; DePriest, A; Heltsley, R; Hild, C; Knight, J; Puet, BL; Robert, T | 1 |
| Andresen-Streichert, H; Elakkary, S; Heinemann, A; Iwersen-Bergmann, S; Jungen, H; Müller, A; Püschel, K | 1 |
| Ekhtiari, H; Rezaee, S | 1 |
| Casati, A; Pfeiffer-Gerschel, T; Piontek, D | 1 |
| Amato, L; Bellisario, C; Davoli, M; Minozzi, S | 1 |
| Ali, R; Carragher, N; Degenhardt, L; Larance, B; Lintzeris, N; Mattick, RP | 1 |
| Comer, SD; Fischer, G; Metz, VE; Pribasnig, A; Wuerzl, J | 1 |
| Beck, O; Carlsson, S; Franzen, L; Hulten, P; Olsson, R; Tusic, M | 1 |
| Copeland, AL; Herschman, PL; Kopak, AM; Polukhina, N; Proctor, SL | 1 |
| Lautermilch, NJ; Morgan, MM; Reid, RA; Stormann, TM | 1 |
| Blyth, A; Holland, R; Maskrey, V; Notley, C; Pinto, H | 1 |
| Duncan, MH; Merrill, JO | 1 |
| Brogly, SB; Du, HM; Saia, KA; Sebastiani, P; Walley, AY | 1 |
| Hall, ES; Lewis, D; Marcotte, M; Theobald, J; Van Hook, J; Wexelblatt, SL; Wilder, C; Winhusen, T | 1 |
| Bagley, SM; Brogly, SB; Holland, E; Wachman, EM | 1 |
| Burns, RM; Dick, AW; Farmer, CM; Gordon, AJ; Leslie, DL; Pacula, RL; Sorbero, M; Stein, BD | 1 |
| Bawor, M; Bonner, A; Daiter, J; Dennis, BB; Desai, D; Marsh, DC; Naji, L; Pare, G; Plater, C; Samaan, Z; Thabane, L; Varenbut, M; Worster, A | 1 |
| Bruce, D; Chhatre, S; Hillhouse, M; Jacobs, P; Korthuis, PT; Ling, W; Metzger, D; Poole, S; Saxon, AJ; Sorensen, J; Woody, G | 1 |
| Friedmann, PD; Park, TW | 1 |
| Bruno, R; Hall, W; Kirkbride, KP; Lai, FY; Mueller, JF; Ort, C; Prichard, J; Thai, PK; van Dyken, E | 1 |
| Flanigan, T; Islam, Z; Larney, S; Mazhnaya, A; Prokhorova, T; Rybak, N; Shost, A; Zaller, N | 1 |
| Bouchkira, H; Remy, AJ; Wenger, H | 1 |
| Fürst, Z; Hosztafi, S | 1 |
| Evans, JL; Hahn, JA; Lum, PJ; Page, K; Tsui, JI | 1 |
| Brown, MS; Hayes, MJ; Thornton, LM | 1 |
| Allouche, S; Coquerel, A; Le Marec, T; Marie, N; Noble, F | 1 |
| Hickman, M; Maher, L; Page, K; Vickerman, P | 1 |
| Adeniji, A; Elgadi, M; Huang, F; Joseph, D; Riesenberg, RR; Schobelock, MJ; Vince, BD; Webster, LR | 1 |
| Ayres, R; Beattie, A; Ingram, J; Neale, J; Rees, A; Telfer, M | 1 |
| Soyka, M | 1 |
| Gonzalez, G; Wachholtz, A | 1 |
| DInh, AT; Fiellin, DA; Fiellin, LE; Lruie, BS; McCance-Katz, EF; Moody, DE; Tetrault, JM | 1 |
| Abreu, M; Aguado, D; Benito, J; García-Fernández, J; Segura, IA | 1 |
| Assar, N; Bayat, AH; Haghparast, A; Hashemi Demaneh, B; Hassanian-Moghaddam, H; Rahimi, M; Shadnia, S; Zamani, N | 1 |
| Burns, L; Butler, T; Degenhardt, L; Dobbins, T; Gibson, A; Gisev, N; Kimber, J; Larance, B; Larney, S; Mattick, RP | 1 |
| Conroy, S; Hill, D | 1 |
| Andreas, JB; Bretteville-Jensen, AL; Gjersing, L; Lillehagen, M | 1 |
| Beck, O; Carlsson, S; Lindkvist, I; Olsson, R | 1 |
| Jones, H; Seashore, C; Stringer, EM; Stuebe, AM; Thorp, J; Wiegand, SL | 1 |
| Akerman, SC; Blunt, HB; Brunette, MF; Goodman, DJ; Green, AI; Heil, SH | 1 |
| Blom Nilsson, M; Chassler, D; Lundgren, LM | 1 |
| Alho, H; Castrén, S; Lahti, T; Salonen, AH; Simojoki, K | 1 |
| Bruce, RD; Butterton, JR; Feng, HP; Hulskotte, EG; Lin, WH; O'Mara, E; Wagner, JA; Webster, LR; Xuan, F | 1 |
| Lewis, D; Wilder, C; Winhusen, T | 1 |
| Madsen, SL; Nikolajsen, L; Sonne, NM; Zinck, L | 1 |
| Afsharimani, B; Good, P; Hardy, J; Kindl, K | 1 |
| Arends, MT; De Haan, HA; Van 't Hoff, GI | 1 |
| El-Hage, N; Fitting, S; Hauser, KF; Knapp, PE; Paris, JJ; Rodríguez, JW; Rodriguez, M; Schier, CJ; Suzuki, M; Zou, S | 1 |
| Abood, ME; Benamar, K; Palma, J | 1 |
| Saxon, AJ | 2 |
| Chatterjee, D; Jackson, H; Johnson, K; Mandell, K; Vanness, DJ | 1 |
| Brasch-Andersen, C; Brøsen, K; Christoffersen, DJ; Damkier, P; Thomsen, JL; Worm-Leonhard, M | 1 |
| Brown, S; Carmical, J; Kyle, AR; Pryor, J; Shah, D | 1 |
| Salisbury-Afshar, E | 1 |
| Bier, BA; Bier, JB; Coyle, MG; Finger, AS; Johnson, TA | 1 |
| Charles, M; Curran, HV; Freeman, TP; Mokrysz, C; O'Ryan, D; Wellington, CE | 1 |
| Aguilar, H; Cohen, DE; Felizarta, F; Galen, E; King, M; Kowdley, KV; Lalezari, J; McGovern, B; Polepally, AR; Rustgi, V; Sullivan, JG; Varunok, P | 1 |
| Altice, FL; Bazazi, AR; Kamarulzaman, A; Vijay, A; Yee, I | 1 |
| Fang, WB; Liu, F; Moody, DE | 1 |
| Simpatico, TA | 1 |
| Bakstad, B; Bjarkø, L; Ravndal, E; Skurtveit, S; Tanum, L; Waal, H; Welle-Strand, GK | 1 |
| Aweh, G; Barton, BA; Baxter, JD; Clark, RE; Fisher, WH; O'Connell, E | 1 |
| Robertson, AR; Robertson, JR | 1 |
| Marteau, D; McDonald, R; Patel, K | 1 |
| Mjåland, K | 1 |
| Glanville, JM; Godfrey, C; Hewitt, C; Martyn-St James, M; Neilson, M; Perry, AE; Woodhouse, R | 1 |
| Oretti, R | 1 |
| Alford, DP; Cheng, DM; Edwards, RR; Liebschutz, JM; Lira, MC; Mao, J; Samet, JH; Tsui, JI; Winter, MR | 1 |
| Burns, RM; Dick, AW; Gordon, AJ; Leslie, D; Pacula, RL; Sorbero, M; Stein, BD | 1 |
| Baldwin, G; Campopiano, M; Jones, CM; McCance-Katz, E | 1 |
| Haigney, MC; Kao, DP; Krantz, MJ; Mehler, PS | 1 |
| Rich, JD; Wakeman, SE | 1 |
| Gryczynski, J; Jaffe, JH; Kelly, SM; Mitchell, SG; O'Grady, KE; Schwartz, RP | 1 |
| Joseph, H; Maghsoudi, N; Phillips, BW; Stancliff, S | 1 |
| Maremmani, AG; Maremmani, I; Parrino, MW; Samuels, PN | 1 |
| Bertz, R; Bifano, M; Bruce, RD; DeMicco, M; Garimella, T; Hwang, C; Kandoussi, H; Luo, WL; Wang, R; Wastall, P | 1 |
| Holbrook, AM | 1 |
| Aletraris, L; Edmond, MB; Fields, D; Paino, M; Roman, PM | 1 |
| Bailey, C; Henderson, G; Hickman, M; Hill, R; Kelly, E; Kershaw, Y; Lingford-Hughes, A; Lyndon, A; MacLachlan, J; Roberts, J; Withey, S | 1 |
| Finlayson, AJ; Martin, PR | 1 |
| Burns, L; Degenhardt, L; Gisev, N; Larney, S; Mattick, RP; Shanahan, M; Weatherburn, DJ | 1 |
| Meyer, M; Phillips, J | 1 |
| Wilder, CM; Winhusen, T | 1 |
| Granerud, A; Toft, H | 1 |
| Degenhardt, L; Hickman, M; Kimber, J; Larney, S; Randall, D | 1 |
| Henderson, C; Karnack, C | 1 |
| Brown, MS | 1 |
| Díaz, T; Domínguez-Hernández, R; Fernández, JM; Forcada, R; Martínez, JM; Oyagüez, I; Roncero, C; Seijo, P; Terán, A | 1 |
| Bird, SM; Dunn, G; Hickman, M; Jones, A; Marsden, J; Millar, T; Pierce, M | 1 |
| Altice, FL; Bachireddy, C; Weisberg, DF | 1 |
| Cucciare, MA; Garrison-Diehn, C; Schultz, NR; Timko, C; Vittorio, L | 1 |
| Combs, G; Humphreys, R; Minear, S; Philipp, BL; Saia, K; Wachman, EM | 1 |
| Dunn, KE; Finan, PH; Fingerhood, M; Strain, EC; Tompkins, DA | 1 |
| Bauhoff, S; Burns, RM; Gordon, AJ; Hendrikson, H; Leslie, DL; Pacula, RL; Stein, BD | 1 |
| Miller, SC; Stein, MD; Tiffany, E; Wilder, CM; Winhusen, T; Winstanley, EL | 1 |
| Björkman, P; Blomé, MA; Dahlman, D; Håkansson, A; Kral, AH | 1 |
| Bråbäck, M; Brådvik, L; Håkansson, A; Isendahl, P; Nilsson, S; Troberg, K | 1 |
| Degenhardt, L; Hickman, M; Macleod, J | 1 |
| Akinbi, HT; Hall, ES; Harvey, S; Isemann, BT; Meinzen-Derr, J; Wexelblatt, SL; Wiles, JR | 1 |
| Bond, C; Matheson, C; Robertson, H; Thiruvothiyur, M | 1 |
| Banta-Green, CJ; Coffin, PO | 1 |
| Green, CA; McCarty, D; Mertens, J; Stumbo, SP; Weisner, C; Yarborough, BJ | 1 |
| Cullen, W; Ducray, K; Smyth, BP | 1 |
| Manhapra, A; Quinones, L; Rosenheck, R | 1 |
| Fischer, B; Götzke, C; Hiller, P; Reimer, J; Schmidt, CS; Schulte, B; Strada, L | 1 |
| Danaee, M; Loh, HS; Ng, CG; Sulaiman, AH; Yee, A | 1 |
| Kourounis, G; Kyprianou, E; Malliori, MM; Richards, BD; Samartzis, L; Symeonidou, E | 1 |
| Binswanger, I; Blue-Howells, J; Clark, S; Finlay, AK; Frayne, SM; Harris, AH; McGuire, J; Oliva, E; Rosenthal, J; Smelson, D; Timko, C | 1 |
| Alati, R; Betts, KS; Burns, L; Chan, G; Dietze, P; McIlwraith, F; Whittaker, E | 1 |
| Arulkumar, S; Cornett, EM; Flower, RR; Fox, CJ; Gayle, JA; Kaye, AD; Sen, S | 1 |
| Hansen, LE; Matson, CA; Pevear, ME; Smith, EL; Stone, GL; Tybor, DJ | 1 |
| Heinlein, H | 1 |
| Suzuki, J | 1 |
| Authier, N; Brousse, G; Chenaf, C; Delorme, J; Kabore, JL; Laporte, C; Mulliez, A; Pereira, B; Tremey, A; Zenut, M | 1 |
| Bellows, BK; King, JB; Sainski-Nguyen, AM | 1 |
| Ling, W | 1 |
| Berman, JW; Carvallo, L; Jaureguiberry-Bravo, M; Wilson, R | 1 |
| Beck, KD; Casbolt, PA; Elsayed, M; Haber, P; Hogarth, L; Moustafa, AA; Myers, CE; Servatius, RJ; Sheynin, J | 1 |
| Doan, TJ; Tsai, LC | 1 |
| Barnes, AJ; Huestis, MA; Jansson, LM; Scheidweiler, KB; Swortwood, MJ | 1 |
| Brooner, RK; Harris, EE; King, VL; Rastegar, DA; Sharfstein Kawasaki, S | 1 |
| Bruce, RD; Friedland, G; Ogbuagu, O | 1 |
| Degenhardt, L; Gowing, L; Kehler, C; Larance, B; Lintzeris, N; Nielsen, S | 1 |
| DiRocco, D; Hansen, H; Siegel, C; Wanderling, J | 1 |
| Campbell, K; Crannage, E; Forinash, A; Noormohammadi, A; Shyken, J; Yancey, A | 1 |
| Berkhout, C; Calafiore, M; Cottencin, O; Favre, J; Messaadi, N; Rolland, B; Stalnikiewicz, B | 1 |
| Anderson, B; Bailey, G; Herman, D; Stein, M; Uebelacker, LA | 1 |
| Amick, HR; Jones, HE; Joyce, AR; Kim, MM; Mann, AL; Murrelle, EL; Zedler, BK | 1 |
| Klein, JW | 1 |
| Amaslidou, D; Frauger, E; Gentile, G; Giocanti, A; Micallef, J; Orleans, V; Pauly, V; Thirion, X | 1 |
| Bruno, R; Degenhardt, L; Demirkol, A; Lintzeris, N; Nielsen, S | 1 |
| Cataldo, M | 1 |
| Haigney, MC; Kao, D; Krantz, M; Mehler, PS | 1 |
| Andringa, K; Grossman, MR; Holmes, AV; Horton, E; Johnson, E; Jones, HE; O'Grady, KE; Seashore, C; Whalen, B | 1 |
| Christensen, H; Davies, CF; French, C; Guise, A; Hickman, M; Looker, KJ; Low, AJ; May, MT; Mburu, G; McLean, S; Platt, L; Rhodes, T; Turner, KM; Vickerman, P; Welton, NJ | 1 |
| Altice, FL; Bojko, MJ; Dvoriak, S; Filippovych, S; Makarenko, I; Marcus, R; Mazhnaya, A; Polonsky, M; Springer, S | 1 |
| Alford, DP; Cheng, DM; Edwards, RR; Liebschutz, JM; Lira, MC; Samet, JH; Tsui, JI; Winter, MR | 1 |
| Schuckit, MA | 1 |
| Farr, A; Hagmann, M; Holzer, I; Husslein, PW; Kiss, H; Kueronya, V; Petricevic, L | 1 |
| Altice, F; Barr, E; Chen, E; Conway, B; Dalgard, O; Dore, GJ; Dutko, FJ; Gane, EJ; Gendrano, IN; Grebely, J; Howe, AY; Huang, HC; Litwin, AH; Luetkemeyer, A; Nahass, R; Nguyen, BY; Nickle, DC; Peng, CY; Platt, HL; Robertson, MN; Shibolet, O; Wahl, J | 1 |
| Barry, DT; Beitel, M; Cutter, CJ; Kerns, RD; Liong, C; Schottenfeld, RS | 1 |
| Addolorato, G; Casari, R; Cossari, A; Faccini, M; Gasbarrini, A; Lugoboni, F; Mirijello, A; Zamboni, L | 1 |
| McPherson, C | 1 |
| Eibl, JK; Marsh, DC; Morin-Taus, KA | 1 |
| Donroe, JH; Holt, SR; Tetrault, JM | 1 |
| Bührer, C; Hüseman, D; Mücke, S; Nagel, M; Siedentopf, J | 1 |
| Fassbender, C; Finnegan, LP; Leamon, MH; McCarthy, JJ | 1 |
| Ayanga, D; Kosten, TR; Shorter, D | 1 |
| Carrieri, P; Lions, C; Maradan, G; Michel, L; Mora, M; Morel, A; Nordmann, S; Roux, P; Spire, B; Vilotitch, A | 1 |
| Authier, N; Brousse, G; Chenaf, C; Delorme, J; Kabore, JL; Kernisant, M; Laporte, C; Zenut, M | 1 |
| Gröer, M; Maguire, D | 1 |
| Brown, AM; Byford, S; Hellier, J; Kelleher, M; Kelly, J; Marsden, J; Mitcheson, L; Murphy, C; Shearer, J; Stillwell, G | 1 |
| Alagoz, E; Gustafson, DH; Johnson, RA; Kornfield, R; Landucci, G; Mares, ML; McTavish, F; Pe-Romashko, K; Quanbeck, A; Shah, D; Thomas, C; Westergaard, RP | 1 |
| Berrettini, WH; Crist, RC; Degenhardt, L; Doyle, GA; Ling, W; Martin, NG; Montgomery, GW; Nelson, EC; Saxon, AJ | 1 |
| Liao, MZ; Mao, Q; Neradugomma, NK | 1 |
| Carroll, KM; Weiss, RD | 1 |
| Caritis, SN; Catov, JM; Lemon, LS; Mokhtari, NB; Parks, WT; Serra, AE; Venkataramanan, R | 1 |
| Amick, HR; Jones, HE; Joyce, AR; Murrelle, EL; Zedler, BK | 1 |
| Brogly, SB; Hernández-Diaz, S; Saia, K; Sebastiani, P; Werler, M | 1 |
| Andresen-Streichert, H; Iwersen-Bergmann, S; Jungen, H; Müller, A | 1 |
| Cabanis, M; Connemann, BJ; Eller, J; Freudenmann, RW; Gahr, M; Hiemke, C; Lang, D; Schönfeldt-Lecuona, C | 1 |
| Raistrick, D | 1 |
| Brown, JL; Gause, NK; Lewis, D; Winhusen, T | 1 |
| Adelson, M; Peles, E; Sason, A; Schreiber, S | 1 |
| Kim, H; Kim, J; Kim, SY; Koo, SH; Kwon, GC; Lim, J; Park, Y | 1 |
| Ali, R; Gowing, L; Mbewe, D; White, JM | 1 |
| Hassanian-Moghaddam, H; Zamani, N | 1 |
| Altice, FL; Dvoriak, S; Morozova, O; Pykalo, I | 1 |
| Feder, KA; Krawczyk, N; Saloner, B | 1 |
| Dürsteler, KM; Herdener, M; Nordt, C; Seifritz, E | 1 |
| Larance, B; Lintzeris, N; Nielsen, S | 1 |
| Higgins, ST; Schwartz, RP; Sigmon, SC | 1 |
| Yan, K | 1 |
| Wakeman, SE | 2 |
| Abrahamsson, T; Berge, J; Håkansson, A; Öjehagen, A | 1 |
| Anderson, BJ; Lee, CS; Liebschutz, JM; Stein, MD | 1 |
| Callea, A; Cibin, M; De Risio, L; Di Nicola, M; Janiri, L; Leone, B; Lugoboni, F; Moccia, L; Nucara, G; Pettorruso, M; Zamboni, L | 1 |
| Brogly, SB; Davies, G; Dow, K; Johnson, A; Lajkosz, K; Newman, A; Turner, S | 1 |
| Bühringer, G; Rehm, J; Soyka, M; Strehle, J; Wittchen, HU | 1 |
| Brodie, JD; Carrion, J; Dewey, SL; Patel, K; Santoro, GC; Veith, J; Vilchez, C | 1 |
| Pan, A; Zakowski, M | 1 |
| Barrio, G; Bravo, MJ; Degenhardt, L; Ferri, M; Indave, BI; Pastor-Barriuso, R; Sordo, L; Wiessing, L | 1 |
| Gerra, G; Levin, FR; Lugoboni, F; Manfredini, M; Pieri, MC; Somaini, L; Zamboni, L | 1 |
| Brown, AL; Calver, L; Dunlop, AJ; Gill, A; Isbister, GK; Scott, AJ | 1 |
| Brown, J; Dunlop, WCN; Kenworthy, J; Maria Madrigal, A; Wright, A; Yi, Y | 1 |
| Agosti, M; Allegaert, K; Cavallaro, G; Fumagalli, M; Mosca, F; Raffaeli, G; Tibboel, D; Wildschut, ED | 1 |
| Gryczynski, J; Kelly, SM; Mitchell, SG; O'Grady, KE; Schwartz, RP; Sharma, A | 1 |
| Chaplin, M; Hoefer, G; Modesto-Lowe, V; Swiezbin, K | 1 |
| Hulse, G; Kelty, E | 4 |
| Griffin, BL; Stone, RH; Todd, TJ; Tran, TH; Vest, KM | 1 |
| Chavoustie, S; Dammerman, R; Darwish, M; Frost, M; Owen, J; Sanjurjo, V; Snyder, O | 1 |
| Ahmadi, J; Razeghian Jahromi, L | 1 |
| Epstein, DH; Jobes, ML; Kowalczyk, WJ; Lin, JL; Mezghanni, M; Phillips, KA; Preston, KL; Vahabzadeh, M | 1 |
| Ballardini, G; Grassi, A | 1 |
| Brünés, N; Højsted, J; Rindom, H | 1 |
| Bell, RF; Derry, S; Moore, RA; Wee, B; Wiffen, PJ | 1 |
| Heikman, PK; Muhonen, LH; Ojanperä, IA | 1 |
| Gomes, T; Guan, Q; Kahan, M; Khuu, W; Kiran, T; Leece, P; Martins, D; Spithoff, S; Tadrous, M | 2 |
| Andrew Tompkins, D; Dunn, KE; Finan, PH; Strain, EC | 1 |
| Burt, R; Glick, SN; Thiede, H; Tsui, JI | 1 |
| Altice, FL; Chernova, O; Dumchev, K; Dvoryak, S; Morozova, O | 1 |
| Asatryan, A; Geoffroy, P; Kort, J; Kosloski, MP; Liu, W; Zhao, W | 1 |
| Johnson, S; Martin, PR | 1 |
| McElrath, K | 1 |
| DiPietro, JA; Gandotra, N; Jansson, LM; Jones, H; King, VL; McConnell, K; Millio, L; Rios, R; Spencer, N; Tuten, M; Velez, ML | 1 |
| Christiansen, S | 1 |
| Adeniyi-Jones, SC; Ehrlich, ME; Kraft, WK | 1 |
| Edwards, W; MacMillan, K; Whalen, B | 1 |
| Berkwitt, AK; Grossman, MR; Osborn, RR | 1 |
| Altice, FL; Barry, D; Bojko, MJ; Dvoryak, S; Farnum, S; Filippovych, S; Fomenko, T; Ivanchuk, I; Kolomiets, V; Madden, L; Marcus, R; Mazhnaya, A | 1 |
| Bohnert, A; Bush, C; Chopra, V; Heisler, M; Klasa, K; Lagisetty, P | 1 |
| Benjamin, DK; Bennett, MM; Clark, RH; Miller, ES; Murthy, K; Smith, PB; Tolia, VN | 1 |
| Elsayed, M; Espinoza, D; Haber, PS; Hallinan, R; Lintzeris, N; Veillard, AS | 1 |
| Adam, VN; Matolić, M; Mršić, V; Rašić, Ž; Stojčić, EG | 1 |
| Dawkins, L; Heidebrecht, F; MacLeod, MB | 1 |
| Perrone, J; Weinrieb, RM; Winetsky, D | 1 |
| Bodnar, LM; Caritis, SN; Lemon, LS; Platt, RW; Venkataramanan, R | 1 |
| Folger, AT; Hall, ES; Rice, WR; Wexelblatt, SL | 1 |
| Lemon, LS | 1 |
| Brogly, SB; Fadli, E; Hahn, KA; Hernández-Diaz, S; Regan, E; Werler, MM | 1 |
| Bogdanowicz, KM; Chang, CK; Day, E; Hayes, RD; Khondoker, M; Shetty, H; Stewart, R; Strang, J | 1 |
| Alam, F; Alho, H; Auriacombe, M; Benyamina, A; Bobes, J; D'Agnone, O; Daulouede, JP; Dematteis, M; Leonardi, C; Littlewood, R; Maremmani, I; Somaini, L; Soyka, M; Szerman, N; Torrens, M; Walcher, S | 1 |
| Chang, DC; Fairbairn, N; Klimas, J; Wood, E | 1 |
| Federico, A; Lugoboni, F; Tamburin, S; Zamboni, L | 1 |
| Feder, KA; Krawczyk, N; Picher, CE; Saloner, B | 1 |
| Joseph, H; McElrath, K | 1 |
| Marotta, PL; McCullagh, CA | 1 |
| Aiyer, R; Bhatia, A; Gulati, A; Gungor, S; Mehta, N | 1 |
| Desai, N; Kelly, MM; Quiñones, T; Reilly, E; Rosenheck, R | 1 |
| Danaee, M; Loh, HS; Ng, CG; Riahi, S; Sulaiman, AH; Yee, A | 1 |
| Chaplin, MM; Farahmand, P; Modesto-Lowe, V | 1 |
| Bagley, SM; Carney, BL; Hadland, SE | 1 |
| Beasley, C; Bobak, TJ; Callahan, S; Dovale, I; Gelfman, N; Jason, LA; Majer, JM; Nguyen, HM; Norris, J; Ogata, M; Siegel, J; Stecker, E; Wiedbusch, E | 1 |
| Atreja, N; Duncan, M; Gore, M; Shah, A; Tai, KS | 1 |
| McDonald, R; Neale, J; Strang, J; Tompkins, CNE | 1 |
| Fredheim, OMS | 1 |
| Bodnar, LM; Caritis, SN; Lemon, LS; Naimi, A; Platt, RW; Venkataramanan, R | 1 |
| Bunn, JY; Heil, SH; Higgins, ST; Sigmon, SC; Streck, JM | 1 |
| Coyle, MG; Fischer, G; Heil, SH; Jones, HE; Kaltenbach, K; Martin, PR; O'Grady, KE; Salisbury, AL; Stine, S | 1 |
| Agyemang, L; Akiyama, MJ; Arnsten, JH; Heo, M; Linas, BP; Litwin, AH; Norton, BL; Schackman, BR | 1 |
| de C Williams, AC; Donaldson, LJ; Mordecai, L; Reynolds, C | 1 |
| Engeland, A; Gabrhelík, R; Handal, M; Lund, IO; Mravčík, V; Nechanská, B; Skurtveit, S | 2 |
| Kiefer, L; Kouyoumdjian, FG; Patel, A; Regenstreif, L; To, MJ | 1 |
| Alexander-Scott, N; Boss, R; Brinkley-Rubinstein, L; Clarke, J; Green, TC; Marshall, BDL; Rich, JD | 1 |
| Altice, FL; Dvoriak, S; Filippovich, S; Madden, L; Makarenko, I; Marcus, R; Mazhnaya, A; Pykalo, I | 1 |
| Fang, WB; Fu, Y; Moody, DE | 1 |
| Athanasos, P; Bochner, F; Ling, W; Somogyi, AA; White, JM | 1 |
| Cavallo, DA; Donroe, JH; Holt, SR; Tetrault, JM | 1 |
| Schiff, DM; Silverstein, M; Wachman, EM | 1 |
| Bjørnestad, R; Clausen, T; Muller, AE | 1 |
| Hickman, M; Lim, AG; Macleod, J; Marsden, J; Millar, T; Steer, C; Strang, J; Telfer, M; Tilling, K; Vickerman, P | 1 |
| Abbass, Z; Ghaddar, A; Khandaqji, S | 1 |
| Seftel, AD | 1 |
| Brooke Lerner, E; Fumo, N; Peterson, BL; Schreiber, S | 1 |
| Azhar, G; Chen, C; Hempel, S; Maglione, MA; Maksabedian, E; Newberry, S; Raaen, L; Shahidinia, N; Shanman, RM; Shen, M | 1 |
| Graham, DP; Kosten, TR; Nielsen, DA | 1 |
| Cullen, W; Elmusharaf, K; Smyth, BP | 1 |
| Hunt, J; Murrell, JC; Shah, MD; Yates, D | 1 |
| Quaye, AN; Ward, EN; Wilens, TE | 1 |
| Cropsey, KL; Dantzler, J; Galbraith, JW; Hodgin, K; Schiavon, S; Sellers, A; Word, M | 1 |
| Akhtar, S; Astbury, M; Bajaria, J; Bennett, C; Bijral, P; Bishop, E; Bogdan, N; Bowden-Jones, O; Byford, S; Charles, V; Davey, C; Day, E; Desai, R; Dunn, J; Finch, E; Forshall, S; Glasper, A; Goodfellow, C; Haque, F; Hellier, J; Little, N; McKechnie, H; Metrebian, N; Mitcheson, L; Morris, J; Morse, G; Mosler, F; Mutz, J; Pauli, R; Pilling, S; Poovendran, D; Shearer, J; Slater, E; Strang, J; Weaver, T | 1 |
| Bisaga, A; Campbell, AN; Crystal, S; Friedmann, PD; Johnson, KA; Levin, FR; Nunes, EV; Olfson, M; Pincus, HA; Remien, RH; Williams, AR | 1 |
| Bagley, SM; Bernson, D; Land, T; Larochelle, MR; Liebschutz, JM; Stopka, TJ; Walley, AY; Wang, N; Xuan, Z | 1 |
| Amato, L; Amin-Esmaeili, M; Gholami, J; Hoseinie, L; Rahimi-Movaghar, A; Yousefi-Nooraie, R | 1 |
| Burns, RM; Dick, AW; Gordon, AJ; Leslie, DL; Pacula, RL; Sorbero, M; Stein, BD | 1 |
| Bao, YP; Blow, FC; Degenhardt, L; Farrell, M; Ilgen, M; Li, JQ; Liu, MX; Lu, L; Ma, J; Shi, J; Su, MF; Wang, RJ | 1 |
| Buntin, MB; Cooper, WO; Dupont, W; Martin, PR; Patrick, SW; Richards, M; Scott, TA | 1 |
| Krieg, B | 1 |
| Streisel, SE | 1 |
| Briand-Madrid, L; Carrieri, P; Debrus, M; Khatmi, N; Maradan, G; Mezaache, S; Protopopescu, C; Rojas-Castro, D; Roux, P | 1 |
| Alexander, GC; Saloner, B; Stoller, KB | 1 |
| Husby, MF; Jondalen, NM; Konijnenberg, C; Melinder, A | 1 |
| Bernson, D; Bharel, M; Diop, H; Hood, M; Land, T; LaRochelle, M; Nielsen, T; Schiff, DM; Terplan, M; Walley, AY; Wilens, TE | 1 |
| Bishop, B; Deering, D; Gilmour, J | 1 |
| Aschenbrenner, DS | 1 |
| Binswanger, IA; Fazel, S; Hellner, C; Larsson, H; Molero, Y; Zetterqvist, J | 1 |
| Ali, R; Degenhardt, L; Dobbins, T; Fiellin, DA; Hickman, M; Jones, NR; Larney, S; Mattick, RP; Nielsen, S | 1 |
| Aggarwal, AK; Harrison, TK; Kornfeld, H; Lembke, A | 1 |
| Haffajee, RL; Weintraub, E; Yang, YT | 1 |
| Johnson, Q; Joudrey, PJ; Mund, B | 1 |
| D'Alton, ME; Duffy, CR; Friedman, AM; Kern-Goldberger, AR; Landau, R; Mourad, MJ; Siddiq, Z; Wright, JD | 1 |
| Brogly, SB; Hernández-Díaz, S; Regan, E; Saia, KE; Werler, MM | 1 |
| Nikita, FNU; Saia, K; Schiff, DM; Shaw, D; Shrestha, H; Thomas, Z; Thomas-Lewis, JA; Wachman, EM; Warden, AH | 1 |
| Clarke, JG; Gresko, SA; Martin, RA; Rich, JD | 1 |
| Bagley, SM; Hadland, SE; Larochelle, MR; Levy, S; Rodean, J; Samet, JH; Silverstein, M; Zima, BT | 1 |
| Beck, T; Berthel, T; Dey, M; Dürsteler, KM; Herdener, M; Moldovanyi, A; Nordt, C; Seifritz, E; Vogel, M; Walter, M | 1 |
| Broglio, K; Matzo, M | 1 |
| Dantzler, J; Harper, LM; Kuper, SG; Muir, S; Paddock, CS; Sims, B; Wang, MJ | 1 |
| Catlin, D; Coker, JL; Knight, B; Ray-Griffith, S; Stowe, ZN | 1 |
| Altice, FL; Bojko, MJ; Dvoriak, S; Filippovych, S; Makarenko, I; Marcus, R; Mazhnaya, A; Pykalo, I; Zelenev, A | 1 |
| Binswanger, IA; Bowe, T; Finlay, AK; Harris, AHS; Smelson, D; Stimmel, MA; Timko, C; Yu, M | 1 |
| Boyer, EW; Burns, MM; Chai, PR; Toce, MS | 1 |
| Nesic, N; Raketic, D; Sarajlija, M | 1 |
| Cabral, HJ; Lloyd-Travaglini, C; Rose-Jacobs, R; Saia, K; Trevino-Talbot, M; Vibbert, M; Wachman, EM | 1 |
| Bierut, LJ; Cavazos-Rehg, PA; Costello, SJ; Gunderson, S; Krauss, MJ; Marsch, LA; Petkas, D; Ramsey, AT | 1 |
| Peters, L; Soyka, M | 1 |
| Bellini, L; De Benedictis, GM | 1 |
| Eastwood, B; Marsden, J; Strang, J | 1 |
| Drbohlavová, B; Janíková, B; Mravčík, V; Pirona, A; Popov, P | 1 |
| Gjerde, H; Mørland, JG; Ramaekers, JG; Strand, MC; Vindenes, V | 1 |
| Gordon, MS; Gryczynski, J; Jaffe, JH; Kelly, SM; Mitchell, MM; Mitchell, SG; O'Grady, KE; Schwartz, RP | 1 |
| Glance, J; Gopalan, P; Shenai, N | 1 |
| Beck, O; Böttcher, M; Picht, F | 1 |
| Bowe, TR; Burden, JL; Ellerbe, LS; Finlay, AK; Gupta, S; Harris, AHS; Rubinsky, A; Schmidt, EM; Timko, C; Wong, JJ | 1 |
| Kaplan, L | 1 |
| Ali, R; Hu, L; Marsden, J; Rush, AJ; Tai, B; Volkow, N | 1 |
| James, DL; Jowza, M | 1 |
| Fiscella, K; Peeler, M; Sufrin, C; Terplan, M | 1 |
| Cibin, M; Lugoboni, F; Tamburin, S; Zamboni, L | 1 |
| Begovac, J; Bozicevic, I; Handanagic, S; Rutherford, GW; Sekerija, M | 1 |
| Fanucchi, L; Korthuis, PT; Springer, SA | 1 |
| Cole, ES; Donohue, JM; Hollander, MAG; Jarlenski, MP; Kelley, D; Krans, EE | 1 |
| Humphreys, K; Saitz, R | 1 |
| Gabrhelík, R; Handal, M; Mahic, M; Mravčík, V; Nechanská, B; Skurtveit, S | 1 |
| Carter, LC; Nicholas, JS; Read, L; Read, MA; Schmidt, E | 1 |
| Kraft, WK; Mangat, AK; Schmölzer, GM | 1 |
| Klie, KA; Rodriguez, CE | 1 |
| Fairbairn, N; Gorfinkel, L; Jones, AA; Klimas, J; McCarty, D; Priest, KC | 1 |
| Baldassarri, SR; Barry, DT; Beitel, M; Bollampally, P; Camenga, D; Dhingra, LK; Fiellin, DA; Fucito, L; Madden, LM; Savage, ME | 1 |
| Kunøe, N; Lee, JD | 1 |
| McKee, SA; Moore, KE; Oberleitner, LMS; Reid, HH; Roberts, W; Smith, KMZ | 1 |
| Heller, NM; Maher, DP; Walia, D | 1 |
| Andorn, A; Curd, L; Laffont, CM; Lohmer, LRL; Schmith, VD; Young, MA | 1 |
| Binswanger, IA | 1 |
| Cleverley, K; Ling, S; Mangaoil, R; Puts, M; Sproule, B | 1 |
| Butler, F; Witt, L | 1 |
| Hulse, G; Joyce, D; Kelty, E | 1 |
| Bird, SM; Gao, L; Robertson, JR | 2 |
| Moerke, MJ; Negus, SS | 1 |
| Barnett, BS; Suzuki, J; Ward, HB | 1 |
| O'Brien, L; O'Connor, A; Watson, L | 1 |
| Barnes, DE; Marton, T; Wallace, A; Woolley, JD | 1 |
| Barry, CL; Gollust, SE; Kennedy-Hendricks, A; Levin, J; McGinty, EE; Stone, E | 1 |
| Rosenberg, L | 1 |
| Neale, J; Strang, J; Tompkins, CNE | 2 |
| James, AE; Jarlenski, MP; Kelley, D; Kim, JY; Krans, EE | 1 |
| Cosci, F; Lugoboni, F; Mansueto, G; Zamboni, L | 1 |
| Landau, R | 1 |
| Cao, J; Jordan, CJ; Newman, AH; Xi, ZX | 1 |
| Jones, HE; Kraft, WK | 1 |
| Artenie, AA; Bruneau, J; Gauvin, L; Høj, S; Jacka, B; Jutras-Aswad, D; Minoyan, N; Roy, É; Zang, G | 1 |
| Kahan, M; Leece, P; McAndrew, A; Srivastava, A | 1 |
| Dzau, VJ; Leshner, AI | 1 |
| Baumgartner, MR; Gastberger, S; Herdener, M; Hulka, LM; Mutschler, J; Quednow, BB; Seifritz, E; Soyka, M | 1 |
| Duello, A; Green, L; Horn, P; Presnall, N; Rudder, T; Stringfellow, E; Winograd, RP; Wood, C | 1 |
| Allan, GM; Dugré, N; Finley, CR; Garrison, S; Kolber, MR; Korownyk, C; Lindblad, AJ; Perry, D; Thomas, B; Ting, R; Ton, J; Vandermeer, B; Yang, PR | 1 |
| Goutzourelas, N; Kampitsi, A; Kortsinidou, A; Kouretas, D; Leventelis, C; Spanidis, Y; Stagos, D; Toulia, G; Tsitsimpikou, C; Veskoukis, AS | 1 |
| Ghazanfarpour, M; Keramat-Roudi, A; Mashhadi, ME; Mégarbane, B; Moghaddam, MMM; Najafi, MN; Rezaee, R; Roozbeh, N; Tsatsakis, A | 1 |
| Amariei, A; Cottencin, O; Danel, T; Dervaux, A; Martinetti, MP; Naassila, M; Plancke, L; Tahon, M; Trouiller, P | 1 |
| Madden, EF | 1 |
| Elsayed, M; Espinoza, D; Haber, P; Hallinan, R; Lintzeris, N; Morley, KC; Veillard, AS | 1 |
| Banken, R; Kumar, VM; Otuonye, IS; Pearson, SD | 1 |
| Babu, KM; Brent, J; Juurlink, DN | 1 |
| Ibsen, IO; Jørgensen, JS; Lamont, RF; Rausgaard, NLK; Ravn, P | 1 |
| Anyama, BC; Cornett, EM; Gennuso, SA; Green, JB; Kaye, AD; Kline, RJ; Okereke, EC; Robichaux, SL | 1 |
| Choi, S; Healy, S; Neighbors, CJ; Shapoval, L; Sun, T; Yerneni, R | 1 |
| Gonzalez, G; Wachholtz, A; Ziedonis, D | 1 |
| Cook, CE; Fantasia, HC | 1 |
| Bech, AB; Clausen, T; Šaltytė Benth, J; Skeie, I; Waal, H | 1 |
| Laes, JR; Schwarz, ES; Wiegand, TJ | 1 |
| Chen, J; Davis, JM; Eisler, L; Lee, JJ; Li, G; Sun, LS | 1 |
| Carr, DH; Davis, CS | 1 |
| Calcaterra, SL; Smith, C; Terasaki, D | 1 |
| Hills-Evans, K; Hsu, D; Marshall, J; O'Donoghue, S; Reichheld, AM; Sheehan, JK; Stevens, JP; Tandon, M; Tocci, NX | 1 |
| Andersen, JM; Austdal, LPE; Fjelldal, MF; Hadera, MG; Kongstorp, M; Paulsen, RE; Šulović, A | 1 |
| Goodman, DJ; Higgins, TM; Meyer, MC | 1 |
| Andersen, JM; Bogen, IL; Kongstorp, M; Stiris, T | 2 |
| Glance, JB; Gopalan, P; Kmiec, J; Spada, M | 1 |
| Bridgeman, PJ; Koehl, JL; Zimmerman, DE | 1 |
| Cousins, S; McCann, M; Pearce, R; Rawson, RA; Rieckmann, T | 1 |
| Daley, D; Houck, PR; Kinsky, S; Loveland, D; Mayes, K; Schuster, JM | 1 |
| Friedmann, PD; Jablonski, L; Klepacki, A; Paterno, MT | 1 |
| Katz, E; Towers, CV; Visconti, K; Weitz, B | 1 |
| Ardid, D; Authier, N; Bertin, C; Brousse, G; Chenaf, C; Delorme, J; Eschalier, A; Peyrière, H; Riquelme, M | 1 |
| Manhapra, A; Rosenheck, R; Stefanovics, E | 1 |
| Lin, MP; Manini, AF; Richardson, LD; Shastry, S | 1 |
| Bahji, A; Cheng, B; Gray, S; Stuart, H | 1 |
| Bell, J; Strang, J | 1 |
| Busardò, FP; Carlier, J; Di Trana, A; Huestis, MA; La Maida, N; Pichini, S; Tittarelli, R | 1 |
| Chemi, C; Dickson, V; Lee, JD; Suhail-Sindhu, S; Tofighi, B; Williams, AR | 1 |
| Abrantes, A; Bailey, G; Stein, M; Tremont, G; Uebelacker, LA; Van Noppen, D | 1 |
| Chung, KS; Hsu, CY; Li, DJ; Lu, YS; Wu, HC | 1 |
| Hileman, CO; McComsey, GA | 1 |
| Camenga, DR; Colon-Rivera, HA; Muvvala, SB | 1 |
| Demirkol, A; Hayes, V; Lintzeris, N; Murnion, BP; Nielsen, S; Rivas, C | 1 |
| Coker, JL; Doyle, R; Knight, BT; Kroska, EB; Meller, EW; Nembhard, WN; Ray-Griffith, SL; Stowe, ZN | 1 |
| Gryczynski, J; Hill, P; Mitchell, SG; Nichols, H; Schwartz, RP; Wireman, K | 1 |
| Murrell, J; Petty, MC | 1 |
| Alam, F; Dhadley, S; Roberts, P; Townley, J; Webster, R; Wright, N | 1 |
| Bertz, JW; Epstein, DH; Figueiro, MG; Jobes, ML; Kennedy, AP; Kowalczyk, WJ; Phillips, KA; Plitnick, BA; Preston, KL; Rea, MS; Reamer, D; Ward, G | 1 |
| Gold, MS; Oesterle, TS; Rummans, TA; Thusius, NJ | 1 |
| Allen, B; Nolan, ML; Paone, D | 1 |
| Badolato, R; Flannery, M; Garment, AR; Giftos, J; Lee, JD; McDonald, RD; Tofighi, B; Velasquez, M; Vittitow, A | 1 |
| Coffa, D; Snyder, H | 1 |
| Abraham, AJ; Adams, GB; Yarbrough, CR | 1 |
| Degenhardt, L; Dobbins, T; Gisev, N; Jones, NR; Larney, S; Montebello, M; Shanahan, M | 1 |
| Bagley, SM; Bernson, D; Hadland, SE; Land, T; Larochelle, MR; Patel, A; Samet, JH; Silverstein, M; Walley, AY; Wang, N; Xuan, Z | 1 |
| Grobman, WA; Miller, ES; Premkumar, A; Terplan, M | 2 |
| Bonny-Noach, H | 1 |
| Afarinesh, MR; Golshan, F; Haghpanah, T; Sabzalizadeh, M; Shafiei, F; Sheibani, V; Zangiabadi, I | 1 |
| MacMillan, KDL | 1 |
| Byrd, DJ; Campbell, TB; Clarke, TJ; Jones, CM; McCance-Katz, EF; Ohuoha, C | 1 |
| Forray, A; Habecker, E; Tobon, AL | 1 |
| Brown, JN; Elias, AM; Pepin, MJ | 1 |
| Blanco, C; Volkow, ND | 1 |
| Brezel, ER; Fox, AD; Powell, T | 1 |
| Alves, P; Bivin, B; Waring, A | 1 |
| Agage, D; Epstein, DH; Finan, PH; Kowalczyk, WJ; Mun, CJ; Phillips, KA; Preston, KL; Smith, MT | 1 |
| Felix, C; Olsen, Y; Sharfstein, JM | 1 |
| Reimer, J; Scherbaum, N; Trümper, D; Vogelmann, T | 1 |
| Ahmadi, AA; Asouri, M; Gholami, M; Nasirikenari, M; Rostamnezhad, M; Saboory, E | 1 |
| Homayra, F; Hongdilokkul, N; McGowan, G; Min, JE; Nosyk, B; Pearce, LA; Piske, M; Socias, ME; Zhou, H | 1 |
| Andersson, L; Håkansson, A; Johnson, B; Krantz, P | 1 |
| Johnson, JA; Liebschutz, JW; Martin, B; Montgomery, MW; Mosquera, M; Price, CD; Robinson, D; Schnipper, JL; Solomon, DA; Suzuki, J; Weiss, RD | 1 |
| Banks, ML; Negus, SS; Townsend, EA | 1 |
| Choi, S; Goyal, M; Healy, S; Neighbors, CJ; Yerneni, R | 1 |
| Compton, P | 1 |
| Ali, MM; Hinde, JM; Meinhofer, A | 1 |
| Bowling, N; O'Connor, A | 1 |
| Ait-Daoud, N; Holstege, CP; Ngo, DA; Rege, SV; Rizer, J; Sharma, S | 1 |
| Ameli, O; Azocar, F; Chaisson, CE; Crown, WH; Larochelle, MR; McPheeters, JT; Sanghavi, DM; Wakeman, SE | 2 |
| Bergeria, CL; Dunn, KE; Hobelmann, JG; Huhn, AS; Oyler, GA; Strickland, JC; Umbricht, A | 1 |
| Buckley, NA; Hassanian-Moghaddam, H; Zamani, N | 1 |
| Agus, D; Fingerhood, M; Krawczyk, N; Lyons, BC; Mojtabai, R; Saloner, B; Stuart, EA; Weiner, JP | 1 |
| Babakhanlou-Chase, H; Bernson, D; Land, T; Larochelle, MR; Li, Y; Lodi, S; Walley, AY | 1 |
| Fuehrlein, B; Jaeger, S | 1 |
| Brayne, C; Roman-Urrestarazu, A; Yang, JC | 1 |
| Beal, L; Clarke, JG; Latkin, C; Sufrin, C; Sutherland, L; Terplan, M | 1 |
| Andersen, JM; Høiseth, G; Nygaard, E | 1 |
| Bobby, LE; Frazier, LM; Gawronski, KM | 1 |
| Bhatt, J; Carson-Stevens, A; Donaldson, LJ; Gibson, R; Hibbert, P; MacLeod, N; Parry, G; Sheikh, A; Williams, H | 1 |
| Domino, ME; Gertner, AK; Jones, H; Powell, BJ; Robertson, AG; Silberman, P | 2 |
| Baldwin, JA; Haberstroh, S; Pro, G; Utter, J | 1 |
| Dart, RC; Green, JL; Olsen, H; Severtson, G; Wang, GS | 1 |
| Hsi, A; Nelson, LF; Patel, KD; Qeadan, F; Weitzen, S; Yocum, VK | 1 |
| Hulse, G; Joyce, D; Kelty, E; Preen, DB | 1 |
| Calcaterra, SL; Klie, KA | 1 |
| Bart, G; Giang, LM; King, C; Korthuis, PT; Kunkel, L | 1 |
| Homayra, F; Irvine, M; McGowan, G; Min, JE; Nosyk, B; Pearce, LA; Piske, M; Slaunwhite, A; Zhou, H | 1 |
| Altice, FL; Bromberg, DJ; Nyhan, K; Refsland, BM; Stanojlović, M; Viera, A; Whittaker, S | 1 |
| Andrews, L; Davies, TH; Haas, J; Heyward, A; Loudin, S; Werthammer, J | 1 |
| Ali, R; Bruneau, J; Degenhardt, L; Fiellin, DA; Hickman, M; Jin, H; Larney, S; Marshall, BDL; Strang, J | 1 |
| Cueni, C; Nytko, KJ; Rohrer Bley, C; Thumser-Henner, P; Weyland, MS | 1 |
| Herbst, ED; Kalapatapu, RK; Kinasz, KR | 1 |
| Bratberg, J; Finnell, DS; Green, TC | 1 |
| Cerdá, M; Goedel, WC; Hadland, SE; Marshall, BDL; Shapiro, A; Tsai, JW | 1 |
| Babulovska, A; Simonovska, NK; Stefanovska, VV | 1 |
| Chevillard, L; Mégarbane, B; Vodovar, D | 1 |
| Abel, KF; Chalabianloo, F; Sarfi, M; Skurtveit, S; Welle-Strand, GK | 1 |
| Druss, BG; Saloner, B; Wen, H | 1 |
| Galaj, E; Newman, AH; Xi, ZX | 1 |
| Andraka-Christou, B; Atkins, D; Madeira, J; Silverman, RD | 1 |
| Bautista, A; Clifford, S; Sritapan, Y | 1 |
| Altice, FL; Bojko, MJ; Dvoriak, S; Farnum, SO; Islam, Z; Madden, L; Makarenko, I; Marcus, R; Mazhnaya, A; Prokhorova, T; Rozanova, J | 1 |
| Blow, FC; Bohnert, ASB; Gordon, AJ; Ignacio, RV; Ilgen, MA; Kim, HM; Lin, LA | 1 |
| Ahmed, S; Pena, E | 1 |
| Bernson, D; Bharel, M; Diop, H; Hansen, H; Hoeppner, BB; Kelly, JF; Krans, EE; Nielsen, T; Schiff, DM; Selk, S; Taveras, EM; Terplan, M; Wilens, TE | 1 |
| Hoggatt, K; Timko, C | 1 |
| Bach, P; Kimmel, S; Walley, AY | 1 |
| Garvan, C; Roussos-Ross, D; Wendling, AL; Zeng, D; Zhang, L | 1 |
| Köck, P; Strasser, J | 1 |
| Fine, M; Herscher, M; Hirt, L; Navalurkar, R; Wang, L | 1 |
| Geddes, L; Iversen, J; Maher, L; Wand, H | 1 |
| Baschirotto, C; Kuhn, S; Lehmann, K; Reimer, J; Verthein, U | 1 |
| Agus, D; Fingerhood, MI; Krawczyk, N | 1 |
| Davis, JA; Garretto, D; Garry, ET; Herrera, KM; Ly, V; Staszewski, CL | 1 |
| Amos, E; Jones, HE; Knittel, AK; Thorp, JM; Zarnick, S | 1 |
| Burden, J; Codell, NK; Drexler, K; Dungan, MT; Gordon, AJ; Hagedorn, H; Hawkins, EJ; Mhatre-Owens, A | 1 |
| Bruneau, J; Cochran, G; Cox, N; Gordon, AJ | 1 |
| Andrade, G; Câmara-Pestana, L; Simões do Couto, F | 1 |
| Boaz, T; Kirby, RS; Ma, J; Sahasranaman, V | 1 |
| Brown, HL | 1 |
| Chalhoub, RM; Kalivas, PW | 1 |
| Bachhuber, MA; Barry, CL; Kennedy-Hendricks, A; McGinty, EE; Stone, E | 1 |
| Acevedo-Mackey, D; Acharjee, N; Akhtar, K; Al-Buriahi, MS; Amandi, A; An, Y; Anjum, NA; Asgari, Q; Badiei, B; Baez Vasquez, AY; Bagley, GD; Bahreini, MS; Bajelan, S; Baluja, MQ; Barbieri, MA; Batalha, MA; Bettiol, H; Bhattarai, U; Biset, JC; Bjerg, M; Björnsson, BT; Boag, AM; Borthwick, MS; Boukhris, I; Bragança, MLBM; Breves, JP; Britz-McKibbin, P; Broaddus, RR; Burnell, JE; Camargo, CA; Campo, M; Carlsen, KL; Catchpole, B; Cavalli, L; Chai, C; Chanakya, HN; Chang, AYH; Chantada, A; Chen, W; Chen, X; Chen, Y; Cheng, ZL; Chenoweth, DA; Chhetri, S; Coelho, CCNDS; Coker, ES; Cole, MA; Coniglio, A; Connor, TR; Corbishley, A; D'Arienzo, M; da Silva, AAM; Dai, Y; de Oliveira, BR; Dignac, MF; Dong, A; Dottino, JA; Duo, J; Einarsdottir, IE; Ekanayake, EMDNK; El Fels, L; El Hayany, B; El Shahawy, O; Elliott, RJR; Fabrizi, E; Farkas, K; Fellman, B; Fenoglio, D; Ferrario, M; Flögel, F; Fujiogi, M; Gamage, BD; Ganson, KT; Gao, X; Gärtner, S; Gautam, A; Gautam, S; Gaze, WH; Gosse, JA; Graham, DW; Graham, PA; Guastella, G; Guerrero, S; Gul, M; Guo, B; Guo, X; Gupta, VK; Hafidi, M; Halland, A; Han, W; Hardisty, M; Hasegawa, K; Hess, ST; Heydari, R; Hillary, LS; Holm, R; Huang, L; Jaleh, B; Jayasundara, JASB; Ji, X; Jiang, L; Jones, DL; Kac, G; Kebaili, I; Kelley, JB; Kelum, SHP; Kennedy, LJ; Khan, NA; Khazalpour, S; Khuntia, HK; Kinney, MS; Kommedal, Ø; Koomhin, P; Krawczyk, N; Kæstel, T; Lakmal, MAC; Li, H; Li, K; Li, R; Li, S; Li, W; Li, X; Li, Y; Liang, L; Lin, Y; Lippo, E; Liu, B; Liu, F; Liu, J; Liu, X; Liu, Y; Lodha, D; Loose, DS; López-Meza, P; Lu, F; Lu, KH; Lu, Y; Luo, Y; Ma, B; Malham, SK; Masood, A; Matan, N; McCormick, SD; McDonald, JE; McKenzie, LJ; Melendez, BD; Mikaeili, F; Mir, IR; Mirjalili, MH; Moreno, KP; Moura, IB; Müller, S; Nagata, JM; Nasri, A; Nasrollahzadeh, M; Navarro-Jiménez, E; Nie, E; Nielsen, CU; Nielsen, S; Nøhr, MK; Obeng, B; Odetayo, AA; Ortiz-Barrios, M; Ozgen, C; Pan, X; Parisi, ML; Paskavitz, AL; Patel, AK; Pedersen, M; Pontarollo, N; Potts, CM; Price, C; Pu, Y; Quénéa, K; Rahimi Khonakdari, M; Rather, BA; Raut, P; Regish, AM; Reible, DD; Rezadoost, H; Rizzati, M; Roviello, GN; Roviello, V; Rumpel, C; Sang, J; Sangroula, S; Saraiva, MDCP; Sarker, A; Sayyed, MI; Segoshi, A; Sehar, Z; Shao, X; Shaw, D; Shaw, L; Shekhawat, NS; Shim, JK; Shokouhimehr, M; Short, A; Soliman, PT; Songsamoe, S; Springer-Miller, RH; Stenstad, T; Strobl, E; Sun, R; Syme, H; Thai, L; Tian, G; Tofighi, B; Tonguc, B; Tuyiringire, D; Ulaganathan, N; Ulvestad, E; Varacca, A; Vergalli, S; Verma, DK; Villmones, HC; Wang, D; Wang, H; Wang, J; Wang, L; Wang, M; Wang, S; Wang, Y; Wang, Z; Weedon-Fekjær, H; Weller, SR; West, BE; Wilcox, MH; Wu, W; Wufuer, R; Xia, S; Xiang, H; Xu, H; Yan, L; Yang, RK; Yang, Y; Yates, MS; Ye, Q; Yin, H; Yin, Y; Yuan, Y; Yucesan, M; Yue, W; Zeng, W; Zhang, C; Zhang, D; Zhang, H; Zhang, L; Zhang, Q; Zhang, Y; Zhou, B; Zhou, Y; Zhu, Y; Zhu, Z | 1 |
| Black, KI; Day, CA; Fowler, M; Reid, SE; White, B | 1 |
| Durkin, MJ; Liang, SY; Liss, DB; Marks, LR; Munigala, S; Schwarz, ES; Warren, DK | 1 |
| Bruneau, J; Greenland, S; Gustafson, P; Hongdilokkul, N; Karim, ME; Krebs, E; Maclure, M; McCandless, LC; Nosyk, B; Piske, M; Platt, RW; Siebert, U; Socías, ME; Thomson, T; Tsui, JI; Wood, E | 1 |
| Andraka-Christou, B; Attermann, J; Beck, AJ; Buche, J; Cupito, A; Haffajee, RL | 1 |
| Andraka-Christou, B; Atkins, D | 1 |
| Armstrong, G; Choudhurimayum, RS; Haregu, T; Kermode, M; Rajkumar, LS | 1 |
| Bui, Q; Dumchev, K; Go, VF; Hamilton, EL; Hershow, RB; Hoffman, IF; Kiriazova, T; Lancaster, KE; Latkin, CA; Miller, WC; Sarasvita, R | 1 |
| Woody, GE | 1 |
| Lake, S; St Pierre, M | 1 |
| Del Pozo, B; Rich, JD | 1 |
| Biondi, BE; Cioe, K; Easly, R; Simard, A; Springer, SA; Zheng, X | 1 |
| Boyer, K; Braun, S; Gerwien, R; Imbert, B; Kuo, A; Luderer, HF; Maricich, YA; Velez, F; Williams, K; Xiong, X | 1 |
| Allen, J; Beauchamp, GA; Boateng, N; Burmeister, DB; Esposito, SB; Laubach, LT; Lauber, P; Roth, P; Shaak, S; Yazdanyar, A | 1 |
| Baron, CA; Blinova, K; Johannesen, L; Patel, D; Randolph, AL; Ren, M; Sheng, J; Strauss, DG; Thiebaud, N; Tran, PN; Volpe, DA; Wu, M; Wu, WW | 1 |
| Amato, L; Bellisario, C; Davoli, M; Ferri, M; Jahanfar, S; Minozzi, S | 1 |
| Altice, FL; Dvoryak, S; Farnum, SO; Filippovych, M; Fomenko, T; Galvez de Leon, SJ; Islam, ZM; Madden, LM; Meteliuk, A; Pykalo, I | 1 |
| Bebek-Ivankovic, H; Bevanda, M; Grgic, S; Nikolic, J; Soldo-Coric, L; Susak, B | 1 |
| El-Bassel, N; Levin, FR; Nunes, EV; Reilly, MP | 1 |
| Peters, H; Pollini, RA; Showalter, D; Snell-Rood, C; Willging, C | 1 |
| Donelan, CJ; Evans, EA; Hayes, E; Potee, RA; Schwartz, L | 1 |
| Donoyan, A; Hughto, JMW; Mimiaga, MJ; Nelson, KM; Pantalone, DW; Perry, NS; Peterson, L | 1 |
| Ameral, V; Banducci, AN; Livingston, NA; Weisberg, RB | 1 |
| Culhane, J; Meisel, ZF; Nguemeni Tiako, MJ; South, E; Srinivas, SK | 1 |
| Choi, S; Forthal, S; Healy, S; Neighbors, CJ; Shapoval, L | 1 |
| Bailit, JL; Gibson, KS; Lappen, JR; Stark, S | 1 |
| Joseph, G; Mund, PA; Nahvi, S; Stein, MR; Torres-Lockhart, K | 1 |
| Crawford, TN; Fischer, KB; Gainer, DM; Wright, MD | 1 |
| Akinbi, H; Butler, D; Emoto, C; Fukuda, T; McPhail, BT; Vinks, AA | 1 |
| Mohd Effendy, N; Ramli, FF; Syed Hashim, SA | 1 |
| Ellis, JD; Himle, JA; Ledgerwood, DM; Lister, JJ; Molfenter, T; Weaver, A | 1 |
| Basaraba, C; Bisaga, A; Brooks, DJ; Choi, CJ; Levin, FR; Mahony, AL; Mariani, JJ; Naqvi, N; Pavlicova, M | 1 |
| Dale, RC; Ford, LT; Street, C | 1 |
| Finnegan, LP; McCarthy, JJ | 1 |
| Bailit, JL; Gibson, KS; Lappen, JR | 1 |
| Caughey, AB; Hersh, AR; John, C; Robin, AM | 1 |
| Hayes, V; Lintzeris, N; Oakley, B; Wilson, H | 1 |
| Bachellier, J; Bendimerad, P; Brousse, G; Chappuy, M; Hjelmström, P; Kosim, M; Meroueh, F; Nourredine, M; Nubukpo, P; Rolland, B; Trojak, B | 1 |
| Baratta, JL; Ferd, P; Patel, N; Schwenk, ES; Torjman, MC; Viscusi, ER | 1 |
| Ahmad, NJ; Garrett, B; Krawczyk, N; Patel, E; Saloner, B; Solomon, K; Stuart, EA | 1 |
| Burke-Shyne, N; Chang, J; Daniels, C; Nguyen, VTT; Sabin, KM; Verster, A | 1 |
| Bart, G; Bielavitz, S; Cook, RR; Giang, LM; Khuyen, TT; King, C; Korthuis, PT; Kunkel, LE; Nguyen, DB; Nguyen, T; Tam, NTM; Thuy, DT | 1 |
| Benoit Hardouin, J; Challet-Bouju, G; Dany, A; Grall-Bronnec, M; Guillou-Landreat, M; Laforgue, E; Leboucher, J; Victorri-Vigneau, C | 1 |
| Bertz, JW; Burgess-Hull, AJ; Curtis, BL; Epstein, DH; Lanza, ST; Panlilio, LV; Phillips, KA; Preston, KL; Stull, SW | 1 |
| Andersson, L; Berge, J; Håkansson, A; Johnson, B | 1 |
| Brockmann, B; Langdon, KJ; Marotta, P; McKenzie, M; Stringer, KL | 1 |
| Amini, M; Arezoomandan, M; Arezoomandan, R; Feyzi, YF; Nikbakht-Zadeh, M; Nikraftar, NS; Ramzani, F; Shiehmorteza, M | 1 |
| Bhat, NR; Bierut, LJ; Borodovsky, JT; Grucza, RA; Mintz, CM; Presnall, N; Xu, KY | 1 |
| Bergeria, CL; Dunn, KE; Huhn, AS; Nayak, SM; Strain, EC | 1 |
| Ball, EL; Becker, SJ; Garner, BR; Hartzler, B; Jacka, BP; Janssen, T; Yap, KR; Yermash, J | 1 |
| Benville, JR; Cheatle, MD; Compton, P; Giordano, NA | 1 |
| Eveland, J; Knight, KR; Mehtani, NJ; Ristau, JT; Smith-Bernardin, S; Snyder, H; Surlyn, C | 1 |
| Adekoya, P; Gulati, A; Hunter, C; Jones, MR; Kaye, AD; Kaye, AM; Kuppalli, S; Orhurhu, V; Seth, R; Urits, I | 1 |
| Bachireddy, C; Terplan, M | 1 |
| Latif, ZH; Skjaervø, I; Solli, KK; Tanum, L | 1 |
| Freeman, PR; Huang, Z; Oser, C; Sohn, M; Talbert, JC | 1 |
| Clark, SA; Davis, C; Keeler, LAJ; Reddy, N; Samuels, EA; Wightman, RS; Wunsch, C | 1 |
| Campbell, ANC; Choo, TH; Haenlein, P; Lee, JD; Nunes, EV; Pavlicova, M; Rotrosen, J; Scodes, J; Shulman, M; Tofighi, B; Wai, J | 1 |
| Clapp, J; Howard, H; Madden, D; Spadola, C; Syvertsen, JL; Toneff, H | 1 |
| Bohr, U; Enge, S; Guillery, SPE; Hellweg, R; Kronenberg, G; Kunte, H | 1 |
| Asch, SM; Bounthavong, M; Brandeau, ML; Combs, A; Fairley, M; Goldhaber-Fiebert, JD; Humphreys, K; Joyce, VR; Oliva, EM; Owens, DK; Trafton, J | 1 |
| Guille, C; McCauley, JL; Moreland, A | 1 |
| Agbalajobi, O; Belperio, P; Fine, MJ; Gellad, W; Good, CB; Kraemer, K; Morgan, T; Rogal, S; Youk, A; Zhang, H | 1 |
| Adekola, H; Bruder, A; Kumar, N; Masten, M; Monga, R; Moustafa, ASZ; Parmar, K; Rocha, FG; Sampath, V | 1 |
| Bernson, D; Bernstein, J; Bharel, M; Greenfield, SF; Hadland, SE; Hoeppner, BB; Kelly, JF; Nielsen, TC; Reddy, J; Schiff, DM; Taveras, EM; Terplan, M; Wilens, TE | 1 |
| García-Marchena, N; Martinez Delgado, JM; Ruíz Ruíz, JJ | 1 |
| Adimi Naghan, P; Malekmohammad, M; Setareh, J | 1 |
| Nys, H | 1 |
| Hoffmann, O; Ljungberg, T | 1 |
| Bart, G; Cook, R; Giang, LM; Hoffman, K; King, C; Korthuis, PT; Waddell, EN | 1 |
| Filipe, R; Meira, J; Nunes, I; Oliveira, C; Rodrigues, J; Sampaio, L; Tavares, J; Teixeira, L | 1 |
| Ahmed, S; Galbis-Reig, D; Hybki, B; Penders, T; Stanciu, C | 1 |
| Bain, PA; Carrero, ND; Chatterjee, A; Li, R; McLaughlin, MF | 1 |
| Bandara, S; Barry, CL; Kennedy-Hendricks, A; Merritt, S; Saloner, B | 2 |
| Ching, JH; Goldhaber-Fiebert, JD; Owens, DK; Salomon, JA; Trafton, JA | 1 |
| Chen, Q; James, AE; Jarlenski, MP; Kelley, D; Kim, JY; Krans, EE; Rothenberger, SD | 1 |
| Annika, M; Carolien, K | 1 |
| Li, L; Liu, N; Liu, Y; Shen, W; Xu, L; Zhou, W | 1 |
| Assoumou, SA; Barocas, J; Chatterjee, A; Hadland, SE; Linas, BP; Morgan, JR; Murphy, SM; Walley, AY | 1 |
| Bhatraju, E; Glick, SN; Hiser, JKD; Poorman, E; Tsui, JI | 1 |
| Candon, M; Kramer, S; Kwon, N; Lamb, R; Mandell, DS; Rothbard, AB; Shen, L; Stewart, RE; Vigderman, J | 1 |
| Fingerhood, M; Holtyn, AF; Leoutsakos, JM; Novak, MD; Silverman, K; Toegel, F | 1 |
| Carter, C; Gold, L; Homayra, F; Krebs, E; MacDonald, S; Min, JE; Nosyk, B | 1 |
| Andraka-Christou, B | 1 |
| Adam, GP; Balk, EM; Becker, SJ; Danko, KJ; Helseth, SA; Saldanha, IJ; Scott, K; Steele, DW | 1 |
| dellaBitta, V; Drainoni, ML; Park, TW; Saitz, R; Sikov, J; Walley, AY | 1 |
| Abatemarco, DJ; Barber, C; Baxter, JK; Cruz, Y; Hand, DJ; Roman, AR; Rosenthal, EW; Short, VL | 1 |
| Evans, EA; Fei, Z; Hser, YI; Kelleghan, A; Matthews, A; Mooney, LJ; Saxon, AJ; Yoo, C; Zhu, Y | 1 |
| Havig, SM; Rogde, S; Thaulow, CH; Vindenes, V; Øiestad, ÅML | 1 |
| Clausen, T; Hesse, M; Seid, AK; Thylstrup, B; Tjagvad, C | 1 |
| Ahounbar, E; Armoon, B; Karamouzian, M; Kebriaeezadeh, A; Mirrahimi, B; Narenjiha, H; Noroozi, A; Salehi, M | 1 |
| Cao, DN; Li, F; Li, J; Wu, N | 1 |
| Bryant, K; Edelman, EJ; Fiellin, DA; Gordon, AJ; Justice, A; Kennedy, AJ; Korthuis, PT; Kraemer, KL; McGinnis, KA; Merlin, JS; Oldfield, B; Skanderson, M; Williams, EC; Wyse, J | 1 |
| Amaro, H; Guerrero, E; Khachikian, T; Kong, Y; Marsh, JC | 1 |
| Furst, JA; McCall, KL; Mynarski, NJ; Piper, BJ | 1 |
| Attalla, D; Attia, J; Cretikos, M; Doyle, MF; Dunlop, AJ; Haber, PS; Howard, MV; Ling, R; Lintzeris, N; Mackson, J; McEntyre, E; Murrell, T; Oldmeadow, C; Roberts, J; Searles, A; White, B | 1 |
| Maina, G; Marshall, K; Sherstobitoff, J | 1 |
| Andraka-Christou, B; Randall-Kosich, O; Totaram, R | 1 |
| Davey, JG; Martin, J; Osborn, DA; Zankl, A | 1 |
| Andraka-Christou, B; Atkins, DN; Clark, MH; Del Pozo, B | 1 |
| Nalven, T; Schick, MR; Spillane, NS; Weyandt, LL | 1 |
| Bierut, LJ; Grucza, RA; Hartz, SM; Mintz, CM; Presnall, NJ; Sahrmann, JM; Xu, KY | 1 |
| Beck, O; Böttcher, M; Keller, T; Lierheimer, S; Monticelli, FC | 1 |
| Ahrens, K; Allen, L; Austin, A; Barnes, AJ; Burns, M; Chang, CH; Clark, S; Cole, E; Crane, D; Cunningham, P; Donohue, JM; Gordon, AJ; Idala, D; Jarlenski, MP; Junker, S; Kennedy, S; Kim, JY; Lanier, P; Mauk, R; McDuffie, MJ; Mohamoud, S; Pauly, N; Sheets, L; Talbert, J; Tang, L; Zivin, K | 1 |
| Arnold, S; Conklen, K; Deshpande, M; Surbeck, E; Vogler, C | 1 |
| Aguilar, L; Álvarez-Navares, A; Casado-Espada, N; Gamonal-Limcaoco, S; Grau-López, L; Lozano-López, MT; Roncero, C; Vicente-Hernández, B | 1 |
| Binder, H; Dürsteler, KM; Falcato, L; Kalbermatten, C; Köck, P; Kormann, A; Krausz, M; Strasser, J; Vogel, M; Walter, M | 1 |
| Griffin, B; Philip, S | 1 |
| Brothers, TD; Fraser, J; MacAdam, E; Morgan, B; Webster, D | 1 |
| Adam, A; Cullen, W; Gorfinkel, L; Hamilton, MA; Klimas, J; Wood, E | 1 |
| Alexander, K; Gerolamo, A; Hassen, N; Kelly, EL; Pogorzelska-Maziarz, M; Rising, KL | 1 |
| Chan, HY; Wei, LC | 1 |
| Groß, G; Soyka, M | 1 |
| Chambers, LC; Daly, M; Gargano, L; Hallowell, BD; McDonald, J; Scagos, RP; Weidele, HR | 1 |
| Arunogiri, S; Barnett, A; Bathish, R; Dunlop, AJ; Graham, R; Haber, P; Hayes, V; Lintzeris, N; Lubman, DI; Savic, M | 1 |
| Astronomo, R; Gornalusse, GG; Hladik, F; Hughes, SM; Kim, Y; Levy, CN; McElrath, J; Ochsenbauer, C; Pandey, U; Valdez, R; Vojtech, LN | 1 |
| Giri, P; Roth, P | 1 |
| Homayra, F; Marchand, C; Mead, A; Min, JE; Ng, J; Nosyk, B; Piske, M; Woolner, M; Zhou, H | 1 |
| Dufort, A; Samaan, Z | 1 |
| Brousseau, NM; Earnshaw, VA; Farmer, H; Hill, EC; Karpyn, A; Kelly, JF; Laurenceau, JP | 1 |
| Eidbo, SA; Hagedorn, JD; Kaufman, DE; Kropp Lopez, AK; Mathew, V; McCall, KL; Nichols, SD; Piper, BJ | 1 |
| Komrowski, MD; Sekhri, NK | 1 |
| Betsch, B; Sethi, R; Singh, G; Sri Konakanchi, J; Thapa, A | 1 |
| Bougatsos, C; Chan, B; Chou, R; Grusing, S; McCarty, D; Priest, KC | 1 |
| Brown, AR | 1 |
| Aujla, R; Boyars, L; Cleary, E; Douglas, E; Guille, C; Smith, C; Sujan, A | 1 |
| Light, T; Madden, EF; Prevedel, S; Sulzer, SH | 1 |
| Hochheimer, M; Unick, GJ | 1 |
| Dougherty, J; Englander, H; Herreid-O'Neill, A; Lovejoy, TI; Mackey, K; Priest, KC; Shull, S; Thoma, J; Wyse, JJ | 1 |
| Kessler, SH; Liss, DB; Schwarz, ES | 1 |
| Curtis, ME; Evans, EA; Hser, YI; Kelleghan, A; Mooney, LJ; Saxon, AJ; Yoo, C; Zhu, Y | 1 |
| Czynski, A; Davis, JM; Devlin, LA; Jones, HE; Kraft, WK; Matthews, AG; Merhar, SL; Poindexter, BB; Salisbury, AL; Wachman, EM; Wakschlag, LS; Winhusen, T; Young, LW | 1 |
| Binswanger, IA; Finlay, AK; Harris, AHS; Smelson, D; Stimmel, M; Taylor, EN; Timko, C | 1 |
| Barbieri, S; Bharat, C; Degenhardt, L; Dobbins, T; Farrell, M; Larney, S | 1 |
| Berger, CA; Crocker, AM; Francis-Fath, S; Sobel, HG; Warrington, JS | 1 |
| Avila-Quintero, VJ; Compton, P; De Aquino, JP; Flores, J; Gómez, O; Hickey, T; Parida, S; Sofuoglu, M | 1 |
| Bart, G; Brooner, RK; Brown, L; Dickson-Gomez, J; Fiellin, DA; Gordon, A; Joudrey, PJ; Kawasaki, SS; Liebschutz, JM; McCarty, D; Nunes, E; Schwartz, RP; Szapocnik, J; Trivedi, M; Tsui, JI; Williams, A; Wu, LT | 1 |
| Bowles, JM; Davidson, PJ; Faul, M; Gaines, TL | 1 |
| Frost, MC; Iles-Shih, MD; Lampert, H; Tsui, JI; Williams, EC | 1 |
| Chen, R; Degenhardt, L; Farrell, M; Larance, B; Nielsen, S; Santo, T; Tran, AD; Zahra, E | 1 |
| Beauchamp, T; Derkzen, D; Farrell MacDonald, S; Fischer, B; Russell, C | 1 |
| Garretto, D; Garry, DJ; Herrera, KM; Iovino, N; Kaplan, C; Kertowidjojo, E; Ly, V; Persad, MD; Staszewski, C | 1 |
| Baldacchino, A; Davey, F; Steele, JD; Tolomeo, S | 1 |
| Assaf, C; Casado, MÁ; Flórez, G; Gómez, M; Gonzalvo, B; Muñoz, A; Notario, P; Oraa, R; Pascual, FS; Seijo, P | 1 |
| Buchman, DZ; Majid, U; Sabioni, P; Salamanca-Buentello, F; Sud, A | 1 |
| Allen, LR; Manini, AF; Nobel, I; Richardson, LD; Shastry, S; Vidal, K | 1 |
| Dale, LM; Kurz, M; Min, JE; Nosyk, B | 1 |
| Bart, G; Blazes, CK; Button, D; Cook, R; Giang, LM; Khuyen, TT; King, C; Korthuis, PT; Kunkel, L; Nguyen, DB; Thuy, DT | 1 |
| Abdukalikov, R; McAullife, A; Quaye, A; Richard, J; Sauer, W; Smith, K; Wang, M; Whitesell, D | 1 |
| Bodkin, C; Bondy, S; Kiefer, L; Kouyoumdjian, F; Regenstreif, L | 1 |
| Olsen, Y | 1 |
| Laks, J; Peterkin, A; Weinstein, ZM | 1 |
| Abdullah, A; Bansal, N; Chawar, C; D'Elia, A; Guan, L; Hillmer, A; Kapczinski, F; Panesar, B; Pare, G; Samaan, Z; Sanger, S; Thabane, L; Xie, DX | 1 |
| Aghvinian, M; Arias, F; Arnsten, JH; Coulehan, K; Cunningham, CO; Mindt, MR; Olsen, JP; Scott, TM | 1 |
| Bromberg, DJ; Karamouzian, M; Pilarinos, A | 1 |
| Degenhardt, L; Forbes, H; Gunnell, D; Hickman, M; Lewer, D; Moran, P; Padmanathan, P; Redaniel, MT; Watson, B | 1 |
| Ashmead, R; Bailey, E; Bickert, T; Bonny, AE; Doogan, NJ; Mack, A; Schmidt, S; Tossone, K; Zhang, P | 1 |
| Farrell, NM; Kehoe, J; Kolodziej, J; Komaromy, M; Laks, J; Taylor, JL; Walley, AY | 1 |
| Binswanger, IA; Calcaterra, SL; Callister, C; Hoover, K; Lockhart, S | 1 |
| Chaisson, CE; Ciemins, E; LaRochelle, MR; Linas, BP; Morgan, JR; Quinn, EK; Stempniewicz, N; Walley, AY; White, LF | 1 |
| Frank, CJ; Morrison, L | 1 |
| Heikkinen, M; Lähteenvuo, M; Mittendorfer-Rutz, E; Taipale, H; Tanskanen, A; Tiihonen, J | 1 |
| Amaducci, AM; Beauchamp, GA; Hanisak, JL; Koons, AL; Laskosky, J; Maron, BM; McLoughlin, TM | 1 |
| Puig, T; Samsó Jofra, L; Solà, I; Trujols, J | 1 |
| Fradkin, D; Kameg, B; Lepore, M | 1 |
| Checkley, L; Knight, KR; Steiger, S | 1 |
| Abdelwahab, M; Cleary, EM; Petrich, M; Rood, KM; Walker, E; Wang, H | 1 |
| Barrass, S; Corace, K; Cragg, S; Hutton, B; Konefal, S; Leece, P; Pana, P; Porath, A; Suschinsky, K; Wyman, J | 1 |
| Ali, R; Byrne, J; Chen, R; Degenhardt, L; Farrell, M; Larance, B; Nielsen, S; Santo, T; Tran, AD; Zahra, E | 1 |
| Dale, RC; Delgado, C; Dinges, EM; Komatsu, R; Nash, M; Peperzak, KA; Terman, GW; Wu, J; Ziga, TM | 1 |
| Beck, M; Kay, A; Shmuts, R | 1 |
| Digbeu, B; Kuo, YF; Priyadarshni, S; Raji, MA; Yu, X | 1 |
| Ball, CM; Featherstone, PJ | 1 |
| Manu, P; Rogozea, LM; Shulman, M | 1 |
| Alawa, J; Bromberg, DJ; Garcia, D; Ghandour, L; Kazemitabar, M; Khoshnood, K; Muhammad, M | 1 |
| Demirkol, A; Murnion, BP | 1 |
| Bailit, JL; Sadananda, GB; Sundaresh, S | 1 |
| Antoniou, T; Bozinoff, N; Campbell, TJ; Garg, R; Gomes, T; Kitchen, SA; Men, S; Munro, C; Tadrous, M; Werb, D; Wyman, J | 2 |
| Cason, R; Comartin, E; Costello, M; Dunnigan, M; Hamameh, N; Kubiak, S; Ray, B; Victor, G; Zettner, C | 1 |
| Anderson-Harper, R; Duello, A; Gochez-Kerr, T; Lohmann, B; Miles, J; Richardson, K; Winograd, RP; Wood, CA | 1 |
| Biondi, BE; Schlossberg, EF; Shaw, A; Springer, SA; Vander Wyk, B | 1 |
| Antoniou, T; Bozinoff, N; Campbell, T; Gomes, T; Mamdani, M; McCormack, D; Munro, C; Paterson, JM; Sproule, B; Tadrous, M | 1 |
| Baldacchino, A; Conti, AA; Hemmati, Z | 1 |
| Antoniou, T; Bozinoff, N; Campbell, TJ; Gomes, T; Kitchen, SA; Men, S; Munro, C; Tadrous, M; Werb, D; Wyman, J | 1 |
| Dromgoole, D; Ghanem, N; Hussein, A; Jermyn, RT | 1 |
| Coffee, Z; Goza, J; Jasmine Silva, M; Rumrill, K | 1 |
| Buttram, ME; Ellis, MS; Kasper, ZA | 1 |
| Cho, P; Jolley, CJ; Kalk, NJ; Kelleher, M; Lozano-García, M; Moxham, J; Rafferty, GF; Strang, J; Tas, B | 1 |
| Bernstein, J; Gray, JR; Greenfield, SF; Hoeppner, BB; Jones, HE; Kelly, JF; MacMillan, KDL; Muftu, S; Partridge, S; Schiff, DM; Terplan, M; Wilens, TE; Work, EC | 1 |
| Challet Bouju, G; Cholet, J; Dany, A; Grall Bronnec, M; Guillou Landreat, M; Hardouin, JB; Laforgue, EJ; Leboucher, J; Victorri Vigneau, C | 1 |
| Douros, A; Farhat, I; Lim, J; Panagiotoglou, D | 1 |
| Godley, MD; Hunter, BD; Mataczynski, MJ; Passetti, LL; Welsh, JW | 1 |
| Beck, SA; Girardin, AL; Potee, BG; Schoenfeld, EM; Simon, C; Soares, WE; Tozloski, JM; Vysetty, S; Westafer, LM | 1 |
| Bart, G; Brown, PCM; Dinh, TTT; Edsall, A; Hoffman, K; Korthuis, PT; Le, MG; Mai, PP; Nguyen, TH | 1 |
| Anguiano, V; Joudrey, PJ; Kolak, M; Lin, Q; Paykin, S; Wang, EA | 1 |
| Chen, Q; Gao, A; Jarlenski, M; Krans, EE; Rothenberger, SD | 1 |
| Frank, D; Guarino, H; Mateu-Gelabert, P; Perlman, DC; Walters, SM | 1 |
| Browne, T; Foster, R; Matheson, C; Schofield, J | 1 |
| Calomarde-Gómez, C; Gual, A; Jiménez-Fernández, B; Lligoña, A; López-Lazcano, A; López-Pelayo, H | 1 |
| Arezoomandan, M; Arezoomandan, R; Eshrati, S; Mehrzad, J; Motavalizadehkakhky, A; Zhiani, R | 1 |
| Butler, GC; Grucza, RA; Presnall, NJ | 1 |
| Ariyawansa, P; Hayllar, J; Khan, T; Quinn, J | 1 |
| Jalali, A; Kapadia, SN; Meinhofer, A; Morgan, JR; Tabatabaeepour, N | 1 |
| Corry, B; Cremer, LJ; Jones, C; Rooks-Peck, CR; Underwood, N | 1 |
| Epstein, RL; Friedman, A; Meinhofer, A; Meisel, ZF; Morgan, JR; Nguemeni Tiako, MJ; South, EC | 1 |
| Anselin, L; Kolak, M; Lin, Q; Pollack, H; Schneider, J; Taylor, B; Watts, B | 1 |
| Coulter, C; Garnier, M; Moore, C | 1 |
| Jalali, MS; Lich, KH; Marrero, WJ; Naumann, RB; Stafford, C; Wakeman, S | 1 |
| Ellis, JD; Epstein, DH; Finan, PH; Mun, CJ; Phillips, KA; Preston, KL | 1 |
| Englander, H; King, CA; Lovejoy, TI; McCarty, D; Priest, KC | 1 |
| Baston, KE; Carroll, G; Ganetsky, VS; Haroz, R; Heil, J; Hunter, K; Ketcham, E; Salzman, MS | 1 |
| Ahamad, K; Brissette, S; Bruneau, J; Fikowski, J; Fischer, B; Gagnon, L; Jutras-Aswad, D; Le Foll, B; Ledjiar, O; Lim, R; Masse, B; Rehm, J; Socias, ME; Wild, TC; Wood, E | 1 |
| Bozinoff, N; Bruneau, J; Choi, JC; Hassan, A; Jutras-Aswad, D; Le Foll, B; Lim, R; Mok, WY; Rehm, J; Socias, ME; Wild, TC; Wood, E | 1 |
| Blosnich, JR; Edelman, EJ; Frost, MC; Hawkins, EJ; Richards, JE; Tsui, JI; Williams, EC | 1 |
| Bodnar, AR; Jablonski, LA; Stewart, RW | 1 |
| Capel, Y; Halliday, LOE; Kearns, RJ; Kinsella, M; Nelson, SM; Shaw, M | 1 |
| Bierut, LJ; Grucza, RA; Mintz, CM; Presnall, N; Xu, KY | 1 |
| Brandt, NJ | 1 |
| Arnold, R; Bulls, H; Dao, E; Fitzgerald Jones, K; Kapo, J; Khodyakov, D; Liebschutz, J; Meier, D; Merlin, J; Paice, J; Ritchie, C | 1 |
| Andraka-Christou, B; Golan, M; Gordon, AJ; Randall-Kosich, O; Saloner, B; Stein, BD; Totaram, R | 1 |
| Angermaier, G; Carswell, N; Castaneda, C; Delgado, F | 1 |
| Gottlieb, DJ; Hoyt, JE; Peltzman, T; Riblet, NB; Shiner, B; Teja, N; Watts, BV | 1 |
| Abare, M; Chyorny, A; Olson, M; Wilhelm-Leen, E; Will, J | 1 |
| Dennis, E; Hu, L; Johnson, A; Kroll, D; Manza, P; McPherson, KL; Tai, B; Volkow, ND | 1 |
| Bottner, R; Buresh, M; Calcaterra, SL; Englander, H; Herzig, SJ; Huerta, S; Lambert, E; Martin, M; O'Brien, MT; Peterkin, AF; Ronan, MV; Snyder, H; Torres-Lockhart, K; Ullal, M; Weimer, MB; Weinstein, ZM; Zaman, T | 1 |
| Chen, AY; Powell, D; Stein, BD | 1 |
| Acton, EK; Bilker, WB; Brensinger, CM; Dawwas, GK; Hennessy, S; Leonard, CE; Li, L; Miano, TA; Neuman, M; Nguyen, TPP; Soprano, SE; Wang, L; Woody, G; Yu, E | 1 |
| Berro, LF; Freeman, KB; Rowlett, JK; Talley, JT; Zamarripa, CA | 1 |
| Chan Osilla, K; Danovitch, I; Friedmann, PD; Huerta, S; Leamon, I; Mazer, MW; Messineo, G; Murray-Krezan, C; Nuckols, T; Ober, AJ; Page, K; Ryzewicz, S; Watkins, KE | 1 |
| Bromley, E; Hunter, SB; Leamon, I; Martinez, J; McCreary, M; Montero, A; Ober, AJ; Sheehe, J; Shih, KJ; Tarn, DM; Watkins, KE | 1 |
| Banks, ML; Blough, BE; Epstein, DH; Negus, SS; Shaham, Y; Townsend, EA | 1 |
| Sadek, J; Saunders, J | 1 |
| Behpour, M; Maghsoudi, M; Nojavan, S | 1 |
| Borquez, A | 1 |
| Keppler, K; Stöver, H | 1 |
| Andraka-Christou, B; Buche, J; Haffajee, RL; Page, C; Schoebel, V | 1 |
| Lin, LC; Lin, WC; Tsai, MC; You, WR | 1 |
| Bisla, J; Cape, A; Cowden, F; Day, E; Dewhurst, J; Evans, R; Gilvarry, E; Hearn, A; Hoare, Z; Hughes, D; Kelleher, M; Kelly, J; Lowry, N; Marsden, J; McCusker, M; Mitcheson, L; Murphy, C; Murray, R; Myton, T; Quarshie, S; Scott, G; Turner, S; Vanderwaal, R; Wareham, A | 1 |
| Di Paola, A; Lier, AJ; Seval, N; Springer, SA; Vander Wyk, B | 1 |
| Cao, C; Shan, X; Yang, B | 1 |
| Bastien, G; Brissette, S; Bruneau, J; Eugenia Socias, M; Foll, BL; Jutras-Aswad, D; Ledjiar, O; Lim, R; Marsan, S; McAnulty, C; Talbot, A | 1 |
| Agius, E; Kollin, R; Lee, G; Madden, EF; Pasman, E; Resko, SM; Rodriguez, B | 1 |
| Blanco, C; Compton, WM; Hodges, K; Jones, CM; Ling, SM; Losby, JL; Shoff, C | 1 |
| Dahan, A; Ellerbroek, H; Kramers, C; Schellekens, AFA; Timmerman, H; van den Heuvel, SAS | 1 |
| Larance, B; Nielsen, S; Tse, WC | 1 |
| Díez-Pascual, AM; Kahrizi, M; Mirinejad, S; Mishra, S; Rahdar, A; Razlansari, M; Sargazi, S; Ulucan-Karnak, F | 1 |
| Díaz, I; Fishman, M; Goodwin, ATS; Luo, S; Nunes, EV; Rotrosen, J; Rudolph, KE; Shulman, M; Williams, NT | 1 |
| Danø, A; Gibbons, C; Jensen, R; Pedersen, MH | 1 |
| Saunders, EC | 1 |
| D M, S; E J, M; K K, A | 1 |
| Cornell, M; Davies, MA; Egger, M; Haas, AD; Johnson, LF; Maartens, G; Ruffieux, Y; Scheibe, A; Tlali, M; Wettstein, AE | 1 |
| Alvanzo, AAH; Antoine, D; Buresh, ME; Ott, GE; Peirce, JM; Tassey, TE | 1 |
| Gadji, M; Gaye, S; Malissin, I; Mégarbane, B; Thiam, MH | 1 |
| Ho Chui, KK; Joshi, C; Skeer, MR; Stopka, TJ | 1 |
| Authier, N; Bertin, C; Chenaf, C; Delorme, J; Kerckhove, N; Pereira, B | 1 |
| Bolton, J; Hoang, H; Laiteerapong, N; Marsh, J; Murugesan, M; Nocon, R; Peterson, L; Pollack, H | 1 |
| Aldabergenov, D; Copeland, CS; Kalk, NJ; Kelleher, MJ; Reynolds, L; Scott, J; Strang, J | 1 |
| Nathan, N | 1 |
| Cowden, F; Day, E; Gilvarry, E; Johnstone, S; Kelleher, M; Lowry, N; Marsden, J; Mitcheson, L; Murray, R | 1 |
| Acuña, AM; Leyrer-Jackson, JM; Olive, MF | 1 |
| Andres, HJ; Arredondo, C; Bentele, KG; Brady, BR; Coles, H; Downer, M; Garcia, RC; Garnett, I; Granillo, B; Lutz, R; Mahoney, A; Meyerson, BE; Russell, DM; Samorano, S | 1 |
| Braunstein, S; Cherian, T; Goldfeld, KS; Jalali, A; Jeng, PJ; Katyal, M; Khan, M; Krawczyk, N; Lee, JD; Lim, S; MacDonald, R; McDonald, R; Murphy, SM; Wiewel, E | 1 |
| Cheng, A; Garrity, K; Hey, SP; Lee, JD; Lindquist, K; Malone, M; McDonald, R; McNeely, J; Pace, N; Roberts, T; Schatz, D; Sugarman, A; Tofighi, B; Vittitow, A; Williams, O | 1 |
| Cretikos, M; Dunlop, AJ; Haber, PS; Howard, MV; Ling, R; Lintzeris, N; Reeves, P; Roberts, J; Searles, A; White, B | 1 |
| Banducci, AN; Camacho-Cook, J; Chen, DC; Davenport, M; Gibson, TB; Head, M; Henke, R; Hyde, J; Jayanthi, S; LeBeau, LS; Livingston, NA; Meng, F; Mulvaney-Day, N; Roth, C; Sarpong, A; Stein, MD; Weisberg, R; White, M | 1 |
| Abedini, M; Amirinejad, M; Haghpanah, T; Moinaddini, F; Nematollahi-Mahani, SN; Yoosefi, F | 1 |
| Bayoumi, AM; Besharah, J; Bitonti-Bengert, L; Chen, C; Crichlow, F; Gomes, T; Kahan, M; Kendall, C; Kocovska, E; Leece, P; Manson, H; Munro, C; Nosyk, B; Paul, LA; Raboud, JM; Rosella, LC; Rush, B; Smith, BT; Spithoff, S; Strike, C; Taha, S; Watford, J; Wright, A; Yu, M | 1 |
| Bateman, BT; Connery, HS; Davis, JM; Gray, KJ; Hernández-Díaz, S; Huybrechts, KF; Jones, HE; Lester, B; Mogun, H; Straub, L; Suarez, EA; Terplan, M | 1 |
| Buttram, ME; Ellis, MS; Qureshi, R | 1 |
| Baconi, DL; Ciobanu, AM; Ciucă Anghel, DM; Guțu, CM; Stan, M; Tudor, G | 1 |
| Cox, DF; Craig, AK; Cutler, AJ; Gabrielson, SMB; Picarillo, AP | 1 |
| Dekeseredy, P; Haggerty, T; Sedney, CL; Turiano, NA; Turner, T | 1 |
| Bastien, G; Brissette, S; Hassan, AN; Jutras-Aswad, D; Le Foll, B; Ledjiar, O; Lim, R; Marsan, S; McAnulty, C; Socias, ME; Talbot, A | 1 |
| Decker, E; El Metwally, D; Gopalakrishnan, M; Hughes Driscoll, CA; Ronan, K | 1 |
| Tamburello, A | 1 |
| Díaz, I; Luo, SX; Nunes, EV; Rotrosen, J; Rudolph, KE; Williams, NT | 1 |
| Kahila, HK; Kanervo, MM; Nikkola, EM; Rantakari, KM; Tupola, SJ | 1 |
| Batki, SL; Baxley, C; Becker, W; Borsari, B; Herbst, E; Manuel, JK; Pennington, D; Reavis, JV; Seal, K | 1 |
| Konakanchi, JS; Salapenka, I; Sethi, R | 1 |
| Ellis, JD; Greenwald, MK; Ledgerwood, DM; Lister, JJ; Wohl, MJA | 1 |
| Konakanchi, JS; Sethi, R | 1 |
| Brothers, TN; Hartzema, A; Lewkowitz, AK; Meador, KJ; Pawasauskas, J; Quilliam, BJ; Wang, S; Ward, KE; Wen, X | 1 |
| Carlson, KF; Gordon, AJ; Korthuis, PT; Liberto, JG; Lindner, S; Lovejoy, TI; Morasco, BJ; Ono, SS; Shull, S; Wyse, JJ | 1 |
| Levy, I; Marom, A; Rosca, P | 1 |
| Dumont, GJH; Neven, A | 1 |
| Dale, L; Guerra-Alejos, BC; Kurz, M; Min, JE; Nosyk, B; Piske, M | 1 |
| Allen, E; Altobelli, G; Holmwood, C; Johnson, J; Samadian, S | 1 |
| Krans, EE; Lim, G; Sanjanwala, AR | 1 |
| Caputo, A; Christopher, C; Compton, P; Delgado, MK; Lowenstein, M; McFadden, R; Olenik, JM; Perrone, J; Ronning, K; Sigueza, AL; Thakrar, AP; Uritsky, TJ; Winston, A | 1 |
| Ali, R; Degenhardt, L; Hickman, M; Jones, NR; Larney, S; Nielsen, S | 1 |
| Bateman, BT; Huybrechts, KF; Suarez, EA | 1 |
| Balise, RR; Brandt, L; Castillo, F; Feaster, DJ; Hu, MC; Liu, Y; Luo, SX; Nunes, EV; Odom, GJ | 1 |
| Benyamina, A; Karila, L | 1 |
| Bierut, LJ; Carter, EB; Grucza, RA; Jones, HE; Kelly, JC; Martin, CE; Schiff, DM; Xu, KY | 1 |
| Barry, CL; Busch, AB; Eisenberg, MD; Hollander, M; Huskamp, HA; Kennedy-Hendricks, A; Meiselbach, MK; Schilling, C; Stuart, EA | 1 |
| Bisaga, A; Dresser, L; Fishman, M; Ghitza, UE; Greiner, MG; Hamilton, A; Hefner, K; Ho, R; Jelstrom, E; Nunes, EV; Opara, O; Potter, K; Rotrosen, J; Scheele, C; Shulman, M; Tafessu, HM; Voronca, DC | 1 |
| Ashraf, W; Hodge, A; Kelleher, M; Lowry, N; Marsden, J; McClean, K; Mitcheson, L; Scott, G; Turner, S | 1 |
| Calcaterra, S; Kulick, B; Ray, L; Terasaki, D | 1 |
| Elmore, AL; Fryer, K; Marshall, J; McNeer, E; Mehra, S; Patrick, SW; Reid, CN; Salemi, JL; Sappenfield, WM | 1 |
| Bakouni, H; Bastien, G; Brissette, S; Elkrief, L; Hébert, FO; Jutras-Aswad, D; Le Foll, B; Ledjiar, O; Lim, R; Marsan, S; McAnulty, C; Socias, ME | 1 |
| Heapy, AA; MacLean, RR; Meyerovich, J; Sofuoglu, M; Szollosy, SK; Waters, AJ; Wolkowicz, N | 1 |
| Carroll, G; Haroz, R; Heil, J; Huo, S; Salzman, MS | 1 |
| Bush, H; Chen, J; Dwoskin, LP; Fouladvand, S; Kavuluru, R; Meadows, AL; Mishra, YR; Peterson, LE; Roggenkamp, SK; Talbert, J; Wang, F | 1 |
| Beckwith, C; Benck, KN; Jones, AK; Nowotny, KM; Omori, M; Rubinstein, LB; Seide, K | 1 |
| Batty, E; Booty, MD; Harp, K; Knudsen, HK; Oser, CB; Staton, M | 1 |
| Chander, G; Pytell, JD; Stoller, KB; Thakrar, AP; Walters, V; Weiss, RD | 1 |
| Fanucchi, L; Lofwall, M; South, AM | 1 |
| Cox, KM; Doyle, M; Marsch, LA; McLeman, BM; Murray, OB; Ryer, J; Saunders, EC; Watts, D | 1 |
| Cornett, EM; Edinoff, AN; Flanagan, CJ; Jackson, ED; Kaye, AD; Kaye, AM; Pearl, NZ; Sinnathamby, ES; Wenger, DM | 1 |
| Enns, B; Jutras-Aswad, D; Krebs, E; Le Foll, B; Nosyk, B; Socias, ME; Whitehurst, DGT | 1 |
| Clark, B; Degenhardt, L; Farrell, M; Hickman, M; Kimber, J; Larance, B; Leppan, O; Macpherson, G; Martino-Burke, D; Nielsen, S; Zahra, E | 1 |
| Bradford, AC; Cantor, JH; Simon, K; Stein, BD; Taylor, EA | 1 |
| Achu, R; Bateman, BT; Gibbs, L; Guang, Z; Holland, E; Saia, K; Spence, NZ; Wachman, EM; Werler, MM; Young, M | 1 |
| Mahmood, T; Savona-Ventura, C; Vella, A | 1 |
| Case, P; Green, TC; Hughto, JMW; Moyo, P; Palacios, WR; Rapisarda, SS; Silcox, J; Stopka, TJ; Tapper, A | 1 |
| Bozinoff, N; Cheol Choi, J; Eugenia Socias, M; Jutras-Aswad, D; Le Foll, B; Lim, R; Mocanu, V; Wood, E; Yin Mok, W | 1 |
| Andersen, CU; Eriksen, T; Lund, T; Mortensen, JB; Møller, T; Pedersen, S; Sædder, EA | 1 |
| Brar, R; Choi, JC; Debeck, K; Eugenia Socias, M; Fairbairn, N; Hayashi, K; Johnson, C; Wilson, D | 1 |
| Haigney, MCP; Kao, DP; Kleiman, RB; Klein, M; Krantz, MJ; Rudo, TJ; Stockbridge, N | 1 |
| Fowler, S; Fox, AD; Jakubowski, A | 1 |
| Ahamad, K; Bakouni, H; Foll, BL; Jutras-Aswad, D; Lim, R; McAnulty, C; Socias, ME; Tatar, O | 1 |
| Havard, A; Kelty, E; Preen, DB | 1 |
| Abraham, AJ; Harris, SJ; Yarbrough, CR | 1 |
| Astemborski, J; Cepeda, JA; Genberg, BL; Kirk, GD; Mehta, SH; Rudolph, JE | 1 |
| Duran-Sindreu, S; Portella, MJ; Trujols, J; Vicent-Gil, M | 1 |
| Abu-Obaid, R; Achtyes, ED; Allgaier, B; Amaratunga, P; Lee-Easton, MJ; Levitas, M; Lorenz-Lemberg, B; Magura, S; Reed, P | 1 |
| Maiti, R; Mishra, BR; Mohapatra, D; Padhan, M | 1 |
| Gleeson, J; Haddad, GG; Hu, D; Wang, J; Wang, L; Wu, W; Yao, H; Zhao, HH | 1 |
| Brown, R; Chan, B; Cooper, HLF; Crane, HM; de Gijsel, D; Delaney, JA; Feinberg, J; Fredericksen, R; Friedmann, PD; Go, VF; Jenkins, WD; Korthuis, PT; Miller, WC; Mixson, LS; Pho, MT; Seal, DW; Smith, GS; Stopka, TJ; Tsui, JI; Westergaard, R; Whitney, BM; Young, AM; Zule, WA | 1 |
| Kuhn, S; Lehmann, K; Schulte, B; Verthein, U | 1 |
| Graziane, N; Patel, K; Waldron, D | 1 |
| Berger, NA; Davis, PB; Kaelber, DC; Volkow, ND; Wang, L; Xu, R | 1 |
| Asadi, M; Jamshidi, A; Kheirabadi, G; Mahdavi, F; Niroumand Sarvandani, M | 1 |
| Balise, RR; Castillo, F; Feaster, DJ; Hu, MC; Liu, Y; Luo, SX; Nunes, EV; Rotrosen, J; Saxon, AJ; Weiss, RD | 1 |
| Calcaterra, SL; Lockhart, S; Mikulich, S; Natvig, C | 1 |
| Bech, AB; Clausen, T; McDonald, R | 1 |
| Castellanos, S; Joshi, N; Knight, KR; Lambdin, BH; Shapiro, B; Steiger, S; Suen, LW | 1 |
| Bukten, A; Clausen, T; Gabrhelík, R; Handal, M; Hesse, M; Mravčík, V; Nechanská, B; Seid, AK; Skurtveit, S; Thylstrup, B; Tjagvad, C | 1 |
| Dasgupta, N; Edwards, JK; Figgatt, MC; Golightly, YM; Hincapie-Castillo, JM; Jackson, BE; Marshall, SW; Schranz, AJ | 1 |
| Bart, G; Bratberg, J; Burns, AL; Cochran, G; DiPaula, BA; Elmes, A; Ghitza, UE; Green, TC; Hill, LG; Homsted, F; Hsia, SL; Jarrett, JB; Legreid Dopp, A; Matthews, ML; Wu, LT | 1 |
| Carr, MM; Cave, S; Martino, S; Masheb, R; Midboe, AM; Wolkowicz, NR | 1 |
305 review(s) available for methadone and buprenorphine
| Article | Year |
|---|---|
[Delayed-action opioids--limitations and advantages].
Topics: Buprenorphine; Delayed-Action Preparations; Humans; Methadone; Morphine; Pain; Palliative Care | 1990 |
Buprenorphine: beyond methadone?
Topics: Acquired Immunodeficiency Syndrome; Buprenorphine; Cocaine; Humans; Methadone; Opioid-Related Disorders; Risk Factors; Substance Abuse, Intravenous; Substance-Related Disorders | 1991 |
Clinical toxicology of drugs used in the treatment of opiate dependency.
Topics: Buprenorphine; Clonidine; Humans; Methadone; Methadyl Acetate; Naltrexone; Opioid-Related Disorders | 1990 |
Behavioral pharmacology of buprenorphine.
Topics: Adult; Animals; Buprenorphine; Conditioning, Operant; Eating; Heroin Dependence; Humans; Macaca; Male; Methadone; Morphinans; Naltrexone; Opioid-Related Disorders; Reinforcement, Psychology; Self Administration | 1985 |
Managing illicit drug use. A practical guide.
Topics: Buprenorphine; Counseling; Disulfiram; Humans; Methadone; Methadyl Acetate; Naltrexone; Psychotherapy; Self-Help Groups; Substance Abuse Treatment Centers; Substance-Related Disorders | 1994 |
[Do substitution treatments reduce the incidence of human immunodeficiency virus infections in intravenous heroin addicts? Review of pertinent literature].
Topics: Acquired Immunodeficiency Syndrome; Buprenorphine; Codeine; Female; Heroin Dependence; HIV Infections; HIV Seropositivity; HIV Seroprevalence; Humans; Incidence; Male; Methadone; Prospective Studies; Risk Factors; Self Medication; Sex Work; Sexual Behavior; Substance Abuse, Intravenous | 1994 |
Common errors in the pharmacologic treatment of drug dependence and withdrawal.
Topics: Behavior Therapy; Buprenorphine; Clonidine; Humans; Lithium; Methadone; Narcotics; Nicotine; Psychotherapy; Substance Withdrawal Syndrome; Thiamine | 1994 |
Opiate addiction and the locus coeruleus. The clinical utility of clonidine, naltrexone, methadone, and buprenorphine.
Topics: Animals; Buprenorphine; Clonidine; Humans; Locus Coeruleus; Methadone; Naltrexone; Opioid-Related Disorders; Substance Withdrawal Syndrome | 1993 |
Buprenorphine as a pharmacotherapy for cocaine abuse: a review of the evidence.
Topics: Analgesics, Opioid; Buprenorphine; Cocaine; Dose-Response Relationship, Drug; Female; Humans; Male; Methadone; Substance-Related Disorders | 1995 |
What is important in drug misuse treatment?
Topics: Buprenorphine; Clonidine; Humans; Methadone; Naltrexone; Narcotic Antagonists; Substance Withdrawal Syndrome; Substance-Related Disorders; United Kingdom | 1996 |
Screening for drugs of abuse (II): Cannabinoids, lysergic acid diethylamide, buprenorphine, methadone, barbiturates, benzodiazepines and other drugs.
Topics: Barbiturates; Benzodiazepines; Buprenorphine; Cannabinoids; Cyclizine; Dextropropoxyphene; Drug Combinations; Fentanyl; Humans; Ketamine; Lysergic Acid Diethylamide; Methadone; Pentazocine; Substance Abuse Detection | 1997 |
[Substitution therapy of drug addicts].
Topics: Analgesics, Opioid; Buprenorphine; Female; Humans; Methadone; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Pregnancy, High-Risk; Prognosis; Substance-Related Disorders | 1998 |
Treatment considerations in the opioid dependent patient.
Topics: Analgesics, Opioid; Buprenorphine; Drug and Narcotic Control; Humans; Methadone; Methadyl Acetate; Opioid-Related Disorders; Treatment Outcome | 1999 |
[Drug withdrawal therapies].
Topics: Ambulatory Care; Buprenorphine; Combined Modality Therapy; Drug Administration Schedule; Humans; Methadone; Neurologic Examination; Patient Admission; Patient Care Team; Substance Withdrawal Syndrome; Substance-Related Disorders | 1999 |
Pharmacologic treatment of heroin-dependent patients.
Topics: Analgesics, Opioid; Buprenorphine; Counseling; Heroin Dependence; Humans; Mental Disorders; Methadone; Methadyl Acetate; Naltrexone; Narcotic Antagonists; Physician's Role; Substance Withdrawal Syndrome | 2000 |
[Contemporary methods in pharmacotherapy in the opiate dependent treatment].
Topics: Adrenergic alpha-Agonists; Buprenorphine; Clonidine; Heroin Dependence; Humans; Inactivation, Metabolic; Methadone; Naltrexone; Narcotic Antagonists; Narcotics | 2000 |
A meta-analysis comparing buprenorphine to methadone for treatment of opiate dependence.
Topics: Analysis of Variance; Buprenorphine; Humans; Methadone; Narcotics; Opioid-Related Disorders; Patient Compliance; Patient Dropouts; Proportional Hazards Models; Treatment Outcome | 2001 |
A meta-analysis comparing the effectiveness of buprenorphine and methadone.
Topics: Buprenorphine; Female; Humans; Male; Methadone; Opioid-Related Disorders; Substance Withdrawal Syndrome; Treatment Outcome | 2000 |
Retention rate and illicit opioid use during methadone maintenance interventions: a meta-analysis.
Topics: Buprenorphine; Humans; Methadone; Methadyl Acetate; Narcotics; Opioid-Related Disorders; Patient Dropouts; Randomized Controlled Trials as Topic; Substance Abuse Detection; Treatment Outcome | 2002 |
[Blessing or problem child? Substitution therapy for opiate-addicted patients].
Topics: Buprenorphine; Heroin Dependence; Humans; Methadone; Narcotics; Opioid-Related Disorders | 2002 |
Toxicologic aspects of heroin substitution treatment.
Topics: Buprenorphine; Hair; Heroin Dependence; Humans; Methadone; Methadyl Acetate; Narcotics; Saliva; Sweat | 2002 |
Pharmacotherapy of addictions.
Topics: Alcoholism; Buprenorphine; Humans; Methadone; Naltrexone; Narcotic Antagonists; Receptors, Opioid, mu; Substance-Related Disorders | 2002 |
History and current status of opioid maintenance treatments: blending conference session.
Topics: Buprenorphine; Clinical Trials as Topic; History, 20th Century; Humans; Methadone; Methadyl Acetate; Naloxone; Narcotic Antagonists; Narcotics; Opioid-Related Disorders | 2002 |
[Buprenorphine as maintenance treatment in rehabilitation of heroin addicts].
Topics: Buprenorphine; Dose-Response Relationship, Drug; Heroin Dependence; Humans; Methadone; Narcotics; Receptors, Opioid | 2002 |
[Is buprenorphine a potential alternative to methadone for treating pregnant drug users? Inventory of clinical data in the literature].
Topics: Buprenorphine; Female; Humans; Infant, Newborn; Methadone; Narcotic Antagonists; Narcotics; Neonatal Abstinence Syndrome; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Substance-Related Disorders | 2002 |
Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence.
Topics: Buprenorphine; Humans; Methadone; Narcotic Antagonists; Narcotics; Opioid-Related Disorders; Randomized Controlled Trials as Topic | 2002 |
From morphine clinics to buprenorphine: regulating opioid agonist treatment of addiction in the United States.
Topics: Analgesics, Opioid; Behavior, Addictive; Buprenorphine; Humans; Methadone; Morphine; Opioid-Related Disorders; Substance Abuse Treatment Centers; United States; United States Food and Drug Administration | 2003 |
Clinical efficacy of buprenorphine: comparisons to methadone and placebo.
Topics: Buprenorphine; Controlled Clinical Trials as Topic; Humans; Methadone; Narcotic Antagonists; Opioid-Related Disorders; Placebos; Substance Withdrawal Syndrome | 2003 |
Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence.
Topics: Buprenorphine; Humans; Methadone; Narcotic Antagonists; Narcotics; Opioid-Related Disorders; Randomized Controlled Trials as Topic | 2003 |
Pharmacologic treatments for heroin and cocaine dependence.
Topics: Buprenorphine; Clonidine; Cocaine-Related Disorders; Comorbidity; Heroin Dependence; Humans; Mental Disorders; Methadone; Methadyl Acetate; Naltrexone; Narcotic Antagonists; Narcotics | 2003 |
Behavioral health issue brief: pharmacotherapy treatment of alcoholism and drug addiction: overview and bibliography: year end report-2002.
Topics: Alcohol Deterrents; Alcoholism; Analgesics, Opioid; Buprenorphine; Drug Therapy; Humans; Methadone; Methadyl Acetate; Naltrexone; Narcotic Antagonists; Substance-Related Disorders; United States | 2002 |
[Substitution therapy in drug addictions].
Topics: Buprenorphine; Ganglionic Stimulants; Heroin Dependence; Humans; Methadone; Narcotics; Nicotine; Prognosis; Substance-Related Disorders; Tobacco Use Disorder; Treatment Outcome | 2003 |
Substitution management in opioid dependence.
Topics: Animals; Buprenorphine; Drug Therapy, Combination; Humans; Methadone; Opioid-Related Disorders | 2003 |
Treating opioid dependence. Growing implications for primary care.
Topics: Analgesics, Opioid; Arrhythmias, Cardiac; Buprenorphine; Europe; Humans; Methadone; Methadyl Acetate; Opioid-Related Disorders; Prevalence; Primary Health Care; Substance Withdrawal Syndrome; United States | 2004 |
Effectiveness of interventions on opiate withdrawal treatment: an overview of systematic reviews.
Topics: Adrenergic alpha-Agonists; Antidepressive Agents, Tricyclic; Buprenorphine; Humans; Methadone; Narcotic Antagonists; Narcotics; Opioid-Related Disorders; Reproducibility of Results; Review Literature as Topic; Secondary Prevention; Substance Withdrawal Syndrome; Time Factors; Treatment Outcome | 2004 |
Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence.
Topics: Buprenorphine; Humans; Methadone; Narcotic Antagonists; Narcotics; Opioid-Related Disorders; Randomized Controlled Trials as Topic | 2004 |
Pharmacological treatments for substance use disorders.
Topics: Adrenergic beta-Antagonists; Alcohol Deterrents; Anti-Anxiety Agents; Benzodiazepines; Buprenorphine; Disulfiram; Humans; Methadone; Naltrexone; Narcotic Antagonists; Narcotics; Neurobiology; Neuropharmacology; Psychopharmacology; Substance Withdrawal Syndrome; Substance-Related Disorders | 2004 |
[Therapeutic strategies for opioid addiction: the role of substitution therapy].
Topics: Buprenorphine; Female; Humans; Mental Disorders; Methadone; Narcotic Antagonists; Narcotics; Opioid-Related Disorders; Patient Selection; Physician's Role; Pregnancy; Pregnancy Complications; Prisoners; Psychotropic Drugs; Social Support | 2004 |
Decreasing international HIV transmission: the role of expanding access to opioid agonist therapies for injection drug users.
Topics: Buprenorphine; Drug Evaluation; Health Services Accessibility; HIV Infections; Humans; Methadone; Narcotic Antagonists; Narcotics; Substance Abuse, Intravenous | 2005 |
The effectiveness of community maintenance with methadone or buprenorphine for treating opiate dependence.
Topics: Adolescent; Adult; Aged; Buprenorphine; Community Health Services; Humans; Methadone; Middle Aged; Narcotic Antagonists; Narcotics; Opioid-Related Disorders; Primary Health Care; Randomized Controlled Trials as Topic | 2005 |
Justification for routine screening of pharmaceutical products in immune function tests: a review of the recommendations of Putman et al. (2003).
Topics: Adrenergic beta-Agonists; Albuterol; Animals; Buprenorphine; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Guidelines as Topic; Humans; Immune System Diseases; Immunity; Methadone; Morphine; Narcotics; Salmeterol Xinafoate | 2005 |
An overview of systematic reviews of the effectiveness of opiate maintenance therapies: available evidence to inform clinical practice and research.
Topics: Buprenorphine; Humans; Information Dissemination; Methadone; Narcotic Antagonists; Opioid-Related Disorders; Research; Substance Abuse Treatment Centers | 2005 |
From opioid maintenance to abstinence: a literature review.
Topics: Buprenorphine; Humans; Inactivation, Metabolic; Methadone; Narcotic Antagonists; Opioid-Related Disorders; Time Factors; Treatment Outcome | 2005 |
Treatment of opioid dependence and coinfection with HIV and hepatitis C virus in opioid-dependent patients: the importance of drug interactions between opioids and antiretroviral agents.
Topics: Anti-Retroviral Agents; Antiretroviral Therapy, Highly Active; Buprenorphine; Drug Evaluation; Drug Interactions; Hepatitis C; HIV Infections; Humans; Methadone; Narcotics; Protease Inhibitors; Substance Abuse, Intravenous | 2005 |
Pharmaco-economics of community maintenance for opiate dependence: a review of evidence and methodology.
Topics: Buprenorphine; Community Mental Health Services; Cost-Benefit Analysis; Evaluation Studies as Topic; Health Status; Humans; Methadone; Narcotics; Opioid-Related Disorders | 2006 |
Acute pain management for patients receiving maintenance methadone or buprenorphine therapy.
Topics: Acute Disease; Adult; Analgesics, Opioid; Buprenorphine; Female; Heroin Dependence; Humans; Methadone; Narcotic Antagonists; Pain; Recurrence; Ulna Fractures | 2006 |
Provider satisfaction with office-based treatment of opioid dependence: a systematic review.
Topics: Ambulatory Care; Attitude of Health Personnel; Buprenorphine; Cooperative Behavior; Humans; Methadone; Narcotics; Opioid-Related Disorders; Patient Care Team; Physician-Patient Relations; Physicians, Family | 2005 |
A critical appraisal of the Australian comparative trial of methadone and buprenorphine maintenance.
Topics: Australia; Buprenorphine; Cost-Benefit Analysis; Data Interpretation, Statistical; Evaluation Studies as Topic; Heroin Dependence; Humans; Methadone; Randomized Controlled Trials as Topic; Research Design | 2006 |
Pharmacokinetic drug interactions between opioid agonist therapy and antiretroviral medications: implications and management for clinical practice.
Topics: Acquired Immunodeficiency Syndrome; Analgesics, Opioid; Anti-HIV Agents; Buprenorphine; Drug Interactions; HIV Infections; Humans; Methadone | 2006 |
Opiate addiction in China: current situation and treatments.
Topics: Buprenorphine; China; Clonidine; Drugs, Chinese Herbal; HIV Infections; Humans; Methadone; Naltrexone; Narcotic Antagonists; Narcotics; Opioid-Related Disorders; Substance Abuse, Intravenous; Substance Withdrawal Syndrome; Sympatholytics | 2006 |
Multimodal drug addiction treatment: a field comparison of methadone and buprenorphine among heroin- and cocaine-dependent patients.
Topics: Adult; Buprenorphine; Cocaine-Related Disorders; Female; Heroin Dependence; Humans; Male; Methadone; Narcotics; Occupational Therapy; Psychiatric Status Rating Scales; Social Support; Substance Abuse Detection; Substance-Related Disorders; Treatment Outcome | 2006 |
Non-commercial clinical trials of a medicinal product: can they survive the current process of research approvals in the UK?
Topics: Analgesics, Opioid; Buprenorphine; Drug Approval; Ethics, Research; Humans; Methadone; Multicenter Studies as Topic; Prisons; Randomized Controlled Trials as Topic; State Medicine; United Kingdom | 2006 |
Pharmacokinetic interactions between HIV antiretroviral therapy and drugs used to treat opioid dependence.
Topics: Animals; Anti-HIV Agents; Buprenorphine; Drug Interactions; Humans; Methadone; Methadyl Acetate; Narcotic Antagonists; Narcotics; Opioid-Related Disorders | 2006 |
Innovations in agonist maintenance treatment of opioid-dependent patients.
Topics: Buprenorphine; Controlled Clinical Trials as Topic; Delayed-Action Preparations; Heroin; Humans; Methadone; Morphine; Narcotics; Opioid-Related Disorders; Quality of Life | 2006 |
The medical management of opioid dependence in HIV primary care settings.
Topics: Anti-HIV Agents; Buprenorphine; HIV Infections; Humans; Methadone; Narcotic Antagonists; Narcotics; Opioid-Related Disorders; Primary Health Care; Substance Abuse, Intravenous | 2006 |
Opioid dependence: rationale for and efficacy of existing and new treatments.
Topics: Buprenorphine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Female; Humans; Male; Methadone; Naloxone; Narcotic Antagonists; Opioid-Related Disorders; Prognosis; Risk Assessment; Substance Abuse Detection; Substance Withdrawal Syndrome; Treatment Outcome | 2006 |
Initial strategies for integrating buprenorphine into HIV care settings in the United States.
Topics: Antiretroviral Therapy, Highly Active; Buprenorphine; Centers for Disease Control and Prevention, U.S.; Delivery of Health Care, Integrated; Female; Health Resources; Health Services Needs and Demand; HIV Infections; Humans; Male; Methadone; Naloxone; Narcotic Antagonists; Opioid-Related Disorders; Patient Selection; Primary Health Care; Program Evaluation; Risk Assessment; Substance Abuse Treatment Centers; United States | 2006 |
Buprenorphine use: the international experience.
Topics: Antiretroviral Therapy, Highly Active; Buprenorphine; Comorbidity; Female; Follow-Up Studies; Global Health; Heroin Dependence; HIV Infections; Humans; International Cooperation; Male; Methadone; Narcotic Antagonists; Patient Selection; Quality of Health Care; Risk Assessment; Substance Abuse, Intravenous; Treatment Outcome; World Health Organization | 2006 |
Methadone and buprenorphine for the management of opioid dependence: a systematic review and economic evaluation.
Topics: Analgesics, Opioid; Buprenorphine; Cost-Benefit Analysis; Female; Heroin Dependence; Humans; Male; Methadone | 2007 |
Buprenorphine for opioid dependence.
Topics: Analgesics, Opioid; Buprenorphine; Humans; Methadone; Opioid-Related Disorders | 2007 |
Adherence to HIV treatment among IDUs and the role of opioid substitution treatment (OST).
Topics: Antiretroviral Therapy, Highly Active; Buprenorphine; HIV Infections; Humans; Methadone; Narcotics; Opioid-Related Disorders; Patient Compliance; Substance Abuse Treatment Centers; Substance Abuse, Intravenous | 2007 |
Behavioral counseling content for optimizing the use of buprenorphine for treatment of opioid dependence in community-based settings: a review of the empirical evidence.
Topics: Adaptation, Psychological; Buprenorphine; Cognitive Behavioral Therapy; Combined Modality Therapy; Counseling; Humans; Methadone; Motivation; Narcotic Antagonists; Narcotics; Opioid-Related Disorders; Patient Dropouts; Secondary Prevention; Substance Abuse Treatment Centers; Treatment Outcome; United States | 2007 |
Buprenorphine in the treatment of opioid dependence.
Topics: Buprenorphine; Heroin Dependence; Humans; Methadone; Narcotic Antagonists; Treatment Outcome | 2007 |
Methadone and buprenorphine treatment during pregnancy: what are the effects on infants?
Topics: Analgesics, Opioid; Buprenorphine; Female; Fetus; Humans; Infant, Low Birth Weight; Infant, Newborn; Methadone; Neonatal Abstinence Syndrome; Pregnancy; Pregnancy Complications; Prenatal Care; Substance Withdrawal Syndrome; Substance-Related Disorders | 2007 |
Office-based maintenance treatment of opioid dependence: how does it compare with traditional approaches?
Topics: Analgesics, Opioid; Buprenorphine; Humans; Methadone; Office Visits; Opioid-Related Disorders; Primary Health Care | 2008 |
Treatment of opioid-dependent pregnant women: clinical and research issues.
Topics: Analgesics, Opioid; Buprenorphine; Clinical Trials as Topic; Decision Making; Female; Humans; Infant, Newborn; Methadone; Opioid-Related Disorders; Pain; Pregnancy; Pregnancy Complications | 2008 |
Pharmacologic treatments for opioid dependence: detoxification and maintenance options.
Topics: Analgesics, Opioid; Animals; Buprenorphine; Humans; Inactivation, Metabolic; Methadone; Naloxone; Opioid-Related Disorders; Substance Withdrawal Syndrome | 2007 |
Opioid dependence and pregnancy.
Topics: Buprenorphine; Female; Humans; Methadone; Narcotics; Opioid-Related Disorders; Pregnancy | 2008 |
Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence.
Topics: Buprenorphine; Humans; Methadone; Narcotic Antagonists; Narcotics; Opioid-Related Disorders; Randomized Controlled Trials as Topic | 2008 |
Maintenance agonist treatments for opiate dependent pregnant women.
Topics: Birth Weight; Buprenorphine; Female; Humans; Infant; Infant, Newborn; Methadone; Narcotics; Opioid-Related Disorders; Pregnancy; Pregnancy Complications; Randomized Controlled Trials as Topic | 2008 |
Narrative review: buprenorphine for opioid-dependent patients in office practice.
Topics: Adult; Buprenorphine; Drug Combinations; Female; Humans; Methadone; Naloxone; Narcotic Antagonists; Narcotics; Opioid-Related Disorders; Patient Care Planning; Physician's Role; Primary Health Care | 2008 |
Practical considerations for the clinical use of buprenorphine.
Topics: Buprenorphine; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Interactions; Education, Continuing; Health Services Accessibility; Humans; Methadone; Naloxone; Narcotic Antagonists; Narcotics; Opioid-Related Disorders; Patient Education as Topic; Patient Selection | 2004 |
Treating pregnant women dependent on opioids is not the same as treating pregnancy and opioid dependence: a knowledge synthesis for better treatment for women and neonates.
Topics: Buprenorphine; Diagnosis, Dual (Psychiatry); Female; GABA Modulators; Humans; Infant, Newborn; Mental Disorders; Methadone; Narcotics; Neonatal Abstinence Syndrome; Opioid-Related Disorders; Phenobarbital; Pregnancy; Pregnancy Complications | 2008 |
Psychotherapeutic benefits of opioid agonist therapy.
Topics: Anxiety Disorders; Brain; Buprenorphine; Comorbidity; Depressive Disorder; Diagnosis, Dual (Psychiatry); Dose-Response Relationship, Drug; Humans; Methadone; Narcotics; Opioid-Related Disorders; Receptors, Neurotransmitter | 2008 |
A literature review of international implementation of opioid substitution treatment in prisons: equivalence of care?
Topics: Buprenorphine; Heroin Dependence; HIV Infections; Humans; International Cooperation; Methadone; Naltrexone; Narcotic Antagonists; Patient Care; Prisoners; Prisons | 2009 |
Pediatric palliative care: use of opioids for the management of pain.
Topics: Administration, Cutaneous; Administration, Oral; Analgesics, Opioid; Buprenorphine; Child; Delayed-Action Preparations; Fentanyl; Humans; Hydromorphone; Methadone; Morphine; Narcotics; Pain; Palliative Care | 2009 |
The implications of medication development in the treatment of substance use disorders in developing countries.
Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Buprenorphine; Comorbidity; Developing Countries; Disulfiram; HIV Infections; Humans; Methadone; Narcotic Antagonists; Prevalence; Public Policy; Substance Abuse, Intravenous; Substance-Related Disorders; Taurine | 2009 |
Long-acting opioid-agonists in the treatment of heroin addiction: why should we call them "substitution"?
Topics: Arousal; Brain; Buprenorphine; Delayed-Action Preparations; Heroin; Heroin Dependence; Humans; Immunocompetence; Methadone; Motivation; Narcotics; Receptors, Opioid; Treatment Outcome | 2009 |
Buprenorphine/naloxone: a review of its use in the treatment of opioid dependence.
Topics: Buprenorphine; Clinical Trials as Topic; Drug Combinations; Drug Interactions; Humans; Methadone; Naloxone; Narcotic Antagonists; Opioid-Related Disorders | 2009 |
Maintenance treatments for opiate dependent adolescent.
Topics: Adolescent; Buprenorphine; Humans; Methadone; Methadyl Acetate; Naloxone; Narcotics; Opioid-Related Disorders; Randomized Controlled Trials as Topic; Young Adult | 2009 |
[Accompanying patients in substitution treatment for opiates: consulting and coaching in the office]].
Topics: Buprenorphine; Counseling; Drug Delivery Systems; Drug Tolerance; Humans; Methadone; Narcotics; Opioid-Related Disorders; Patient Education as Topic; Pharmacies | 2009 |
Opioid dependence treatment: options in pharmacotherapy.
Topics: Adrenergic alpha-Agonists; Analgesics, Opioid; Buprenorphine; Clinical Trials as Topic; Humans; Methadone; Narcotic Antagonists; Opioid-Related Disorders; Substance Withdrawal Syndrome | 2009 |
[Abuse of alcohol and benzodiazepine during substitution therapy in heroin addicts: a review of the literature].
Topics: Adolescent; Adult; Alcoholism; Benzodiazepines; Buprenorphine; Clonazepam; Clorazepate Dipotassium; Comorbidity; Controlled Clinical Trials as Topic; Diazepam; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Ethanol; Euphoria; Flunitrazepam; Heroin Dependence; Humans; Metabolic Clearance Rate; Methadone; Narcotics; Substance-Related Disorders; Young Adult | 2009 |
[Opiate replacement therapy in France: assessment of the public policies].
Topics: Buprenorphine; France; Health Policy; Humans; Legislation, Medical; Mental Disorders; Methadone; Narcotic Antagonists; Narcotics; Opioid-Related Disorders; Substance-Related Disorders | 2009 |
[Mechanisms of opioid-induced overdose: experimental approach to clinical concerns].
Topics: Analgesics, Opioid; Animals; Buprenorphine; Drug Interactions; Drug Overdose; France; Humans; Methadone; Narcotic Antagonists; Narcotics; Opioid-Related Disorders; Respiratory System | 2009 |
A comparison of methadone, buprenorphine and alpha(2) adrenergic agonists for opioid detoxification: a mixed treatment comparison meta-analysis.
Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-Agonists; Buprenorphine; Clonidine; Data Interpretation, Statistical; Humans; Methadone; Narcotic Antagonists; Narcotics; Odds Ratio; Opioid-Related Disorders; Randomized Controlled Trials as Topic; Treatment Outcome | 2010 |
Does opioid substitution treatment in prisons reduce injecting-related HIV risk behaviours? A systematic review.
Topics: Buprenorphine; Health Knowledge, Attitudes, Practice; HIV Infections; Humans; Methadone; Narcotics; Needle Sharing; Prisons; Risk-Taking; Substance Abuse, Intravenous | 2010 |
The pharmacological treatment of opioid addiction--a clinical perspective.
Topics: Adrenergic Agonists; Analgesics, Opioid; Buprenorphine; Clonidine; Drug Therapy, Combination; Humans; Inactivation, Metabolic; Methadone; Naloxone; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders; Social Support; Substance Withdrawal Syndrome | 2010 |
Efficacy of opiate maintenance therapy and adjunctive interventions for opioid dependence with comorbid cocaine use disorders: A systematic review and meta-analysis of controlled clinical trials.
Topics: Behavior Therapy; Buprenorphine; Cocaine-Related Disorders; Humans; Methadone; Narcotics; Opioid-Related Disorders; Treatment Outcome | 2009 |
HIV prevention, treatment, and care services for people who inject drugs: a systematic review of global, regional, and national coverage.
Topics: Africa; Anti-Retroviral Agents; Buprenorphine; Europe; HIV Infections; Humans; Methadone; Middle East; Narcotic Antagonists; Needle-Exchange Programs; Substance Abuse, Intravenous | 2010 |
[Treatment of acute pain during drug-assisted rehabilitation].
Topics: Acetaminophen; Acute Disease; Analgesics, Non-Narcotic; Analgesics, Opioid; Anti-Inflammatory Agents, Non-Steroidal; Buprenorphine; Glucocorticoids; Humans; Ketamine; Methadone; Opioid-Related Disorders; Pain; Pain, Postoperative; Surgical Procedures, Operative | 2010 |
Prenatal drug exposure: infant and toddler outcomes.
Topics: Buprenorphine; Child Development; Child, Preschool; Cocaine; Cocaine-Related Disorders; Female; Heroin; Humans; Infant; Infant, Newborn; Male; Methadone; Neonatal Abstinence Syndrome; Pregnancy; Prenatal Exposure Delayed Effects; Substance-Related Disorders | 2010 |
Methadone, buprenorphine, and street drug interactions with antiretroviral medications.
Topics: Analgesics, Opioid; Anti-HIV Agents; Buprenorphine; Drug Interactions; HIV Infections; Humans; Illicit Drugs; Methadone; Opioid-Related Disorders; Ritonavir | 2010 |
The management of heroin misuse in pregnancy: time for a rethink?
Topics: Buprenorphine; Child, Preschool; Developmental Disabilities; Female; Heroin Dependence; Humans; Infant; Infant, Newborn; Maternal-Fetal Exchange; Methadone; Opiate Substitution Treatment; Pregnancy; Pregnancy Complications; Prenatal Care; Prenatal Exposure Delayed Effects | 2011 |
Treatment and care for injecting drug users with HIV infection: a review of barriers and ways forward.
Topics: Anti-HIV Agents; Anti-Retroviral Agents; Buprenorphine; China; Cost-Benefit Analysis; Developing Countries; Drug Costs; Health Services Accessibility; HIV Infections; Humans; Income; Malaysia; Methadone; Narcotic Antagonists; Narcotics; Narration; Prisoners; Prisons; Russia; Substance Abuse, Intravenous; Ukraine; Vietnam | 2010 |
Drug treatment as HIV prevention: expanding treatment options.
Topics: Alcoholism; Buprenorphine; Clinical Protocols; Drug Users; Health Promotion; HIV Infections; Humans; Methadone; Naltrexone; Opiate Substitution Treatment; Risk Reduction Behavior; Risk-Taking; Substance Abuse, Intravenous; Substance-Related Disorders | 2010 |
Buprenorphine: a more accessible treatment for opioid dependence.
Topics: Analgesics, Opioid; Buprenorphine; Counseling; Humans; Methadone; Opioid-Related Disorders; United States | 2010 |
Heroin anticraving medications: a systematic review.
Topics: Buprenorphine; Heroin; Heroin Dependence; Humans; Methadone; Naltrexone; Narcotic Antagonists; Narcotics; Opiate Substitution Treatment; Opioid-Related Disorders; Randomized Controlled Trials as Topic; Substance Withdrawal Syndrome | 2010 |
Drug interactions associated with methadone, buprenorphine, cocaine, and HIV medications: implications for pregnant women.
Topics: Anti-HIV Agents; Buprenorphine; Cocaine; Drug Interactions; Female; HIV Infections; Humans; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Pregnancy; Pregnancy Complications; Pregnancy Complications, Infectious; Substance-Related Disorders | 2011 |
Opioid dependence.
Topics: Analgesics, Opioid; Behavior Therapy; Buprenorphine; Cognitive Behavioral Therapy; Humans; Methadone; Narcotic Antagonists; Opioid-Related Disorders; Psychotherapy; Substance Withdrawal Syndrome; United States | 2011 |
Prenatal exposure to methadone and buprenorphine: a review of the potential effects on cognitive development.
Topics: Analgesics, Opioid; Buprenorphine; Child; Child Development; Cognition; Female; Humans; Male; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Pregnancy; Prenatal Exposure Delayed Effects | 2011 |
Prescription pain medication dependence.
Topics: Analgesics; Buprenorphine; Humans; Methadone; Naltrexone; Narcotic Antagonists; Opiate Substitution Treatment; Pain; Prescription Drugs; Substance-Related Disorders | 2011 |
Opioid dependence.
Topics: Analgesics, Opioid; Buprenorphine; Evidence-Based Medicine; Heroin Dependence; Humans; Incidence; Methadone; Naltrexone; Opioid-Related Disorders | 2009 |
Oral substitution treatment of injecting opioid users for prevention of HIV infection.
Topics: Administration, Oral; Buprenorphine; HIV Infections; Humans; Methadone; Narcotics; Opioid-Related Disorders; Randomized Controlled Trials as Topic; Risk-Taking; Sexual Behavior; Substance Abuse, Intravenous | 2011 |
Intrauterine abstinence syndrome (IAS) during buprenorphine inductions and methadone tapers: can we assure the safety of the fetus?
Topics: Buprenorphine; Epigenesis, Genetic; Female; Fetal Diseases; Humans; Methadone; Narcotics; Pregnancy; Substance Withdrawal Syndrome | 2012 |
Update on the pharmacologic management of neonatal abstinence syndrome.
Topics: Benzodiazepines; Buprenorphine; Clonidine; Female; Humans; Hypnotics and Sedatives; Infant, Newborn; Methadone; Narcotics; Neonatal Abstinence Syndrome; Phenobarbital; Pregnancy | 2011 |
Psychosocial and pharmacological treatments versus pharmacological treatments for opioid detoxification.
Topics: Adult; Buprenorphine; Combined Modality Therapy; Female; Humans; Male; Methadone; Narcotics; Opioid-Related Disorders; Psychotherapy; Randomized Controlled Trials as Topic | 2011 |
Opioid dependence.
Topics: Analgesics, Opioid; Buprenorphine; Evidence-Based Medicine; Heroin Dependence; Humans; Incidence; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Treatment Outcome | 2011 |
The effectiveness of opioid maintenance treatment in prison settings: a systematic review.
Topics: Buprenorphine; Cocaine-Related Disorders; Continuity of Patient Care; Crime; Epidemiologic Methods; Heroin Dependence; Humans; Illicit Drugs; Methadone; Narcotics; Opiate Substitution Treatment; Opioid-Related Disorders; Patient Compliance; Prisoners; Risk-Taking; Treatment Outcome | 2012 |
[Breast feeding during methadon- and buprenorphin therapy].
Topics: Analgesics, Opioid; Breast Feeding; Buprenorphine; Contraindications; Dose-Response Relationship, Drug; Female; Germany; Humans; Infant; Infant, Newborn; Male; Metabolic Clearance Rate; Methadone; Milk, Human; Neonatal Abstinence Syndrome; Opiate Substitution Treatment; Opioid-Related Disorders; Pregnancy | 2011 |
Acute pain management in opioid-tolerant patients: a growing challenge.
Topics: Acute Disease; Analgesics; Analgesics, Opioid; Animals; Australia; Buprenorphine; Buprenorphine, Naloxone Drug Combination; Drug Tolerance; Humans; Hyperalgesia; Illicit Drugs; Methadone; Naloxone; Narcotic Antagonists; Narcotics; New Zealand; Opiate Substitution Treatment; Opioid-Related Disorders; Pain; Pain, Postoperative; Patient Discharge; Preoperative Care; Substance Withdrawal Syndrome | 2011 |
Comparison of methadone and buprenorphine for opiate detoxification (LEEDS trial): a randomised controlled trial.
Topics: Administration, Oral; Administration, Sublingual; Adult; Aged; Buprenorphine; Humans; Methadone; Middle Aged; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Prisoners; Young Adult | 2011 |
Buprenorphine-mediated transition from opioid agonist to antagonist treatment: state of the art and new perspectives.
Topics: Biological Availability; Buprenorphine; Chemistry, Pharmaceutical; Humans; Methadone; Naltrexone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Substance Withdrawal Syndrome | 2012 |
Opioid detoxification and naltrexone induction strategies: recommendations for clinical practice.
Topics: Adrenergic alpha-2 Receptor Agonists; Buprenorphine; Clinical Protocols; Clonidine; Drug Administration Schedule; Drug Therapy, Combination; Humans; Methadone; Naltrexone; Narcotic Antagonists; Narcotics; Opiate Substitution Treatment; Opioid-Related Disorders; Substance Withdrawal Syndrome | 2012 |
Management of opioid substitution therapy during medical intervention.
Topics: Analgesics; Australia; Buprenorphine; Comorbidity; Drug Interactions; Female; Humans; Liver Diseases; Mental Disorders; Methadone; Naloxone; Opiate Substitution Treatment; Pain; Pain Management; Palliative Care; Polypharmacy; Pregnancy; Pregnancy Complications; Respiratory Insufficiency; Substance-Related Disorders; Virus Diseases | 2012 |
Naltrexone in the treatment of opioid-dependent pregnant women: the case for a considered and measured approach to research.
Topics: Buprenorphine; Female; Humans; Infant, Newborn; Methadone; Naltrexone; Narcotic Antagonists; Narcotics; Neonatal Abstinence Syndrome; Opiate Substitution Treatment; Opioid-Related Disorders; Pregnancy; Pregnancy Complications; Risk Assessment; Risk Factors; Treatment Outcome | 2013 |
Methadone and buprenorphine for the management of opioid dependence in pregnancy.
Topics: Analgesics, Opioid; Buprenorphine; Female; Humans; Infant, Newborn; Methadone; Neonatal Abstinence Syndrome; Opiate Substitution Treatment; Opioid-Related Disorders; Pregnancy; Pregnancy Complications; Randomized Controlled Trials as Topic | 2012 |
Maintenance medication for opiate addiction: the foundation of recovery.
Topics: Analgesics, Opioid; Buprenorphine; Humans; Long-Term Care; Methadone; Naltrexone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Substance Withdrawal Syndrome; Treatment Outcome | 2012 |
Novel pharmacotherapeutic strategies for treatment of opioid-induced neonatal abstinence syndrome.
Topics: Analgesics, Opioid; Buprenorphine; Female; Humans; Immunotherapy; Infant, Newborn; Methadone; Neonatal Abstinence Syndrome; Opiate Substitution Treatment; Pregnancy; Selective Serotonin Reuptake Inhibitors | 2013 |
Buprenorphine treatment of opioid-dependent pregnant women: a comprehensive review.
Topics: Buprenorphine; Child Development; Female; Fetus; Humans; Infant, Newborn; Length of Stay; Methadone; Milk, Human; Morphine; Narcotic Antagonists; Neonatal Abstinence Syndrome; Opiate Substitution Treatment; Opioid-Related Disorders; Pain Management; Patient Dropouts; Pregnancy; Pregnancy Complications; Prenatal Exposure Delayed Effects; Randomized Controlled Trials as Topic; Substance Abuse Detection; Treatment Outcome | 2012 |
Medications development for opioid abuse.
Topics: Analgesics, Opioid; Buprenorphine; Choice Behavior; Endocannabinoids; Evidence-Based Medicine; Humans; Methadone; Naltrexone; Narcotic Antagonists; Narcotics; Neuroglia; Opioid-Related Disorders; Receptors, Opioid, mu; Reinforcement, Psychology; Self Administration; Substance Withdrawal Syndrome; Treatment Outcome | 2013 |
Clinical management of drug-drug interactions in HCV therapy: challenges and solutions.
Topics: Anti-Infective Agents; Antidepressive Agents; Antiviral Agents; Buprenorphine; Cardiovascular Agents; Drug Interactions; Drug Therapy, Combination; Hepatitis C, Chronic; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypnotics and Sedatives; Hypoglycemic Agents; Immunosuppressive Agents; Methadone; Opiate Substitution Treatment | 2013 |
Long term outcomes of pharmacological treatments for opioid dependence: does methadone still lead the pack?
Topics: Buprenorphine; Heroin; Heroin Dependence; Humans; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Time Factors; Treatment Outcome | 2014 |
Pharmacological maintenance treatments of opiate addiction.
Topics: Buprenorphine; Drug Overdose; Heroin; Heroin Dependence; Humans; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Reinforcement, Psychology; Substance Withdrawal Syndrome; Time Factors | 2014 |
Opioid addiction in pregnancy.
Topics: Analgesics, Opioid; Breast Feeding; Buprenorphine; Female; Humans; Infant, Newborn; Methadone; Neonatal Abstinence Syndrome; Opiate Substitution Treatment; Opioid-Related Disorders; Pain Management; Pregnancy; Pregnancy Complications | 2012 |
Can patients receiving opioid maintenance therapy safely drive? A systematic review of epidemiological and experimental studies on driving ability with a focus on concomitant methadone or buprenorphine administration.
Topics: Accidents, Traffic; Analgesics, Opioid; Automobile Driving; Buprenorphine; Humans; Methadone; Opiate Substitution Treatment; Psychomotor Performance; Risk Assessment | 2013 |
Breastfeeding and substance abuse.
Topics: Breast Feeding; Buprenorphine; Cocaine; Contraindications; Dronabinol; Ethanol; Female; Heroin; Humans; Infant; Lactation; Methadone; Milk, Human; Substance-Related Disorders | 2013 |
Metabolic and toxicological considerations of the opioid replacement therapy and analgesic drugs: methadone and buprenorphine.
Topics: Analgesics, Opioid; Animals; Buprenorphine; Drug Interactions; Humans; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Pain | 2013 |
Mitigating the risk of HIV infection with opioid substitution treatment.
Topics: Antiretroviral Therapy, Highly Active; Buprenorphine; Comorbidity; Evidence-Based Medicine; Harm Reduction; HIV Infections; Humans; Incidence; Medication Adherence; Methadone; Needle Sharing; Opiate Substitution Treatment; Opioid-Related Disorders; Risk Factors; Substance Abuse, Intravenous; Tuberculosis; Unsafe Sex | 2013 |
A review of pharmacological interactions between HIV or hepatitis C virus medications and opioid agonist therapy: implications and management for clinical practice.
Topics: Acquired Immunodeficiency Syndrome; Analgesics, Opioid; Anti-Retroviral Agents; Buprenorphine; Drug Interactions; Hepatitis C; HIV Infections; Humans; Methadone; Opiate Substitution Treatment; Receptors, Opioid | 2013 |
Retention of participants in medication-assisted programs in low- and middle-income countries: an international systematic review.
Topics: Analgesics, Opioid; Buprenorphine; Developing Countries; Humans; Medication Adherence; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders | 2014 |
Chronic opioid use during pregnancy: maternal and fetal implications.
Topics: Analgesics, Opioid; Buprenorphine; Female; Humans; Infant, Newborn; Methadone; Neonatal Abstinence Syndrome; Opiate Substitution Treatment; Opioid-Related Disorders; Pregnancy; Pregnancy Complications; Prenatal Care | 2013 |
Management of neonatal abstinence syndrome from opioids.
Topics: Analgesics, Opioid; Buprenorphine; Feeding Methods; Humans; Infant Care; Infant, Newborn; Methadone; Morphine; Neonatal Abstinence Syndrome; Opiate Substitution Treatment; Pacifiers; Treatment Outcome | 2013 |
Managing opioid dependence in pregnancy -- a general practice perspective.
Topics: Adult; Buprenorphine; Female; General Practice; Humans; Methadone; Narcotics; Neonatal Abstinence Syndrome; Opiate Substitution Treatment; Opioid-Related Disorders; Practice Guidelines as Topic; Pregnancy; Pregnancy Complications; Prenatal Care; Young Adult | 2013 |
The prevalence of sexual dysfunction among male patients on methadone and buprenorphine treatments: a meta-analysis study.
Topics: Buprenorphine; Humans; Male; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Prevalence; Sexual Dysfunction, Physiological; Sexual Dysfunctions, Psychological | 2014 |
Pharmacological interventions for drug-using offenders.
Topics: Adult; Buprenorphine; Criminals; Female; Heroin; Humans; Male; Methadone; Naltrexone; Narcotics; Randomized Controlled Trials as Topic; Substance-Related Disorders | 2013 |
Maintenance agonist treatments for opiate-dependent pregnant women.
Topics: Birth Weight; Buprenorphine; Delayed-Action Preparations; Female; Humans; Infant; Infant, Newborn; Methadone; Morphine; Narcotics; Opioid-Related Disorders; Pregnancy; Pregnancy Complications; Randomized Controlled Trials as Topic | 2013 |
Mixed κ/μ partial opioid agonists as potential treatments for cocaine dependence.
Topics: Analgesics, Opioid; Animals; Buprenorphine; Cocaine-Related Disorders; Dose-Response Relationship, Drug; Humans; Methadone; Peptides, Cyclic; Receptors, Opioid, kappa; Receptors, Opioid, mu; Structure-Activity Relationship | 2014 |
Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence.
Topics: Buprenorphine; Humans; Maintenance Chemotherapy; Methadone; Narcotic Antagonists; Narcotics; Opioid-Related Disorders; Randomized Controlled Trials as Topic | 2014 |
Buprenorphine and methadone for opioid addiction during pregnancy.
Topics: Analgesics, Opioid; Buprenorphine; Drug Administration Schedule; Female; Humans; Methadone; Neonatal Abstinence Syndrome; Opiate Substitution Treatment; Opioid-Related Disorders; Practice Guidelines as Topic; Pregnancy; Pregnancy Complications; Pregnant Women; Prenatal Exposure Delayed Effects; Substance-Related Disorders; Treatment Outcome | 2014 |
Neonatal opioid withdrawal syndrome.
Topics: Analgesics, Opioid; Breast Feeding; Buprenorphine; Female; Humans; Infant, Newborn; Male; Methadone; Neonatal Abstinence Syndrome; Opiate Substitution Treatment; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Risk Factors; Substance-Related Disorders; United States | 2014 |
Maintenance treatments for opiate -dependent adolescents.
Topics: Adolescent; Buprenorphine; Humans; Maintenance Chemotherapy; Methadone; Methadyl Acetate; Naloxone; Narcotics; Opiate Substitution Treatment; Opioid-Related Disorders; Randomized Controlled Trials as Topic | 2014 |
Addiction disorders.
Topics: Alcohol Deterrents; Analgesics, Opioid; Buprenorphine; Cognitive Behavioral Therapy; Comorbidity; Harm Reduction; Humans; Mass Screening; Methadone; Motivational Interviewing; Narcotic Antagonists; Narcotics; Opiate Substitution Treatment; Physician-Patient Relations; Primary Health Care; Secondary Prevention; Self-Help Groups; Substance Abuse Detection; Substance Withdrawal Syndrome; Substance-Related Disorders; Surveys and Questionnaires | 2014 |
Prenatal buprenorphine versus methadone exposure and neonatal outcomes: systematic review and meta-analysis.
Topics: Buprenorphine; Female; Humans; Infant, Newborn; Methadone; Models, Statistical; Neonatal Abstinence Syndrome; Opiate Substitution Treatment; Opioid-Related Disorders; Pregnancy; Pregnancy Complications; Treatment Outcome | 2014 |
Review of the assessment and management of neonatal abstinence syndrome.
Topics: Breast Feeding; Buprenorphine; Clonidine; Female; Humans; Infant, Newborn; Methadone; Narcotics; Neonatal Abstinence Syndrome; Opiate Substitution Treatment; Pregnancy; Pregnancy Complications; Prenatal Exposure Delayed Effects | 2014 |
Medications for addiction treatment: an opportunity for prescribing clinicians to facilitate remission from alcohol and opioid use disorders.
Topics: Acamprosate; Analgesics, Opioid; Behavior, Addictive; Buprenorphine; Directive Counseling; Disulfiram; Humans; Methadone; Naltrexone; Narcotic Antagonists; Practice Patterns, Physicians'; Substance-Related Disorders; Taurine; United States | 2014 |
[Therapy in heroin addiction].
Topics: Adrenergic alpha-2 Receptor Agonists; Analgesics, Opioid; Buprenorphine; Euphoria; Heroin; Heroin Dependence; Humans; Methadone; Naltrexone; Narcotic Antagonists; Narcotics; Opiate Substitution Treatment | 2014 |
Alcohol use disorders in opioid maintenance therapy: prevalence, clinical correlates and treatment.
Topics: Alcohol Drinking; Alcohol-Related Disorders; Brain; Buprenorphine; Chemical and Drug Induced Liver Injury; Comorbidity; Humans; Methadone; Narcotics; Opiate Substitution Treatment; Opioid-Related Disorders; Prevalence | 2015 |
Treating tobacco use disorder in pregnant women in medication-assisted treatment for an opioid use disorder: a systematic review.
Topics: Analgesics, Opioid; Behavior Therapy; Buprenorphine; Female; Humans; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Pregnancy; Smoking Cessation; Tobacco Use Disorder; Treatment Outcome | 2015 |
Medication assisted treatment discontinuation in pregnant and postpartum women with opioid use disorder.
Topics: Buprenorphine; Female; Humans; Kaplan-Meier Estimate; Methadone; Narcotic Antagonists; Narcotics; Opiate Substitution Treatment; Opioid-Related Disorders; Patient Dropouts; Postpartum Period; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Retrospective Studies | 2015 |
[Analgesic management of acute pain in patients receiving methadone or buprenorphine].
Topics: Acute Pain; Analgesics, Opioid; Buprenorphine; Drug Tolerance; Drug Users; Humans; Methadone; Morphine; Opiate Substitution Treatment; Opioid-Related Disorders; Pain Management | 2015 |
Pharmacological options for the management of refractory cancer pain-what is the evidence?
Topics: Acetaminophen; Analgesics, Opioid; Anti-Inflammatory Agents, Non-Steroidal; Antidepressive Agents; Buprenorphine; Drug Therapy, Combination; Drug Tolerance; Humans; Methadone; Neoplasms; Pain Management; Pain, Intractable | 2015 |
Responding to illicit drug use in family practice.
Topics: Analgesics, Opioid; Buprenorphine; Chronic Disease; Disease Management; Family Practice; Humans; Illicit Drugs; Methadone; Primary Health Care; Substance-Related Disorders | 2015 |
Pharmacological interventions for drug-using offenders.
Topics: Adult; Buprenorphine; Crime; Criminals; Female; Heroin; Humans; Male; Methadone; Naltrexone; Narcotics; Opiate Substitution Treatment; Randomized Controlled Trials as Topic; Substance-Related Disorders | 2015 |
Pharmacological Management of Opioid Use Disorder in Pregnant Women.
Topics: Analgesics, Opioid; Animals; Buprenorphine; Female; Humans; Infant, Newborn; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Pregnancy; Pregnancy Complications | 2015 |
Retention in medication-assisted treatment for opiate dependence: A systematic review.
Topics: Behavior Therapy; Buprenorphine; Heroin; Humans; Methadone; Naltrexone; Narcotic Antagonists; Narcotics; Opiate Substitution Treatment; Opioid-Related Disorders; Randomized Controlled Trials as Topic; Treatment Outcome | 2016 |
Opioid substitution therapy: Lowering the treatment thresholds.
Topics: Buprenorphine; Health Services Accessibility; Humans; Methadone; Narcotics; Opiate Substitution Treatment; Opioid-Related Disorders; Patient Compliance; Waiting Lists | 2016 |
New Pain Management Options for the Surgical Patient on Methadone and Buprenorphine.
Topics: Buprenorphine; Drug Administration Schedule; Female; Humans; Methadone; Neonatal Abstinence Syndrome; Opiate Substitution Treatment; Opioid-Related Disorders; Pain Management; Pain, Postoperative; Postpartum Period; Practice Guidelines as Topic; Pregnancy; Pregnancy Outcome | 2016 |
A Perspective on Opioid Pharmacotherapy: Where We Are and How We Got Here.
Topics: Analgesics, Opioid; Buprenorphine; Humans; Methadone; Naltrexone; Opiate Substitution Treatment; Opioid-Related Disorders | 2016 |
Opioids and Opioid Maintenance Therapies: Their Impact on Monocyte-Mediated HIV Neuropathogenesis.
Topics: AIDS Dementia Complex; Analgesics, Opioid; Blood-Brain Barrier; Buprenorphine; Cell Movement; HIV Infections; Humans; Maintenance Chemotherapy; Methadone; Monocytes; Narcotic Antagonists; Narcotics; Substance Abuse, Intravenous | 2016 |
Breastfeeding among Mothers on Opioid Maintenance Treatment: A Literature Review.
Topics: Analgesics, Opioid; Breast Feeding; Buprenorphine; Female; Health Promotion; Humans; Infant, Newborn; Methadone; Neonatal Abstinence Syndrome; Opiate Substitution Treatment; Opioid-Related Disorders | 2016 |
Drug interactions between buprenorphine, methadone and hepatitis C therapeutics.
Topics: Animals; Antiviral Agents; Buprenorphine; Drug Interactions; Hepatitis C; Humans; Methadone; Opioid-Related Disorders; Substance Abuse, Intravenous | 2016 |
Opioid agonist treatment for pharmaceutical opioid dependent people.
Topics: Analgesics, Opioid; Buprenorphine; Humans; Methadone; Narcotics; Opiate Substitution Treatment; Opioid-Related Disorders; Prescription Drug Misuse; Randomized Controlled Trials as Topic | 2016 |
Buprenorphine Versus Methadone for Opioid Dependence in Pregnancy.
Topics: Buprenorphine; Female; Humans; Infant; Infant, Newborn; Length of Stay; Methadone; Neonatal Abstinence Syndrome; Opiate Substitution Treatment; Opioid-Related Disorders; Pregnancy; Pregnancy Complications; Randomized Controlled Trials as Topic | 2016 |
Buprenorphine compared with methadone to treat pregnant women with opioid use disorder: a systematic review and meta-analysis of safety in the mother, fetus and child.
Topics: Abnormalities, Drug-Induced; Analgesics, Opioid; Birth Weight; Buprenorphine; Female; Fetal Death; Fetal Development; Humans; Infant, Newborn; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Patient Safety; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Premature Birth; Prenatal Care; Randomized Controlled Trials as Topic; Sudden Infant Death | 2016 |
Pharmacotherapy for Substance Use Disorders.
Topics: Age Factors; Alcohol Deterrents; Alcoholism; Antidepressive Agents; Buprenorphine; Bupropion; Drug Therapy, Combination; Humans; Methadone; Naltrexone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Recurrence; Substance Withdrawal Syndrome; Substance-Related Disorders; Tobacco Use Cessation Devices; Tobacco Use Disorder; Varenicline | 2016 |
Impact of Opioid Substitution Therapy on Antiretroviral Therapy Outcomes: A Systematic Review and Meta-Analysis.
Topics: Anti-Retroviral Agents; Antiretroviral Therapy, Highly Active; Buprenorphine; CD4 Lymphocyte Count; HIV Infections; Humans; Medication Adherence; Methadone; Odds Ratio; Opiate Substitution Treatment; Publication Bias; Substance-Related Disorders; Treatment Outcome; Viral Load | 2016 |
Treatment of Opioid-Use Disorders.
Topics: Adrenergic alpha-Agonists; Buprenorphine; Humans; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Substance Withdrawal Syndrome | 2016 |
Pharmacotherapy for Neonatal Abstinence Syndrome: Choosing the Right Opioid or No Opioid at All.
Topics: Analgesics; Buprenorphine; Clonidine; Drug Therapy, Combination; Humans; Hypnotics and Sedatives; Infant, Newborn; Methadone; Morphine; Neonatal Abstinence Syndrome; Opiate Substitution Treatment; Phenobarbital | 2016 |
Caring for patients with opioid use disorder in the hospital.
Topics: Acute Pain; Analgesics, Non-Narcotic; Analgesics, Opioid; Buprenorphine; Buprenorphine, Naloxone Drug Combination; Drug Overdose; Hospitalization; Humans; Methadone; Naloxone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Respiration, Artificial; Substance Withdrawal Syndrome | 2016 |
Opioid dependence and pregnancy: minimizing stress on the fetal brain.
Topics: Brain Diseases; Buprenorphine; Female; Fetal Diseases; Humans; Methadone; Opioid-Related Disorders; Pregnancy; Pregnancy Complications | 2017 |
Update on pharmacotherapy for treatment of opioid use disorder.
Topics: Adrenergic alpha-2 Receptor Agonists; Buprenorphine; Clonidine; Combined Modality Therapy; Humans; Methadone; Naltrexone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Treatment Outcome | 2016 |
The Role of Behavioral Interventions in Buprenorphine Maintenance Treatment: A Review.
Topics: Behavior Therapy; Buprenorphine; Cocaine-Related Disorders; Combined Modality Therapy; Heroin Dependence; Humans; Long-Term Care; Methadone; Opioid-Related Disorders; Outcome and Process Assessment, Health Care; Patient Compliance; Patient Preference; Randomized Controlled Trials as Topic | 2017 |
Buprenorphine for managing opioid withdrawal.
Topics: Acute Disease; Buprenorphine; Clonidine; Female; Humans; Male; Methadone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Randomized Controlled Trials as Topic; Substance Withdrawal Syndrome | 2017 |
Peripartum Anesthetic Management of the Opioid-tolerant or Buprenorphine/Suboxone-dependent Patient.
Topics: Analgesics, Opioid; Buprenorphine; Buprenorphine, Naloxone Drug Combination; Female; Humans; Methadone; Neonatal Abstinence Syndrome; Opiate Substitution Treatment; Opioid-Related Disorders; Peripartum Period; Pregnancy; Pregnancy Complications; Treatment Outcome | 2017 |
Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies.
Topics: Buprenorphine; Drug Overdose; Humans; Methadone; Narcotics; Opiate Substitution Treatment; Opioid-Related Disorders; Risk | 2017 |
Neonatal Abstinence Syndrome: Update on Diagnostic and Therapeutic Strategies.
Topics: Analgesics, Opioid; Antidepressive Agents; Buprenorphine; Female; Humans; Infant, Newborn; Methadone; Neonatal Abstinence Syndrome; Neurodevelopmental Disorders; Opiate Substitution Treatment; Pregnancy | 2017 |
Update on Barriers to Pharmacotherapy for Opioid Use Disorders.
Topics: Analgesics, Opioid; Buprenorphine; Health Services Accessibility; Humans; Methadone; Naltrexone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; United States | 2017 |
Use and misuse of opioid agonists in opioid addiction.
Topics: Analgesics, Opioid; Buprenorphine; Humans; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Prevalence; United States | 2017 |
A Retrospective Cohort Study of Obstetric Outcomes in Opioid-Dependent Women Treated with Implant Naltrexone, Oral Methadone or Sublingual Buprenorphine, and Non-Dependent Controls.
Topics: Administration, Oral; Administration, Sublingual; Buprenorphine; Drug Implants; Female; Humans; Methadone; Naltrexone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Retrospective Studies | 2017 |
Methadone, Buprenorphine, and Naltrexone for the Treatment of Opioid Use Disorder in Pregnant Women.
Topics: Analgesics, Opioid; Animals; Buprenorphine; Female; Humans; Infant, Newborn; Methadone; Naltrexone; Neonatal Abstinence Syndrome; Opiate Substitution Treatment; Opioid-Related Disorders; Pregnancy; Pregnancy Complications; Treatment Outcome | 2017 |
Buprenorphine implants in medical treatment of opioid addiction.
Topics: Analgesics, Opioid; Buprenorphine; Delayed-Action Preparations; Drug Implants; Humans; Methadone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders | 2017 |
[Treatment of acute pain in opioid addicts].
Topics: Acute Pain; Analgesics, Opioid; Buprenorphine; Humans; Methadone; Morphine; Opiate Substitution Treatment; Opioid-Related Disorders; Pain Management; Pain Measurement; Professional-Patient Relations | 2017 |
Opioids for cancer pain - an overview of Cochrane reviews.
Topics: Acetaminophen; Administration, Cutaneous; Administration, Oral; Analgesics, Opioid; Buprenorphine; Cancer Pain; Codeine; Fentanyl; Humans; Hydromorphone; Methadone; Oxycodone; Phenols; Review Literature as Topic; Tapentadol; Tramadol | 2017 |
Primary care models for treating opioid use disorders: What actually works? A systematic review.
Topics: Adult; Buprenorphine; Delivery of Health Care; Humans; Methadone; Opioid-Related Disorders; Primary Health Care | 2017 |
Recommendations for buprenorphine and methadone therapy in opioid use disorder: a European consensus.
Topics: Buprenorphine; Consensus; Europe; Humans; Mental Disorders; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Patient Preference; Quality of Life; Risk Reduction Behavior | 2017 |
Treatment of Chronic Pain With Various Buprenorphine Formulations: A Systematic Review of Clinical Studies.
Topics: Administration, Buccal; Administration, Cutaneous; Administration, Sublingual; Analgesics, Opioid; Buprenorphine; Buprenorphine, Naloxone Drug Combination; Chronic Disease; Chronic Pain; Clinical Trials as Topic; Humans; Methadone; Neoplasms; Pain Management; Pain Measurement; Risk; Treatment Outcome | 2018 |
Medication Treatment of Adolescent Opioid Use Disorder in Primary Care.
Topics: Adolescent; Analgesics, Opioid; Buprenorphine; Clinical Protocols; Humans; Methadone; Naltrexone; Opiate Substitution Treatment; Opioid-Related Disorders; Primary Health Care | 2018 |
[Pain management for cancer patients in drug-assisted rehabilitation].
Topics: Acetaminophen; Analgesics, Non-Narcotic; Analgesics, Opioid; Anti-Inflammatory Agents, Non-Steroidal; Buprenorphine; Cancer Pain; Humans; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Pain Management; Pain Measurement; Pain, Postoperative; Palliative Care; Terminal Care | 2018 |
Neonatal Abstinence Syndrome: Advances in Diagnosis and Treatment.
Topics: Acupuncture Therapy; Analgesics; Breast Feeding; Buprenorphine; Clonidine; Female; Humans; Infant, Newborn; Methadone; Morphine; Mothers; Neonatal Abstinence Syndrome; Opiate Substitution Treatment; Rooming-in Care | 2018 |
Effects of medication assisted treatment (MAT) for opioid use disorder on functional outcomes: A systematic review.
Topics: Buprenorphine; Humans; Methadone; Naltrexone; Opiate Substitution Treatment; Opioid-Related Disorders | 2018 |
Opioid Use Disorders: Perioperative Management of a Special Population.
Topics: Analgesics, Opioid; Buprenorphine; Drug Overdose; Drug Tolerance; Humans; Interdisciplinary Communication; Methadone; Naltrexone; Opiate Substitution Treatment; Opioid-Related Disorders; Pain Management; Patient Discharge; Patient-Centered Care; Perioperative Care | 2018 |
Developing an opioid use disorder treatment cascade: A review of quality measures.
Topics: Analgesics, Opioid; Buprenorphine; Drug Overdose; Humans; Methadone; Naltrexone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Treatment Outcome | 2018 |
Pharmacological therapies for management of opium withdrawal.
Topics: Amantadine; Amines; Baclofen; Buprenorphine; Clonidine; Cyclohexanecarboxylic Acids; Gabapentin; gamma-Aminobutyric Acid; Humans; Methadone; Opioid-Related Disorders; Opium; Randomized Controlled Trials as Topic; Substance Withdrawal Syndrome; Tramadol | 2018 |
Effects of medication-assisted treatment on mortality among opioids users: a systematic review and meta-analysis.
Topics: Adult; Analgesics, Opioid; Buprenorphine; Cohort Studies; Drug Overdose; Female; Humans; Male; Methadone; Naltrexone; Opiate Substitution Treatment; Opioid-Related Disorders; Risk | 2019 |
Perioperative Considerations for the Patient with Opioid Use Disorder on Buprenorphine, Methadone, or Naltrexone Maintenance Therapy.
Topics: Buprenorphine; Humans; Methadone; Naltrexone; Opioid-Related Disorders; Pain Management; Perioperative Care | 2018 |
CE: Acute Pain Management for People with Opioid Use Disorder.
Topics: Analgesics, Opioid; Buprenorphine; Female; Humans; Methadone; Middle Aged; Naltrexone; Narcotic Antagonists; Nurse's Role; Opiate Substitution Treatment; Opioid-Related Disorders; Pain Management; Palliative Care; Substance Withdrawal Syndrome | 2018 |
Opioid Detoxification in Pregnancy: Systematic Review and Meta-Analysis of Perinatal Outcomes.
Topics: Analgesics, Opioid; Buprenorphine; Female; Humans; Infant, Newborn; Methadone; Neonatal Abstinence Syndrome; Opioid-Related Disorders; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Premature Birth; Recurrence | 2019 |
Pharmacologic Treatment of Opioid Use Disorder: a Review of Pharmacotherapy, Adjuncts, and Toxicity.
Topics: Buprenorphine; Humans; Methadone; Narcotic Antagonists; Narcotics; Opiate Substitution Treatment; Opioid-Related Disorders | 2018 |
Pharmacotherapy for opioid addiction in community corrections.
Topics: Buprenorphine; Criminal Law; Humans; Methadone; Naltrexone; Opiate Substitution Treatment; Opioid-Related Disorders; Prisons | 2018 |
Treating Opioid Dependence: Pain Medicine Physiology of Tolerance and Addiction.
Topics: Analgesics, Opioid; Buprenorphine; Cognitive Behavioral Therapy; Humans; Methadone; Naloxone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Practice Patterns, Physicians' | 2019 |
Medications for Treatment of Opioid Use Disorder among Persons Living with HIV.
Topics: Buprenorphine; HIV Infections; Humans; Methadone; Naltrexone; Opioid-Related Disorders; Treatment Outcome | 2019 |
Opioid use disorder during pregnancy: An overview.
Topics: Adolescent; Adult; Analgesics, Opioid; Buprenorphine; Cognitive Behavioral Therapy; Female; Fetal Diseases; Humans; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Physician Assistants; Practice Guidelines as Topic; Pregnancy; Pregnancy Complications; Professional Role; Regional Health Planning; Young Adult | 2019 |
Pharmacological and non-pharmacological treatments for the Neonatal Abstinence Syndrome (NAS).
Topics: Analgesics, Opioid; Breast Feeding; Buprenorphine; Humans; Infant, Newborn; Methadone; Morphine; Neonatal Abstinence Syndrome | 2019 |
Pharmacological treatment of opioid use disorder in pregnancy.
Topics: Adult; Analgesics, Opioid; Buprenorphine; Female; Guidelines as Topic; Humans; Methadone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Pregnancy; Pregnancy Complications; Pregnant Women | 2019 |
Effectiveness of medication assisted treatment for opioid use in prison and jail settings: A meta-analysis and systematic review.
Topics: Buprenorphine; Humans; Methadone; Naltrexone; Opiate Substitution Treatment; Opioid-Related Disorders; Prisons; Randomized Controlled Trials as Topic; Recidivism; Risk-Taking | 2019 |
A systematic review of sex differences in treatment outcomes among people with opioid use disorder receiving buprenorphine maintenance versus other treatment conditions.
Topics: Analgesics, Opioid; Buprenorphine; Clinical Trials as Topic; Female; Humans; Male; Methadone; North America; Opiate Substitution Treatment; Opioid-Related Disorders; Quality of Life; Sex Characteristics; Treatment Outcome | 2019 |
Medication Treatment For Substance Abuse.
Topics: Adult; Buprenorphine; Female; Humans; Male; Methadone; Naltrexone; Opiate Substitution Treatment; Patient Compliance; Patient Safety; Quality of Life; Risk Assessment; Severity of Illness Index; Substance-Related Disorders; Treatment Outcome; United States | 2019 |
Post-cesarean delivery pain. Management of the opioid-dependent patient before, during and after cesarean delivery.
Topics: Analgesia, Patient-Controlled; Buprenorphine; Cesarean Section; Female; Humans; Methadone; Naltrexone; Opioid-Related Disorders; Pain, Postoperative; Pregnancy; Pregnancy Complications | 2019 |
Progress in agonist therapy for substance use disorders: Lessons learned from methadone and buprenorphine.
Topics: Analgesics, Opioid; Buprenorphine; Central Nervous System Stimulants; Cocaine-Related Disorders; Dextroamphetamine; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Drug Development; Humans; Methadone; Methylphenidate; Modafinil; Nicotinic Agonists; Opiate Substitution Treatment; Opioid-Related Disorders; Oxalates; Piperazines; Receptors, Opioid, mu; Tobacco Use Disorder; Tropanes; Varenicline | 2019 |
Analgesia, Opioids, and Other Drug Use During Pregnancy and Neonatal Abstinence Syndrome.
Topics: Analgesia, Obstetrical; Analgesics; Analgesics, Opioid; Breast Feeding; Buprenorphine; Buprenorphine, Naloxone Drug Combination; Clonidine; Female; Humans; Hypnotics and Sedatives; Infant, Newborn; Kangaroo-Mother Care Method; Maternal-Fetal Exchange; Methadone; Neonatal Abstinence Syndrome; Occupational Therapy; Opiate Substitution Treatment; Opioid-Related Disorders; Pain Management; Patient Education as Topic; Phenobarbital; Physical Therapy Modalities; Pregnancy; Pregnancy Complications; Rooming-in Care | 2019 |
Opioid use disorder in primary care: PEER umbrella systematic review of systematic reviews.
Topics: Analgesics, Opioid; Buprenorphine; Counseling; Humans; Methadone; Naltrexone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Primary Health Care; Randomized Controlled Trials as Topic; Systematic Reviews as Topic | 2019 |
Therapeutic approaches for neonatal abstinence syndrome: a systematic review of randomized clinical trials.
Topics: Analgesics, Opioid; Buprenorphine; Clonidine; Drug Therapy, Combination; Humans; Infant, Newborn; Length of Stay; Methadone; Neonatal Abstinence Syndrome; Opiate Substitution Treatment; Randomized Controlled Trials as Topic; Time Factors; Treatment Outcome | 2019 |
A Summary from the Institute for Clinical and Economic Review's New England Comparative Effectiveness Public Advisory Council.
Topics: Analgesics, Opioid; Buprenorphine; Cost-Benefit Analysis; Delayed-Action Preparations; Humans; Methadone; Models, Economic; Naltrexone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Policy; Treatment Outcome; United States | 2019 |
Prevention of Opioid Overdose.
Topics: Analgesics, Opioid; Buprenorphine; Chronic Pain; Drug Overdose; Humans; Methadone; Naloxone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Risk Assessment; Substance Abuse Detection | 2019 |
Management and monitoring of opioid use in pregnancy.
Topics: Adult; Analgesics, Opioid; Buprenorphine; Female; Humans; Maternal-Fetal Exchange; Methadone; Narcotic Antagonists; Neonatal Abstinence Syndrome; Opiate Substitution Treatment; Opioid-Related Disorders; Practice Guidelines as Topic; Pregnancy; Pregnancy Complications | 2020 |
Comprehensive Perioperative Management Considerations in Patients Taking Methadone.
Topics: Analgesics, Opioid; Buprenorphine; Chronic Pain; Humans; Methadone; Opioid-Related Disorders; Pain Management | 2019 |
Comparative effectiveness of opioid replacement agents for neonatal opioid withdrawal syndrome: a systematic review and meta-analysis.
Topics: Analgesics, Opioid; Buprenorphine; Humans; Infant, Newborn; Length of Stay; Methadone; Morphine; Neonatal Abstinence Syndrome; Opiate Substitution Treatment | 2019 |
Consideration of opioid agonist treatment in a pregnant adolescent: A case report and literature review.
Topics: Adolescent; Ambulatory Care; Analgesics, Opioid; Buprenorphine; Child, Foster; Female; Humans; Lost to Follow-Up; Methadone; Naltrexone; Opiate Substitution Treatment; Opioid-Related Disorders; Practice Guidelines as Topic; Pregnancy; Pregnancy Complications; Pregnancy in Adolescence | 2020 |
Medications for management of opioid use disorder.
Topics: Analgesics, Opioid; Buprenorphine; Drug Prescriptions; Evidence-Based Medicine; Humans; Methadone; Naltrexone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders | 2019 |
Reduction in mortality risk with opioid agonist therapy: a systematic review and meta-analysis.
Topics: Adult; Analgesics, Opioid; Buprenorphine; Case-Control Studies; Cohort Studies; Databases, Factual; Drug Overdose; Drug Tolerance; Female; Humans; Male; Methadone; Monitoring, Physiologic; Narcotic Antagonists; Opioid-Related Disorders; Patient Education as Topic; Quality of Life; Risk | 2019 |
Medication Treatment of Opioid Use Disorder.
Topics: Analgesics, Opioid; Buprenorphine; Humans; Methadone; Naltrexone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders | 2020 |
Monitoring Prenatal Exposure to Buprenorphine and Methadone.
Topics: Analgesics, Opioid; Buprenorphine; Drug Monitoring; Female; Hair; Humans; Meconium; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Pregnancy; Prenatal Exposure Delayed Effects; Umbilical Cord | 2020 |
The Opioid Epidemic: Impact on Inflammation and Cardiovascular Disease Risk in HIV.
Topics: Analgesics, Opioid; Buprenorphine; Cardiovascular Diseases; HIV Infections; Humans; Inflammation; Methadone; Opioid Epidemic; Opioid-Related Disorders; Substance Abuse, Intravenous | 2019 |
Medications for Maintenance Treatment of Opioid Use Disorder in Adolescents: A Narrative Review and Assessment of Clinical Benefits and Potential Risks.
Topics: Adolescent; Adolescent Behavior; Analgesics, Opioid; Buprenorphine; Humans; Methadone; Naltrexone; Opiate Substitution Treatment; Opioid-Related Disorders | 2019 |
Medication-Assisted Treatment for Opioid-Use Disorder.
Topics: Algorithms; Buprenorphine; Decision Trees; Humans; Methadone; Naltrexone; Opiate Substitution Treatment; Opioid-Related Disorders | 2019 |
Opioid Use Disorder: Medical Treatment Options.
Topics: Analgesics, Opioid; Buprenorphine; Chronic Disease; Evidence-Based Medicine; Female; Humans; Male; Mass Screening; Methadone; Naltrexone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Pregnancy | 2019 |
Neonatal Abstinence Syndrome: Review of Epidemiology, Care Models, and Current Understanding of Outcomes.
Topics: Analgesics, Opioid; Breast Feeding; Buprenorphine; Female; Humans; Hypnotics and Sedatives; Infant, Newborn; Intensive Care Units, Neonatal; Length of Stay; Methadone; Morphine; Neonatal Abstinence Syndrome; Nurseries, Hospital; Opiate Substitution Treatment; Opioid-Related Disorders; Parents; Phenobarbital; Pregnancy; Pregnancy Complications; Prenatal Exposure Delayed Effects; Rooming-in Care; Severity of Illness Index; Treatment Outcome | 2019 |
Opioid Use in Pregnancy.
Topics: Buprenorphine; Child Development; Female; Humans; Infant, Newborn; Methadone; Neonatal Abstinence Syndrome; Opiate Substitution Treatment; Opioid-Related Disorders; Pregnancy; Pregnancy Complications; Treatment Outcome | 2019 |
Adjunctive memantine for opioid use disorder treatment: A systematic review.
Topics: Analgesics, Opioid; Buprenorphine; Drug Therapy, Combination; Excitatory Amino Acid Antagonists; Humans; Memantine; Methadone; Naltrexone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Outcome Assessment, Health Care; Substance Withdrawal Syndrome | 2019 |
Medications Development for Treatment of Opioid Use Disorder.
Topics: Analgesics, Opioid; Buprenorphine; Choice Behavior; Drug Development; Evidence-Based Medicine; Humans; Methadone; Naltrexone; Narcotic Antagonists; Narcotics; Opioid-Related Disorders; Receptors, Opioid, mu; Self Administration; Substance Withdrawal Syndrome; Treatment Outcome | 2021 |
Buprenorphine initiation to treat opioid use disorder in emergency rooms.
Topics: Analgesics, Opioid; Buprenorphine; Emergency Service, Hospital; Humans; Methadone; Naltrexone; Opioid-Related Disorders; United States | 2020 |
Prenatal exposure to methadone or buprenorphine and long-term outcomes: A meta-analysis.
Topics: Analgesics, Opioid; Animals; Buprenorphine; Child; Female; Humans; Infant, Newborn; Male; Methadone; Neurodevelopmental Disorders; Opiate Substitution Treatment; Pregnancy; Prenatal Exposure Delayed Effects; Vision Disorders | 2020 |
Cognitive Outcomes of Young Children After Prenatal Exposure to Medications for Opioid Use Disorder: A Systematic Review and Meta-analysis.
Topics: Analgesics, Opioid; Buprenorphine; Child Development; Child, Preschool; Cognition; Cognitive Dysfunction; Female; Humans; Infant; Infant, Newborn; Male; Maternal Exposure; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Pregnancy; Pregnancy Complications; Prenatal Exposure Delayed Effects; Risk Factors | 2020 |
Impact of Pharmacological Treatments for Opioid Use Disorder on Mortality.
Topics: Analgesics, Opioid; Buprenorphine; Drug Administration Schedule; Humans; Methadone; Naltrexone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Risk Management | 2020 |
Adherence to and Retention in Medications for Opioid Use Disorder Among Adolescents and Young Adults.
Topics: Adolescent; Buprenorphine; Child; Humans; Methadone; Naltrexone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Young Adult | 2020 |
Global opioid agonist treatment: a review of clinical practices by country.
Topics: Analgesics, Opioid; Buprenorphine; Buprenorphine, Naloxone Drug Combination; Humans; Methadone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders | 2020 |
Case Report: Buprenorphine Induction Using Transdermal Buprenorphine in a Veteran With Opioid Use Disorder and Psychosis, Managing Precipitated Withdrawal.
Topics: Buprenorphine; Humans; Methadone; Opioid-Related Disorders; Psychotic Disorders; Substance Withdrawal Syndrome; Veterans | 2020 |
Dopamine D3 receptor-based medication development for the treatment of opioid use disorder: Rationale, progress, and challenges.
Topics: Analgesics, Opioid; Animals; Buprenorphine; Drug Development; Methadone; Opioid-Related Disorders; Receptors, Dopamine D3; United States | 2020 |
Perioperative Management of Patients on Buprenorphine and Methadone: A Narrative Review
Topics: Buprenorphine; Humans; Methadone; Pain Management; Perioperative Care | 2020 |
Comparison of Treatment Options for Refractory Opioid Use Disorder in the United States and Canada: a Narrative Review.
Topics: Analgesics, Opioid; Buprenorphine; Canada; Humans; Male; Methadone; Methicillin-Resistant Staphylococcus aureus; Opiate Substitution Treatment; Opioid-Related Disorders; United States | 2020 |
Diagnosis and Management of Opioid Use Disorder in Hospitalized Patients.
Topics: Analgesics, Opioid; Buprenorphine; Harm Reduction; Hospitalization; Humans; Methadone; Naltrexone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Patient Education as Topic | 2020 |
[Recommendations about the Use of Psychotropic Medications during the COVID-19 Pandemic].
Topics: Antiviral Agents; Benzodiazepines; Betacoronavirus; Bipolar Disorder; Body Temperature Regulation; Buprenorphine; Clozapine; Coronavirus Infections; COVID-19; Delayed-Action Preparations; Drug Interactions; Hospitalization; Humans; Lithium Compounds; Mental Disorders; Methadone; Narcotic Antagonists; Pandemics; Pneumonia, Viral; Psychotropic Drugs; SARS-CoV-2; Schizophrenia; Smoking Cessation Agents; Valproic Acid | 2020 |
Opioid Management in Pregnancy and Postpartum.
Topics: Adult; Analgesics, Opioid; Buprenorphine; Cesarean Section; Female; Humans; Infant, Newborn; Labor, Obstetric; Methadone; Neonatal Abstinence Syndrome; Opiate Substitution Treatment; Opioid-Related Disorders; Pain Management; Perinatal Care; Postpartum Period; Pregnancy; Pregnancy Complications | 2020 |
Non-Opioid Treatments for Opioid Use Disorder: Rationales and Data to Date.
Topics: Analgesics, Opioid; Animals; Behavior, Addictive; Brain; Buprenorphine; Disease Models, Animal; Endocannabinoids; Glutamic Acid; Humans; Methadone; Naltrexone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Orexins; Reward; Secondary Prevention; Signal Transduction; Treatment Outcome | 2020 |
Topics: Acyclic Monoterpenes; Adipose Tissue; Adolescent; Adult; Aged; Aged, 80 and over; Air Pollutants; Air Pollutants, Occupational; Amino Acid Transport Systems; Analgesics, Opioid; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Arthrobacter; Bacteria; Bacteriological Techniques; Benzaldehydes; Biodegradation, Environmental; Biofilms; Biological Transport; Biomarkers; Biomass; Bioreactors; Body Composition; Body Mass Index; Brassica; Brazil; Buprenorphine; Buprenorphine, Naloxone Drug Combination; Caco-2 Cells; Cadmium; Calcium; Calcium Carbonate; Calcium Channels; Catalysis; Cell Degranulation; Cell Line; Cell Membrane; Chitosan; Chromatography, High Pressure Liquid; Chromium; Cobalt; Cohort Studies; Colony Count, Microbial; Composting; Copper; COVID-19; Cross-Sectional Studies; Cytoplasm; Delayed-Action Preparations; Diabetes Mellitus, Type 2; Diarrhea; Diethylhexyl Phthalate; Dose-Response Relationship, Drug; Drug Implants; Drug Stability; Drug Synergism; Electroplating; Endometrial Neoplasms; Endometrium; Environmental Monitoring; Environmental Restoration and Remediation; Estradiol; Estrogens; Feces; Female; Food Microbiology; Food Preservation; Fruit and Vegetable Juices; Gasotransmitters; Gastrointestinal Diseases; Gastrointestinal Microbiome; Gene Expression Regulation, Developmental; Genetic Predisposition to Disease; Glutathione; Gold; Graphite; Growth Hormone; Harm Reduction; Hot Temperature; Humans; Hydrocortisone; Hydrogen; Hydrogen Peroxide; Hydrogen Sulfide; Hydrogen-Ion Concentration; Ileum; Imidazoles; Injections, Intraperitoneal; Insecticides; Insulin-Like Growth Factor Binding Protein 1; Insulin-Like Growth Factor Binding Protein 2; Insulin-Like Growth Factor Binding Protein 5; Insulin-Like Growth Factor I; Intestinal Absorption; Light; Lignin; Liver; Magnetics; Male; Manganese; Mast Cells; Melanoma; Membrane Potentials; Metals; Methadone; Microbial Viability; Microplastics; Microscopy, Electron, Scanning; Microscopy, Electron, Transmission; Middle Aged; Mitochondrial Swelling; Molecular Dynamics Simulation; Monophenol Monooxygenase; Morocco; Naloxone; Naltrexone; Nanocomposites; Nanomedicine; Nanoparticles; Narcotic Antagonists; Neonicotinoids; Nitric Oxide; Nitro Compounds; Nitrogen; Nitrogen Compounds; Obesity; Obesity, Abdominal; Occupational Exposure; Ontario; Opiate Substitution Treatment; Opioid-Related Disorders; Oryza; Overweight; Oxidative Stress; Oxides; Oxygen; Perception; Photoelectron Spectroscopy; Plants; Plastics; Point Mutation; Polychlorinated Biphenyls; Polycyclic Aromatic Hydrocarbons; Potassium; Premenopause; Prodrugs; Prospective Studies; Protons; Pyrolysis; Qualitative Research; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Resins, Synthetic; Rhodamines; Risk Factors; ROC Curve; Salmo salar; SARS-CoV-2; Seawater; Severity of Illness Index; Sewage; Social Media; Soil; Soil Microbiology; Soil Pollutants; Spectroscopy, Fourier Transform Infrared; Spectrum Analysis, Raman; Staining and Labeling; Stainless Steel; Steel; Stress, Physiological; Substance Abuse Treatment Centers; Symporters; T-Lymphocytes; Toluene; Triclosan; Ultraviolet Rays; Waist Circumference; Waste Disposal, Fluid; Wastewater; Water Purification; Welding; X-Ray Diffraction; Young Adult | 2020 |
The relationship between cannabis use and patient outcomes in medication-based treatment of opioid use disorder: A systematic review.
Topics: Buprenorphine; Cannabis; Humans; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders | 2020 |
A systematic review of patients' and providers' perspectives of medications for treatment of opioid use disorder.
Topics: Buprenorphine; Humans; Methadone; Naltrexone; Opiate Substitution Treatment; Opioid-Related Disorders | 2020 |
Maintenance agonist treatments for opiate-dependent pregnant women.
Topics: Birth Weight; Buprenorphine; Delayed-Action Preparations; Female; Humans; Infant; Infant, Newborn; Methadone; Morphine; Narcotics; Opiate Substitution Treatment; Opioid-Related Disorders; Patient Dropouts; Pregnancy; Pregnancy Complications; Randomized Controlled Trials as Topic | 2020 |
Opioid Treatment for Neonatal Opioid Withdrawal Syndrome: Current Challenges and Future Approaches.
Topics: Buprenorphine; Cytochrome P-450 CYP3A; Dose-Response Relationship, Drug; Humans; Infant, Newborn; Methadone; Models, Biological; Morphine; Narcotics; Neonatal Abstinence Syndrome; Opiate Substitution Treatment; Opioid-Related Disorders | 2021 |
Factors Associated with Low Bone Density in Opioid Substitution Therapy Patients: A Systematic Review.
Topics: Alcoholism; Body Mass Index; Bone Diseases, Metabolic; Buprenorphine; Female; Heroin; Humans; Male; Methadone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Risk Factors; Sex Factors; Testosterone | 2021 |
Recent Advances in the Treatment of Opioid Use Disorder.
Topics: Analgesics, Opioid; Buprenorphine; Delayed-Action Preparations; Drug Implants; Humans; Injections, Intramuscular; Methadone; Molecular Targeted Therapy; Naltrexone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Receptors, G-Protein-Coupled; Receptors, Opioid, mu; Secologanin Tryptamine Alkaloids; Thiophenes; Urea; Vaccines | 2021 |
Pharmacotherapy for Management of 'Kratom Use Disorder': A Systematic Literature Review With Survey of Experts.
Topics: Buprenorphine; Humans; Methadone; Mitragyna; Naltrexone; Opioid-Related Disorders; United States | 2021 |
Opioid use disorder treatment for people experiencing homelessness: A scoping review.
Topics: Buprenorphine; Health Services Accessibility; Health Services Misuse; Humans; Ill-Housed Persons; Methadone; Naltrexone; Opiate Substitution Treatment; Opioid-Related Disorders; United States | 2021 |
Effectiveness of medication for opioid use disorders in transition-age youth: A systematic review.
Topics: Adolescent; Adult; Analgesics, Opioid; Buprenorphine; Humans; Methadone; Naltrexone; Opioid-Related Disorders; United States; Young Adult | 2022 |
Opium tincture-assisted treatment for opioid use disorder: A systematic review.
Topics: Buprenorphine; Humans; Male; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Opium | 2021 |
Insights into the mechanisms underlying opioid use disorder and potential treatment strategies.
Topics: Analgesics, Opioid; Buprenorphine; Humans; Methadone; Naltrexone; Opioid-Related Disorders | 2023 |
Opioid treatment for opioid withdrawal in newborn infants.
Topics: Buprenorphine; Chlorpromazine; Clonidine; Diazepam; Humans; Hypnotics and Sedatives; Infant, Newborn; Methadone; Morphine; Narcotics; Neonatal Abstinence Syndrome; Opioid-Related Disorders; Opium; Phenobarbital; Randomized Controlled Trials as Topic | 2021 |
Diversity inclusion in United States opioid pharmacological treatment trials: A systematic review.
Topics: Analgesics, Opioid; Buprenorphine; Humans; Methadone; Naltrexone; Opioid-Related Disorders; United States | 2021 |
Use of Medications for Treatment of Opioid Use Disorder Among US Medicaid Enrollees in 11 States, 2014-2018.
Topics: Adolescent; Adult; Analgesics, Opioid; Buprenorphine; Child; Cross-Sectional Studies; Female; Humans; Male; Medicaid; Methadone; Middle Aged; Naltrexone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Pregnancy; Pregnancy Complications; United States; Young Adult | 2021 |
Psychosis after buprenorphine, heroin, methadone, morphine, oxycodone, and tramadol withdrawal: a systematic review.
Topics: Analgesics, Opioid; Buprenorphine; Heroin; Humans; Methadone; Morphine; Oxycodone; Psychotic Disorders; Substance Withdrawal Syndrome; Tramadol | 2021 |
Retention in opioid agonist treatment: a rapid review and meta-analysis comparing observational studies and randomized controlled trials.
Topics: Analgesics, Opioid; Buprenorphine; Humans; Methadone; Observational Studies as Topic; Opioid-Related Disorders; Randomized Controlled Trials as Topic | 2021 |
The impact of COVID-19 on healthcare delivery for people who use opioids: a scoping review.
Topics: Buprenorphine; COVID-19; Cross-Sectional Studies; Drug Overdose; Emergency Medical Services; Health Services Accessibility; Humans; Methadone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Pandemics; Patient Satisfaction; SARS-CoV-2; Telemedicine | 2021 |
Problematic Opioid Use Among Older Adults: Epidemiology, Adverse Outcomes and Treatment Considerations.
Topics: Aged; Analgesics, Opioid; Buprenorphine; Humans; Methadone; Opioid-Related Disorders; Pain | 2021 |
Opioid treatment programs, telemedicine and COVID-19: A scoping review.
Topics: Analgesics, Opioid; Buprenorphine; COVID-19 Drug Treatment; Female; Humans; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Pandemics; Pregnancy; Pregnancy Complications, Infectious; SARS-CoV-2; Systematic Reviews as Topic; Telemedicine; United States | 2022 |
Intervention Stigma toward Medications for Opioid Use Disorder: A Systematic Review.
Topics: Analgesics, Opioid; Buprenorphine; Humans; Methadone; Naltrexone; Opiate Substitution Treatment; Opioid-Related Disorders | 2021 |
Systematic review and meta-analysis of retention in treatment using medications for opioid use disorder by medication, race/ethnicity, and gender in the United States.
Topics: Analgesics, Opioid; Buprenorphine; Ethnicity; Female; Humans; Male; Methadone; Naltrexone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Retrospective Studies; United States | 2022 |
Neonatal opioid withdrawal syndrome: a review of the science and a look toward the use of buprenorphine for affected infants.
Topics: Analgesics, Opioid; Buprenorphine; Female; Humans; Infant; Infant, Newborn; Methadone; Neonatal Abstinence Syndrome; Opioid-Related Disorders; Pregnancy | 2022 |
Opioid-induced analgesia among persons with opioid use disorder receiving methadone or buprenorphine: A systematic review of experimental pain studies.
Topics: Acute Pain; Analgesia; Analgesics, Opioid; Buprenorphine; Female; Humans; Male; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders | 2021 |
The impact of methamphetamine/amphetamine use on receipt and outcomes of medications for opioid use disorder: a systematic review.
Topics: Buprenorphine; Humans; Methadone; Methamphetamine; Opiate Substitution Treatment; Opioid-Related Disorders | 2021 |
Beyond harm-producing versus harm-reducing: A qualitative meta-synthesis of people who use drugs' perspectives of and experiences with the extramedical use and diversion of buprenorphine.
Topics: Analgesics, Opioid; Buprenorphine; Humans; Methadone; Motivation; Opiate Substitution Treatment; Opioid-Related Disorders | 2022 |
Pain Management Considerations in Patients With Opioid Use Disorder Requiring Critical Care.
Topics: Acute Pain; Analgesics, Non-Narcotic; Analgesics, Opioid; Buprenorphine; Critical Care; Humans; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Pain Management | 2022 |
What Is Addiction? History, Terminology, and Core Concepts.
Topics: Adolescent; Analgesics, Opioid; Behavior; Behavior, Addictive; Buprenorphine; Comprehensive Health Care; Environment; Female; History, 20th Century; Humans; Life Change Events; Male; Methadone; Neurobiology; Social Stigma; Substance Withdrawal Syndrome; Substance-Related Disorders; Terminology as Topic; Transgender Persons; Young Adult | 2022 |
Current Best Practices for Acute and Chronic Management of Patients with Opioid Use Disorder.
Topics: Adult; Analgesics, Opioid; Buprenorphine; Comorbidity; Disease Management; Drug Overdose; Female; Fentanyl; Harm Reduction; Humans; Male; Mental Disorders; Methadone; Middle Aged; Naltrexone; Narcotic Antagonists; Narcotics; Opioid-Related Disorders; Practice Guidelines as Topic; Prevalence | 2022 |
A systematic review of GWAS identified SNPs associated with outcomes of medications for opioid use disorder.
Topics: Buprenorphine; Calcium-Calmodulin-Dependent Protein Kinases; Eye Proteins; Genome-Wide Association Study; Humans; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Polymorphism, Single Nucleotide | 2021 |
Underrepresentation of diverse populations and clinical characterization in opioid agonist treatment research: A systematic review of the neurocognitive effects of buprenorphine and methadone treatment.
Topics: Adult; Analgesics, Opioid; Buprenorphine; Female; Humans; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders | 2022 |
Access to Medications for Opioid Use Disorder and Associated Factors Among Adolescents and Young Adults: A Systematic Review.
Topics: Adolescent; Adult; Analgesics, Opioid; Buprenorphine; Cross-Sectional Studies; Female; Health Services Accessibility; Humans; Male; Methadone; Naltrexone; Opiate Substitution Treatment; Opioid-Related Disorders; Young Adult | 2022 |
Interim opioid agonist treatment for opioid addiction: a systematic review.
Topics: Analgesics, Opioid; Buprenorphine; Humans; Methadone; Observational Studies as Topic; Opiate Substitution Treatment; Opioid-Related Disorders; Quality of Life | 2022 |
An overview of buprenorphine prescribing for the advanced practice psychiatric nurse.
Topics: Analgesics, Opioid; Buprenorphine; Humans; Methadone; Naltrexone; Opiate Substitution Treatment; Opioid-Related Disorders | 2022 |
Medication for opioid use disorder in the Arab World: A systematic review.
Topics: Analgesics, Opioid; Arab World; Buprenorphine; Humans; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Pharmaceutical Preparations; Quality of Life | 2022 |
Ophthalmic outcomes in children exposed to opioid maintenance treatment in utero: A systematic review and meta-analysis.
Topics: Analgesics, Opioid; Buprenorphine; Child; Female; Humans; Infant; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Pregnancy; Prenatal Exposure Delayed Effects | 2022 |
Review of medication-assisted treatment for opioid use disorder.
Topics: Buprenorphine; COVID-19; COVID-19 Drug Treatment; Humans; Methadone; Naltrexone; Opiate Substitution Treatment; Opioid-Related Disorders; United States | 2022 |
Relative effectiveness of medications for opioid-related disorders: A systematic review and network meta-analysis of randomized controlled trials.
Topics: Analgesics, Opioid; Buprenorphine; Humans; Methadone; Morphine; Naltrexone; Network Meta-Analysis; Opioid-Related Disorders; Randomized Controlled Trials as Topic | 2022 |
Systematic review on the clinical management of chronic pain and comorbid opioid use disorder.
Topics: Analgesics, Opioid; Buprenorphine; Chronic Pain; Humans; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders | 2023 |
Buprenorphine Compared with Methadone in Pregnancy: A Systematic Review and Meta-Analysis.
Topics: Analgesics, Opioid; Buprenorphine; Child; Female; Humans; Infant, Newborn; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Pregnancy | 2022 |
Management of opioid withdrawal and initiation of medications for opioid use disorder in the hospital setting.
Topics: Analgesics, Opioid; Antiemetics; Benzodiazepines; Buprenorphine; Hospitals; Humans; Methadone; Naltrexone; Opiate Substitution Treatment; Opioid-Related Disorders; Recurrence; Substance Withdrawal Syndrome; United States | 2022 |
Sex differences in weight gain during medication-based treatment for opioid use disorder: A meta-analysis and retrospective analysis of clinical trial data.
Topics: Analgesics, Opioid; Buprenorphine; Female; Humans; Male; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Retrospective Studies; Sex Characteristics; United States; Weight Gain | 2022 |
Management of opioid use disorder, opioid withdrawal, and opioid overdose prevention in hospitalized adults: A systematic review of existing guidelines.
Topics: Adult; Analgesics, Opioid; Buprenorphine; Hospitalization; Humans; Methadone; Opiate Overdose; Opioid-Related Disorders | 2022 |
Analytical Approaches for the Determination of Buprenorphine, Methadone and Their Metabolites in Biological Matrices.
Topics: Buprenorphine; Chromatography, Liquid; Humans; Methadone; Tandem Mass Spectrometry | 2022 |
Opioid agonist treatment for people who are dependent on pharmaceutical opioids.
Topics: Adolescent; Analgesics, Opioid; Buprenorphine; Heroin; Humans; Methadone; Opioid-Related Disorders; Pharmaceutical Preparations | 2022 |
Nanobiosensors for detection of opioids: A review of latest advancements.
Topics: Analgesics, Opioid; Buprenorphine; Fentanyl; Gold; Illicit Drugs; Methadone; Oxycodone; Silver; Tramadol; Wastewater | 2022 |
Factors that distinguish opioid withdrawal during induction with buprenorphine microdosing: a configurational analysis.
Topics: Analgesics, Opioid; Buprenorphine; Heroin; Humans; Methadone; Narcotics; Opioid-Related Disorders; Substance Withdrawal Syndrome | 2022 |
Systematic Review and Meta-Analysis of the Prevalence of Chronic Pain Among Patients With Opioid Use Disorder and Receiving Opioid Substitution Therapy.
Topics: Adult; Analgesics, Opioid; Buprenorphine; Chronic Pain; Humans; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Prevalence | 2023 |
Opioid Use Disorder in Pregnant Patients.
Topics: Analgesics, Opioid; Anesthetics; Buprenorphine; Female; Humans; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Pregnancy | 2022 |
Current and emerging pharmacotherapies for opioid dependence treatments in adults: a comprehensive update.
Topics: Adult; Analgesics, Opioid; Buprenorphine; Humans; Methadone; Naltrexone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; United States | 2022 |
Opioid Use Disorder Treatments: An Evidence Map.
Topics: Analgesics, Opioid; Buprenorphine; Humans; Methadone; Naltrexone; Opiate Substitution Treatment; Opioid-Related Disorders | 2022 |
Effects of buprenorphine on opioid craving in comparison to other medications for opioid use disorder: A systematic review of randomized controlled trials.
Topics: Analgesics, Opioid; Buprenorphine; Buprenorphine, Naloxone Drug Combination; Craving; Delayed-Action Preparations; Humans; Methadone; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders; Randomized Controlled Trials as Topic | 2023 |
The Growing Epidemic of Opioid Use Disorder in the Elderly and Its Treatment: A Review of the Literature.
Topics: Aged; Analgesics, Opioid; Buprenorphine; Drug-Related Side Effects and Adverse Reactions; Humans; Methadone; Naltrexone; Opiate Substitution Treatment; Opioid-Related Disorders | 2023 |
Opioids and Opioid Use Disorder in Pregnancy.
Topics: Analgesics, Opioid; Buprenorphine; Female; Humans; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Pregnancy; United States | 2023 |
Treatment of Acute Pain in Patients on Naltrexone: A Narrative Review.
Topics: Acute Pain; Analgesics, Opioid; Buprenorphine; Humans; Methadone; Naltrexone; Opiate Substitution Treatment; Opioid-Related Disorders; Pain, Postoperative | 2023 |
Buprenorphine versus methadone for the treatment of opioid dependence: a systematic review and meta-analysis of randomised and observational studies.
Topics: Adolescent; Adult; Analgesics, Opioid; Australia; Buprenorphine; Cocaine; Female; Humans; Male; Methadone; Opioid-Related Disorders | 2023 |
Harmful effects of opioid use in pregnancy: A scientific review commissioned by the European Board and College of obstetrics and gynaecology (EBCOG).
Topics: Analgesics, Opioid; Buprenorphine; Female; Gynecology; Humans; Infant; Methadone; Obstetrics; Opiate Substitution Treatment; Opioid-Related Disorders; Pregnancy; Pregnancy Complications; Pregnancy Outcome | 2023 |
Topics: Analgesics, Opioid; Buprenorphine; Humans; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Quality of Life | 2023 |
Three decades of research in substance use disorder treatment for syringe services program participants: a scoping review of the literature.
Topics: Buprenorphine; Case Management; Central Nervous System Stimulants; Humans; Methadone; Motivational Interviewing; Opiate Substitution Treatment; Opioid-Related Disorders | 2023 |
Efficacy and safety of tramadol in the treatment of opioid withdrawal: A meta-analysis of randomized controlled trials.
Topics: Bayes Theorem; Buprenorphine; Clonidine; Humans; Methadone; Narcotics; Opioid-Related Disorders; Randomized Controlled Trials as Topic; Substance Withdrawal Syndrome; Tramadol | 2023 |
188 trial(s) available for methadone and buprenorphine
| Article | Year |
|---|---|
Human pharmacology and abuse potential of the analgesic buprenorphine: a potential agent for treating narcotic addiction.
Topics: Adult; Blood Pressure; Buprenorphine; Clinical Trials as Topic; Dose-Response Relationship, Drug; Double-Blind Method; Euphoria; Humans; Male; Methadone; Middle Aged; Morphinans; Morphine; Naloxone; Narcotics; Pulse; Pupil; Receptors, Opioid; Substance Withdrawal Syndrome; Substance-Related Disorders | 1978 |
Assessment and management of opioid withdrawal symptoms in buprenorphine-dependent subjects.
Topics: Adult; Buprenorphine; Double-Blind Method; Female; Heroin Dependence; Humans; Male; Methadone; Neurologic Examination; Opioid-Related Disorders; Substance Abuse Treatment Centers; Substance Withdrawal Syndrome | 1992 |
Weighing up the pros and cons: help-seeking by drug misusers in Baltimore, USA.
Topics: Adult; Bromocriptine; Buprenorphine; Cocaine; Desipramine; Fear; Female; Fluoxetine; Humans; Male; Methadone; Middle Aged; Motivation; Opioid-Related Disorders; Patient Acceptance of Health Care; Phencyclidine Abuse; Substance Abuse Treatment Centers; Substance-Related Disorders; Urban Population | 1992 |
Acute effects of buprenorphine, hydromorphone and naloxone in methadone-maintained volunteers.
Topics: Adult; Buprenorphine; Cognition; Drug Interactions; Hemodynamics; Humans; Hydromorphone; Injections, Intramuscular; Male; Methadone; Naloxone; Psychomotor Performance; Substance Abuse Treatment Centers; Substance-Related Disorders | 1992 |
Phase II clinical trials of buprenorphine: detoxification and induction onto naltrexone.
Topics: Adult; Blood Pressure; Buprenorphine; Double-Blind Method; Female; Humans; Male; Methadone; Methoxyhydroxyphenylglycol; Naloxone; Naltrexone; Opioid-Related Disorders; Substance Withdrawal Syndrome | 1992 |
Background and design of a controlled clinical trial (ARC 090) for the treatment of opioid dependence.
Topics: Adult; Buprenorphine; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Methadone; Middle Aged; Opioid-Related Disorders; Patient Compliance; Placebos; Research Design | 1992 |
A controlled trial of buprenorphine treatment for opioid dependence.
Topics: Adult; Buprenorphine; Double-Blind Method; Female; Heroin; Heroin Dependence; Humans; Male; Methadone; Middle Aged; Narcotics; Opioid-Related Disorders; Proportional Hazards Models | 1992 |
Treatment of heroin addicts using buprenorphine.
Topics: Adult; Buprenorphine; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Heroin Dependence; Humans; Male; Methadone; Naltrexone; Neurologic Examination; Substance Withdrawal Syndrome | 1991 |
Buprenorphine treatment for concurrent heroin and cocaine dependence: phase I study.
Topics: Adult; Buprenorphine; Cocaine; Dose-Response Relationship, Drug; Drug Evaluation; Heroin Dependence; Humans; Male; Methadone; Substance Abuse, Intravenous | 1990 |
Opioid antagonist challenges in buprenorphine maintained patients.
Topics: Administration, Sublingual; Adult; Buprenorphine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Heroin Dependence; Humans; Infusions, Intravenous; Male; Methadone; Naloxone; Naltrexone; Substance Withdrawal Syndrome | 1990 |
A clinical trial of buprenorphine: I. Comparison with methadone in the detoxification of heroin addicts. II. Examination of its opioid blocking properties.
Topics: Adult; Analysis of Variance; Buprenorphine; Clinical Trials as Topic; Heroin Dependence; Humans; Hydromorphone; Male; Methadone; Narcotic Antagonists; Substance Withdrawal Syndrome | 1987 |
A clinical trial of buprenorphine: comparison with methadone in the detoxification of heroin addicts.
Topics: Adult; Buprenorphine; Clinical Trials as Topic; Double-Blind Method; Heroin Dependence; Humans; Male; Methadone; Random Allocation | 1988 |
Buprenorphine detoxification from opioid dependence: a pilot study.
Topics: Adult; Buprenorphine; Clinical Trials as Topic; Female; Heroin Dependence; Humans; Male; Methadone; Substance Withdrawal Syndrome | 1988 |
Buprenorphine effects on cigarette smoking.
Topics: Adult; Buprenorphine; Dextroamphetamine; Dose-Response Relationship, Drug; Endorphins; Ethanol; Heroin; Heroin Dependence; Humans; Male; Methadone; Morphinans; Smoking; Time Factors | 1985 |
Acute administration of buprenorphine in humans: partial agonist and blockade effects.
Topics: Adult; Buprenorphine; Cross-Over Studies; Double-Blind Method; Humans; Hydromorphone; Male; Methadone; Narcotic Antagonists; Receptors, Opioid; Respiration | 1995 |
Effects of buprenorphine and methadone in methadone-maintained subjects.
Topics: Administration, Oral; Adult; Buprenorphine; Dose-Response Relationship, Drug; Humans; Male; Methadone; Middle Aged; Opioid-Related Disorders; Substance Withdrawal Syndrome; Time Factors | 1995 |
Buprenorphine versus methadone in the treatment of opioid-dependent cocaine users.
Topics: Adolescent; Adult; Buprenorphine; Cocaine; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Methadone; Opioid-Related Disorders; Patient Compliance; Psychiatric Status Rating Scales; Substance-Related Disorders; Treatment Outcome | 1994 |
Reduction of opiate withdrawal-like symptoms by cocaine abuse during methadone and buprenorphine maintenance.
Topics: Adult; Buprenorphine; Cocaine; Comorbidity; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Methadone; Neurologic Examination; Opioid-Related Disorders; Substance Abuse Detection; Substance Withdrawal Syndrome; Substance-Related Disorders | 1994 |
Opiate detoxification of methadone maintenance patients using lefetamine, clonidine and buprenorphine.
Topics: Adult; Analgesics, Opioid; Buprenorphine; Clonidine; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Heroin Dependence; Humans; Male; Methadone; Neurologic Examination; Opioid-Related Disorders; Patient Admission; Phenethylamines; Substance Withdrawal Syndrome | 1994 |
Comparison of buprenorphine and methadone in the treatment of opioid dependence.
Topics: Administration, Oral; Administration, Sublingual; Adult; Buprenorphine; Cocaine; Comorbidity; Double-Blind Method; Female; Humans; Male; Methadone; Middle Aged; Opioid-Related Disorders; Patient Compliance; Substance Abuse Detection; Substance-Related Disorders; Treatment Outcome | 1994 |
Buprenorphine for benzodiazepine-abusing heroin addicts.
Topics: Administration, Sublingual; Benzodiazepines; Buprenorphine; Heroin Dependence; Humans; Methadone; Naltrexone; Substance-Related Disorders | 1994 |
Buprenorphine versus methadone maintenance for opioid dependence.
Topics: Adult; Buprenorphine; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Heroin Dependence; Humans; Male; Methadone; Opioid-Related Disorders; Substance Abuse Detection; Treatment Outcome | 1993 |
A controlled trial comparing buprenorphine and methadone maintenance in opioid dependence.
Topics: Adult; Buprenorphine; Cocaine; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Heroin Dependence; Humans; Male; Methadone; Opioid-Related Disorders; Placebos; Substance Abuse Detection; Substance-Related Disorders; Treatment Outcome | 1996 |
Urine toxicology as an outcome measure in drug abuse clinical trials: must every sample be analyzed?
Topics: Adult; Analgesics, Opioid; Buprenorphine; Female; Humans; Male; Methadone; Middle Aged; Narcotics; Substance-Related Disorders | 1996 |
Effects of methadone or buprenorphine maintenance on the subjective and reinforcing effects of intravenous cocaine in humans.
Topics: Adult; Buprenorphine; Cocaine; Dose-Response Relationship, Drug; Female; Humans; Infusions, Intravenous; Male; Methadone; Opioid-Related Disorders; Self Administration; Substance Withdrawal Syndrome; Surveys and Questionnaires | 1996 |
Buprenorphine versus methadone in the treatment of opioid dependence: self-reports, urinalysis, and addiction severity index.
Topics: Adolescent; Adult; Alcoholism; Buprenorphine; Cocaine; Double-Blind Method; Female; Heroin Dependence; Humans; Male; Methadone; Middle Aged; Narcotic Antagonists; Narcotics; Opioid-Related Disorders; Substance Abuse Detection; Substance Withdrawal Syndrome; Treatment Outcome | 1996 |
A protocol to switch high-dose, methadone-maintained subjects to buprenorphine.
Topics: Adult; Anti-Anxiety Agents; Anxiety; Buprenorphine; Clonidine; Cocaine; Drug Administration Schedule; Female; Humans; Inpatients; Male; Methadone; Narcotic Antagonists; Narcotics; Opioid-Related Disorders; Oxazepam; Substance Abuse Treatment Centers; Substance Withdrawal Syndrome; Sympatholytics; Treatment Outcome | 1997 |
Buprenorphine and naloxone interactions in methadone maintenance patients.
Topics: Adult; Buprenorphine; Drug Interactions; Drug Therapy, Combination; Female; Humans; Male; Methadone; Middle Aged; Naloxone; Narcotic Antagonists; Narcotics; Substance Withdrawal Syndrome; Substance-Related Disorders | 1997 |
Buprenorphine vs methadone maintenance treatment for concurrent opioid dependence and cocaine abuse.
Topics: Adult; Buprenorphine; Cocaine; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Methadone; Opioid-Related Disorders; Substance-Related Disorders; Treatment Outcome | 1997 |
Prognostic factors in Buprenorphine- versus methadone-maintained patients.
Topics: Adult; Alcoholism; Antisocial Personality Disorder; Benzodiazepines; Buprenorphine; Cocaine-Related Disorders; Comorbidity; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Methadone; Opioid-Related Disorders; Patient Dropouts; Prognosis; Sex Factors; Substance Abuse Detection; Substance-Related Disorders; Treatment Outcome | 1998 |
Comparison of buprenorphine and methadone maintenance in opiate addicts.
Topics: Adolescent; Adult; Buprenorphine; Dose-Response Relationship, Drug; Female; Humans; Male; Methadone; Narcotics; Opioid-Related Disorders | 1998 |
Substitution with buprenorphine in methadone- and morphine sulfate-dependent patients. Preliminary results.
Topics: Adult; Buprenorphine; Dose-Response Relationship, Drug; Female; Humans; Male; Methadone; Morphine; Narcotics; Opioid-Related Disorders | 1998 |
Differences between general practitioner- and addiction centre-prescribed buprenorphine substitution therapy in France. Preliminary results.
Topics: Adult; Buprenorphine; Family Practice; Follow-Up Studies; France; Humans; Methadone; Narcotics; Prospective Studies; Substance Abuse Treatment Centers; Substance-Related Disorders | 1998 |
[Buprenorphine vs. methadone as maintenance treatment for opioid dependence].
Topics: Administration, Sublingual; Adult; Buprenorphine; Female; Humans; Male; Methadone; Narcotic Antagonists; Narcotics; Opioid-Related Disorders; Patient Dropouts; Substance Abuse Detection; Treatment Outcome | 1999 |
Buprenorphine versus methadone maintenance for the treatment of opioid dependence.
Topics: Adolescent; Adult; Ambulatory Care; Ambulatory Care Facilities; Buprenorphine; Female; Humans; Male; Methadone; Narcotics; Opioid-Related Disorders | 1999 |
Comparing buprenorphine and methadone maintenance.
Topics: Buprenorphine; Drug Administration Schedule; Humans; Methadone; Opioid-Related Disorders; Research Design; United States | 1994 |
Buprenorphine: a controlled clinical trial in the treatment of opioid dependence.
Topics: Adolescent; Adult; Behavior, Addictive; Buprenorphine; Double-Blind Method; Female; Humans; Male; Methadone; Multivariate Analysis; Narcotics; Opioid-Related Disorders; Tablets | 2000 |
A comparison of levomethadyl acetate, buprenorphine, and methadone for opioid dependence.
Topics: Adult; Analgesics, Opioid; Buprenorphine; Cocaine-Related Disorders; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Methadone; Methadyl Acetate; Middle Aged; Narcotics; Opioid-Related Disorders; Treatment Outcome | 2000 |
Double-blind randomized trial of buprenorphine and methadone in opiate dependence.
Topics: Adult; Analysis of Variance; Behavior, Addictive; Buprenorphine; Chi-Square Distribution; Double-Blind Method; Female; Heroin Dependence; Humans; Male; Methadone; Narcotic Antagonists; Opioid-Related Disorders; Patient Compliance | 2001 |
Pain intolerance in opioid-maintained former opiate addicts: effect of long-acting maintenance agent.
Topics: Adult; Buprenorphine; Cold Temperature; Female; Humans; Male; Methadone; Middle Aged; Opioid-Related Disorders; Pain Threshold; Reaction Time | 2001 |
[Use of buprenorphine as a substitute treatment for opiate dependence in the Toxicology Clinics--introductory clinical report].
Topics: Adolescent; Adult; Buprenorphine; Female; Humans; Male; Methadone; Middle Aged; Narcotic Antagonists; Opioid-Related Disorders; Treatment Outcome | 2001 |
[Withdrawal syndromes of newborns of pregnant drug abusers maintained under methadone or high-dose buprenorphine: 246 cases].
Topics: Analgesics, Opioid; Buprenorphine; Female; Humans; Infant, Newborn; Methadone; Morphine; Neonatal Abstinence Syndrome; Pregnancy; Pregnancy Complications; Prenatal Care; Prognosis; Prospective Studies; Substance-Related Disorders | 2001 |
Utility of crossover designs in clinical trials: efficacy of desipramine vs. placebo in opioid-dependent cocaine abusers.
Topics: Adult; Analgesics, Opioid; Antidepressive Agents, Tricyclic; Buprenorphine; Clinical Trials as Topic; Cocaine-Related Disorders; Cross-Over Studies; Desipramine; Double-Blind Method; Female; Humans; Male; Methadone; Middle Aged; Narcotics; Opioid-Related Disorders; Placebos; Time Factors; Treatment Outcome | 2002 |
Detoxification of opiate addicts with multiple drug abuse: a comparison of buprenorphine vs. methadone.
Topics: Adult; Anticonvulsants; Buprenorphine; Carbamazepine; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Methadone; Narcotic Antagonists; Narcotics; Opioid-Related Disorders; Substance-Related Disorders; Treatment Outcome | 2002 |
Opioid detoxification with buprenorphine, clonidine, or methadone in hospitalized heroin-dependent patients with HIV infection.
Topics: Administration, Oral; Adrenergic alpha-Agonists; Adult; Buprenorphine; Clonidine; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Heroin Dependence; HIV Infections; Hospitalization; Humans; Injections, Intramuscular; Male; Methadone; Middle Aged; Narcotics; Pain Measurement; Receptors, Opioid; Substance Abuse, Intravenous; Substance Withdrawal Syndrome; Treatment Outcome | 2003 |
Buprenorphine versus methadone maintenance therapy: a randomized double-blind trial with 405 opioid-dependent patients.
Topics: Adult; Buprenorphine; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Methadone; Narcotic Antagonists; Opioid-Related Disorders; Treatment Outcome | 2003 |
Methadone versus buprenorphine maintenance for the treatment of heroin-dependent outpatients.
Topics: Adult; Buprenorphine; Dose-Response Relationship, Drug; Double-Blind Method; Heroin; Humans; Iran; Male; Methadone; Narcotic Antagonists; Narcotics; Opioid-Related Disorders; Treatment Outcome | 2003 |
Cessation of methadone maintenance treatment using buprenorphine: transfer from methadone to buprenorphine and subsequent buprenorphine reductions.
Topics: Adult; Buprenorphine; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Male; Methadone; Pilot Projects; Substance Withdrawal Syndrome; Treatment Outcome | 2003 |
Desipramine in opioid-dependent cocaine abusers maintained on buprenorphine vs methadone.
Topics: Adult; Analgesics, Opioid; Antidepressive Agents, Tricyclic; Buprenorphine; Cocaine-Related Disorders; Comorbidity; Desipramine; Drug Administration Schedule; Drug Therapy, Combination; Female; Heroin Dependence; Humans; Male; Methadone; Middle Aged; Narcotic Antagonists; Opioid-Related Disorders; Sex Factors; Treatment Outcome | 1999 |
Controlled, randomized trial in maintenance treatment of intravenous buprenorphine dependence with naltrexone, methadone or buprenorphine: a novel study.
Topics: Administration, Oral; Administration, Sublingual; Adolescent; Adult; Age Distribution; Buprenorphine; Humans; Male; Methadone; Middle Aged; Naltrexone; Socioeconomic Factors; Substance Abuse, Intravenous; Treatment Outcome | 2003 |
The effects of the opioid pharmacotherapies methadone, LAAM and buprenorphine, alone and in combination with alcohol, on simulated driving.
Topics: Adult; Automobile Driving; Buprenorphine; Drug Combinations; Ethanol; Female; Humans; Male; Methadone; Methadyl Acetate; Narcotics; Opioid-Related Disorders; Victoria | 2003 |
The Leeds Evaluation of Efficacy of Detoxification Study (LEEDS) project: an open-label pragmatic randomised control trial comparing the efficacy of differing therapeutic agents for primary care detoxification from either street heroin or methadone [ISRCT
Topics: Adolescent; Adult; Buprenorphine; Codeine; England; Follow-Up Studies; Health Services Research; Heroin Dependence; Humans; Methadone; Narcotic Antagonists; Opioid-Related Disorders; Primary Health Care; State Medicine; Substance Abuse Detection; Treatment Outcome | 2004 |
Buprenorphine versus methadone for opioid dependence: predictor variables for treatment outcome.
Topics: Adult; Analysis of Variance; Buprenorphine; Female; Heroin Dependence; Humans; Male; Methadone; Opioid-Related Disorders; Predictive Value of Tests; Treatment Outcome | 2004 |
[Buprenorphine or methadone for detoxification of young opioid addicts?].
Topics: Adolescent; Adult; Buprenorphine; Female; Germany; Humans; Male; Methadone; Narcotics; Opioid-Related Disorders; Treatment Outcome | 2004 |
Depressive symptoms during buprenorphine vs. methadone maintenance: findings from a randomised, controlled trial in opioid dependence.
Topics: Adult; Buprenorphine; Depression; Female; Humans; Male; Methadone; Narcotic Antagonists; Narcotics; Opioid-Related Disorders; Severity of Illness Index; Surveys and Questionnaires | 2004 |
[Buprenorphine and methadone to opiate addicts--a randomized trial].
Topics: Adult; Buprenorphine; Female; Humans; Male; Methadone; Narcotics; Opioid-Related Disorders; Surveys and Questionnaires; Treatment Outcome | 2005 |
Methadone versus buprenorphine with contingency management or performance feedback for cocaine and opioid dependence.
Topics: Adult; Analgesics, Opioid; Behavior Therapy; Buprenorphine; Cocaine-Related Disorders; Combined Modality Therapy; Comorbidity; Female; Humans; Male; Methadone; Opioid-Related Disorders; Substance Abuse Detection; Token Economy; Treatment Outcome | 2005 |
A randomised trial of the cost effectiveness of buprenorphine as an alternative to methadone maintenance treatment for heroin dependence in a primary care setting.
Topics: Adolescent; Adult; Aged; Buprenorphine; Cost-Benefit Analysis; Disease-Free Survival; Female; Heroin Dependence; Humans; Male; Methadone; Middle Aged; Narcotic Antagonists; Primary Health Care; Quality-Adjusted Life Years; Treatment Outcome | 2005 |
Randomized controlled study transitioning opioid-dependent pregnant women from short-acting morphine to buprenorphine or methadone.
Topics: Adult; Buprenorphine; Double-Blind Method; Female; Humans; Methadone; Morphine; Opioid-Related Disorders; Pregnancy; Substance Withdrawal Syndrome | 2005 |
Randomized clinical trial to compare the effects of methadone and buprenorphine on the immune system in drug abusers.
Topics: Adult; Buprenorphine; Cytokines; Female; Humans; Lipopolysaccharide Receptors; Male; Methadone; Substance-Related Disorders | 2005 |
Buprenorphine versus methadone in the treatment of pregnant opioid-dependent patients: effects on the neonatal abstinence syndrome.
Topics: Administration, Sublingual; Adult; Buprenorphine; Double-Blind Method; Female; Heroin Dependence; Humans; Infant, Newborn; Methadone; Narcotic Antagonists; Neonatal Abstinence Syndrome; Pregnancy; Pregnancy Complications; Severity of Illness Index | 2005 |
Less impairment on one portion of a driving-relevant psychomotor battery in buprenorphine-maintained than in methadone-maintained patients: results of a randomized clinical trial.
Topics: Adult; Aging; Attention; Automobile Driving; Buprenorphine; Cognition; Female; Humans; Male; Memory, Short-Term; Methadone; Middle Aged; Narcotic Antagonists; Neuropsychological Tests; Opioid-Related Disorders; Psychomotor Performance; Reaction Time; Verbal Behavior; Visual Perception | 2005 |
Mood and affect during detoxification of opiate addicts: a comparison of buprenorphine versus methadone.
Topics: Adult; Anticonvulsants; Buprenorphine; Carbamazepine; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Hospitalization; Humans; Inactivation, Metabolic; Male; Methadone; Mood Disorders; Narcotic Antagonists; Opioid-Related Disorders | 2005 |
Opioid plasma concentrations in methadone-and buprenorphine-maintained patients.
Topics: Administration, Oral; Administration, Sublingual; Adolescent; Adult; Buprenorphine; Dose-Response Relationship, Drug; Female; Humans; Long-Term Care; Male; Methadone; Middle Aged; Opioid-Related Disorders; Patient Acceptance of Health Care; Patient Dropouts; Statistics as Topic; Substance Withdrawal Syndrome | 2005 |
Predictors of outcome in LAAM, buprenorphine, and methadone treatment for opioid dependence.
Topics: Adult; Analgesics, Opioid; Buprenorphine; Double-Blind Method; Female; Humans; Male; Methadone; Methadyl Acetate; Middle Aged; Opioid-Related Disorders; Prospective Studies; Receptors, Opioid, mu; Regression Analysis; Treatment Outcome | 2005 |
Opioid addicts at admission vs. slow-release oral morphine, methadone, and sublingual buprenorphine maintenance treatment participants.
Topics: Adult; Austria; Buprenorphine; Delayed-Action Preparations; Female; Humans; Male; Methadone; Morphine; Opioid-Related Disorders; Quality of Life; Substance Abuse Treatment Centers | 2006 |
Methadone versus buprenorphine in pregnant addicts: a double-blind, double-dummy comparison study.
Topics: Buprenorphine; Double-Blind Method; Female; Humans; Infant, Newborn; Methadone; Neonatal Abstinence Syndrome; Opioid-Related Disorders; Pregnancy; Pregnancy Complications | 2006 |
Interactions on mixing diazepam with methadone or buprenorphine in maintenance patients.
Topics: Adolescent; Adult; Buprenorphine; Diazepam; Double-Blind Method; Drug Interactions; Female; Heroin Dependence; Humans; Hypnotics and Sedatives; Male; Methadone; Narcotics; Oxygen Consumption; Psychomotor Performance; Reaction Time; Substance-Related Disorders; Treatment Outcome | 2006 |
Analgesic effects of subarachnoidally administered hyperbaric opioids in horses.
Topics: Analgesia; Analgesics, Opioid; Animals; Buprenorphine; Cross-Over Studies; Female; Horse Diseases; Horses; Injections, Spinal; Male; Methadone; Morphine; Pain | 2006 |
Relationship between plasma cortisol levels, withdrawal symptoms and craving in abstinent and treated heroin addicts.
Topics: Adult; Buprenorphine; Female; Follow-Up Studies; Heroin; Heroin Dependence; Humans; Hydrocortisone; Hypothalamo-Hypophyseal System; Male; Methadone; Motivation; Narcotics; Pituitary-Adrenal System; Statistics as Topic; Substance Withdrawal Syndrome | 2006 |
HIV risk behaviors during pharmacologic treatment for opioid dependence: a comparison of levomethadyl acetate [corrected] buprenorphine, and methadone.
Topics: Adult; Buprenorphine; Double-Blind Method; Drug Administration Schedule; Female; HIV Infections; Humans; Male; Methadone; Methadyl Acetate; Narcotic Antagonists; Narcotics; Opioid-Related Disorders; Risk-Taking | 2006 |
Experimentally induced aggressiveness in heroin-dependent patients treated with buprenorphine: comparison of patients receiving methadone and healthy subjects.
Topics: Adrenocorticotropic Hormone; Adult; Aggression; Blood Pressure; Buprenorphine; Epinephrine; Heart Rate; Heroin Dependence; Humans; Hydrocortisone; Male; Methadone; Monoamine Oxidase; Narcotic Antagonists; Norepinephrine; Psychometrics; Surveys and Questionnaires | 2007 |
Simultaneous determination of buprenorphine, norbuprenorphine and the enantiomers of methadone and its metabolite (EDDP) in human plasma by liquid chromatography/mass spectrometry.
Topics: Buprenorphine; Calibration; Humans; Mass Spectrometry; Methadone; Reference Standards; Reproducibility of Results; Sensitivity and Specificity | 2007 |
Patterns of nonfatal heroin overdose over a 3-year period: findings from the Australian treatment outcome study.
Topics: Adolescent; Adult; Buprenorphine; Cohort Studies; Drug Overdose; Episode of Care; Female; Follow-Up Studies; Heroin; Heroin Dependence; Humans; Inactivation, Metabolic; Incidence; Interviews as Topic; Male; Methadone; Middle Aged; Naloxone; Needle-Exchange Programs; New South Wales; Substance Abuse Treatment Centers; Treatment Outcome | 2007 |
Comparison of buprenorphine and methadone in the treatment of opiate withdrawal: possible advantages of buprenorphine for the treatment of opiate-benzodiazepine codependent patients?
Topics: Adult; Anti-Anxiety Agents; Benzodiazepines; Buprenorphine; Diazepam; Female; Humans; Male; Methadone; Narcotic Antagonists; Opioid Peptides; Opioid-Related Disorders; Severity of Illness Index; Sex Factors; Substance Withdrawal Syndrome | 2007 |
A stepped care strategy using buprenorphine and methadone versus conventional methadone maintenance in heroin dependence: a randomized controlled trial.
Topics: Adult; Behavior Therapy; Buprenorphine; Combined Modality Therapy; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Female; Heroin; Heroin Dependence; Humans; Longitudinal Studies; Male; Methadone; Naloxone; Patient Compliance; Patient Dropouts; Severity of Illness Index; Single-Blind Method; Substance Abuse Detection; Treatment Outcome | 2007 |
Sublingual buprenorphine/naloxone precipitated withdrawal in subjects maintained on 100mg of daily methadone.
Topics: Administration, Sublingual; Adult; Buprenorphine; Cognition Disorders; Double-Blind Method; Drug Combinations; Female; Humans; Male; Methadone; Middle Aged; Naloxone; Neuropsychological Tests; Opioid-Related Disorders; Psychomotor Disorders; Substance Withdrawal Syndrome | 2007 |
Influence of peak and trough levels of opioid maintenance therapy on driving aptitude.
Topics: Adult; Attention; Austria; Automobile Driving; Buprenorphine; Decision Making; Female; Humans; Male; Metabolic Clearance Rate; Methadone; Narcotics; Neuropsychological Tests; Opioid-Related Disorders; Prospective Studies; Reaction Time | 2007 |
A history of sexual, emotional, or physical abuse predicts adjustment during opioid maintenance treatment.
Topics: Adolescent; Adult; Aged; Analgesics, Opioid; Buprenorphine; Domestic Violence; Double-Blind Method; Female; Heroin Dependence; Humans; Male; Methadone; Middle Aged; Naloxone; Narcotic Antagonists; Psychiatric Status Rating Scales; Severity of Illness Index; Sex Factors; Sex Offenses; Social Adjustment; Time Factors; Treatment Outcome | 2008 |
Pharmacodynamics of diazepam co-administered with methadone or buprenorphine under high dose conditions in opioid dependent patients.
Topics: Adult; Buprenorphine; Cross-Over Studies; Diazepam; Double-Blind Method; Drug Interactions; Drug Therapy, Combination; Half-Life; Humans; Metabolic Clearance Rate; Methadone; Opioid-Related Disorders; Oxygen | 2007 |
Treatment for hepatitis C virus in injection drug users on opioid replacement therapy: a prospective multicentre study.
Topics: Adolescent; Adult; Antiviral Agents; Buprenorphine; Female; Hepatitis C, Chronic; Humans; Male; Methadone; Middle Aged; Pilot Projects; Prospective Studies; Substance Abuse, Intravenous; Treatment Outcome | 2007 |
Hepatitis C treatment of opioid dependants receiving maintenance treatment: results of a Norwegian pilot study.
Topics: Administration, Oral; Adult; Antiviral Agents; Buprenorphine; Comorbidity; Drug Therapy, Combination; Feasibility Studies; Female; Hepatitis C, Chronic; Humans; Injections, Subcutaneous; Interferon alpha-2; Interferon-alpha; Male; Methadone; Middle Aged; Narcotics; Norway; Opioid-Related Disorders; Patient Compliance; Pilot Projects; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Social Support; Substance Abuse, Intravenous | 2007 |
Exposure to opioid maintenance treatment reduces long-term mortality.
Topics: Adolescent; Adult; Australia; Buprenorphine; Cause of Death; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Methadone; Middle Aged; Narcotic Antagonists; Opioid-Related Disorders; Treatment Outcome | 2008 |
Retention rate and substance use in methadone and buprenorphine maintenance therapy and predictors of outcome: results from a randomized study.
Topics: Adult; Analysis of Variance; Buprenorphine; Chi-Square Distribution; Double-Blind Method; Female; Humans; Male; Methadone; Narcotics; Opioid-Related Disorders; Predictive Value of Tests; Prospective Studies; Substance Withdrawal Syndrome; Survival Analysis; Time Factors; Treatment Outcome | 2008 |
Prospective randomised comparative study of the effect of buprenorphine, methadone and heroin on the course of pregnancy, birthweight of newborns, early postpartum adaptation and course of the neonatal abstinence syndrome (NAS) in women followed up in the
Topics: Adult; Birth Weight; Buprenorphine; Female; Fetal Growth Retardation; Heroin; Heroin Dependence; Humans; Infant, Newborn; Life Style; Methadone; Narcotics; Neonatal Abstinence Syndrome; Outpatients; Postpartum Period; Pregnancy; Pregnancy Outcome; Prospective Studies; Severity of Illness Index | 2008 |
Buprenorphine and methadone maintenance treatment of heroin addicts preserves immune function.
Topics: Adult; Analgesics, Opioid; Buprenorphine; Female; Heroin Dependence; Humans; Immune System; Immunocompetence; Interferon-gamma; Interleukin-2; Interleukin-4; Male; Methadone; T-Lymphocytes; Tumor Necrosis Factor-alpha | 2008 |
Optimising the benefits of unobserved dose administration for stable opioid maintenance patients: follow-up of a randomised trial.
Topics: Adult; Australia; Buprenorphine; Directly Observed Therapy; Drug Administration Schedule; Drug Combinations; Female; Follow-Up Studies; Humans; Male; Methadone; Naloxone; Narcotic Antagonists; Opioid-Related Disorders; Patient Dropouts; Proportional Hazards Models; Secondary Prevention; Self Administration; Substance Abuse Treatment Centers; Treatment Outcome | 2008 |
Correlations of maternal buprenorphine dose, buprenorphine, and metabolite concentrations in meconium with neonatal outcomes.
Topics: Adult; Buprenorphine; Cocaine; Double-Blind Method; Female; Humans; Infant, Newborn; Male; Maternal Behavior; Maternal-Fetal Exchange; Meconium; Methadone; Narcotic Antagonists; Neonatal Abstinence Syndrome; Nicotine; Opiate Alkaloids; Opioid-Related Disorders; Pregnancy; Smoking | 2008 |
Neuropsychological functioning of opiate-dependent patients: a nonrandomized comparison of patients preferring either buprenorphine or methadone maintenance treatment.
Topics: Adult; Analgesics, Opioid; Buprenorphine; Cognition Disorders; Dose-Response Relationship, Drug; Female; Humans; Male; Methadone; Middle Aged; Neuropsychological Tests; Opioid-Related Disorders; Receptors, Opioid, mu; Young Adult | 2008 |
Opioid maintenance therapy suppresses alcohol intake in heroin addicts with alcohol dependence: preliminary results of an open randomized study.
Topics: Adult; Alcohol Drinking; Alcoholism; Analysis of Variance; Buprenorphine; Dose-Response Relationship, Drug; Drug Evaluation; Female; Heroin Dependence; Humans; Male; Methadone; Narcotics; Prospective Studies; Young Adult | 2008 |
Buprenorphine and methadone maintenance in jail and post-release: a randomized clinical trial.
Topics: Adolescent; Adult; Aged; Buprenorphine; Diagnosis, Dual (Psychiatry); Female; Follow-Up Studies; HIV Infections; Humans; Male; Mental Disorders; Methadone; Middle Aged; Narcotics; Opioid-Related Disorders; Patient Selection; Prisons; Recurrence; Socioeconomic Factors; Treatment Outcome; Young Adult | 2009 |
Cognitive functioning during methadone and buprenorphine treatment: results of a randomized clinical trial.
Topics: Analgesics, Opioid; Attention; Buprenorphine; Cognition; Humans; Memory; Methadone; Neuropsychological Tests; Opioid-Related Disorders; Patient Dropouts; Perception; Psychomotor Performance; Stress, Psychological; Substance Withdrawal Syndrome; Surveys and Questionnaires; Time Factors; Treatment Outcome | 2008 |
Memory function in opioid-dependent patients treated with methadone or buprenorphine along with benzodiazepine: longitudinal change in comparison to healthy individuals.
Topics: Adult; Analgesics, Opioid; Benzodiazepines; Buprenorphine; Drug Interactions; Drug Therapy, Combination; Female; Humans; Male; Memory; Methadone; Naloxone; Opioid-Related Disorders; Substance-Related Disorders; Time Factors | 2009 |
The Leeds Evaluation of Efficacy of Detoxification Study (LEEDS) Prisons Project Study: protocol for a randomised controlled trial comparing methadone and buprenorphine for opiate detoxification.
Topics: Buprenorphine; Humans; Methadone; Narcotics; Opioid-Related Disorders; Prisoners; Prisons; Research Design; United Kingdom | 2009 |
Improved HIV and substance abuse treatment outcomes for released HIV-infected prisoners: the impact of buprenorphine treatment.
Topics: Anti-Retroviral Agents; Buprenorphine; Buprenorphine, Naloxone Drug Combination; CD4 Lymphocyte Count; Female; HIV Infections; Humans; Male; Mental Disorders; Methadone; Middle Aged; Naloxone; Narcotic Antagonists; Narcotics; Prisoners; Substance-Related Disorders | 2010 |
Pharmacokinetic interactions between darunavir/ritonavir and opioid maintenance therapy using methadone or buprenorphine/naloxone.
Topics: Adult; Analgesics, Opioid; Buprenorphine; Darunavir; Drug Interactions; Female; HIV Protease Inhibitors; Humans; Male; Methadone; Middle Aged; Naloxone; Narcotic Antagonists; Opiate Substitution Treatment; Ritonavir; Sulfonamides | 2011 |
The SUMMIT trial: a field comparison of buprenorphine versus methadone maintenance treatment.
Topics: Adult; Buprenorphine; Choice Behavior; England; Female; Humans; Male; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Patient Preference; Pilot Projects; Proportional Hazards Models; Prospective Studies; Severity of Illness Index; Treatment Outcome; Young Adult | 2010 |
Neonatal abstinence syndrome after methadone or buprenorphine exposure.
Topics: Adult; Buprenorphine; Double-Blind Method; Female; Head; History, Ancient; Humans; Infant, Newborn; Length of Stay; Logistic Models; Methadone; Morphine; Narcotics; Neonatal Abstinence Syndrome; Opioid-Related Disorders; Pregnancy; Pregnancy Complications | 2010 |
(R)- and (S)-methadone and buprenorphine concentration ratios in maternal and umbilical cord plasma following chronic maintenance dosing in pregnancy.
Topics: Analgesics, Opioid; Buprenorphine; Drug Administration Schedule; Female; Fetal Blood; Humans; Infant, Newborn; Maternal-Fetal Exchange; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Pregnancy; Pregnancy Complications | 2010 |
The BHIVES collaborative: organization and evaluation of a multisite demonstration of integrated buprenorphine/naloxone and HIV treatment.
Topics: Ambulatory Care; Buprenorphine; Buprenorphine, Naloxone Drug Combination; HIV Infections; Humans; Methadone; Multicenter Studies as Topic; Naloxone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Pilot Projects; United States | 2011 |
Randomized controlled trials in pregnancy: scientific and ethical aspects. Exposure to different opioid medications during pregnancy in an intra-individual comparison.
Topics: Adult; Analgesics, Opioid; Birth Weight; Buprenorphine; Double-Blind Method; Female; Humans; Infant, Newborn; Male; Methadone; Neonatal Abstinence Syndrome; Opiate Substitution Treatment; Opioid-Related Disorders; Pregnancy; Pregnancy Complications; Severity of Illness Index; Smoking; Treatment Outcome; Young Adult | 2011 |
Buprenorphine versus methadone in pregnant opioid-dependent women: a prospective multicenter study.
Topics: Adult; Analgesics, Opioid; Birth Weight; Buprenorphine; Female; Heroin; Heroin Dependence; Humans; Infant, Newborn; Methadone; Narcotics; Neonatal Abstinence Syndrome; Opiate Substitution Treatment; Opioid-Related Disorders; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Prospective Studies | 2011 |
Cue-induced reactivity, cortisol response and substance use outcome in treated heroin dependent individuals.
Topics: Adult; Buprenorphine; Cues; Drug-Seeking Behavior; Female; Galvanic Skin Response; Heroin Dependence; Humans; Hydrocortisone; Logistic Models; Male; Methadone; Opiate Substitution Treatment; Recurrence; Saliva | 2011 |
Methadone, cocaine, opiates, and metabolite disposition in umbilical cord and correlations to maternal methadone dose and neonatal outcomes.
Topics: Adult; Analgesics, Opioid; Buprenorphine; Cocaine; Dose-Response Relationship, Drug; Female; Humans; Infant, Newborn; Maternal-Fetal Exchange; Meconium; Methadone; Narcotics; Neonatal Abstinence Syndrome; Opioid-Related Disorders; Placenta; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Pyrrolidines; Umbilical Cord | 2011 |
Impact of treatment approach on maternal and neonatal outcome in pregnant opioid-maintained women.
Topics: Adult; Austria; Birth Weight; Buprenorphine; Double-Blind Method; Female; Gestational Age; Humans; Infant, Newborn; Length of Stay; Male; Methadone; Morphine; Neonatal Abstinence Syndrome; Opiate Substitution Treatment; Opioid-Related Disorders; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Pregnancy Trimester, Third; Prospective Studies; Time Factors; Young Adult | 2011 |
Buprenorphine/naloxone versus methadone in opioid dependence: a longitudinal survey.
Topics: Adult; Analgesics, Opioid; Buprenorphine; Cocaine; Drug Therapy, Combination; Educational Status; Female; Humans; Longitudinal Studies; Male; Methadone; Naloxone; Opiate Substitution Treatment; Opioid-Related Disorders; Social Behavior | 2011 |
Cognitive functioning in opioid-dependent patients treated with buprenorphine, methadone, and other psychoactive medications: stability and correlates.
Topics: Adult; Analgesics, Opioid; Buprenorphine; Cognition; Female; Follow-Up Studies; Humans; Male; Methadone; Neuropsychological Tests; Opiate Substitution Treatment; Opioid-Related Disorders; Psychomotor Performance; Statistics as Topic | 2011 |
Are male neonates more vulnerable to neonatal abstinence syndrome than female neonates?
Topics: Birth Weight; Buprenorphine; Double-Blind Method; Female; Humans; Infant, Newborn; Male; Methadone; Neonatal Abstinence Syndrome; Opioid-Related Disorders; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Prenatal Exposure Delayed Effects; Prospective Studies; Risk Factors; Severity of Illness Index; Sex Distribution; Sex Factors | 2011 |
Comparison of methadone and buprenorphine for opiate detoxification (LEEDS trial): a randomised controlled trial.
Topics: Administration, Oral; Administration, Sublingual; Adult; Aged; Buprenorphine; Humans; Methadone; Middle Aged; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Prisoners; Young Adult | 2011 |
Influence of site differences between urban and rural American and Central European opioid-dependent pregnant women and neonatal outcome characteristics.
Topics: Adolescent; Adult; Buprenorphine; Double-Blind Method; Europe; Female; Humans; Infant, Newborn; Methadone; Opioid-Related Disorders; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Pregnant Women; Prospective Studies; Rural Population; United States; Urban Population; Young Adult | 2012 |
Inhibition of CYP2D6-mediated tramadol O-demethylation in methadone but not buprenorphine maintenance patients.
Topics: Administration, Oral; Adolescent; Adult; Analgesics, Opioid; Buprenorphine; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Cytochrome P-450 CYP3A; Drug Interactions; Female; Humans; Male; Methadone; Middle Aged; Opiate Substitution Treatment; Tramadol; Young Adult | 2012 |
Peripartum pain management in opioid dependent women.
Topics: Adult; Analgesics; Buprenorphine; Cesarean Section; Delivery, Obstetric; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Infant, Newborn; Methadone; Narcotics; Opioid-Related Disorders; Pain Management; Peripartum Period; Postpartum Period; Pregnancy; Pregnancy Outcome; Smoking; Young Adult | 2012 |
Medically assisted recovery from opiate dependence within the context of the UK drug strategy: methadone and Suboxone (buprenorphine-naloxone) patients compared.
Topics: Adult; Buprenorphine; Buprenorphine, Naloxone Drug Combination; Female; Follow-Up Studies; Health Policy; Heroin Dependence; Humans; Male; Methadone; Naloxone; Opiate Substitution Treatment; Opioid-Related Disorders; Recurrence; Time Factors; Treatment Outcome; United Kingdom | 2013 |
Buprenorphine/Naloxone and methadone effects on laboratory indices of liver health: a randomized trial.
Topics: Adolescent; Adult; Buprenorphine; Chemical and Drug Induced Liver Injury; Drug Combinations; Female; Humans; Liver; Male; Methadone; Middle Aged; Naloxone; Opioid-Related Disorders; Transaminases; Treatment Outcome | 2013 |
Cingulate biochemistry in heroin users on substitution pharmacotherapy.
Topics: Adult; Aspartic Acid; Buprenorphine; Depression; Dose-Response Relationship, Drug; Female; Functional Neuroimaging; Glutamic Acid; Glutamine; Gyrus Cinguli; Heroin Dependence; Humans; Inositol; Male; Methadone; Opiate Substitution Treatment | 2013 |
Maternal Opioid Treatment: Human Experimental Research (MOTHER) Study: maternal, fetal and neonatal outcomes from secondary analyses.
Topics: Adolescent; Adult; Buprenorphine; Female; Humans; Infant, Newborn; Methadone; Neonatal Abstinence Syndrome; Opiate Substitution Treatment; Opioid-Related Disorders; Pregnancy; Pregnancy Complications; Treatment Outcome; Young Adult | 2012 |
Fetal assessment before and after dosing with buprenorphine or methadone.
Topics: Adolescent; Adult; Analgesics, Opioid; Biophysical Phenomena; Buprenorphine; Double-Blind Method; Female; Fetal Monitoring; Fetal Movement; Fetus; Gestational Age; Heart Rate, Fetal; Humans; Infant, Newborn; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Outcome Assessment, Health Care; Pregnancy; Pregnancy Complications; Young Adult | 2012 |
Predicting treatment for neonatal abstinence syndrome in infants born to women maintained on opioid agonist medication.
Topics: Adolescent; Adult; Analgesics, Opioid; Birth Weight; Buprenorphine; Dose-Response Relationship, Drug; Female; Humans; Infant, Newborn; Length of Stay; Linear Models; Methadone; Morphine; Neonatal Abstinence Syndrome; Opioid-Related Disorders; Pregnancy; Pregnancy Complications; Prenatal Exposure Delayed Effects; Risk Factors; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Smoking; Young Adult | 2012 |
Differences in the profile of neonatal abstinence syndrome signs in methadone- versus buprenorphine-exposed neonates.
Topics: Adult; Analgesics, Opioid; Analysis of Variance; Buprenorphine; Double-Blind Method; Female; Humans; Incidence; Infant, Newborn; Methadone; Neonatal Abstinence Syndrome; Opiate Substitution Treatment; Opioid-Related Disorders; Pregnancy; Pregnancy Complications; Prenatal Exposure Delayed Effects; Severity of Illness Index; Symptom Assessment; Time Factors; Treatment Outcome | 2012 |
Neonatal neurobehavior effects following buprenorphine versus methadone exposure.
Topics: Adolescent; Adult; Analgesics, Opioid; Buprenorphine; Female; Humans; Infant Behavior; Infant, Newborn; Linear Models; Male; Methadone; Morphine; Neonatal Abstinence Syndrome; Opiate Substitution Treatment; Opioid-Related Disorders; Pregnancy; Pregnancy Complications; Prenatal Exposure Delayed Effects; Severity of Illness Index; Young Adult | 2012 |
Opioid dependence during pregnancy: relationships of anxiety and depression symptoms to treatment outcomes.
Topics: Adolescent; Adult; Analgesics, Opioid; Anxiety; Buprenorphine; Comorbidity; Depression; Double-Blind Method; Female; Humans; Interview, Psychological; Logistic Models; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Patient Compliance; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Severity of Illness Index; Treatment Outcome; Young Adult | 2012 |
Infections and obstetric outcomes in opioid-dependent pregnant women maintained on methadone or buprenorphine.
Topics: Adolescent; Adult; Analgesics, Opioid; Analysis of Variance; Buprenorphine; Communicable Diseases; Female; Humans; Incidence; Infant, Newborn; Logistic Models; Methadone; Opioid-Related Disorders; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Respiratory Distress Syndrome, Newborn; Young Adult | 2012 |
Effect of hepatitis C virus status on liver enzymes in opioid-dependent pregnant women maintained on opioid-agonist medication.
Topics: Adolescent; Adult; Analgesics, Opioid; Buprenorphine; Female; gamma-Glutamyltransferase; Hepatitis C; Humans; Linear Models; Liver; Liver Function Tests; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Pregnancy; Pregnancy Trimesters; Transaminases; Young Adult | 2012 |
Lessons learned from a comparison of evidence-based research in pregnant opioid-dependent women.
Topics: Adolescent; Adult; Buprenorphine; Double-Blind Method; Evidence-Based Medicine; Female; Humans; Infant, Newborn; Learning; Methadone; Opioid-Related Disorders; Pilot Projects; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Young Adult | 2013 |
A comparison of cigarette smoking profiles in opioid-dependent pregnant patients receiving methadone or buprenorphine.
Topics: Adolescent; Adult; Buprenorphine; Female; Humans; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Pregnancy; Smoking; Young Adult | 2013 |
Opiate agonists and antagonists modulate taste perception in opiate-maintained and recently detoxified subjects.
Topics: Adult; Analgesics, Opioid; Buprenorphine; Cohort Studies; Cross-Over Studies; Dietary Sucrose; Double-Blind Method; England; Female; Food Preferences; Humans; Male; Methadone; Naltrexone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Osmolar Concentration; Sodium Chloride, Dietary; Taste Perception; Taste Threshold; Young Adult | 2013 |
A preliminary study comparing methadone and buprenorphine in patients with chronic pain and coexistent opioid addiction.
Topics: Administration, Sublingual; Analgesics, Opioid; Analysis of Variance; Buprenorphine; Chronic Pain; Drug Combinations; Female; Humans; Male; Methadone; Middle Aged; Naloxone; Opioid-Related Disorders; Prescription Drug Misuse; Severity of Illness Index; Substance Abuse Detection; Treatment Outcome | 2013 |
Induction of pregnant women onto opioid-agonist maintenance medication: an analysis of withdrawal symptoms and study retention.
Topics: Adult; Analysis of Variance; Buprenorphine; Confidence Intervals; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Educational Status; Ethnicity; Female; Humans; Linear Models; Methadone; Morphine; Narcotics; Patient Dropouts; Pregnancy; Pregnancy Complications; Socioeconomic Factors; Substance Withdrawal Syndrome | 2013 |
Retention in methadone and buprenorphine treatment among African Americans.
Topics: Adult; Black or African American; Buprenorphine; Female; Humans; Male; Methadone; Middle Aged; Opiate Substitution Treatment; Opioid-Related Disorders; Patient Compliance; Patient Dropouts; Substance Abuse Treatment Centers; United States; Urban Population | 2013 |
Neurofeedback training for opiate addiction: improvement of mental health and craving.
Topics: Adult; Analgesics, Opioid; Buprenorphine; Humans; Male; Mental Health; Methadone; Middle Aged; Motivation; Neurofeedback; Opiate Substitution Treatment; Opioid-Related Disorders; Surveys and Questionnaires; Treatment Outcome | 2013 |
An intronic variant in OPRD1 predicts treatment outcome for opioid dependence in African-Americans.
Topics: Adult; Analgesics, Opioid; Black or African American; Buprenorphine; Buprenorphine, Naloxone Drug Combination; Female; Genotype; Humans; Introns; Male; Methadone; Middle Aged; Naloxone; Narcotic Antagonists; Narcotics; Opioid-Related Disorders; Polymorphism, Single Nucleotide; Receptors, Opioid, delta; Treatment Outcome; White People | 2013 |
Buprenorphine/naloxone and methadone maintenance treatment outcomes for opioid analgesic, heroin, and combined users: findings from starting treatment with agonist replacement therapies (START).
Topics: Adult; Buprenorphine; Buprenorphine, Naloxone Drug Combination; Female; Heroin Dependence; Humans; Male; Methadone; Middle Aged; Naloxone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Severity of Illness Index; Substance Abuse, Intravenous; Treatment Outcome; Young Adult | 2013 |
Nonserious adverse events in randomized trials with opioid-dependent pregnant women: direct versus indirect measurement.
Topics: Analgesics, Opioid; Buprenorphine; Data Collection; Double-Blind Method; Female; Humans; Infant, Newborn; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Pregnancy; Pregnancy Complications | 2012 |
Methadone and buprenorphine-naloxone are effective in reducing illicit buprenorphine and other opioid use, and reducing HIV risk behavior--outcomes of a randomized trial.
Topics: Adult; Buprenorphine; Female; Georgia (Republic); Hepatitis C; HIV Infections; Humans; Male; Methadone; Narcotics; Needle Sharing; Opiate Substitution Treatment; Opioid-Related Disorders; Risk-Taking; Substance Abuse Detection; Substance Abuse, Intravenous; Treatment Outcome | 2013 |
Treatment retention among patients randomized to buprenorphine/naloxone compared to methadone in a multi-site trial.
Topics: Adolescent; Adult; Analgesics, Opioid; Buprenorphine; Buprenorphine, Naloxone Drug Combination; Female; Humans; Male; Medication Adherence; Methadone; Middle Aged; Naloxone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Treatment Outcome; Young Adult | 2014 |
Regaining control: the patient experience of supervised compared with unsupervised consumption in opiate substitution treatment.
Topics: Attitude of Health Personnel; Buprenorphine; Directly Observed Therapy; Female; Focus Groups; Humans; Interviews as Topic; Male; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Patient Satisfaction; Self Administration | 2014 |
Treatment retention, drug use and social functioning outcomes in those receiving 3 months versus 1 month of supervised opioid maintenance treatment. Results from the Super C randomized controlled trial.
Topics: Adult; Buprenorphine; Crime; Female; Humans; Maintenance Chemotherapy; Male; Medication Adherence; Methadone; Narcotics; Opiate Substitution Treatment; Opioid-Related Disorders; Proportional Hazards Models; Quality of Life; Treatment Outcome; United Kingdom | 2014 |
HIV risk reduction with buprenorphine-naloxone or methadone: findings from a randomized trial.
Topics: Adult; Buprenorphine; Female; HIV Infections; Humans; Male; Methadone; Middle Aged; Naloxone; Narcotic Antagonists; Opioid-Related Disorders; Risk Reduction Behavior; Substance Abuse, Intravenous; Unsafe Sex | 2014 |
Design considerations for point-of-care clinical trials comparing methadone and buprenorphine treatment for opioid dependence in pregnancy and for neonatal abstinence syndrome.
Topics: Adult; Birth Weight; Buprenorphine; Female; Humans; Infant, Newborn; Length of Stay; Methadone; Neonatal Abstinence Syndrome; Opiate Substitution Treatment; Opioid-Related Disorders; Pregnancy; Pregnancy Complications; Research Design | 2014 |
Methadone versus morphine for treatment of neonatal abstinence syndrome: a prospective randomized clinical trial.
Topics: Analgesics, Opioid; Birth Weight; Buprenorphine; Double-Blind Method; Female; Gestational Age; Humans; Infant, Newborn; Length of Stay; Male; Methadone; Morphine; Neonatal Abstinence Syndrome; Prospective Studies; Treatment Outcome | 2015 |
Effect of steady-state faldaprevir on the pharmacokinetics of steady-state methadone and buprenorphine-naloxone in subjects receiving stable addiction management therapy.
Topics: Administration, Oral; Adult; Aminoisobutyric Acids; Buprenorphine; Buprenorphine, Naloxone Drug Combination; Drug Interactions; Female; Humans; Leucine; Male; Methadone; Middle Aged; Oligopeptides; Proline; Quinolines; Substance Withdrawal Syndrome; Substance-Related Disorders; Thiazoles; Young Adult | 2015 |
Enhancing motivation within a rapid opioid substitution treatment feasibility RCT: a nested qualitative study.
Topics: Adult; Analgesics, Opioid; Buprenorphine; Cognitive Dissonance; England; Feasibility Studies; Female; Harm Reduction; Heroin Dependence; Humans; Male; Methadone; Middle Aged; Motivation; Motivational Interviewing; Narcotics; Opiate Substitution Treatment; Patient Satisfaction; Program Evaluation; Qualitative Research; Substance Abuse, Intravenous; Time-to-Treatment; Young Adult | 2014 |
Opioid addicted buprenorphine injectors: drug use during and after 12-weeks of buprenorphine-naloxone or methadone in the Republic of Georgia.
Topics: Adult; Buprenorphine; Buprenorphine, Naloxone Drug Combination; Counseling; Drug Users; Female; Georgia (Republic); Humans; Methadone; Middle Aged; Naloxone; Narcotics; Opiate Substitution Treatment; Opioid-Related Disorders; Substance Abuse, Intravenous; Treatment Outcome | 2015 |
Pharmacokinetic interaction between HCV protease inhibitor boceprevir and methadone or buprenorphine in subjects on stable maintenance therapy.
Topics: Adolescent; Adult; Aged; Buprenorphine; Buprenorphine, Naloxone Drug Combination; Drug Interactions; Female; Humans; Maintenance Chemotherapy; Male; Methadone; Middle Aged; Opiate Substitution Treatment; Proline; Protease Inhibitors; Young Adult | 2015 |
Attentional bias and treatment adherence in substitute-prescribed opiate users.
Topics: Analysis of Variance; Attention; Buprenorphine; Craving; Female; Humans; Impulsive Behavior; Male; Medication Adherence; Methadone; Middle Aged; Narcotics; Opiate Substitution Treatment; Opioid-Related Disorders; Psychotherapy; Surveys and Questionnaires | 2015 |
Ombitasvir/paritaprevir/r and dasabuvir plus ribavirin in HCV genotype 1-infected patients on methadone or buprenorphine.
Topics: 2-Naphthylamine; Adolescent; Adult; Aged; Analgesics, Opioid; Anilides; Antiviral Agents; Buprenorphine; Carbamates; Cyclopropanes; DNA, Viral; Drug Therapy, Combination; Female; Follow-Up Studies; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Lactams, Macrocyclic; Macrocyclic Compounds; Male; Methadone; Middle Aged; Opioid-Related Disorders; Proline; Retrospective Studies; Ribavirin; Sulfonamides; Uracil; Valine; Young Adult | 2015 |
Malmö Treatment Referral and Intervention Study (MATRIS)—effective referral from syringe exchange to treatment for heroin dependence: a pilot randomized controlled trial.
Topics: Adult; Aged; Analgesics, Opioid; Buprenorphine; Female; Heroin Dependence; Humans; Male; Methadone; Middle Aged; Needle-Exchange Programs; Patient Acceptance of Health Care; Pilot Projects; Referral and Consultation; Sweden; Young Adult | 2016 |
Exaggerated acquisition and resistance to extinction of avoidance behavior in treated heroin-dependent men.
Topics: Adult; Analgesics, Opioid; Avoidance Learning; Buprenorphine; Case-Control Studies; Extinction, Psychological; Female; Heroin Dependence; Humans; Male; Methadone; Video Games; Young Adult | 2016 |
Psychometric assessment of the Neonatal Abstinence Scoring System and the MOTHER NAS Scale.
Topics: Adult; Analgesics, Opioid; Buprenorphine; Female; Humans; Infant, Newborn; Methadone; Neonatal Abstinence Syndrome; Neonatal Screening; Opiate Substitution Treatment; Opioid-Related Disorders; Pregnancy; Pregnancy Complications; Psychometrics; Reproducibility of Results | 2016 |
Elbasvir-Grazoprevir to Treat Hepatitis C Virus Infection in Persons Receiving Opioid Agonist Therapy: A Randomized Trial.
Topics: Adolescent; Adult; Aged; Antiviral Agents; Benzofurans; Buprenorphine; Buprenorphine, Naloxone Drug Combination; Double-Blind Method; Drug Combinations; Drug Resistance, Viral; Female; Genotype; Hepatitis C, Chronic; Humans; Imidazoles; Male; Medication Adherence; Methadone; Middle Aged; Opiate Substitution Treatment; Opioid-Related Disorders; Quinoxalines; Recurrence; Substance Abuse, Intravenous; Young Adult | 2016 |
Effectiveness of adjunctive, personalised psychosocial intervention for non-response to opioid agonist treatment: Study protocol for a pragmatic randomised controlled trial.
Topics: Adaptation, Psychological; Analgesics, Opioid; Buprenorphine; Buprenorphine, Naloxone Drug Combination; Cognitive Behavioral Therapy; Combined Modality Therapy; Humans; Methadone; Motivation; Opiate Substitution Treatment; Opioid-Related Disorders; Social Support; United Kingdom | 2017 |
The effect of bundling medication-assisted treatment for opioid addiction with mHealth: study protocol for a randomized clinical trial.
Topics: Adaptation, Psychological; Analgesics, Opioid; Buprenorphine; Clinical Protocols; Combined Modality Therapy; Drug Users; Health Services Accessibility; Humans; Methadone; Mobile Applications; Naltrexone; Opiate Substitution Treatment; Opioid-Related Disorders; Quality of Life; Recurrence; Research Design; Smartphone; Telemedicine; Time Factors; Treatment Outcome; Wisconsin | 2016 |
Newborn birth-weight of pregnant women on methadone or buprenorphine maintenance treatment: A national contingency management approach trial.
Topics: Adult; Age of Onset; Alcohol Drinking; Birth Weight; Buprenorphine; Cigarette Smoking; Female; Humans; Infant, Low Birth Weight; Infant, Newborn; Israel; Methadone; Narcotics; Opiate Substitution Treatment; Opioid-Related Disorders; Patient Care Management; Pregnancy; Pregnancy Complications | 2017 |
Hospitalized opioid-dependent patients: Exploring predictors of buprenorphine treatment entry and retention after discharge.
Topics: Adult; Buprenorphine; Continuity of Patient Care; Female; Hospitalization; Humans; Male; Methadone; Middle Aged; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Patient Discharge; Patient Dropouts; Risk Factors; Treatment Outcome | 2017 |
Comparing the effect of buprenorphine and methadone in the reduction of methamphetamine craving: a randomized clinical trial.
Topics: Adult; Amphetamine-Related Disorders; Analgesics, Opioid; Behavior, Addictive; Buprenorphine; Central Nervous System Stimulants; Craving; Double-Blind Method; Humans; Iran; Male; Methadone; Methamphetamine; Substance Withdrawal Syndrome; Time Factors; Treatment Outcome; Young Adult | 2017 |
No Clinically Relevant Drug-Drug Interactions between Methadone or Buprenorphine-Naloxone and Antiviral Combination Glecaprevir and Pibrentasvir.
Topics: Adult; Aminoisobutyric Acids; Antiviral Agents; Benzimidazoles; Buprenorphine; Buprenorphine, Naloxone Drug Combination; Cyclopropanes; Drug Interactions; Female; Hepacivirus; Hepatitis C, Chronic; Humans; Lactams, Macrocyclic; Leucine; Male; Methadone; Middle Aged; Naloxone; Opiate Substitution Treatment; Opioid-Related Disorders; Proline; Protease Inhibitors; Pyrrolidines; Quinoxalines; Sulfonamides; Surveys and Questionnaires; Young Adult | 2017 |
Prenatal exposure to methadone or buprenorphine: Early childhood developmental outcomes.
Topics: Adult; Buprenorphine; Child Development; Child, Preschool; Cognition; Female; Humans; Infant, Newborn; Male; Methadone; Mothers; Neonatal Abstinence Syndrome; Opioid-Related Disorders; Parenting; Pregnancy; Pregnancy Complications; Prenatal Exposure Delayed Effects; Temperament | 2018 |
Rationale, design, and methodology of a trial evaluating three models of care for HCV treatment among injection drug users on opioid agonist therapy.
Topics: Adult; Antiviral Agents; Buprenorphine; Directly Observed Therapy; Drug Users; Female; Hepacivirus; Hepatitis C, Chronic; Humans; Informed Consent; Male; Medication Adherence; Methadone; New York; Opiate Substitution Treatment; Research Design; Self Report | 2018 |
A comparison between methadone and buprenorphine for perioperative analgesia in dogs undergoing ovariohysterectomy.
Topics: Acepromazine; Analgesia; Analgesics, Opioid; Animals; Buprenorphine; Dogs; Female; Hypnotics and Sedatives; Hysterectomy; Medetomidine; Methadone; Ovariectomy; Pain Measurement; Pain, Postoperative; Random Allocation | 2018 |
Positive reinforcement targeting abstinence in substance misuse (PRAISe): Study protocol for a Cluster RCT & process evaluation of contingency management.
Topics: Adult; Behavior Therapy; Buprenorphine; Cluster Analysis; Drug Misuse; Female; Heroin Dependence; Humans; Male; Medication Therapy Management; Mental Health Services; Methadone; Narcotic Antagonists; Opioid-Related Disorders; Quality Improvement; Reinforcement, Psychology; United Kingdom | 2018 |
A clinical trial on the acute effects of methadone and buprenorphine on actual driving and cognitive function of healthy volunteers.
Topics: Adult; Analgesics, Opioid; Attention; Automobile Driving; Buprenorphine; Cognition; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Female; Healthy Volunteers; Humans; Male; Methadone; Middle Aged; Placebos; Psychomotor Performance; Reaction Time; Young Adult | 2019 |
Buprenorphine and Methadone as Opioid Maintenance Treatments for Heroin-Addicted Patients Induce Oxidative Stress in Blood.
Topics: Adult; Analgesics, Opioid; Antioxidants; Biomarkers; Buprenorphine; Case-Control Studies; Catalase; Female; Glutathione; Heroin Dependence; Humans; Male; Methadone; Oxidation-Reduction; Oxidative Stress; Protein Carbonylation; Thiobarbituric Acid Reactive Substances | 2019 |
A pilot study assessing acceptability and feasibility of hatha yoga for chronic pain in people receiving opioid agonist therapy for opioid use disorder.
Topics: Adult; Analgesics, Opioid; Buprenorphine; Chronic Pain; Feasibility Studies; Female; Health Education; Humans; Male; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Pilot Projects; Yoga | 2019 |
Acute Experimental Pain Responses in Methadone- and Buprenorphine/Naloxone-Maintained Patients Administered Additional Opioid or Gabapentin: A Double-Blind Crossover Pilot Study.
Topics: Analgesics, Opioid; Australia; Buprenorphine; Cross-Over Studies; Double-Blind Method; Gabapentin; Humans; Methadone; Opioid-Related Disorders; Pilot Projects | 2020 |
Sleep reductions associated with illicit opioid use and clinic-hour changes during opioid agonist treatment for opioid dependence: Measurement by electronic diary and actigraphy.
Topics: Actigraphy; Adult; Ambulatory Care Facilities; Appointments and Schedules; Buprenorphine; Cross-Over Studies; Diaries as Topic; Female; Humans; Male; Methadone; Middle Aged; Opiate Substitution Treatment; Opioid-Related Disorders; Sleep; Sleep Wake Disorders; Time Factors | 2019 |
Buprenorphine to reverse respiratory depression from methadone overdose in opioid-dependent patients: a prospective randomized trial.
Topics: Adult; Analgesics, Opioid; Buprenorphine; Drug Overdose; Female; Humans; Male; Methadone; Middle Aged; Naloxone; Narcotic Antagonists; Respiratory Insufficiency; Young Adult | 2020 |
Real-world evidence for a prescription digital therapeutic to treat opioid use disorder.
Topics: Adult; Analgesics, Opioid; Buprenorphine; Combined Modality Therapy; Humans; Male; Methadone; Opioid-Related Disorders; Prescriptions | 2021 |
Lorcaserin treatment for extended-release naltrexone induction and retention for opioid use disorder individuals: A pilot, placebo-controlled randomized trial.
Topics: Adult; Animals; Benzazepines; Buprenorphine; Delayed-Action Preparations; Female; Humans; Injections; Male; Methadone; Middle Aged; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders; Outpatients; Substance Withdrawal Syndrome; Swine | 2021 |
HIV clinic-based buprenorphine plus naloxone versus referral for methadone maintenance therapy for treatment of opioid use disorder in HIV clinics in Vietnam (BRAVO): an open-label, randomised, non-inferiority trial.
Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Buprenorphine; CD4 Lymphocyte Count; Drug Therapy, Combination; Female; HIV Infections; Humans; Male; Methadone; Middle Aged; Naloxone; Narcotic Antagonists; Narcotics; Opiate Substitution Treatment; Opioid-Related Disorders; Patient Compliance; Random Allocation; RNA, Viral; Treatment Outcome; Vietnam; Viral Load | 2021 |
Remotely delivered incentives to promote buprenorphine treatment engagement in out-of-treatment adults with opioid use disorder.
Topics: Adult; Analgesics, Opioid; Buprenorphine; Humans; Methadone; Motivation; Opiate Substitution Treatment; Opioid-Related Disorders | 2021 |
Long-term follow-up assessment of opioid use outcomes among individuals with comorbid mental disorders and opioid use disorder treated with buprenorphine or methadone in a randomized clinical trial.
Topics: Adult; Analgesics, Opioid; Buprenorphine; Buprenorphine, Naloxone Drug Combination; Follow-Up Studies; Humans; Methadone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders | 2022 |
Psychiatric comorbidity and treatment outcomes in patients with opioid use disorder: Results from a multisite trial of buprenorphine-naloxone and methadone.
Topics: Analgesics, Opioid; Buprenorphine; Buprenorphine, Naloxone Drug Combination; Comorbidity; Depressive Disorder, Major; Follow-Up Studies; Humans; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Treatment Outcome | 2021 |
Correlates of days of medication for opioid use disorder exposure among people living with HIV in Northern Vietnam.
Topics: Analgesics, Opioid; Buprenorphine; HIV Infections; Humans; Male; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Vietnam | 2022 |
Flexible Buprenorphine/Naloxone Model of Care for Reducing Opioid Use in Individuals With Prescription-Type Opioid Use Disorder: An Open-Label, Pragmatic, Noninferiority Randomized Controlled Trial.
Topics: Adult; Analgesics, Opioid; Buprenorphine; Buprenorphine, Naloxone Drug Combination; Canada; Drug Overdose; Female; Humans; Male; Methadone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Prescriptions | 2022 |
Impact of fentanyl use on initiation and discontinuation of methadone and buprenorphine/naloxone among people with prescription-type opioid use disorder: secondary analysis of a Canadian treatment trial.
Topics: Analgesics, Opioid; Buprenorphine; Buprenorphine, Naloxone Drug Combination; Canada; Female; Fentanyl; Humans; Male; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Prescriptions | 2022 |
The Substance Use Treatment and Recovery Team (START) study: protocol for a multi-site randomized controlled trial evaluating an intervention to improve initiation of medication and linkage to post-discharge care for hospitalized patients with opioid use
Topics: Aftercare; Buprenorphine; Humans; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Patient Discharge; Randomized Controlled Trials as Topic | 2022 |
Extended-release pharmacotherapy for opioid use disorder (EXPO): protocol for an open-label randomised controlled trial of the effectiveness and cost-effectiveness of injectable buprenorphine versus sublingual tablet buprenorphine and oral liquid methadon
Topics: Adult; Analgesics, Opioid; Buprenorphine; Cost-Benefit Analysis; Delayed-Action Preparations; Humans; Methadone; Multicenter Studies as Topic; Narcotic Antagonists; Opioid-Related Disorders; Pragmatic Clinical Trials as Topic; Randomized Controlled Trials as Topic; State Medicine; Tablets | 2022 |
Maintenance on extended-release naltrexone is associated with reduced injection opioid use among justice-involved persons with opioid use disorder.
Topics: Analgesics, Opioid; Buprenorphine; Delayed-Action Preparations; Hepatitis C; HIV Infections; Humans; Injections, Intramuscular; Methadone; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders; RNA; Social Justice | 2022 |
Buprenorphine/naloxone and methadone effectiveness for reducing craving in individuals with prescription opioid use disorder: Exploratory results from an open-label, pragmatic randomized controlled trial.
Topics: Buprenorphine; Buprenorphine, Naloxone Drug Combination; Craving; Humans; Methadone; Naloxone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Prescriptions | 2022 |
Buprenorphine/naloxone versus methadone opioid rotation in patients with prescription opioid use disorder and chronic pain: study protocol for a randomized controlled trial.
Topics: Analgesics, Opioid; Buprenorphine; Buprenorphine, Naloxone Drug Combination; Chronic Pain; Humans; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Prescriptions; Quality of Life; Randomized Controlled Trials as Topic | 2022 |
Experience and response to a randomised controlled trial of extended-release injectable buprenorphine versus sublingual tablet buprenorphine and oral liquid methadone for opioid use disorder: protocol for a mixed-methods evaluation.
Topics: Buprenorphine; Humans; Methadone; Narcotic Antagonists; Opioid-Related Disorders; Randomized Controlled Trials as Topic; Tablets | 2022 |
Effects of Buprenorphine/Naloxone and Methadone on Depressive Symptoms in People with Prescription Opioid Use Disorder: A Pragmatic Randomised Controlled Trial.
Topics: Analgesics, Opioid; Buprenorphine; Buprenorphine, Naloxone Drug Combination; Canada; Depression; Humans; Methadone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Prescriptions | 2023 |
Surmounting Withdrawal to Initiate Fast Treatment with Naltrexone (SWIFT): A stepped wedge hybrid type 1 effectiveness-implementation study.
Topics: Buprenorphine; Delayed-Action Preparations; Humans; Injections, Intramuscular; Methadone; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders | 2023 |
Differential effect of cannabis use on opioid agonist treatment outcomes: Exploratory analyses from the OPTIMA study.
Topics: Analgesics, Opioid; Bayes Theorem; Buprenorphine; Buprenorphine, Naloxone Drug Combination; Cannabis; Humans; Methadone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Substance Withdrawal Syndrome | 2023 |
Integrating cognitive bias modification for pain and opioid cues into medication for opioid use disorder clinical care: Feasibility, acceptability, and preliminary results.
Topics: Analgesics, Opioid; Buprenorphine; Chronic Pain; Cognition; Cues; Feasibility Studies; Humans; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders | 2023 |
Cost-effectiveness of flexible take-home buprenorphine-naloxone versus methadone for treatment of prescription-type opioid use disorder.
Topics: Analgesics, Opioid; Buprenorphine; Buprenorphine, Naloxone Drug Combination; Cost-Benefit Analysis; Humans; Methadone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Prescriptions | 2023 |
Opioid agonist therapy switching among individuals with prescription-type opioid use disorder: Secondary analysis of a pragmatic randomized trial.
Topics: Analgesics, Opioid; Buprenorphine; Buprenorphine, Naloxone Drug Combination; Canada; Humans; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Prescriptions | 2023 |
Associations of methadone and buprenorphine-naloxone doses with unregulated opioid use, treatment retention, and adverse events in prescription-type opioid use disorders: Exploratory analyses of the OPTIMA study.
Topics: Analgesics, Opioid; Buprenorphine; Buprenorphine, Naloxone Drug Combination; Canada; Heroin; Humans; Methadone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Prescriptions | 2023 |
1099 other study(ies) available for methadone and buprenorphine
| Article | Year |
|---|---|
Pharmacotherapy of narcotic dependence.
Topics: Buprenorphine; Cyclazocine; Dextropropoxyphene; Diphenoxylate; Female; Humans; Infant, Newborn; Infant, Newborn, Diseases; Male; Methadone; Naloxone; Narcotic Antagonists; Narcotics; Pregnancy; Pregnancy Complications; Prognosis; Substance-Related Disorders | 1977 |
Analysis of clinical trials for treatment of opiate dependence: what are the possibilities?
Topics: Buprenorphine; Clinical Trials as Topic; Data Interpretation, Statistical; Humans; Methadone; Narcotics; Opioid-Related Disorders; Patient Compliance; Patient Dropouts; Probability | 1992 |
Toward a dynamic analysis of disease-state transition monitored by serial clinical laboratory tests.
Topics: Buprenorphine; Cohort Studies; Data Interpretation, Statistical; Humans; Markov Chains; Methadone; Models, Statistical; Opioid-Related Disorders; Stochastic Processes; Time Factors | 1992 |
A Markov model for NIDA data on treatment of opiate dependence.
Topics: Bayes Theorem; Buprenorphine; Data Interpretation, Statistical; Humans; Likelihood Functions; Markov Chains; Methadone; Models, Statistical; Opioid-Related Disorders | 1992 |
A Bayesian nonparametric approach to analysis of treatment for drug-dependence data.
Topics: Bayes Theorem; Buprenorphine; Data Interpretation, Statistical; Humans; Methadone; Narcotics; Opioid-Related Disorders; Probability | 1992 |
Three estimators of the probability of opiate use from incomplete data.
Topics: Buprenorphine; Data Interpretation, Statistical; Humans; Methadone; Models, Statistical; Narcotics; Opioid-Related Disorders; Patient Compliance; Patient Dropouts; Probability | 1992 |
Issues in the analysis of clinical trials for opiate dependence.
Topics: Bias; Buprenorphine; Clinical Trials as Topic; Data Interpretation, Statistical; Humans; Methadone; Models, Statistical; Opioid-Related Disorders; Patient Compliance; Patient Dropouts | 1992 |
Beta endorphin levels during heroin, methadone, buprenorphine, and naloxone challenges: preliminary findings.
Topics: Adult; beta-Endorphin; Buprenorphine; Female; Heroin; Humans; Male; Methadone; Middle Aged; Naloxone; Radioimmunoassay; Substance Withdrawal Syndrome; Substance-Related Disorders | 1992 |
The partial opioid agonist, buprenorphine, protects against lethal effects of cocaine.
Topics: Animals; Brain; Buprenorphine; Cocaine; Dose-Response Relationship, Drug; Methadone; Mice; Mice, Inbred Strains; Morphine; Naltrexone; Receptors, Opioid; Receptors, Opioid, mu; Seizures | 1991 |
Onset of tolerance to discriminative stimulus effects of morphine.
Topics: Animals; Buprenorphine; Discrimination, Psychological; Dose-Response Relationship, Drug; Drug Tolerance; Male; Methadone; Morphine; Rats; Rats, Inbred Strains; Receptors, Opioid; Receptors, Opioid, mu | 1991 |
The effects of buprenorphine in methadone-dependent volunteers.
Topics: Buprenorphine; Double-Blind Method; Humans; Hydromorphone; Male; Methadone; Naloxone; Opioid-Related Disorders; Pupil | 1990 |
Double blind assessment of buprenorphine withdrawal in opiate-addicts.
Topics: Buprenorphine; Double-Blind Method; Humans; Methadone; Opioid-Related Disorders; Substance Withdrawal Syndrome | 1990 |
Outpatient comparison of buprenorphine and methadone maintenance. I. Effects on opiate use and self-reported adverse effects and withdrawal symptomatology.
Topics: Adult; Buprenorphine; Double-Blind Method; Female; Humans; Male; Methadone; Middle Aged; Naloxone; Opioid-Related Disorders; Outpatients; Substance Withdrawal Syndrome | 1990 |
Outpatient comparison of buprenorphine and methadone maintenance. II. Effects on cocaine usage, retention time in study and missed clinic visits.
Topics: Adult; Buprenorphine; Cocaine; Female; Humans; Male; Methadone; Middle Aged; Opioid-Related Disorders; Outpatients; Substance-Related Disorders | 1990 |
Tolerance to morphine-like stimulus effects of mu opioid agonists.
Topics: Animals; Buprenorphine; Conditioning, Operant; Dose-Response Relationship, Drug; Drug Tolerance; Etorphine; Male; Methadone; Morphine; Rats; Rats, Inbred Strains | 1991 |
[Effect of buprenorphine on external pancreatic secretion in rats].
Topics: Animals; Buprenorphine; Deoxyglucose; Dose-Response Relationship, Drug; Male; Methadone; Naloxone; Pancreas; Rats; Rats, Inbred Strains | 1990 |
Effects on opioid-induced rate reductions by doxepin and bupropion.
Topics: Animals; Antidepressive Agents; Buprenorphine; Bupropion; Columbidae; Dose-Response Relationship, Drug; Doxepin; Drug Tolerance; Methadone; Propiophenones; Reaction Time; Reinforcement Schedule | 1990 |
Depressive symptoms during buprenorphine treatment of opioid abusers.
Topics: Adult; Buprenorphine; Cocaine; Combined Modality Therapy; Depressive Disorder; Female; Follow-Up Studies; Humans; Male; Methadone; Opioid-Related Disorders; Personality Tests; Substance-Related Disorders | 1990 |
Sublingual absorption of selected opioid analgesics.
Topics: Administration, Sublingual; Adult; Analgesics, Opioid; Analysis of Variance; Biological Availability; Buprenorphine; Fentanyl; Heroin; Humans; Hydromorphone; Levorphanol; Methadone; Morphine; Mouth; Naloxone; Oxycodone; Time Factors | 1988 |
[Prevalence of buprenorphine use by heroin addicts undergoing treatment].
Topics: Adult; Buprenorphine; Female; Heroin Dependence; Humans; Male; Methadone; Substance-Related Disorders | 1989 |
Outpatient maintenance/detoxification comparison of methadone and buprenorphine.
Topics: Adult; Ambulatory Care; Buprenorphine; Drug Evaluation; Female; Humans; Male; Methadone; Middle Aged; Opioid-Related Disorders | 1989 |
Buprenorphine treatment of cocaine abuse.
Topics: Buprenorphine; Cocaine; Humans; Methadone; Opioid-Related Disorders; Substance Abuse Detection; Substance-Related Disorders | 1989 |
Treatment of cocaine abuse with buprenorphine.
Topics: Administration, Oral; Administration, Sublingual; Adult; Buprenorphine; Cocaine; Combined Modality Therapy; Female; Follow-Up Studies; Heroin Dependence; Humans; Male; Methadone; Substance-Related Disorders | 1989 |
Role of opioid antagonists in treating intravenous cocaine abuse.
Topics: Adult; Buprenorphine; Cocaine; Female; Humans; Injections, Intravenous; Male; Methadone; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders; Substance-Related Disorders | 1989 |
Use of beta-funaltrexamine to determine mu opioid receptor involvement in the analgesic activity of various opioid ligands.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Analgesia; Animals; Biological Assay; Buprenorphine; Butorphanol; Cyclazocine; Dose-Response Relationship, Drug; Ethylketocyclazocine; Etorphine; Fentanyl; Methadone; Mice; Morphine; Muscle Contraction; Nalbuphine; Nalorphine; Naltrexone; Pyrrolidines; Receptors, Opioid; Receptors, Opioid, mu | 1987 |
Effects of buprenorphine, methadone and naloxone on acquisition of behavioral chains.
Topics: Animals; Behavior, Animal; Buprenorphine; Columbidae; Conditioning, Operant; Dose-Response Relationship, Drug; Learning; Male; Methadone; Naloxone | 1988 |
Effects of exposure in utero to methadone and buprenorphine on enkephalin levels in the developing rat brain.
Topics: Animals; Brain; Buprenorphine; Dose-Response Relationship, Drug; Enkephalins; Female; Methadone; Pregnancy; Prenatal Exposure Delayed Effects; Rats | 1988 |
Progressive ratio performance maintained by buprenorphine, heroin and methadone in Macaque monkeys.
Topics: Animals; Buprenorphine; Conditioning, Operant; Dose-Response Relationship, Drug; Heroin; Macaca mulatta; Macaca nemestrina; Male; Methadone; Motivation; Reinforcement Schedule; Self Administration | 1988 |
Progress report from the NIDA Addiction Research Center, Baltimore, Maryland.
Topics: Anti-Anxiety Agents; Buprenorphine; Double-Blind Method; Dronabinol; Drug Synergism; Heroin Dependence; Humans; Marijuana Abuse; Methadone; Opioid-Related Disorders; Pentazocine; Smoking Prevention; Substance Withdrawal Syndrome; Substance-Related Disorders; Tripelennamine | 1984 |
Comparison of the effects of buprenorphine and methadone on opiate self-administration in primates.
Topics: Animals; Buprenorphine; Dose-Response Relationship, Drug; Eating; Heroin Dependence; Humans; Hydromorphone; Macaca mulatta; Macaca nemestrina; Male; Methadone; Morphinans; Opioid-Related Disorders; Self Administration | 1982 |
Comparison of buprenorphine and methadone effects on opiate self-administration in primates.
Topics: Animals; Buprenorphine; Depression, Chemical; Disease Models, Animal; Feeding Behavior; Heroin; Humans; Hydromorphone; Macaca mulatta; Macaca nemestrina; Methadone; Morphinans; Opioid-Related Disorders; Self Administration | 1983 |
Buprenorphrine: demonstration of physical dependence liability.
Topics: Animals; Buprenorphine; Drug Tolerance; Humans; Male; Methadone; Morphinans; Morphine; Naloxone; Rats; Receptors, Opioid; Substance Withdrawal Syndrome; Substance-Related Disorders | 1981 |
Effects of opioids on accuracy of a fixed-ratio discrimination in monkeys and rats.
Topics: Animals; Buprenorphine; Cyclazocine; Discrimination Learning; Dose-Response Relationship, Drug; Erythrocebus patas; Ethylketocyclazocine; Isomerism; Macaca mulatta; Male; Methadone; Morphinans; Morphine; Phenazocine; Rats | 1984 |
Buprenorphine, heroin, and methadone: comparison of relative reinforcing properties.
Topics: Animals; Appetitive Behavior; Buprenorphine; Conditioning, Operant; Dose-Response Relationship, Drug; Heroin; Infusions, Parenteral; Macaca mulatta; Macaca nemestrina; Male; Methadone; Morphinans; Motivation; Reinforcement Schedule; Self Administration | 1984 |
Combined use of sedatives and opiates in horses.
Topics: Acepromazine; Analgesia; Animals; Buprenorphine; Hemodynamics; Horses; Immobilization; Injections, Intravenous; Methadone; Morphinans; Respiration; Thiazines; Xylazine | 1984 |
A novel form of dependency of hepatic extraction ratio of opioids in vivo upon the portal vein concentration of drug: comparison of morphine, diamorphine, fentanyl, methadone and buprenorphine in the chronically cannulated cow.
Topics: Animals; Buprenorphine; Cattle; Female; Fentanyl; Heroin; Kinetics; Liver; Liver Circulation; Methadone; Morphinans; Morphine; Narcotics | 1984 |
Electroencephalographic and behavioral correlates of buprenorphine administration.
Topics: Adult; Behavior; Buprenorphine; Double-Blind Method; Drug Evaluation; Electroencephalography; Humans; Male; Methadone; Morphinans; Opioid-Related Disorders | 1984 |
Comparative study on the circulatory and respiratory effects of buprenorphine and methadone.
Topics: Adult; Buprenorphine; Carbon Dioxide; Double-Blind Method; Electrocardiography; Female; Hemodynamics; Humans; Male; Methadone; Morphinans; Respiration; Tidal Volume | 1981 |
Clinical pharmacology of mixed agonist-antagonist drugs [proceedings].
Topics: Buprenorphine; Cyclazocine; Humans; Methadone; Morphinans; Morphine Dependence; Naltrexone | 1981 |
An approximate generalized linear model with random effects for informative missing data.
Topics: Bayes Theorem; Biometry; Buprenorphine; Dose-Response Relationship, Drug; Humans; Longitudinal Studies; Mathematics; Methadone; Models, Statistical; Random Allocation; Randomized Controlled Trials as Topic; Substance-Related Disorders; Time Factors | 1995 |
[Current status and prospectives of combating addiction of heroin].
Topics: Buprenorphine; Clonidine; Heroin Dependence; Humans; Methadone; Methadyl Acetate | 1995 |
Buprenorphine effects in methadone-maintained volunteers: effects at two hours after methadone.
Topics: Adult; Buprenorphine; Humans; Male; Methadone; Middle Aged; Naloxone; Opioid-Related Disorders; Psychomotor Performance; Pupil; Substance Withdrawal Syndrome | 1995 |
[Comparative pharmacodynamics of methadone, buprenorphine and codeine].
Topics: Administration, Oral; Biotransformation; Buprenorphine; Codeine; Drug Tolerance; Humans; Methadone; Time Factors | 1994 |
[Comparative value of buprenorphine and methadone].
Topics: Administration, Oral; Adolescent; Adult; Buprenorphine; Heroin Dependence; Humans; Injections, Intramuscular; Methadone; Patient Compliance; Therapeutic Equivalency; Time Factors | 1994 |
[Buprenorphine in the treatment of opiate dependence].
Topics: Administration, Sublingual; Buprenorphine; Drug Evaluation; France; Heroin Dependence; Humans; Methadone; Opioid-Related Disorders; Time Factors | 1994 |
[Report on the buprenorphine substitution experience in urban medicine in Belgium].
Topics: Belgium; Buprenorphine; Drug Prescriptions; France; Heroin Dependence; Humans; Methadone; Physicians, Family; Recurrence; Time Factors; Urban Population | 1994 |
[Value and limitations of substitution treatments in the care of drug addicts].
Topics: Acquired Immunodeficiency Syndrome; Adult; Buprenorphine; France; HIV Infections; HIV Seropositivity; Humans; Mental Disorders; Methadone; Morphine; Paris; Substance-Related Disorders; Time Factors | 1994 |
[How to treat a patient with AIDS and drug dependence unwilling and/or unable to withdraw? Give substitution drugs at the hospital? Should substitution be continued after discharge? Is substitution a useful adjuvant to programs designed to prevent opportu
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Buprenorphine; Emergencies; Heroin Dependence; HIV Infections; Hospitalization; Humans; Methadone; Morphine; Outpatients; Patient Care Team; Substance-Related Disorders | 1994 |
[Role of pharmacy professionals in the network of drug addict care. Follow-up: buprenorphine, methadone, general practitioner network].
Topics: Buprenorphine; Drug Prescriptions; Family Practice; Follow-Up Studies; France; Humans; Medical Records; Methadone; Pharmacists; Substance-Related Disorders | 1994 |
[Criteria of evaluation of results of drug dependence substitution programs as a function of objectives and means: high threshold, low threshold, withdrawal...].
Topics: Buprenorphine; Clinical Trials as Topic; Double-Blind Method; Evaluation Studies as Topic; Humans; Methadone; Narcotics; Psychotropic Drugs; Randomized Controlled Trials as Topic; Risk Factors; Social Problems; Substance-Related Disorders | 1994 |
[Incidence of the development of substitution treatments and specialized care centers].
Topics: Buprenorphine; Family Practice; France; Health Services; Humans; Illicit Drugs; Methadone; Narcotics; Social Problems; Substance-Related Disorders | 1994 |
[Are maintenance substitution practices indicated in the framework of health care of drug addicts?].
Topics: Buprenorphine; Clinical Trials as Topic; Heroin; Heroin Dependence; Humans; Methadone; Narcotics; Quality of Life; Social Support; Substance Withdrawal Syndrome; Substance-Related Disorders; Time Factors | 1994 |
[Can substitution practices be indicated in withdrawal programs for heroin addicts?].
Topics: Buprenorphine; Heroin Dependence; Humans; Inpatients; Methadone; Narcotics; Outpatients; Patient Compliance; Recurrence; Time Factors | 1994 |
[Substitution treatments].
Topics: Buprenorphine; France; Humans; Methadone; Substance Abuse Treatment Centers; Substance-Related Disorders; United States | 1993 |
Changes in food-maintained progressive-ratio responding of rats following chronic buprenorphine or methadone administration.
Topics: Animals; Buprenorphine; Conditioning, Operant; Drug Tolerance; Food; Male; Methadone; Motivation; Rats; Rats, Wistar; Reinforcement Schedule | 1994 |
Position statement on methadone maintenance treatment.
Topics: Buprenorphine; Heroin Dependence; Humans; Methadone; Methadyl Acetate; Practice Guidelines as Topic; Psychiatry; Societies, Medical; United States | 1994 |
Clinical pharmacology of buprenorphine: ceiling effects at high doses.
Topics: Administration, Sublingual; Adult; Analysis of Variance; Buprenorphine; Humans; Male; Methadone; Reference Values | 1994 |
Cocaine abuse among methadone-maintained patients.
Topics: Buprenorphine; Cocaine; Comorbidity; Double-Blind Method; Humans; Methadone; Opioid-Related Disorders; Randomized Controlled Trials as Topic; Substance-Related Disorders | 1993 |
Consumption of buprenorphine and other drugs among heroin addicts under ambulatory treatment: results from cross-sectional studies in 1988 and 1990.
Topics: Adult; Ambulatory Care; Benzodiazepines; Buprenorphine; Cannabis; Cross-Sectional Studies; Female; Heroin; Humans; Male; Methadone; Psychiatric Status Rating Scales; Sex Factors; Substance Abuse Detection; Substance Abuse, Intravenous; Substance-Related Disorders | 1993 |
Community based heroin addicts who turn to experimental treatment rather than conventional care.
Topics: Adult; Analgesics, Opioid; Buprenorphine; Community Health Services; Educational Status; Female; Heroin; Humans; Interpersonal Relations; Male; Methadone; Substance Abuse, Intravenous | 1995 |
Legal opioid consumption in Denmark 1981-1993.
Topics: Analgesia; Analgesics, Opioid; Buprenorphine; Denmark; Humans; Legislation, Drug; Meperidine; Methadone; Morphine | 1995 |
Buprenorphine for depression: the un-adoptable orphan.
Topics: Administration, Intranasal; Administration, Sublingual; Antidepressive Agents; Buprenorphine; Depressive Disorder; Dose-Response Relationship, Drug; Drug Approval; Humans; Methadone; Narcotic Antagonists; Opioid-Related Disorders; Treatment Outcome | 1996 |
Differential opioid agonist regulation of the mouse mu opioid receptor.
Topics: Adenylate Cyclase Toxin; Analgesics; Animals; Buprenorphine; Colforsin; Cyclic AMP; Diprenorphine; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalins; Etorphine; Guanosine 5'-O-(3-Thiotriphosphate); Humans; Levorphanol; Methadone; Mice; Morphine; Pertussis Toxin; Receptors, Opioid, mu; Virulence Factors, Bordetella | 1997 |
Discriminative stimulus effects of l-alpha-acetylmethadol (LAAM), buprenorphine and methadone in morphine-treated rhesus monkeys.
Topics: Animals; Buprenorphine; Discrimination, Psychological; Dose-Response Relationship, Drug; Female; Macaca mulatta; Male; Methadone; Methadyl Acetate; Morphine; Naltrexone; Narcotic Antagonists; Narcotics | 1997 |
[Changes in the pattern of opioid analgesic consumption in Spain].
Topics: Administration, Oral; Administration, Rectal; Analgesics, Opioid; Buprenorphine; Codeine; Databases as Topic; Dextropropoxyphene; Drug Prescriptions; Humans; Injections, Intravenous; Linear Models; Meperidine; Methadone; Morphine; Pentazocine; Spain; Tilidine; Tramadol | 1997 |
Inhibition of methadone and buprenorphine N-dealkylations by three HIV-1 protease inhibitors.
Topics: Alkylation; Buprenorphine; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Enzyme Inhibitors; HIV Protease Inhibitors; Humans; Indinavir; Kinetics; Methadone; Microsomes, Liver; Mixed Function Oxygenases; Oxidoreductases, N-Demethylating; Ritonavir; Saquinavir | 1998 |
A preliminary investigation of lamotrigine for cocaine abuse in HIV-seropositive patients.
Topics: Adult; Buprenorphine; Cocaine-Related Disorders; Combined Modality Therapy; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Excitatory Amino Acid Antagonists; Female; HIV Seropositivity; Humans; Lamotrigine; Male; Methadone; Middle Aged; Neuropsychological Tests; Psychotherapy, Group; Substance Abuse Detection; Substance Abuse, Intravenous; Treatment Outcome; Triazines | 1998 |
Incorporation of drugs for the treatment of substance abuse into pigmented and nonpigmented hair.
Topics: Animals; Area Under Curve; Buprenorphine; Chromatography, Liquid; Hair; Male; Mass Spectrometry; Methadone; Methadyl Acetate; Narcotics; Patient Compliance; Rats; Substance-Related Disorders | 1998 |
In vitro interactions between fluoxetine or fluvoxamine and methadone or buprenorphine.
Topics: Buprenorphine; Cytochrome P-450 Enzyme System; Fluoxetine; Fluvoxamine; Humans; In Vitro Techniques; Linear Models; Methadone; Microsomes, Liver; Narcotic Antagonists; Narcotics; Selective Serotonin Reuptake Inhibitors | 1998 |
[Ambulatory opiate withdrawal].
Topics: Ambulatory Care; Buprenorphine; Hospitalization; Humans; Methadone; Narcotics; Opioid-Related Disorders; Recurrence; Risk Factors; Substance Withdrawal Syndrome | 1998 |
The mu opioid irreversible antagonist beta-funaltrexamine differentiates the discriminative stimulus effects of opioids with high and low efficacy at the mu opioid receptor.
Topics: Animals; Buprenorphine; Butorphanol; Columbidae; Discrimination Learning; Female; Fentanyl; Levallorphan; Methadone; Morphine; Nalbuphine; Nalorphine; Naltrexone; Narcotic Antagonists; Receptors, Opioid, mu | 1998 |
[Pregnancy, abortion and delivery in a cohort of heroin dependent patients treated with drug substitution (methadone and buprenorphine) in Aquitaine].
Topics: Abortion, Legal; Adult; Buprenorphine; Cohort Studies; Female; France; Heroin Dependence; Humans; Methadone; Obstetric Labor Complications; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Prospective Studies | 1999 |
Should cocaine-abusing, buprenorphine-maintained patients receive auricular acupuncture? Findings from an acute effects study.
Topics: Acupuncture, Ear; Adult; Analgesics, Opioid; Buprenorphine; Cocaine-Related Disorders; Female; Humans; Male; Methadone; Substance Abuse Treatment Centers; Treatment Outcome | 1999 |
Effects of opioid receptor agonists on cAMP second messenger system.
Topics: Adenylyl Cyclases; Analgesics, Opioid; Buprenorphine; Cyclic AMP; Etorphine; Glioma; Humans; Hybrid Cells; Methadone; Morphine; Neuroblastoma; Opioid-Related Disorders; Receptors, Opioid; Receptors, Opioid, delta; Tumor Cells, Cultured | 1999 |
Effects of low-pH treatment on cAMP second messenger system regulated by different opioid agonists.
Topics: Adenylyl Cyclases; Analgesics, Opioid; Buprenorphine; Cyclic AMP; Etorphine; Glioma; Humans; Hybrid Cells; Hydrogen-Ion Concentration; Methadone; Morphine; Neuroblastoma; Opioid-Related Disorders; Receptors, Opioid, delta; Tumor Cells, Cultured | 1999 |
Community reinforcement approach for combined opioid and cocaine dependence. Patterns of engagement in alternate activities.
Topics: Adult; Buprenorphine; Clinical Trials as Topic; Cocaine-Related Disorders; Community Networks; Counseling; Female; Humans; Male; Methadone; Narcotics; Opioid-Related Disorders; Recurrence; Social Support; Socioenvironmental Therapy; Temperance; Treatment Outcome; United States | 2000 |
[Maintenance treatment for opioid dependence in care centers: the OPPIDUM program of the Evaluation and Information Centers for Drug Addiction].
Topics: Adult; Buprenorphine; Female; Humans; Male; Methadone; Narcotics; Opioid-Related Disorders; Population Surveillance; Program Evaluation; Substance Abuse Treatment Centers | 2000 |
[Drug dependence in pregnancy. Better to substitute than complete withdrawal].
Topics: Analgesics, Opioid; Buprenorphine; Female; Heroin Dependence; Humans; Infant, Newborn; Methadone; Neonatal Abstinence Syndrome; Pregnancy; Pregnancy Complications; Risk Factors; Treatment Outcome | 2000 |
Dilated bile duct in patients receiving narcotic substitution: an early report.
Topics: Adult; Bile Duct Diseases; Bile Ducts; Biopsy; Buprenorphine; Common Bile Duct; Common Bile Duct Diseases; Dilatation, Pathologic; Endoscopy; Female; Hepatitis C; HIV Seronegativity; Humans; Liver; Liver Function Tests; Male; Methadone; Middle Aged; Narcotics; Prospective Studies; Substance Abuse, Intravenous; Ultrasonography | 2000 |
Treating opioid dependence--new data and new opportunities.
Topics: Analgesics, Opioid; Buprenorphine; Drug Administration Schedule; Humans; Methadone; Methadyl Acetate; Opioid-Related Disorders | 2000 |
Impact of drug maintenance treatment on injection practices among French HIV-infected IDUs. The MANIF 2000 Study Group.
Topics: Adult; Buprenorphine; Female; France; HIV Infections; Humans; Male; Methadone; Narcotics; Needle Sharing; Risk-Taking; Substance Abuse, Intravenous | 2000 |
[A clear look].
Topics: Buprenorphine; Europe; France; Humans; Methadone; Narcotic Antagonists; Narcotics; Prisoners; Substance-Related Disorders | 2000 |
Deaths attributable to methadone vs buprenorphine in France.
Topics: Buprenorphine; Drug Overdose; France; Heroin Dependence; Humans; Methadone; Narcotics | 2001 |
Recent evolution in opiate dependence in France during generalisation of maintenance treatments.
Topics: Adult; Buprenorphine; Chi-Square Distribution; Female; France; Humans; Male; Methadone; Narcotics; Opioid-Related Disorders | 2001 |
[Evolution and update of detoxification techniques for opiate addicts].
Topics: Animals; Buprenorphine; Humans; Methadone; Naloxone; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders; Substance Withdrawal Syndrome | 2000 |
Treating opioid dependence.
Topics: Analgesics, Opioid; Buprenorphine; Humans; Methadone; Narcotic Antagonists; Opioid-Related Disorders | 2001 |
Perinatal opioids reduce striatal nerve growth factor content in rat striatum.
Topics: Animals; Animals, Newborn; Buprenorphine; Corpus Striatum; Female; Male; Methadone; Narcotics; Nerve Growth Factor; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Sprague-Dawley; RNA, Messenger | 2001 |
Agonists determine the pattern of G-protein activation in mu-opioid receptor-mediated supraspinal analgesia.
Topics: Analgesics, Opioid; Animals; Buprenorphine; GTP-Binding Protein alpha Subunits, Gi-Go; GTP-Binding Protein alpha Subunits, Gq-G11; Heroin; Heterotrimeric GTP-Binding Proteins; Lateral Ventricles; Male; Methadone; Mice; Morphine; Pain Measurement; Receptors, Opioid, mu | 2001 |
Observation of psychoactive substance consumption: methods and results of the French OPPIDUM programme.
Topics: Adolescent; Adult; Anti-Anxiety Agents; Benzodiazepines; Buprenorphine; Data Collection; Female; France; Humans; Male; Methadone; Narcotics; Program Evaluation; Psychotropic Drugs; Substance Abuse Treatment Centers; Substance-Related Disorders | 2001 |
Treatment of opioid addiction in physicians' offices: it's about time.
Topics: Buprenorphine; Humans; Methadone; Narcotics; Opioid-Related Disorders; Physicians' Offices | 2001 |
Buprenorphine for opiate addiction: potential economic impact.
Topics: Buprenorphine; Cost-Benefit Analysis; Counseling; Drug Evaluation, Preclinical; Health Care Costs; Humans; Methadone; Opioid-Related Disorders | 2001 |
A new era in opioid dependency treatment. Recent law allows qualified physicians to provide care in office setting.
Topics: Buprenorphine; Certification; Communicable Diseases; Family Practice; Humans; Information Services; Legislation, Medical; Methadone; Office Visits; Opioid-Related Disorders; Substance Abuse Treatment Centers; United States; United States Food and Drug Administration | 2001 |
[Reduction in the number of lethal heroin overdoses in France since 1994. Focus on substitution treatments].
Topics: Acquired Immunodeficiency Syndrome; Attitude to Health; Buprenorphine; Drug Overdose; Drug Prescriptions; Drug Utilization; Female; France; Health Knowledge, Attitudes, Practice; Heroin; Heroin Dependence; Humans; Linear Models; Male; Methadone; Mortality; Narcotics; Population Surveillance; Risk Factors | 2001 |
Effect of perinatal buprenorphine exposure on development in the rat.
Topics: Animals; Animals, Newborn; Buprenorphine; Drinking; Eating; Female; Growth; Litter Size; Methadone; Narcotics; Pain Measurement; Rats; Rats, Sprague-Dawley; Substance Withdrawal Syndrome; Weight Gain | 2001 |
Comparison of methadone and high dosage buprenorphine users in French care centres.
Topics: Adult; Analgesics, Opioid; Buprenorphine; Female; France; Humans; Logistic Models; Male; Methadone; Odds Ratio; Socioeconomic Factors; Substance Abuse Treatment Centers; Substance-Related Disorders | 2001 |
[A national model for drug-supported rehabilitation of opiate addicts].
Topics: Adult; Buprenorphine; Community Health Services; Humans; Methadone; Models, Organizational; Narcotics; National Health Programs; Norway; Opioid-Related Disorders; Physician's Role; Regional Medical Programs; Social Support; Social Work; Treatment Outcome | 2001 |
[Use of a new drug in the treatment of heroin addicts should not be obstructed by political dogmatism].
Topics: Buprenorphine; Drug and Narcotic Control; Drug Prescriptions; Heroin Dependence; Humans; Methadone; Narcotics; Politics; Regional Medical Programs; Sweden | 2001 |
Cost-effectiveness of buprenorphine maintenance versus methadone maintenance.
Topics: Buprenorphine; Cost-Benefit Analysis; Heroin Dependence; Humans; Methadone; Narcotics; Quality-Adjusted Life Years | 2001 |
Opioid maintenance: the politics matter.
Topics: Buprenorphine; Cost-Benefit Analysis; Humans; Methadone; Narcotics | 2001 |
[Treatment of heroin addiction--clinical findings hand-in-hand with evidence].
Topics: Buprenorphine; Evidence-Based Medicine; Heroin Dependence; Humans; Methadone; Narcotics; Psychotherapy; Social Support | 2001 |
Buprenorphine: better late than never.
Topics: Australia; Buprenorphine; Female; Follow-Up Studies; Heroin; Humans; Male; Methadone; Narcotic Antagonists; Sensitivity and Specificity; Substance Abuse, Intravenous; Treatment Outcome | 2001 |
Less driving impairment on buprenorphine than methadone in drug-dependent patients?
Topics: Adult; Attention; Automobile Driving; Buprenorphine; Female; Humans; Male; Methadone; Opioid-Related Disorders; Psychomotor Performance; Reaction Time; Visual Fields | 2001 |
Maintenance therapy for opioid addiction with methadone, LAAM and buprenorphine: the Emperor's New Clothes Phenomenon.
Topics: Buprenorphine; Electrocardiography; Heroin Dependence; Humans; Methadone; Methadyl Acetate; Naltrexone; Narcotic Antagonists; Narcotics; Opioid-Related Disorders; Time Factors | 2001 |
[Changes in pharmacists practices (1996 - 2000) related to harm reduction policy (condoms, injecting equipment, methylmorphine) and maintenance therapy delivery (buprenorphine, methadone)].
Topics: Acquired Immunodeficiency Syndrome; Analgesics, Opioid; Attitude of Health Personnel; Buprenorphine; Condoms; Health Policy; Humans; Longitudinal Studies; Methadone; Needle-Exchange Programs; Pharmacists; Professional Role; Risk; Substance Abuse, Intravenous; Surveys and Questionnaires | 2001 |
[Persistent injecting practices in subjects on methadone or buprenorphine maintenance therapy. A study of 600 cases].
Topics: Adult; Analgesics, Opioid; Buprenorphine; Female; Humans; Male; Methadone; Opioid-Related Disorders; Substance Abuse, Intravenous; Substance Withdrawal Syndrome | 2001 |
Policy progress for physician treatment of opiate addiction.
Topics: Buprenorphine; Humans; Methadone; Narcotic Antagonists; Opioid-Related Disorders; Physicians, Family; Public Policy; Substance Abuse Treatment Centers; United States | 2002 |
Which substitution pharmacotherapy is most effective in treating opioid dependence?
Topics: Analgesics, Opioid; Buprenorphine; Humans; Methadone; Methadyl Acetate; Opioid-Related Disorders | 2002 |
[Regular prescription of narcotics and sedatives to drug-addicted patients in general practice].
Topics: Adult; Analgesics, Opioid; Buprenorphine; Drug Prescriptions; Family Practice; Female; Humans; Male; Methadone; Narcotics; Norway; Opioid-Related Disorders; Substance-Related Disorders | 2002 |
[Frequency of re-incarcerations in the same detention center: role of substitution therapy. A preliminary retrospective analysis].
Topics: Adult; Buprenorphine; Female; France; Heroin Dependence; Humans; Male; Methadone; Narcotic Antagonists; Prisoners; Recurrence; Retrospective Studies | 2002 |
A latent autoregressive model for longitudinal binary data subject to informative missingness.
Topics: Algorithms; Biometry; Buprenorphine; Clinical Trials as Topic; Humans; Longitudinal Studies; Methadone; Models, Statistical; Monte Carlo Method; Narcotics; Opioid-Related Disorders; Regression Analysis | 2002 |
Flunitrazepam variably alters morphine, buprenorphine, and methadone lethality in the rat.
Topics: Animals; Anti-Anxiety Agents; Buprenorphine; Drug Interactions; Flunitrazepam; Injections, Intraperitoneal; Injections, Intravenous; Lethal Dose 50; Male; Methadone; Morphine; Narcotics; Rats; Rats, Sprague-Dawley | 2002 |
Office-based treatment of opioid-dependent patients.
Topics: Buprenorphine; Drug and Narcotic Control; Drug Combinations; Drug Overdose; Family Practice; Humans; Methadone; Naloxone; Narcotic Antagonists; Narcotics; Opioid-Related Disorders; Practice Patterns, Physicians'; United Kingdom | 2003 |
Buprenorphine: an alternative to methadone.
Topics: Administration, Sublingual; Buprenorphine; Clinical Trials as Topic; Dose-Response Relationship, Drug; Humans; Methadone; Narcotic Antagonists; Opioid-Related Disorders | 2003 |
Clinical treatment of opioid addiction and dependence.
Topics: Administration, Oral; Administration, Sublingual; Buprenorphine; Humans; Inactivation, Metabolic; Methadone; Methadyl Acetate; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders | 2003 |
Buprenorphine versus methadone maintenance treatment in an ambulant setting: a health-related quality of life assessment.
Topics: Adult; Buprenorphine; Female; Humans; Male; Methadone; Narcotics; Opioid-Related Disorders; Quality of Life; Treatment Outcome | 2003 |
May 1999 NSW Drug Summit.
Topics: Buprenorphine; Delivery of Health Care, Integrated; Drug and Narcotic Control; Health Services Accessibility; Health Services Needs and Demand; Humans; Methadone; New South Wales; Outcome Assessment, Health Care; Quality of Health Care; Substance Abuse Treatment Centers; Substance-Related Disorders | 2003 |
Managing opioid dependence. Comparing buprenorphine with methadone.
Topics: Buprenorphine; Clinical Trials as Topic; Comorbidity; Humans; Mental Disorders; Meta-Analysis as Topic; Methadone; Narcotics; Opioid-Related Disorders; Physicians, Family; Research Design; Treatment Outcome | 2003 |
[Maintenance treatment for opiate dependence. Which should we deliver and how should we prescribe it?].
Topics: Analgesics, Opioid; Buprenorphine; France; Humans; Methadone; Opioid-Related Disorders; Treatment Outcome | 2003 |
Buprenorphine versus methadone maintenance: a cost-effectiveness analysis.
Topics: Adult; Buprenorphine; Cost-Benefit Analysis; Female; Heroin Dependence; Humans; Male; Methadone; Statistics, Nonparametric | 2003 |
[Reduced drug craving and better social function with buprenorphine therapy. Combination therapy as an alternative to methadone therapy in heroin addiction].
Topics: Buprenorphine; Drug Therapy, Combination; Heroin Dependence; Humans; Methadone; Narcotic Antagonists; Narcotics; Socioeconomic Factors; Sweden | 2003 |
[Substitutions therapy of opiate addiction in Denmark].
Topics: Benzodiazepines; Buprenorphine; Denmark; Humans; Methadone; Methadyl Acetate; Narcotic Antagonists; Narcotics; Opioid-Related Disorders; Surveys and Questionnaires | 2003 |
[Substitution study. Is it allowed to give placebos to junkies?].
Topics: Buprenorphine; Clinical Trials as Topic; Heroin Dependence; Humans; Methadone; Narcotic Antagonists; Narcotics; Placebos | 2003 |
Illicit drug use and injection practices among drug users on methadone and buprenorphine maintenance treatment in France.
Topics: Adolescent; Adult; Analgesics, Opioid; Buprenorphine; Epidemiologic Methods; Female; France; Housing; Humans; Male; Methadone; Socioeconomic Factors; Substance Abuse Treatment Centers; Substance Abuse, Intravenous; Substance-Related Disorders; Treatment Outcome | 2003 |
Comments on Mattick et al.: the need for independent data re-analyses.
Topics: Buprenorphine; Clinical Trials as Topic; Humans; Methadone; Narcotics; Opioid-Related Disorders; Regression Analysis | 2003 |
[Opioid-related disorders].
Topics: Behavior Therapy; Buprenorphine; Diagnostic and Statistical Manual of Mental Disorders; Humans; International Classification of Diseases; Methadone; Naloxone; Narcotic Antagonists; Narcotics; Opioid-Related Disorders | 2003 |
Attempted suicide among entrants to three treatment modalities for heroin dependence in the Australian Treatment Outcome Study (ATOS): prevalence and risk factors.
Topics: Adolescent; Adult; Age Factors; Ambulatory Care; Antisocial Personality Disorder; Borderline Personality Disorder; Buprenorphine; Cross-Sectional Studies; Depressive Disorder, Major; Drug Overdose; Drug Therapy, Combination; Female; Heroin; Heroin Dependence; Humans; Male; Mass Screening; Methadone; Middle Aged; Narcotics; Needle-Exchange Programs; New South Wales; Outcome and Process Assessment, Health Care; Patient Admission; Rehabilitation Centers; Risk Factors; Sex Factors; Stress Disorders, Post-Traumatic; Substance Abuse, Intravenous; Suicide, Attempted | 2004 |
The emperor' s new clothes.
Topics: Analgesics, Opioid; Buprenorphine; Clinical Trials as Topic; Clonidine; Heroin Dependence; Humans; Methadone; Narcotic Antagonists; Opioid-Related Disorders; Retrospective Studies; Substance Withdrawal Syndrome; Tramadol | 2003 |
Maintenance therapy with synthetic opioids and driving aptitude.
Topics: Adolescent; Adult; Aptitude; Automobile Driving; Buprenorphine; Chi-Square Distribution; Female; Humans; Male; Methadone; Opioid-Related Disorders; Prospective Studies; Reaction Time; Single-Blind Method; Statistics, Nonparametric | 2004 |
Serious adverse events in the Australian National Evaluation of Pharmacotherapies for Opioid Dependence (NEPOD).
Topics: Adult; Analgesics, Opioid; Australia; Buprenorphine; Drug Overdose; Female; Humans; Male; Methadone; Methadyl Acetate; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders | 2004 |
Comparison of the antinociceptive effect of morphine, methadone, buprenorphine and codeine in two substrains of Sprague-Dawley rats.
Topics: Analgesics; Animals; Buprenorphine; Codeine; Injections, Subcutaneous; Male; Methadone; Morphine; Morphine Derivatives; Pain Measurement; Rats; Rats, Sprague-Dawley; Reaction Time; Time Factors | 2004 |
Treatment options for opiate addiction.
Topics: Buprenorphine; Evidence-Based Medicine; Humans; Methadone; Narcotic Antagonists; Narcotics; Opioid-Related Disorders; Outcome and Process Assessment, Health Care; Practice Guidelines as Topic; Substance Abuse Detection; United States; United States Food and Drug Administration | 2004 |
French field experience with buprenorphine.
Topics: Adult; Buprenorphine; Cause of Death; Cross-Cultural Comparison; Drug Approval; Drug Overdose; Drug Utilization; Female; Forecasting; France; Health Services Accessibility; Heroin Dependence; Humans; Infant, Newborn; Male; Methadone; Narcotics; Neonatal Abstinence Syndrome; Opioid-Related Disorders; Pregnancy | 2004 |
Implementing buprenorphine treatment in community settings in Australia: experiences from the Buprenorphine Implementation Trial.
Topics: Adolescent; Adult; Australia; Buprenorphine; Community Health Services; Cost-Benefit Analysis; Female; Health Plan Implementation; Heroin Dependence; Humans; Inservice Training; Long-Term Care; Male; Methadone; Narcotic Antagonists; Narcotics; Outcome Assessment, Health Care; Practice Guidelines as Topic; Randomized Controlled Trials as Topic | 2004 |
Differential effects of gestational buprenorphine, naloxone, and methadone on mesolimbic mu opioid and ORL1 receptor G protein coupling.
Topics: Analgesics, Opioid; Animals; Animals, Newborn; Autoradiography; Buprenorphine; Dose-Response Relationship, Drug; Drug Interactions; Embryo, Mammalian; Female; GTP-Binding Proteins; Guanosine 5'-O-(3-Thiotriphosphate); Limbic System; Male; Methadone; Naloxone; Nociceptin Receptor; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Receptors, Opioid; Receptors, Opioid, mu; Sex Factors; Sulfur Isotopes | 2004 |
A critical review of the causes of death among post-mortem toxicological investigations: analysis of 34 buprenorphine-associated and 35 methadone-associated deaths.
Topics: Adult; Autopsy; Buprenorphine; Cause of Death; Drug Overdose; Female; Humans; Male; Methadone; Middle Aged; Mortality; Narcotics; Retrospective Studies; Substance-Related Disorders | 2004 |
Diffusion of substance abuse treatment: will buprenorphine be a success?
Topics: Buprenorphine; Heroin Dependence; Humans; Methadone; Methadyl Acetate; Narcotic Antagonists; Narcotics; Substance-Related Disorders | 2004 |
Pupillometry in the detection of concomitant drug use in opioid-maintained patients.
Topics: Adult; Biometry; Buprenorphine; Diagnostic Techniques, Ophthalmological; Drug Interactions; Female; Humans; Illicit Drugs; Male; Methadone; Miosis; Opioid-Related Disorders; Pupil; Reflex, Pupillary; Substance Abuse Detection | 2004 |
Opiate agonist maintenance treatment for injecting drug user peer educators.
Topics: Buprenorphine; HIV Infections; Humans; Methadone; Narcotics; Patient Education as Topic; Peer Group; Substance Abuse, Intravenous; Treatment Outcome | 2004 |
Non-injecting routes of administration among entrants to three treatment modalities for heroin dependence.
Topics: Administration, Inhalation; Adolescent; Adult; Antisocial Personality Disorder; Borderline Personality Disorder; Buprenorphine; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Drug Overdose; Female; Follow-Up Studies; Heroin; Heroin Dependence; Humans; Inactivation, Metabolic; Male; Methadone; Middle Aged; Narcotic Antagonists; Residential Treatment; Suicide, Attempted | 2004 |
Plasma testosterone and sexual function in men receiving buprenorphine maintenance for opioid dependence.
Topics: Adult; Buprenorphine; Estradiol; Humans; Male; Methadone; Opioid-Related Disorders; Sex Hormone-Binding Globulin; Sexual Behavior; Testosterone | 2005 |
[Outcome of a substitution therapy program in an outpatient treatment setting of a psychiatric hospital].
Topics: Adult; Buprenorphine; Crime; Female; Follow-Up Studies; Germany; Hospitals, Psychiatric; Humans; Male; Methadone; Middle Aged; Narcotics; Opioid-Related Disorders; Outcome Assessment, Health Care; Outpatient Clinics, Hospital; Rehabilitation, Vocational; Substance Abuse Detection | 2004 |
[A new route].
Topics: Buprenorphine; Family Practice; France; Humans; Methadone; Narcotic Antagonists; Narcotics; Opioid-Related Disorders; Sexually Transmitted Diseases, Viral | 2004 |
[The profile of drug addicts attending the Sainte Marguerite University Hospital in Marseille analysis of the active file from 1996 to 2001].
Topics: Adult; Age Distribution; Buprenorphine; Cohort Studies; Drug Overdose; Female; France; Hallucinogens; Hepatitis C; HIV Infections; Hospitals, University; Humans; Lysergic Acid Diethylamide; Male; Mental Disorders; Methadone; Narcotic Antagonists; Narcotics; Public Assistance; Substance-Related Disorders; Suicide, Attempted; Surveys and Questionnaires | 2004 |
Hepatitis C virus incidence among injecting drug users on opioid replacement therapy.
Topics: Adult; Analgesics, Opioid; Buprenorphine; Cohort Studies; Drug Therapy, Combination; Female; Hepatitis C; Hepatitis C Antibodies; Humans; Incidence; Male; Methadone; Middle Aged; New South Wales; Retrospective Studies; Seroepidemiologic Studies; Substance Abuse Treatment Centers; Substance Abuse, Intravenous | 2004 |
Treating opiate addiction, Part I. Detoxification and maintenance.
Topics: Buprenorphine; Drug Combinations; Humans; Methadone; Naloxone; Narcotics; Opioid-Related Disorders; Substance Withdrawal Syndrome | 2004 |
Short-term outcomes of five heroin detoxification methods in the Australian NEPOD Project.
Topics: Adolescent; Adult; Ambulatory Care; Analgesics, Opioid; Anesthesia; Buprenorphine; Female; Heroin Dependence; Hospitalization; Humans; Hypnotics and Sedatives; Inactivation, Metabolic; Male; Methadone; Middle Aged; Naltrexone; Narcotic Antagonists; Treatment Outcome | 2005 |
Buprenorphine versus methadone--safety first?
Topics: Buprenorphine; Family Practice; Heroin Dependence; Humans; Methadone; Narcotic Antagonists; Narcotics | 2005 |
Sublingual buprenorphine and methadone maintenance treatment: a three-year follow-up of quality of life assessment.
Topics: Administration, Sublingual; Adult; Buprenorphine; Female; Follow-Up Studies; Humans; Male; Methadone; Narcotics; Opioid-Related Disorders; Patient Dropouts; Quality of Life; Treatment Outcome | 2005 |
The prescribing of methadone and other opioids to addicts: national survey of GPs in England and Wales.
Topics: Analgesics, Opioid; Buprenorphine; Codeine; Cohort Studies; England; Family Practice; Female; Humans; Male; Methadone; Narcotics; Opioid-Related Disorders; Organizational Policy; Practice Patterns, Physicians'; Wales | 2005 |
A cost-effectiveness analysis of heroin detoxification methods in the Australian National Evaluation of Pharmacotherapies for Opioid Dependence (NEPOD).
Topics: Adult; Analgesics, Opioid; Analysis of Variance; Buprenorphine; Chi-Square Distribution; Cost-Benefit Analysis; Female; Heroin Dependence; Humans; Hypnotics and Sedatives; Male; Methadone; Naltrexone; Narcotic Antagonists | 2006 |
Effects of buprenorphine on cardiac repolarization in a patient with methadone-related torsade de pointes.
Topics: Analgesics, Opioid; Buprenorphine; Dose-Response Relationship, Drug; Heroin Dependence; Humans; Male; Methadone; Middle Aged; Torsades de Pointes | 2005 |
Methadone vs buprenorphine.
Topics: Buprenorphine; Humans; Methadone; Narcotic Antagonists; Opioid-Related Disorders | 2005 |
[The real border for the treatment of drug addicts].
Topics: Analgesics, Opioid; Buprenorphine; Humans; Methadone; Opioid-Related Disorders | 2005 |
Buprenorphine and methadone in the treatment of opioid dependence: methods and design of the COBRA study.
Topics: Buprenorphine; Cohort Studies; Comorbidity; Cross-Sectional Studies; Dose-Response Relationship, Drug; Follow-Up Studies; Germany; Hepatitis C; Humans; Longitudinal Studies; Methadone; Narcotics; Opioid-Related Disorders; Outcome Assessment, Health Care; Practice Patterns, Physicians'; Prospective Studies; Sampling Studies | 2005 |
Examining the influence of drop-outs in a follow-up of maintained opiate users.
Topics: Adult; Bias; Buprenorphine; Data Interpretation, Statistical; Female; Follow-Up Studies; France; Humans; Linear Models; Longitudinal Studies; Male; Methadone; Models, Statistical; Opioid-Related Disorders; Patient Dropouts; Prospective Studies; Research Design; Severity of Illness Index; Substance Abuse Treatment Centers | 2005 |
Comparison of intravenous buprenorphine and methadone self-administration by recently detoxified heroin-dependent individuals.
Topics: Adult; Black People; Blood Pressure; Buprenorphine; Controlled Clinical Trials as Topic; Dose-Response Relationship, Drug; Double-Blind Method; Female; Heroin Dependence; Hispanic or Latino; Humans; Injections, Intravenous; Male; Methadone; Narcotics; Oximetry; Pupil; Reinforcement, Psychology; Self Administration; Surveys and Questionnaires; White People | 2005 |
Maintenance for opioid addiction with buprenorphine and methadone: "The only thing new in the world is the history you don't know".
Topics: Buprenorphine; Heroin Dependence; Humans; Methadone; Narcotic Antagonists; Narcotics; Opioid-Related Disorders; Treatment Outcome | 2005 |
Public policy statement on Office-Based Opioid Agonist Treatment (OBOT).
Topics: Ambulatory Care; Buprenorphine; Combined Modality Therapy; Comprehensive Health Care; Continuity of Patient Care; Drug Approval; Education, Medical, Continuing; Heroin Dependence; Humans; Methadone; Narcotics; Opioid-Related Disorders; Patient Care Team; Primary Health Care; Psychotherapy; Public Policy; Substance Abuse Detection; Substance Abuse Treatment Centers; United States | 2005 |
Induction of patients with moderately severe methadone dependence onto buprenorphine.
Topics: Adult; Buprenorphine; Clonidine; Drug Administration Schedule; Female; Humans; Male; Methadone; Narcotic Antagonists; Opioid-Related Disorders; Severity of Illness Index; Surveys and Questionnaires | 2005 |
Low efficacy of non-opioid drugs in opioid withdrawal symptoms.
Topics: Adult; Buprenorphine; Drug Administration Schedule; Female; Humans; Inactivation, Metabolic; Male; Methadone; Narcotic Antagonists; Narcotics; Opioid-Related Disorders; Substance Withdrawal Syndrome; Surveys and Questionnaires | 2005 |
Opiate maintenance alternatives: new studies.
Topics: Buprenorphine; Humans; Methadone; Morphine; Narcotic Antagonists; Narcotics; Opioid-Related Disorders | 2005 |
Cytogenetic aspects of buprenorphine maintenance treatment program--preliminary report.
Topics: Adult; Buprenorphine; Female; Genetic Markers; Humans; Lymphocytes; Male; Methadone; Micronuclei, Chromosome-Defective; Micronucleus Tests; Narcotic Antagonists; Narcotics; Opioid-Related Disorders; Poland | 2005 |
Prospective multicenter observational study of 260 infants born to 259 opiate-dependent mothers on methadone or high-dose buprenophine substitution.
Topics: Adult; Buprenorphine; Female; HIV Seropositivity; Humans; Infant Care; Infant, Newborn; Methadone; Narcotic Antagonists; Opioid-Related Disorders; Parity; Perinatal Care; Pregnancy; Pregnancy Complications; Prospective Studies; Socioeconomic Factors; Treatment Outcome | 2006 |
The characteristics of heroin users entering treatment: findings from the Australian treatment outcome study (ATOS).
Topics: Adult; Australia; Buprenorphine; Comorbidity; Crime; Demography; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Female; Health Status; Heroin Dependence; Humans; Inactivation, Metabolic; Male; Methadone; Narcotics; Patient Acceptance of Health Care; Residential Treatment; Severity of Illness Index; Stress Disorders, Post-Traumatic; Suicide; Treatment Outcome | 2005 |
Buprenorphine retention in primary care.
Topics: Adult; Ambulatory Care; Buprenorphine; Cohort Studies; Drug Administration Schedule; Female; Humans; Male; Methadone; Middle Aged; Narcotics; Opioid-Related Disorders; Patient Dropouts; Primary Health Care; Treatment Outcome | 2005 |
Is methadone too dangerous for opiate addiction?
Topics: Analgesics, Opioid; Buprenorphine; Humans; Methadone; Opioid-Related Disorders | 2005 |
Impaired decision-making in opiate-dependent subjects: effect of pharmacological therapies.
Topics: Adult; Buprenorphine; Cognition Disorders; Decision Making; Female; Gambling; Humans; Male; Methadone; Middle Aged; Narcotic Antagonists; Neuropsychological Tests; Opioid-Related Disorders; Severity of Illness Index | 2006 |
Support for buprenorphine and methadone prescription to heroin-dependent patients among New York City physicians.
Topics: Attitude of Health Personnel; Buprenorphine; Drug Prescriptions; Female; Heroin Dependence; Humans; Male; Methadone; Middle Aged; Narcotic Antagonists; New York City; Physicians; Surveys and Questionnaires | 2006 |
The effect of methadone and buprenorphine on human placental aromatase.
Topics: Aromatase; Buprenorphine; Catalysis; Dose-Response Relationship, Drug; Estradiol; Estriol; Humans; In Vitro Techniques; Methadone; Narcotic Antagonists; Placenta; Testosterone | 2006 |
Choice between heroin and food in nondependent and heroin-dependent rhesus monkeys: effects of naloxone, buprenorphine, and methadone.
Topics: Animals; Buprenorphine; Disease Models, Animal; Feeding Behavior; Heroin; Heroin Dependence; Macaca mulatta; Male; Methadone; Naloxone; Self Administration; Substance Withdrawal Syndrome | 2006 |
Slow tapering from methadone maintenance in a program encouraging indefinite maintenance.
Topics: Adult; Buprenorphine; Drug Administration Schedule; Female; Heroin Dependence; Humans; Male; Mental Health Services; Methadone; Middle Aged; Naloxone; Narcotic Antagonists; Program Development; Substance Withdrawal Syndrome | 2006 |
[Quality assurance in patient addiction treated with drug substitution].
Topics: Antiviral Agents; Buprenorphine; Comorbidity; Drug Information Services; Drug Interactions; Drug Therapy, Combination; Education, Medical, Continuing; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Methadone; Multimedia; Narcotic Antagonists; Opioid-Related Disorders; Polyethylene Glycols; Quality Assurance, Health Care; Recombinant Proteins; Ribavirin; Treatment Outcome; Viral Load | 2005 |
Methadone and buprenorphine added to the WHO list of essential medicines.
Topics: Buprenorphine; Drugs, Essential; Humans; Methadone; Risk Factors; Substance Abuse, Intravenous; World Health Organization | 2005 |
Association between the DRD2 A1 allele and response to methadone and buprenorphine maintenance treatments.
Topics: Adult; Alleles; Analgesics, Opioid; Buprenorphine; Deoxyribonucleases, Type II Site-Specific; Female; Gene Frequency; Genotype; Heroin Dependence; Humans; Male; Methadone; Receptors, Dopamine D2; Retrospective Studies; Substance Withdrawal Syndrome; Time Factors; Treatment Outcome | 2006 |
Buprenorphine replacement therapy: a confirmed benefit.
Topics: Benzodiazepines; Buprenorphine; Cohort Studies; Drug Therapy, Combination; Female; France; Heroin Dependence; HIV Seroprevalence; Humans; Male; Meta-Analysis as Topic; Methadone; Pregnancy; Self Medication; Treatment Outcome | 2006 |
Effect of opioid substitution therapy on alcohol metabolism.
Topics: Adult; Analgesics, Opioid; Buprenorphine; Central Nervous System Depressants; Dose-Response Relationship, Drug; Drug Interactions; Ethanol; Female; Humans; Male; Methadone; Methadyl Acetate; Opioid-Related Disorders | 2006 |
Treatment retention in adolescent patients treated with methadone or buprenorphine for opioid dependence: a file review.
Topics: Adolescent; Buprenorphine; Female; Humans; Male; Methadone; Narcotic Antagonists; Narcotics; New South Wales; Opioid-Related Disorders; Patient Compliance; Patient Dropouts; Retreatment; Retrospective Studies | 2006 |
[Heroin substitution treatments. Analysis of current solutions, trends, and perspectives].
Topics: Buprenorphine; Buprenorphine, Naloxone Drug Combination; Drug Combinations; Humans; Methadone; Naloxone; Narcotics; Opioid-Related Disorders | 2006 |
[Accidental ingestion of methadone and buprenorphine by children. A case review of the Lille Poison Centre between 1995 and 2005].
Topics: Adolescent; Buprenorphine; Child; Child, Preschool; Female; Humans; Infant; Male; Methadone; Narcotics; Poisoning; Retrospective Studies | 2006 |
Fatal poisoning in methadone and buprenorphine treated patients -- are there differences?
Topics: Adult; Buprenorphine; Cause of Death; Drug Evaluation, Preclinical; Drug Interactions; Drug Overdose; Ethanol; Female; Germany; Heroin Dependence; Humans; Male; Methadone; Narcotics; Retrospective Studies; Risk; Substance Abuse, Intravenous | 2006 |
Providing opioid substitution treatment to Indigenous heroin users within a community health service setting in Adelaide.
Topics: Buprenorphine; Community Mental Health Services; Community Participation; Female; Health Services, Indigenous; Heroin Dependence; Humans; Male; Methadone; Narcotics; Native Hawaiian or Other Pacific Islander; Patient Acceptance of Health Care; Program Development; Referral and Consultation; Retreatment; South Australia; Treatment Outcome | 2006 |
Medicalising the treatment of opioid dependence.
Topics: Buprenorphine; Humans; Methadone; Naltrexone; Narcotic Antagonists; Narcotics; Opioid-Related Disorders | 2006 |
Substance abuse in pregnancy: opioid substitution in a northern Ireland maternity unit.
Topics: Adult; Buprenorphine; Codeine; Female; Heroin Dependence; Humans; Infant, Newborn; Maternal-Fetal Exchange; Methadone; Neonatal Abstinence Syndrome; Northern Ireland; Obstetrics and Gynecology Department, Hospital; Perinatal Care; Pregnancy; Pregnancy Complications; Risk Assessment; Substance Abuse Detection | 2006 |
Buprenorphine: reflections of an addictions psychiatrist.
Topics: Analgesics, Opioid; Buprenorphine; Humans; Legislation, Drug; Methadone; Narcotics; Opioid-Related Disorders; Receptors, Opioid, mu; Substance Abuse Treatment Centers; Treatment Outcome; United States | 2006 |
Simultaneous determination of methadone, buprenorphine and norbuprenorphine in biological fluids for therapeutic drug monitoring purposes.
Topics: Buprenorphine; Chromatography, High Pressure Liquid; Drug Monitoring; Humans; Methadone; Reproducibility of Results; Solid Phase Extraction | 2007 |
Buprenorphine for heroin addicts: the issue of illicit opioid abuse during maintenance.
Topics: Buprenorphine; Combined Modality Therapy; Double-Blind Method; Heroin Dependence; Humans; Methadone; Narcotics; Opioid-Related Disorders; Randomized Controlled Trials as Topic; Substance Abuse Detection; Treatment Outcome | 2006 |
[Health related quality of life among HIV-HCV co-infected patients].
Topics: Adult; Anti-Retroviral Agents; Buprenorphine; Cohort Studies; Counseling; Data Interpretation, Statistical; Depression; Drug Therapy, Combination; Female; Follow-Up Studies; Hepatitis C; HIV Infections; HIV Seropositivity; HIV-1; Humans; Male; Methadone; Narcotic Antagonists; Narcotics; Quality of Life; Social Support; Socioeconomic Factors; Substance Abuse, Intravenous; Surveys and Questionnaires; Time Factors | 2006 |
Effects of subcutaneous methadone, morphine, buprenorphine or saline on thermal and pressure thresholds in cats.
Topics: Analgesics, Opioid; Animals; Buprenorphine; Cats; Female; Hot Temperature; Injections, Subcutaneous; Male; Methadone; Morphine; Pain; Pain Measurement; Pressure | 2006 |
Intravenous drug use and HIV.
Topics: Analgesics, Opioid; Buprenorphine; Humans; Methadone; Narcotics; National Academies of Science, Engineering, and Medicine, U.S., Health and Medicine Division; Substance Abuse, Intravenous; United States | 2006 |
One-year mortality rates of patients receiving methadone and buprenorphine maintenance therapy: a nationally representative cohort study in 2694 patients.
Topics: Adolescent; Adult; Aged; Buprenorphine; Cohort Studies; Female; Follow-Up Studies; Germany; Humans; Male; Methadone; Middle Aged; Narcotics; Opioid-Related Disorders; Patient Dropouts; Prospective Studies; Time Factors | 2006 |
[Molecular simulations of the loading of methadone and buprenorphine into carbon nanotubes].
Topics: Buprenorphine; Computer Simulation; Methadone; Models, Molecular; Molecular Structure; Nanotubes, Carbon; Narcotic Antagonists | 2006 |
The Beck Depression Inventory in patients undergoing opiate agonist maintenance treatment.
Topics: Adolescent; Adult; Alcoholism; Buprenorphine; Comorbidity; Denmark; Depressive Disorder; Female; Follow-Up Studies; Humans; Illicit Drugs; Male; Methadone; Middle Aged; Narcotics; Opioid-Related Disorders; Outcome Assessment, Health Care; Personality Inventory; Prognosis; Prospective Studies; Psychometrics; Reproducibility of Results; Substance Abuse Treatment Centers; Treatment Refusal | 2006 |
Fatal overdoses and deaths by other causes in a cohort of Norwegian drug abusers--a competing risk approach.
Topics: Adult; Age Factors; Amphetamine-Related Disorders; Buprenorphine; Cause of Death; Cohort Studies; Comorbidity; Drug Overdose; Female; Follow-Up Studies; Heroin Dependence; Humans; Illicit Drugs; Male; Methadone; Middle Aged; Narcotics; Norway; Patient Admission; Poisoning; Proportional Hazards Models; Psychotropic Drugs; Risk; Substance-Related Disorders | 2007 |
Concurrent buprenorphine and benzodiazepines use and self-reported opioid toxicity in opioid substitution treatment.
Topics: Adolescent; Adult; Australia; Benzodiazepines; Buprenorphine; Drug Interactions; Drug Therapy, Combination; Female; Humans; Male; Methadone; Narcotic Antagonists; Narcotics; Opioid-Related Disorders | 2007 |
Client and counselor attitudes toward the use of medications for treatment of opioid dependence.
Topics: Adult; Ambulatory Care; Attitude of Health Personnel; Buprenorphine; Clonidine; Counseling; Culture; Female; Focus Groups; Heroin Dependence; Humans; Ibogaine; Male; Methadone; Middle Aged; Narcotics; Opioid-Related Disorders; Patient Admission; Patient Satisfaction; Peer Group; Psychotropic Drugs; Substance Withdrawal Syndrome; Treatment Outcome | 2007 |
Regarding naltrexone for probationers and parolees.
Topics: Buprenorphine; Heroin Dependence; Humans; Injections; Long-Term Care; Methadone; Naltrexone; Narcotic Antagonists; Narcotics; Pain; Prisoners; Treatment Outcome | 2007 |
Syncope and QT prolongation among patients treated with methadone for heroin dependence in the city of Copenhagen.
Topics: Adult; Buprenorphine; Cross-Sectional Studies; Dose-Response Relationship, Drug; Electrocardiography; Female; Heroin Dependence; Humans; Long QT Syndrome; Male; Methadone; Middle Aged; Narcotics; Syncope | 2007 |
Blockade of morphine-induced behavioral sensitization by a combination of amisulpride and RB101, comparison with classical opioid maintenance treatments.
Topics: Amisulpride; Animals; Behavior, Animal; Buprenorphine; Disulfides; Male; Methadone; Mice; Morphine; Motor Activity; Opioid-Related Disorders; Phenylalanine; Sulpiride | 2007 |
The Australian Treatment Outcome Study (ATOS): what have we learnt about treatment for heroin dependence?
Topics: Australia; Buprenorphine; Cohort Studies; Comorbidity; Cost-Benefit Analysis; Follow-Up Studies; Heroin Dependence; Humans; Methadone; Narcotics; Social Problems; Treatment Outcome | 2007 |
Buprenorphine supply by community pharmacists in Victoria, Australia: perceptions, experiences and key issues identified.
Topics: Attitude of Health Personnel; Australia; Buprenorphine; Catchment Area, Health; Community Pharmacy Services; Cross-Sectional Studies; Demography; Drug Administration Routes; Health Care Surveys; Health Services Misuse; Heroin Dependence; Humans; Methadone; Narcotic Antagonists; Pharmacists; Prevalence | 2007 |
[Guidelines for acute detoxication and substitution treatment in persons unknown or only superficially known to the physician].
Topics: Buprenorphine; Drug Prescriptions; Humans; Inactivation, Metabolic; Methadone; Naloxone; Narcotic Antagonists; Narcotics; Practice Guidelines as Topic; Prisons; Substance Withdrawal Syndrome | 2007 |
Prevalence of psychoactive substances in truck drivers in the Nord-Pas-de-Calais region (France).
Topics: Adolescent; Adult; Aged; Amphetamines; Analgesics, Opioid; Automobile Driving; Benzodiazepines; Buprenorphine; Cannabinoids; Central Nervous System Depressants; Cocaine; Dopamine Uptake Inhibitors; Ethanol; Female; Forensic Toxicology; France; Gas Chromatography-Mass Spectrometry; Humans; Male; Methadone; Middle Aged; Narcotics; Occupations; Prevalence; Substance Abuse Detection; Substance-Related Disorders | 2008 |
Hazardous alcohol consumption and other barriers to antiviral treatment among hepatitis C positive people receiving opioid maintenance treatment.
Topics: Adolescent; Adult; Alcoholism; Antiviral Agents; Anxiety Disorders; Australia; Buprenorphine; Comorbidity; Cross-Sectional Studies; Depressive Disorder, Major; Drug Therapy, Combination; Female; Follow-Up Studies; Health Knowledge, Attitudes, Practice; Health Services Accessibility; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Male; Mass Screening; Methadone; Middle Aged; Narcotics; Opioid-Related Disorders; Patient Acceptance of Health Care; Patient Satisfaction; Psychotherapy, Brief; Substance Abuse, Intravenous | 2007 |
Medical treatment of opiate dependence: expanding treatment options.
Topics: Administration, Sublingual; Ambulatory Care; Buprenorphine; Drug Combinations; Humans; Methadone; Naltrexone; Opioid-Related Disorders; Patient Compliance; Randomized Controlled Trials as Topic; Substance Abuse Detection; Treatment Outcome | 2007 |
Benzodiazepine prescription for patients in opioid maintenance treatment in Norway.
Topics: Adult; Benzodiazepines; Buprenorphine; Drug Prescriptions; Drug Utilization Review; Female; Humans; Male; Mental Health Services; Methadone; Middle Aged; Narcotics; Norway; Opioid-Related Disorders; Practice Patterns, Physicians'; Substance Abuse Treatment Centers | 2007 |
Does prescribing for opiate addiction change after national guidelines? Methadone and buprenorphine prescribing to opiate addicts by general practitioners and hospital doctors in England, 1995-2005.
Topics: Buprenorphine; Drug Prescriptions; England; Family Practice; Humans; Medical Staff, Hospital; Methadone; Narcotics; Opioid-Related Disorders; Practice Guidelines as Topic; Practice Patterns, Physicians' | 2007 |
Re: Illicit opioid use and its key characteristics: a select overview and evidence from a Canadian multisite cohort of illicit opioid users.
Topics: Buprenorphine; Canada; Cohort Studies; Delayed-Action Preparations; Drug Therapy, Combination; Humans; Illicit Drugs; Methadone; Multicenter Studies as Topic; Narcotics; Opioid-Related Disorders; Patient Compliance | 2007 |
Mortality related to pharmacotherapies for opioid dependence: a comparative analysis of coronial records.
Topics: Australia; Buprenorphine; Drug Prescriptions; Drug Therapy; Episode of Care; Humans; Methadone; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders; Registries | 2007 |
Methadone vs. buprenorphine/naloxone during early opioid substitution treatment: a naturalistic comparison of cognitive performance relative to healthy controls.
Topics: Adult; Buprenorphine; Cognition; Cognition Disorders; Drug Therapy, Combination; Female; Humans; Male; Methadone; Naloxone; Opioid-Related Disorders; Reaction Time | 2007 |
Colocating buprenorphine with methadone maintenance and outpatient chemical dependency services.
Topics: Adult; Ambulatory Care; Buprenorphine; Counseling; Delivery of Health Care, Integrated; Female; Health Services Accessibility; Humans; Male; Methadone; Methadyl Acetate; Middle Aged; Naloxone; Narcotics; New York City; Opioid-Related Disorders; Outcome Assessment, Health Care; Patient Care Team; Patient Dropouts; Social Work; Substance Abuse Detection | 2007 |
Substance use and quality of life over 12 months among buprenorphine maintenance-treated and methadone maintenance-treated heroin-addicted patients.
Topics: Adult; Buprenorphine; Cohort Studies; Comorbidity; Diagnosis, Dual (Psychiatry); Female; Follow-Up Studies; Heroin Dependence; Humans; Illicit Drugs; Italy; Male; Mental Disorders; Methadone; Narcotics; Patient Dropouts; Program Evaluation; Prospective Studies; Quality of Life; Substance Abuse Detection; Substance-Related Disorders | 2007 |
Optimizing opioid detoxification: rearranging deck chairs on the Titanic.
Topics: Aftercare; Buprenorphine; Cost Control; Follow-Up Studies; Humans; Length of Stay; Methadone; Narcotics; Opioid-Related Disorders; Outcome and Process Assessment, Health Care; Patient Dropouts; Survival Analysis | 2007 |
Buprenorphine and methadone: a comparison of patient completion rates during inpatient detoxification.
Topics: Adolescent; Adult; Buprenorphine; Female; Follow-Up Studies; Hospitals, Teaching; Humans; Length of Stay; Male; Methadone; Middle Aged; Narcotics; New York; Opioid-Related Disorders; Patient Dropouts; Substance Abuse Treatment Centers; Substance Withdrawal Syndrome | 2007 |
Relationship between therapeutic use and abuse of opioid analgesics in rural, suburban, and urban locations in the United States.
Topics: Analgesics, Opioid; Buprenorphine; Delayed-Action Preparations; Humans; Hydrocodone; Methadone; Opioid-Related Disorders; Oxycodone; Practice Patterns, Physicians'; Risk Assessment; Risk Management; Rural Population; Suburban Population; United States; Urban Population | 2007 |
Clinical update: codeine maintenance in opioid dependence.
Topics: Adult; Analgesics, Opioid; Australia; Buprenorphine; Codeine; Europe; Health Policy; Heroin; Humans; Methadone; Opioid-Related Disorders; Treatment Outcome; United States | 2007 |
Pharmacotherapeutic environments for substance use disorders.
Topics: Ambulatory Care; Buprenorphine; Cognitive Behavioral Therapy; Delayed-Action Preparations; Family Practice; Heroin Dependence; Hospitalization; Humans; Methadone; Naltrexone; Office Visits; Opioid-Related Disorders; Secondary Prevention; Substance-Related Disorders | 2007 |
Quality of life among heroin users on buprenorphine versus methadone maintenance.
Topics: Administration, Oral; Administration, Sublingual; Adult; Buprenorphine; Female; Follow-Up Studies; Heroin Dependence; Humans; Male; Methadone; Narcotic Antagonists; Narcotics; Personal Satisfaction; Quality of Life; Substance Abuse Treatment Centers; Surveys and Questionnaires; Treatment Outcome | 2007 |
Prescription opioid use, misuse, and diversion among street drug users in New York City.
Topics: Administration, Intranasal; Adult; Aged; Analgesics, Opioid; Buprenorphine; Cocaine-Related Disorders; Drug Prescriptions; Ethnicity; Female; Heroin Dependence; Humans; Male; Methadone; Middle Aged; Narcotic Antagonists; Narcotics; New York City; Pain; Patient Selection; Socioeconomic Factors; Substance Abuse, Intravenous; Substance Withdrawal Syndrome; Substance-Related Disorders | 2008 |
Community pharmacies and the provision of opioid substitution services for drug misusers: changes in activity and attitudes of community pharmacists across England 1995-2005.
Topics: Analgesics, Opioid; Attitude of Health Personnel; Buprenorphine; Community Pharmacy Services; England; Female; Health Promotion; Humans; Male; Methadone; Pharmacies; Substance-Related Disorders; Surveys and Questionnaires; Treatment Outcome | 2007 |
[Treatment of opiate addicts in general practice].
Topics: Buprenorphine; Family Practice; Humans; Methadone; Narcotics; Opioid-Related Disorders; Substance Abuse, Intravenous | 2007 |
[The effect of substitution therapy on the birth weight of the newborn, its postpartum adaptation, trophic and course of the neonatal abstinence syndrome].
Topics: Apgar Score; Birth Weight; Buprenorphine; Female; Fetal Growth Retardation; Heroin Dependence; Humans; Infant, Newborn; Methadone; Narcotic Antagonists; Neonatal Abstinence Syndrome; Pregnancy; Pregnancy Complications | 2007 |
Hypogonadism in men receiving methadone and buprenorphine maintenance treatment.
Topics: Adult; Alcoholism; Buprenorphine; Humans; Hypogonadism; Male; Methadone; Narcotics; Prevalence; Substance-Related Disorders; Testosterone | 2009 |
Data do not support buprenorphine as a first-line treatment for addiction.
Topics: Buprenorphine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Heroin Dependence; Humans; Methadone; Naloxone; Narcotic Antagonists; Randomized Controlled Trials as Topic; Treatment Outcome | 2007 |
Community pharmacy harm reduction services for drug misusers: national service delivery and professional attitude development over a decade in Scotland.
Topics: Adolescent; Adult; Aged; Analgesics, Opioid; Attitude of Health Personnel; Blood-Borne Pathogens; Buprenorphine; Community Pharmacy Services; Cross-Sectional Studies; Female; Harm Reduction; Humans; Male; Methadone; Middle Aged; Needle-Exchange Programs; Scotland; State Medicine; Substance Abuse, Intravenous; Surveys and Questionnaires | 2007 |
NMDA receptor antagonists inhibit opiate antinociceptive tolerance and locomotor sensitization in rats.
Topics: Animals; Behavior, Animal; Buprenorphine; Dizocilpine Maleate; Drug Tolerance; Excitatory Amino Acid Antagonists; Isoquinolines; Male; Memantine; Methadone; Morphine; Motor Activity; Narcotics; Opioid-Related Disorders; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate | 2008 |
Hospital morphine preparation for abstinence syndrome in newborns exposed to buprenorphine or methadone.
Topics: Buprenorphine; Chromatography, High Pressure Liquid; Drug Contamination; Drug Stability; Female; Humans; Infant, Newborn; Methadone; Morphine; Narcotic Antagonists; Narcotics; Neonatal Abstinence Syndrome; Pharmaceutical Solutions; Pregnancy; Prospective Studies | 2008 |
Dispensing opioid substitution treatment: practices, attitudes and intentions of community-based pharmacists.
Topics: Adult; Aged; Attitude of Health Personnel; Buprenorphine; Community Pharmacy Services; Delivery of Health Care; Demography; Female; Health Knowledge, Attitudes, Practice; Humans; Male; Methadone; Middle Aged; Narcotics; Opioid-Related Disorders; Pharmacists; Professional Practice Location; South Australia; Surveys and Questionnaires; Telephone | 2008 |
QT-interval effects of methadone, levomethadyl, and buprenorphine in a randomized trial.
Topics: Adult; Analgesics, Opioid; Buprenorphine; Dose-Response Relationship, Drug; Double-Blind Method; Electrocardiography; Female; Follow-Up Studies; Heart Rate; Humans; Male; Methadone; Methadyl Acetate; Opioid-Related Disorders; Randomized Controlled Trials as Topic; Treatment Outcome | 2007 |
Erectile dysfunction in male heroin users, receiving methadone and buprenorphine maintenance treatment.
Topics: Adolescent; Adult; Buprenorphine; Depression; Erectile Dysfunction; Heroin Dependence; Humans; Male; Methadone; Middle Aged; Narcotics; Prevalence; Psychology; Sexual Partners; Statistics, Nonparametric; Surveys and Questionnaires | 2008 |
[End of opioid addicts' dancing around?].
Topics: Buprenorphine; Family Practice; Humans; Methadone; Narcotics; Opioid-Related Disorders | 2007 |
Buprenorphine + naloxone: new combination. Opiate dependence: no proof of reduced risk of self-administered injection.
Topics: Administration, Sublingual; Analgesics, Opioid; Buprenorphine; Drug Therapy, Combination; Finland; France; Heroin Dependence; Humans; Methadone; Morphine; Naloxone; Narcotic Antagonists; Opioid-Related Disorders; Patient Compliance; Patient Dropouts; Randomized Controlled Trials as Topic; Self Administration; Treatment Outcome | 2007 |
Erectile dysfunction in men receiving methadone and buprenorphine maintenance treatment.
Topics: Adult; Age Factors; Buprenorphine; Depression; Dose-Response Relationship, Drug; Erectile Dysfunction; Humans; Libido; Male; Methadone; Middle Aged; Opioid-Related Disorders; Regression Analysis; Testosterone; Treatment Outcome | 2008 |
Mortality prior to, during and after opioid maintenance treatment (OMT): a national prospective cross-registry study.
Topics: Adult; Buprenorphine; Cross-Sectional Studies; Drug Overdose; Female; Follow-Up Studies; Humans; Male; Methadone; Narcotics; Opioid-Related Disorders; Prospective Studies; Registries; Time Factors | 2008 |
Opioid dependent patients' experiences of and attitudes towards having their injecting sites examined.
Topics: Adult; Analgesics, Opioid; Attitude of Health Personnel; Buprenorphine; Cross-Sectional Studies; Drug Users; Female; Health Knowledge, Attitudes, Practice; Humans; Male; Methadone; New South Wales; Opioid-Related Disorders; Patient Acceptance of Health Care; Physical Examination; Physician-Patient Relations; Substance Abuse, Intravenous; Surveys and Questionnaires; Trust; Truth Disclosure | 2009 |
Toward a rational selection of treatment for addiction.
Topics: Alleles; Buprenorphine; Genetic Variation; Heroin Dependence; Humans; Methadone; Naltrexone; Narcotic Antagonists; Receptors, Opioid, mu; Substance-Related Disorders | 2007 |
Ethical and human rights imperatives to ensure medication-assisted treatment for opioid dependence in prisons and pre-trial detention.
Topics: Buprenorphine; Health Services Accessibility; Human Rights; Humans; Methadone; Narcotics; Opioid-Related Disorders; Prisoners; Prisons; Substance Withdrawal Syndrome | 2008 |
Buprenorphine injection in Melbourne, Australia--an update.
Topics: Australia; Buprenorphine; Catchment Area, Health; Cohort Studies; Cross-Sectional Studies; Harm Reduction; Hepatitis C; Humans; Injections, Intravenous; Methadone; Narcotics; Needle Sharing; Prospective Studies; Risk-Taking; Substance Abuse, Intravenous; Substance-Related Disorders | 2008 |
Methadone- and buprenorphine-related ambulance attendances: a population-based indicator of adverse events.
Topics: Adult; Ambulances; Buprenorphine; Databases, Factual; Drug Overdose; Emergency Medical Services; Female; Glasgow Coma Scale; Humans; Male; Methadone; Narcotics; Opioid-Related Disorders; Respiration; Retrospective Studies; Victoria; Young Adult | 2008 |
Feasibility and outcome of substitution treatment of heroin-dependent patients in specialized substitution centers and primary care facilities in Germany: a naturalistic study in 2694 patients.
Topics: Adult; Ambulatory Care Facilities; Buprenorphine; Catchment Area, Health; Feasibility Studies; Female; Germany; Heroin Dependence; Humans; Male; Mental Health Services; Methadone; Narcotics; Prevalence; Primary Health Care; Prospective Studies; Retention, Psychology | 2008 |
Buprenorphine and methadone treatment of opiate dependence during pregnancy: comparison of fetal growth and neonatal outcomes in two consecutive case series.
Topics: Birth Weight; Buprenorphine; Female; Fetal Growth Retardation; Heroin Dependence; Humans; Infant Mortality; Infant, Newborn; Methadone; Narcotic Antagonists; Narcotics; Neonatal Abstinence Syndrome; Opioid-Related Disorders; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Sweden | 2008 |
Prevalence of diversion and injection of methadone and buprenorphine among clients receiving opioid treatment at community pharmacies in New South Wales, Australia.
Topics: Administration, Oral; Adult; Analgesics, Opioid; Behavior, Addictive; Buprenorphine; Community Pharmacy Services; Cross-Sectional Studies; Drug Users; Female; Humans; Male; Methadone; Middle Aged; New South Wales; Opioid-Related Disorders; Pharmaceutical Solutions; Substance Abuse, Intravenous; Surveys and Questionnaires; Tablets | 2008 |
Community treatment programs take up buprenorphine.
Topics: Buprenorphine; Humans; Mental Health Services; Methadone; Naltrexone; Narcotic Antagonists; Narcotics; Opioid-Related Disorders; Patient Selection; Substance Abuse Treatment Centers | 2004 |
Patients' help-seeking behaviours for health problems associated with methadone and buprenorphine treatment.
Topics: Adult; Buprenorphine; Community Pharmacy Services; Cross-Sectional Studies; Dose-Response Relationship, Drug; Female; Health Services Accessibility; Health Services Needs and Demand; Humans; Male; Methadone; Middle Aged; Narcotic Antagonists; Narcotics; New South Wales; Opioid-Related Disorders; Patient Acceptance of Health Care; Sex Factors; Surveys and Questionnaires | 2008 |
Comparison of characteristics of opioid-using pregnant women in rural and urban settings.
Topics: Adult; Buprenorphine; Demography; Female; Humans; Mass Screening; Methadone; Narcotic Antagonists; Opioid-Related Disorders; Patient Acceptance of Health Care; Patient Selection; Pregnancy; Pregnancy Complications; Randomized Controlled Trials as Topic; Rural Population; Urban Population | 2008 |
A 50-year-old woman addicted to heroin: review of treatment of heroin addiction.
Topics: Buprenorphine; Drug Therapy, Combination; Female; Heroin Dependence; History, 19th Century; History, 20th Century; Humans; Methadone; Middle Aged; Naltrexone; Narcotic Antagonists; Narcotics; Opioid-Related Disorders; Recurrence; Self-Help Groups; United States | 2008 |
Key findings from the WHO collaborative study on substitution therapy for opioid dependence and HIV/AIDS.
Topics: Adolescent; Adult; Aged; Buprenorphine; Developing Countries; Female; HIV Infections; Humans; Male; Methadone; Middle Aged; Narcotics; Opioid-Related Disorders; Risk Factors; Treatment Outcome | 2008 |
Successful transition to buprenorphine in a patient with methadone-induced torsades de pointes.
Topics: Buprenorphine; Humans; Male; Methadone; Middle Aged; Narcotic Antagonists; Opioid-Related Disorders; Torsades de Pointes | 2008 |
The underrecognized toll of prescription opioid abuse on young children.
Topics: Adverse Drug Reaction Reporting Systems; Analgesics, Opioid; Buprenorphine; Child, Preschool; Female; Humans; Hydrocodone; Hydromorphone; Infant; Infant, Newborn; Male; Methadone; Morphine; Oxycodone; Poisoning; Prescription Drugs; United States | 2009 |
The impact of methadone or buprenorphine treatment and ongoing injection on highly active antiretroviral therapy (HAART) adherence: evidence from the MANIF2000 cohort study.
Topics: Adult; Antiretroviral Therapy, Highly Active; Buprenorphine; Epidemiologic Studies; Female; HIV Infections; Humans; Male; Methadone; Narcotics; Opioid-Related Disorders; Patient Compliance | 2008 |
Cost analysis of clinic and office-based treatment of opioid dependence: results with methadone and buprenorphine in clinically stable patients.
Topics: Adolescent; Adult; Buprenorphine; Cohort Studies; Cost of Illness; Costs and Cost Analysis; Data Interpretation, Statistical; Female; Health Personnel; Humans; Male; Methadone; Middle Aged; Narcotics; Opioid-Related Disorders; Physicians' Offices; Socioeconomic Factors; Substance Abuse Detection; Substance Abuse Treatment Centers; Treatment Outcome; Young Adult | 2009 |
Substitution treatment in Malaysia.
Topics: Buprenorphine; Drug Utilization; Heroin Dependence; Humans; Malaysia; Methadone; Naltrexone; Patient Compliance; Pilot Projects; Policy Making | 2008 |
Peginterferon plus Ribavirin for chronic hepatitis C in opiate addicts on methadone/buprenorphine maintenance therapy.
Topics: Adolescent; Adult; Antiviral Agents; Buprenorphine; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Methadone; Middle Aged; Narcotics; Patient Compliance; Polyethylene Glycols; Prospective Studies; Recombinant Proteins; Recurrence; Ribavirin; RNA, Viral; Substance Abuse, Intravenous; Treatment Outcome; Young Adult | 2009 |
Electrocardiogram characteristics of methadone and buprenorphine maintained subjects.
Topics: Adult; Buprenorphine; Dose-Response Relationship, Drug; Electrocardiography; Female; Humans; Long QT Syndrome; Long-Term Care; Male; Methadone; Middle Aged; Narcotics; Opioid-Related Disorders; Risk Factors | 2008 |
Factors associated with the prescribing of buprenorphine or methadone for treatment of opiate dependence.
Topics: Adolescent; Adult; Analgesics, Opioid; Attitude to Health; Buprenorphine; Data Collection; Female; Health Knowledge, Attitudes, Practice; Humans; London; Male; Methadone; Middle Aged; Opioid-Related Disorders; Patient Satisfaction; Practice Patterns, Physicians'; Substance Abuse Treatment Centers; Young Adult | 2009 |
Treating opioid dependency and coexistent chronic nonmalignant pain.
Topics: Analgesics, Opioid; Buprenorphine; Chronic Disease; Humans; Methadone; Opioid-Related Disorders; Pain | 2008 |
Distribution of saquinavir, methadone, and buprenorphine in maternal brain, placenta, and fetus during two different gestational stages of pregnancy in mice.
Topics: Animals; Brain; Buprenorphine; Female; Fetal Development; Fetus; Maternal Exposure; Maternal-Fetal Exchange; Methadone; Mice; Placenta; Pregnancy; Pregnancy, Animal; Saquinavir; Tissue Distribution | 2009 |
[General practitioner views on drug-assisted rehabilitation and the Norwegian substance abuse reform].
Topics: Adult; Attitude of Health Personnel; Buprenorphine; Family Practice; Female; Health Policy; Humans; Male; Methadone; Narcotics; Norway; Opioid-Related Disorders; Physicians, Family; Practice Patterns, Physicians'; Social Support; Surveys and Questionnaires | 2009 |
[Treatment of opioid withdrawal].
Topics: Buprenorphine; Humans; Methadone; Narcotics; Opioid-Related Disorders; Social Support; Substance Withdrawal Syndrome | 2009 |
Swiss recommendations for substitution treatment: a report that "got it right".
Topics: Buprenorphine; Europe; Health Planning Guidelines; Health Policy; Humans; Methadone; Narcotics; Opioid-Related Disorders; Patient Acceptance of Health Care; Substance Abuse Treatment Centers; Switzerland; United States | 2009 |
Patterns of major depression and drug-related problems amongst heroin users across 36 months.
Topics: Adolescent; Adult; Buprenorphine; Cohort Studies; Comorbidity; Crime; Depressive Disorder, Major; Drug Overdose; Female; Health Status; Health Status Indicators; Heroin; Heroin Dependence; Humans; Longitudinal Studies; Male; Methadone; Middle Aged; Narcotics; Needle Sharing; New South Wales; Prognosis; Substance Abuse, Intravenous; Suicide, Attempted; Treatment Outcome; Young Adult | 2009 |
[Substitution treatment of drug addicts during pregnancy: consequences for the children?].
Topics: Buprenorphine; Developmental Disabilities; Female; Humans; Infant, Newborn; Methadone; Narcotics; Neonatal Abstinence Syndrome; Opioid-Related Disorders; Pregnancy; Pregnancy Complications; Prenatal Exposure Delayed Effects; Psychomotor Disorders; Risk Factors | 2009 |
Treating chronic hepatitis C in recovering opiate addicts: yes, we can.
Topics: Antiviral Agents; Buprenorphine; Drug Therapy, Combination; Drug Users; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Italy; Methadone; Narcotics; Patient Compliance; Polyethylene Glycols; Practice Guidelines as Topic; Practice Patterns, Physicians'; Recombinant Proteins; Refusal to Treat; Ribavirin; Substance Abuse, Intravenous; Treatment Outcome; United States | 2009 |
Opioid maintenance treatment during pregnancy: occurrence and severity of neonatal abstinence syndrome. A national prospective study.
Topics: Adult; Buprenorphine; Cohort Studies; Female; Humans; Infant, Newborn; Male; Methadone; Neonatal Abstinence Syndrome; Opioid-Related Disorders; Pregnancy; Pregnancy Complications; Prenatal Exposure Delayed Effects; Prospective Studies; Severity of Illness Index; Young Adult | 2009 |
Psychopathological changes and quality of life in hepatitis C virus-infected, opioid-dependent patients during maintenance therapy.
Topics: Adult; Antiviral Agents; Buprenorphine; Female; Germany; Hepatitis C, Chronic; Humans; Interferons; Longitudinal Studies; Male; Methadone; Narcotic Antagonists; Quality of Life; Substance Abuse, Intravenous; Surveys and Questionnaires; Viral Load | 2009 |
Frequency, indications, outcomes, and predictive factors of opioid switching in an acute palliative care unit.
Topics: Adult; Aged; Analgesics, Opioid; Buprenorphine; Female; Fentanyl; Humans; Male; Methadone; Middle Aged; Morphine; Pain; Palliative Care; Prospective Studies; Treatment Outcome | 2009 |
Differential involvement of P-glycoprotein (ABCB1) in permeability, tissue distribution, and antinociceptive activity of methadone, buprenorphine, and diprenorphine: in vitro and in vivo evaluation.
Topics: Adenosine Triphosphatases; Adenosine Triphosphate; Algorithms; Analgesics; Analgesics, Opioid; Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP-Binding Cassette Transporters; Buprenorphine; Caco-2 Cells; Carrier Proteins; Diprenorphine; Humans; Intestinal Absorption; Mannitol; Methadone; Mice; Mice, Knockout; Paclitaxel; Protein Conformation; Reaction Time; Tissue Distribution | 2009 |
Satisfaction guaranteed? What clients on methadone and buprenorphine think about their treatment.
Topics: Adult; Analgesics, Opioid; Buprenorphine; Delivery of Health Care; Drug Users; Female; Health Facility Environment; Humans; Male; Methadone; New South Wales; Opioid-Related Disorders; Patient Satisfaction; Professional-Patient Relations; Substance Abuse Treatment Centers; Surveys and Questionnaires; Treatment Outcome | 2008 |
Buprenorphine and pregnancy.
Topics: Buprenorphine; Congenital Abnormalities; Female; France; Humans; Infant, Newborn; Methadone; Neonatal Abstinence Syndrome; Obstetric Labor, Premature; Opioid-Related Disorders; Pregnancy; Pregnancy Outcome; Premature Birth; Prospective Studies | 2009 |
Prevalence and clinical relevance of corrected QT interval prolongation during methadone and buprenorphine treatment: a mortality assessment study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Buprenorphine; Female; Humans; Long QT Syndrome; Male; Methadone; Middle Aged; Narcotic Antagonists; Norway; Opioid-Related Disorders; Prevalence; Young Adult | 2009 |
What more do we need to know about medication-assisted treatment for prescription opioid abusers?
Topics: Buprenorphine; Humans; Medication Adherence; Methadone; Narcotic Antagonists; Opioid-Related Disorders; Prescription Drugs | 2009 |
Maintenance therapy and 3-year outcome of opioid-dependent prisoners: a prospective study in France (2003-06).
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Buprenorphine; Female; France; Humans; Male; Methadone; Middle Aged; Narcotic Antagonists; Opioid-Related Disorders; Prescription Drugs; Prisoners; Prisons; Prospective Studies; Recurrence; Young Adult | 2009 |
Comparing overdose mortality associated with methadone and buprenorphine treatment.
Topics: Adult; Buprenorphine; Databases, Factual; Drug Overdose; Female; Humans; Male; Methadone; Middle Aged; Narcotics; New South Wales; Opioid-Related Disorders; Risk Assessment | 2009 |
Management of acute postpartum pain in patients maintained on methadone or buprenorphine during pregnancy.
Topics: Acute Disease; Adult; Analgesics, Non-Narcotic; Analgesics, Opioid; Buprenorphine; Controlled Clinical Trials as Topic; Double-Blind Method; Female; Humans; Ibuprofen; Methadone; Opioid-Related Disorders; Pain; Pain Measurement; Postpartum Period; Pregnancy; Pregnancy Complications | 2009 |
Comparison of costs and utilization among buprenorphine and methadone patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Buprenorphine; Drug Utilization; Health Care Costs; Humans; Methadone; Middle Aged; Narcotic Antagonists; Opioid-Related Disorders; Young Adult | 2009 |
Comparing retention in treatment and mortality in people after initial entry to methadone and buprenorphine treatment.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Buprenorphine; Female; Humans; Male; Medication Adherence; Methadone; Middle Aged; Narcotic Antagonists; New South Wales; Opioid-Related Disorders; Poisson Distribution; Remission Induction; Risk Factors; Time Factors; Young Adult | 2009 |
Mortality among clients of a state-wide opioid pharmacotherapy program over 20 years: risk factors and lives saved.
Topics: Adult; Buprenorphine; Cause of Death; Data Interpretation, Statistical; Databases, Factual; Drug Overdose; Female; Humans; Male; Methadone; Middle Aged; Narcotic Antagonists; Narcotics; New South Wales; Opioid-Related Disorders; Risk Assessment; Risk Factors; Young Adult | 2009 |
Methadone and buprenorphine prescribing and referral practices in US prison systems: results from a nationwide survey.
Topics: Buprenorphine; Drug Utilization; Female; Health Care Surveys; Heroin Dependence; Humans; Male; Methadone; Narcotic Antagonists; Narcotics; Pregnancy; Prisoners; Prisons; Referral and Consultation; United States | 2009 |
Injection of medications used in opioid substitution treatment in Australia after the introduction of a mixed partial agonist-antagonist formulation.
Topics: Analgesics, Opioid; Buprenorphine; Drug Combinations; Female; Humans; Injections; Male; Methadone; Naloxone; Narcotic Antagonists; Opioid-Related Disorders; Substance Abuse, Intravenous | 2009 |
Buprenorphine withdrawal in a toddler.
Topics: Analgesics, Opioid; Buprenorphine; Child, Preschool; Critical Care; Emergency Medicine; Female; Humans; Methadone; Substance Abuse Detection; Substance Withdrawal Syndrome | 2009 |
Effect of rifampin and nelfinavir on the metabolism of methadone and buprenorphine in primary cultures of human hepatocytes.
Topics: Adult; Aged; Analgesics, Opioid; Antibiotics, Antitubercular; Biotransformation; Buprenorphine; Cells, Cultured; Chromatography, Liquid; Dealkylation; Drug Interactions; Female; Glucuronides; Hepatocytes; HIV Protease Inhibitors; Humans; Intestinal Mucosa; Kinetics; Male; Methadone; Microsomes, Liver; Middle Aged; Nelfinavir; Pyrrolidines; Rifampin; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry | 2009 |
Effectiveness of community treatments for heroin and crack cocaine addiction in England: a prospective, in-treatment cohort study.
Topics: Adult; Analgesics, Opioid; Buprenorphine; Cocaine-Related Disorders; Community Mental Health Services; England; Female; Heroin Dependence; Humans; Linear Models; Male; Methadone; Multivariate Analysis; Narcotic Antagonists; Program Evaluation; Prospective Studies; Psychotherapy; Treatment Outcome | 2009 |
Retention in opioid substitution treatment: a major predictor of long-term virological success for HIV-infected injection drug users receiving antiretroviral treatment.
Topics: Adult; Antiretroviral Therapy, Highly Active; Buprenorphine; Female; HIV Infections; Humans; Male; Methadone; Narcotics; Patient Compliance; Treatment Outcome | 2009 |
Characteristics and comparative severity of respiratory response to toxic doses of fentanyl, methadone, morphine, and buprenorphine in rats.
Topics: Animals; Blood Gas Analysis; Buprenorphine; Catheterization; Fentanyl; Lactic Acid; Male; Methadone; Morphine; Morphine Derivatives; Naltrexone; Narcotic Antagonists; Narcotics; Plethysmography, Whole Body; Rats; Rats, Sprague-Dawley; Receptors, Opioid; Respiratory Insufficiency; Respiratory Mechanics | 2009 |
[A political order].
Topics: Buprenorphine; Health Policy; Humans; Methadone; Narcotics; Norway; Opioid-Related Disorders; Patient Rights | 2009 |
Determinants of successful chronic hepatitis C case finding among patients receiving opioid maintenance treatment in a primary care setting.
Topics: Adult; Analgesics, Opioid; Buprenorphine; Family Practice; Female; Hepacivirus; Hepatitis C, Chronic; Humans; Male; Methadone; Morphine; Narcotics; Polymerase Chain Reaction; Regression Analysis; Retrospective Studies; Substance Abuse, Intravenous; Switzerland | 2009 |
Feasibility of buprenorphine and methadone maintenance programmes among users of home made opioids in Ukraine.
Topics: Adult; Behavior, Addictive; Buprenorphine; Employment; Feasibility Studies; Female; HIV Infections; Humans; Male; Medication Adherence; Methadone; Opioid-Related Disorders; Risk-Taking; Treatment Outcome; Ukraine | 2010 |
Why do patients report transferring between methadone and buprenorphine?
Topics: Buprenorphine; Humans; Methadone; Opioid-Related Disorders; Patient Compliance | 2009 |
Patterns in sleep-wakefulness in three-month old infants exposed to methadone or buprenorphine.
Topics: Adult; Buprenorphine; Chronobiology Disorders; Female; Humans; Infant; Infant Behavior; Infant, Newborn; Infant, Premature, Diseases; Longitudinal Studies; Methadone; Narcotics; Neonatal Abstinence Syndrome; Opioid-Related Disorders; Pregnancy; Pregnancy Complications; Prenatal Exposure Delayed Effects; Sleep; Stress, Psychological; Wakefulness | 2009 |
[Interactions with methadone and buprenorphine].
Topics: Buprenorphine; Drug Interactions; Humans; Methadone; Narcotics; Opioid-Related Disorders; Risk Factors | 2009 |
[Blasch-kolinear psoriasis revealed by infliximab therapy].
Topics: Adult; Antibodies, Monoclonal; Biopsy; Buprenorphine; Dermatologic Agents; Humans; Infliximab; Male; Methadone; Psoriasis; Skin | 2009 |
Comparison of tuberculin skin testing reactivity in opioid-dependent patients seeking treatment with methadone versus buprenorphine: policy implications for tuberculosis screening.
Topics: Adult; Buprenorphine; Female; Humans; Male; Methadone; Opioid-Related Disorders; Policy Making; Prevalence; Tuberculin Test; Tuberculosis | 2009 |
Diversion and injection of methadone and buprenorphine among clients in public opioid treatment clinics in New South Wales, Australia.
Topics: Adult; Australia; Buprenorphine; Drug Users; Female; Humans; Illicit Drugs; Injections; Male; Methadone; Narcotics; New South Wales; Opioid-Related Disorders; Substance Abuse Treatment Centers | 2010 |
[Guideline 'Medicinal care for drug addicts in penal institutions'].
Topics: Analgesics, Opioid; Buprenorphine; Dose-Response Relationship, Drug; Humans; Methadone; Naloxone; Netherlands; Practice Patterns, Physicians'; Prisoners; Substance Withdrawal Syndrome; Substance-Related Disorders | 2009 |
Problems experienced by community pharmacists delivering opioid substitution treatment in New South Wales and Victoria, Australia.
Topics: Analgesics, Opioid; Buprenorphine; Community Pharmacy Services; Cross-Sectional Studies; Female; Humans; Interprofessional Relations; Male; Medication Adherence; Methadone; New South Wales; Opioid-Related Disorders; Professional-Patient Relations; Refusal to Treat; Surveys and Questionnaires; Victoria | 2010 |
What is diversion of supervised buprenorphine and how common is it?
Topics: Attitude of Health Personnel; Australia; Buprenorphine; Community Pharmacy Services; Cross-Sectional Studies; Drug Compounding; Humans; Methadone; Motivation; New South Wales; Opioid-Related Disorders; Organization and Administration; Prevalence; Victoria | 2009 |
Maximising the treatment outcomes of opioid substitution treatment.
Topics: Buprenorphine; Counseling; Evidence-Based Medicine; Humans; Methadone; Narcotics; Opioid-Related Disorders; Psychotherapy; United Kingdom | 2010 |
Prospective comparative assessment of buprenorphine overdose with heroin and methadone: clinical characteristics and response to antidotal treatment.
Topics: Adult; Antidotes; Buprenorphine; Drug Overdose; Female; Flumazenil; Heroin; Heroin Dependence; Humans; Intensive Care Units; Male; Methadone; Middle Aged; Naloxone; Narcotic Antagonists; Narcotics; Prospective Studies; Suicide, Attempted | 2010 |
Uzbekistan: government discontinues pilot opiate substitution therapy program.
Topics: Buprenorphine; Government; Humans; Methadone; Opioid-Related Disorders; Pilot Projects; Uzbekistan | 2009 |
Pituitary gland volume among heroin users stabilised on substitution pharmacotherapy.
Topics: Adult; Buprenorphine; Female; Heroin Dependence; Humans; Male; Methadone; Narcotic Antagonists; Narcotics; Neuropsychological Tests; Pituitary Gland; Psychiatric Status Rating Scales; Socioeconomic Factors | 2010 |
High rates of sustained virological response in hepatitis C virus-infected injection drug users receiving directly observed therapy with peginterferon alpha-2a (40KD) (PEGASYS) and once-daily ribavirin.
Topics: Adult; Antidepressive Agents; Antiviral Agents; Buprenorphine; Citalopram; Depression; Directly Observed Therapy; Drug Administration Schedule; Female; Hemoglobins; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Methadone; Middle Aged; Narcotics; Polyethylene Glycols; Recombinant Proteins; Retrospective Studies; Ribavirin; Substance Abuse Treatment Centers; Substance Abuse, Intravenous; Treatment Outcome; Young Adult | 2010 |
Treatment of acute pain in opioid tolerant patients.
Topics: Analgesics, Opioid; Buprenorphine; Buprenorphine, Naloxone Drug Combination; Drug Tolerance; Humans; Methadone; Naloxone; Opioid-Related Disorders; Pain; Pain Measurement | 2010 |
The diverse clinical uses of opioid receptor drugs.
Topics: Analgesics, Opioid; Buprenorphine; Drug Combinations; Humans; Methadone; Naloxone; Naltrexone; Narcotic Antagonists | 2010 |
Intravenous misuse of buprenorphine: characteristics and extent among patients undergoing drug maintenance therapy.
Topics: Administration, Sublingual; Adolescent; Adult; Age Factors; Analgesics, Opioid; Behavior, Addictive; Buprenorphine; Female; Health Care Surveys; Humans; Injections, Intravenous; Italy; Male; Methadone; Middle Aged; Motivation; Opioid-Related Disorders; Perception; Prevalence; Risk Factors; Substance Abuse Treatment Centers; Substance Abuse, Intravenous; Substance Withdrawal Syndrome; Surveys and Questionnaires; Young Adult | 2010 |
Infant neurobehavior following prenatal exposure to methadone or buprenorphine: results from the neonatal intensive care unit network neurobehavioral scale.
Topics: Adult; Akathisia, Drug-Induced; Buprenorphine; Female; Humans; Infant, Newborn; Intensive Care Units, Neonatal; Male; Methadone; Narcotics; Pregnancy; Prenatal Exposure Delayed Effects; Randomized Controlled Trials as Topic; Surveys and Questionnaires | 2010 |
Enhancement of tolerance development to morphine in rats prenatally exposed to morphine, methadone, and buprenorphine.
Topics: Analgesics; Animals; Buprenorphine; Disease Models, Animal; Drug Tolerance; Female; Heroin Dependence; Humans; Male; Methadone; Morphine; Morphine Dependence; Pain Measurement; Pregnancy; Pregnancy Complications; Prenatal Exposure Delayed Effects; Rats; Rats, Sprague-Dawley | 2010 |
Post-marketing surveillance of methadone and buprenorphine in the United States.
Topics: Analgesics, Opioid; Buprenorphine; Data Collection; Humans; Marketing; Methadone; Opioid-Related Disorders; Pain; United States | 2010 |
Law enforcement and drug treatment: a culture clash.
Topics: Buprenorphine; Female; Harm Reduction; HIV Infections; Humans; Law Enforcement; Male; Methadone; Narcotics; Opioid-Related Disorders; Police; Substance Abuse, Intravenous; Ukraine | 2010 |
Were the changes to Sweden's maintenance treatment policy 2000-06 related to changes in opiate-related mortality and morbidity?
Topics: Adult; Buprenorphine; Clinical Protocols; Drug Overdose; Female; Hospitalization; Humans; Male; Methadone; Mortality; Narcotic Antagonists; Opioid-Related Disorders; Practice Guidelines as Topic; Substance Abuse Treatment Centers; Substance Abuse, Intravenous; Sweden; Young Adult | 2010 |
Medical treatment of opioid dependence within the South African context.
Topics: Buprenorphine; Drug Combinations; Drug Overdose; Humans; Methadone; Motivation; Naloxone; Narcotic Antagonists; Narcotics; Opioid-Related Disorders; Recurrence; South Africa; Substance Withdrawal Syndrome | 2010 |
High-throughput simultaneous analysis of buprenorphine, methadone, cocaine, opiates, nicotine, and metabolites in oral fluid by liquid chromatography tandem mass spectrometry.
Topics: Anesthetics, Local; Buprenorphine; Chromatography, Liquid; Cocaine; Female; Ganglionic Stimulants; High-Throughput Screening Assays; Humans; Limit of Detection; Methadone; Narcotics; Nicotine; Pregnancy; Saliva; Tandem Mass Spectrometry | 2010 |
Breastfeeding rates among mothers of infants with neonatal abstinence syndrome.
Topics: Adult; Breast Feeding; Buprenorphine; Female; Humans; Infant, Newborn; Methadone; Mothers; Neonatal Abstinence Syndrome; Opioid-Related Disorders; Retrospective Studies; Time Factors; Young Adult | 2010 |
Factors associated with complicated buprenorphine inductions.
Topics: Adult; Benzodiazepines; Buprenorphine; Community Health Centers; Dose-Response Relationship, Drug; Female; Humans; Male; Methadone; Middle Aged; Naloxone; Narcotic Antagonists; Opioid-Related Disorders; Retrospective Studies; Substance Withdrawal Syndrome; Time Factors; Treatment Outcome; Urban Health Services | 2010 |
Opioid maintenance patients with QTc prolongation: congenital long QT syndrome mutation may be a contributing risk factor.
Topics: Adult; Analgesics, Opioid; Buprenorphine; Electrocardiography; Female; Genetic Testing; Heterozygote; Humans; Long QT Syndrome; Male; Methadone; Middle Aged; Mutation; Opiate Substitution Treatment; Risk Factors | 2010 |
Self-reported side effects in buprenorphine and methadone patients receiving antiretroviral therapy: results from the MANIF 2000 cohort study.
Topics: Anti-Retroviral Agents; Attitude to Health; Buprenorphine; Cohort Studies; Depression; Female; France; Health Services Accessibility; HIV Infections; Humans; Longitudinal Studies; Male; Medication Adherence; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Pain; Self Report; Substance Abuse, Intravenous; Substance Withdrawal Syndrome; Treatment Outcome | 2010 |
Neonatal and maternal outcomes following maternal use of buprenorphine or methadone during pregnancy: findings of a retrospective audit.
Topics: Adult; Buprenorphine; Female; Humans; Infant, Newborn; Maternal Health Services; Maternal Welfare; Medical Audit; Medical Records; Methadone; Neonatal Abstinence Syndrome; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Prenatal Care; Retrospective Studies; Substance-Related Disorders; Treatment Outcome; Young Adult | 2011 |
Opioid dependence - management in general practice.
Topics: Adult; Analgesics, Opioid; Australia; Buprenorphine; Chronic Disease; Disease Management; Female; General Practice; Humans; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Patient Care Planning | 2010 |
Addiction treatment in Russia.
Topics: Behavior, Addictive; Buprenorphine; Delayed-Action Preparations; Humans; Methadone; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders; Recurrence; Russia; Substance Abuse, Intravenous; Suicide Prevention | 2010 |
Advances in the treatment of opioid dependence: continued progress and ongoing challenges.
Topics: Buprenorphine; Drug Implants; Health Services Accessibility; Humans; Methadone; Narcotic Antagonists; Opioid-Related Disorders; Randomized Controlled Trials as Topic; United States | 2010 |
"Should I stay or should I go?" Coming off methadone and buprenorphine treatment.
Topics: Analgesics, Opioid; Buprenorphine; Consumer Health Information; Cross-Sectional Studies; Female; Humans; Male; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Self-Help Groups; Substance Withdrawal Syndrome | 2011 |
Risk of death during and after opiate substitution treatment in primary care: prospective observational study in UK General Practice Research Database.
Topics: Adolescent; Adult; Buprenorphine; Female; Humans; Male; Methadone; Middle Aged; Narcotics; Opioid-Related Disorders; Prospective Studies; Risk Factors; Time Factors; United Kingdom; Young Adult | 2010 |
Accidental and non-accidental ingestion of methadone and buprenorphine in childhood: a single center experience, 1999-2009.
Topics: Adolescent; Age Factors; Buprenorphine; Child, Preschool; Female; Humans; Infant; Male; Methadone; Opioid-Related Disorders; Patient Admission; Retrospective Studies; Risk Factors; Suicide, Attempted | 2011 |
Heroin-dependent inmates' experiences with buprenorphine or methadone maintenance.
Topics: Adult; Buprenorphine; Heroin Dependence; Humans; Male; Methadone; Narcotics; New York City; Opiate Substitution Treatment; Patient Preference; Prisoners; Randomized Controlled Trials as Topic; Substance Withdrawal Syndrome; Taste | 2010 |
The prevalence and correlates of buprenorphine inhalation amongst opioid substitution treatment (OST) clients in Australia.
Topics: Administration, Inhalation; Administration, Intranasal; Adult; Age Factors; Analgesics, Opioid; Australia; Behavior, Addictive; Buprenorphine; Buprenorphine, Naloxone Drug Combination; Cross-Sectional Studies; Drug Users; Female; Humans; Interviews as Topic; Logistic Models; Male; Methadone; Naloxone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Prevalence; Prisons; Product Surveillance, Postmarketing; Risk Assessment; Risk Factors; Smoking; Substance Abuse Treatment Centers | 2011 |
Simultaneous analysis of buprenorphine, methadone, cocaine, opiates and nicotine metabolites in sweat by liquid chromatography tandem mass spectrometry.
Topics: Analgesics, Opioid; Buprenorphine; Chromatography, Liquid; Humans; Methadone; Nicotine; Sweat; Tandem Mass Spectrometry | 2011 |
Cardiovascular-associated disease in an addicted population: an observation study.
Topics: Adult; Buprenorphine; Cardiovascular Diseases; Electrocardiography; Female; Humans; Hypertension; Long QT Syndrome; Male; Methadone; Middle Aged; Observation; Opiate Substitution Treatment; Opioid-Related Disorders; Substance Abuse Detection; Torsades de Pointes; Young Adult | 2011 |
Oral fluid is a viable alternative for monitoring drug abuse: detection of drugs in oral fluid by liquid chromatography-tandem mass spectrometry and comparison to the results from urine samples from patients treated with Methadone or Buprenorphine.
Topics: Benzodiazepines; Buprenorphine; Chromatography, Liquid; Drug Monitoring; Humans; Illicit Drugs; Methadone; Morphine; Morphine Derivatives; Saliva; Substance Abuse Detection; Tandem Mass Spectrometry | 2011 |
MR spectroscopy in opiate maintenance therapy: association of glutamate with the number of previous withdrawals in the anterior cingulate cortex.
Topics: Adult; Analysis of Variance; Buprenorphine; Case-Control Studies; Female; Glutamic Acid; Gyrus Cinguli; Heroin Dependence; Humans; Magnetic Resonance Spectroscopy; Male; Methadone; Middle Aged; Narcotics; Substance Withdrawal Syndrome | 2012 |
Participant characteristics and HIV risk behaviors among individuals entering integrated buprenorphine/naloxone and HIV care.
Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Buprenorphine; Buprenorphine, Naloxone Drug Combination; Cross-Sectional Studies; Female; HIV Infections; Humans; Male; Methadone; Middle Aged; Naloxone; Narcotic Antagonists; Needle Sharing; Odds Ratio; Opiate Substitution Treatment; Opioid-Related Disorders; Risk-Taking; Unsafe Sex | 2011 |
Painkillers fuel growth in drug addiction. Opioid overdoses now kill more people than cocaine or heroin.
Topics: Analgesics, Opioid; Buprenorphine; Cocaine; Drug Overdose; Drug Prescriptions; Health Knowledge, Attitudes, Practice; Heroin; Humans; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Pain; Substance-Related Disorders; United States | 2011 |
Methadone and buprenorphine prescribing patterns of Victorian general practitioners: their first 5 years after authorisation.
Topics: Buprenorphine; Databases, Factual; Drug Prescriptions; Drug Utilization; General Practitioners; Humans; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Practice Patterns, Physicians'; Time Factors; Victoria | 2011 |
Prescribers' perceptions of the diversion and injection of medication by opioid substitution treatment patients.
Topics: Attitude of Health Personnel; Australia; Buprenorphine; Data Collection; Humans; Medication Adherence; Methadone; Naloxone; Narcotics; Opiate Substitution Treatment; Opioid-Related Disorders; Perception; Pharmacists; Self Report | 2011 |
Factors associated with Medicaid patients' access to buprenorphine treatment.
Topics: Adult; Buprenorphine; Female; Health Services Accessibility; Humans; Male; Medicaid; Methadone; Middle Aged; Opioid-Related Disorders; United States | 2011 |
The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of substance use and related disorders. Part 2: Opioid dependence.
Topics: Adult; Aryl Hydrocarbon Hydroxylases; Buprenorphine; Cytochrome P-450 CYP2B6; Cytochrome P-450 CYP2D6; Drug Therapy, Combination; Evidence-Based Medicine; Genetic Variation; Humans; Methadone; Narcotic Antagonists; Narcotics; Opiate Substitution Treatment; Opioid-Related Disorders; Oxidoreductases, N-Demethylating; Psychotherapy; Receptors, Opioid; Social Support; Standard of Care; Substance Withdrawal Syndrome | 2011 |
Opioid substitution therapy--a study of GP participation in prescribing.
Topics: Adult; Aged; Aged, 80 and over; Buprenorphine; Female; Heroin Dependence; Humans; Interviews as Topic; Male; Methadone; Middle Aged; Narcotic Antagonists; Practice Patterns, Physicians'; South Australia | 2011 |
Differential antinociceptive effects of buprenorphine and methadone in the presence of HIV-gp120.
Topics: Analgesia; Analgesics, Opioid; Animals; Buprenorphine; HIV Envelope Protein gp120; Hot Temperature; Male; Methadone; Pain; Pain Measurement; Pain Threshold; Periaqueductal Gray; Rats; Rats, Sprague-Dawley | 2011 |
Drug screening of whole blood by ultra-performance liquid chromatography-tandem mass spectrometry.
Topics: Buprenorphine; Chromatography, Liquid; Cocaine; Codeine; Dronabinol; Ethylmorphine; Humans; Illicit Drugs; Methadone; Morphine; Oxycodone; Substance Abuse Detection; Substance-Related Disorders; Tandem Mass Spectrometry | 2011 |
Differential pharmacological actions of methadone and buprenorphine in human embryonic kidney 293 cells coexpressing human μ-opioid and opioid receptor-like 1 receptors.
Topics: Adenylyl Cyclase Inhibitors; Adenylyl Cyclases; Buprenorphine; Drug Interactions; Enzyme Activation; HEK293 Cells; Humans; Methadone; Naloxone; Nociceptin; Nociceptin Receptor; Opioid Peptides; Receptors, Opioid; Receptors, Opioid, mu | 2011 |
Prescribing opioid substitution therapy.
Topics: Buprenorphine; Female; Humans; Male; Methadone; Practice Patterns, Physicians' | 2011 |
A multi-level analysis of counselor attitudes toward the use of buprenorphine in substance abuse treatment.
Topics: Analgesics, Opioid; Attitude; Attitude of Health Personnel; Buprenorphine; Counseling; Culture; Female; Humans; Male; Methadone; Middle Aged; Narcotic Antagonists; Opioid-Related Disorders; Substance-Related Disorders; Surveys and Questionnaires | 2011 |
Risks and realities: dyadic interaction between 6-month-old infants and their mothers in opioid maintenance treatment.
Topics: Adult; Analgesics, Opioid; Buprenorphine; Female; Humans; Infant; Infant Behavior; Longitudinal Studies; Male; Methadone; Mother-Child Relations; Mothers; Opiate Substitution Treatment; Opioid-Related Disorders; Risk Factors | 2011 |
Gabapentin as part of multi-modal analgesia in two cats suffering multiple injuries.
Topics: Amines; Analgesia; Analgesics; Animals; Buprenorphine; Cat Diseases; Cats; Cyclohexanecarboxylic Acids; Drug Therapy, Combination; Gabapentin; gamma-Aminobutyric Acid; Injections, Intravenous; Male; Methadone; Multiple Trauma; Pain; Pain Measurement | 2011 |
Combined liquid chromatography-coulometric detection and microextraction by packed sorbent for the plasma analysis of long acting opioids in heroin addicted patients.
Topics: Acetonitriles; Analgesics, Opioid; Buffers; Buprenorphine; Calibration; Chromatography, High Pressure Liquid; Electrochemical Techniques; Heroin Dependence; Humans; Limit of Detection; Methadone; Naloxone; Phosphates; Solid Phase Microextraction; Solvents | 2011 |
A comparison of cognitive function in patients under maintenance treatment with heroin, methadone, or buprenorphine and healthy controls: an open pilot study.
Topics: Adult; Buprenorphine; Case-Control Studies; Cognition; Female; Heroin; Humans; Male; Methadone; Middle Aged; Neuropsychological Tests; Opiate Substitution Treatment; Opioid-Related Disorders; Pilot Projects; Psychomotor Performance; Young Adult | 2011 |
Transfer from high dose methadone to buprenorphine/naloxone.
Topics: Buprenorphine; Humans; Methadone; Naloxone; Narcotic Antagonists; Opiate Substitution Treatment; Practice Guidelines as Topic | 2011 |
Promise of extended-release naltrexone is a red herring.
Topics: Buprenorphine; Delayed-Action Preparations; Humans; Injections; Methadone; Naltrexone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Russia | 2011 |
The relationship between maternal opioid agonists and psychiatric medications on length of hospitalization for neonatal abstinence syndrome.
Topics: Boston; Buprenorphine; Cross-Sectional Studies; Drug Interactions; Drug Therapy, Combination; Female; Gestational Age; Humans; Infant, Newborn; Length of Stay; Male; Methadone; Neonatal Abstinence Syndrome; Opiate Substitution Treatment; Pregnancy; Prenatal Exposure Delayed Effects; Psychotropic Drugs; Risk Factors | 2011 |
Six-year mortality rates of patients in methadone and buprenorphine maintenance therapy: results from a nationally representative cohort study.
Topics: Adult; Buprenorphine; Cohort Studies; Female; Follow-Up Studies; Humans; Logistic Models; Longitudinal Studies; Male; Methadone; Narcotics; Opiate Substitution Treatment; Opioid-Related Disorders; Prospective Studies | 2011 |
Engagement with opioid maintenance treatment and reductions in crime: a longitudinal national cohort study.
Topics: Adult; Buprenorphine; Crime; Female; Humans; Longitudinal Studies; Male; Methadone; Narcotic Antagonists; Norway; Opiate Substitution Treatment; Opioid-Related Disorders | 2012 |
The worldwide opioid epidemic: implications for treatment and research in pregnancy and the newborn.
Topics: Analgesics, Opioid; Biomedical Research; Buprenorphine; Female; Humans; Infant, Newborn; Internationality; Maternal Exposure; Methadone; Mothers; Neonatal Abstinence Syndrome; Opioid-Related Disorders; Pregnancy; Stereoisomerism | 2011 |
Individual versus team-based case-management for clients of opioid treatment services: an initial evaluation of what clients prefer.
Topics: Adult; Buprenorphine; Case Management; Female; Health Care Surveys; Heroin Dependence; Humans; Male; Methadone; Middle Aged; Naloxone; Narcotic Antagonists; Opiate Substitution Treatment; Patient Preference; Patient Satisfaction | 2012 |
Outcome of heroin-dependent adolescents presenting for opiate substitution treatment.
Topics: Adolescent; Buprenorphine; Cohort Studies; Female; Heroin Dependence; Humans; Male; Methadone; Narcotics; Opiate Substitution Treatment; Prisoners; Retrospective Studies; Sex Factors; Substance Withdrawal Syndrome; Time Factors; Treatment Outcome | 2012 |
African American patients seeking treatment in the public sector: characteristics of buprenorphine vs. methadone patients.
Topics: Adult; Baltimore; Black or African American; Buprenorphine; Female; Heroin Dependence; Humans; Male; Methadone; Middle Aged; Narcotics; Opiate Substitution Treatment; Patient Admission; Public Sector; Sex Factors; Substance Abuse Treatment Centers; Treatment Outcome | 2012 |
Studying up harm reduction policy: the office as an assemblage.
Topics: Administrative Personnel; Analgesics, Opioid; Buprenorphine; Buprenorphine, Naloxone Drug Combination; Drug and Narcotic Control; Drug Users; Government Regulation; Harm Reduction; Health Policy; HIV Infections; Humans; Incidence; Methadone; Naloxone; Needle-Exchange Programs; Opiate Substitution Treatment; Policy Making; Private Sector; Qualitative Research; Social Behavior; Speech; Substance Abuse, Intravenous; Taiwan | 2011 |
Oligodendrocyte responses to buprenorphine uncover novel and opposing roles of μ-opioid- and nociceptin/orphanin FQ receptors in cell development: implications for drug addiction treatment during pregnancy.
Topics: Analgesics, Opioid; Animals; Animals, Newborn; Apoptosis; Brain; Buprenorphine; Dose-Response Relationship, Drug; Gene Expression Regulation; Methadone; Myelin Basic Protein; Nociceptin; Nociceptin Receptor; O Antigens; Oligodendroglia; Opioid Peptides; Rats; Rats, Sprague-Dawley; Receptors, Opioid; Receptors, Opioid, mu; Somatostatin; Time Factors | 2012 |
Efficacy versus effectiveness of buprenorphine and methadone maintenance in pregnancy.
Topics: Buprenorphine; Female; Humans; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Pregnancy; Pregnancy Complications; Randomized Controlled Trials as Topic | 2011 |
Abstinence orientation and treatment practice: an analysis of German settings providing opioid maintenance therapy.
Topics: Analgesics, Opioid; Buprenorphine; Female; Germany; Humans; Male; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Regression Analysis; Substance Abuse Treatment Centers; Treatment Outcome | 2012 |
Methadone inhibits CYP2D6 and UGT2B7/2B4 in vivo: a study using codeine in methadone- and buprenorphine-maintained subjects.
Topics: Adolescent; Adult; Analgesics, Opioid; Buprenorphine; Codeine; Cytochrome P-450 CYP2D6 Inhibitors; Drug Interactions; Female; Genotype; Glucuronosyltransferase; Humans; Male; Methadone; Middle Aged; Statistics as Topic; Young Adult | 2012 |
The impact of buprenorphine on treatment of opioid dependence in a Medicaid population: recent service utilization trends in the use of buprenorphine and methadone.
Topics: Adolescent; Adult; Age Factors; Buprenorphine; Drug Utilization; Ethnicity; Female; Humans; Male; Medicaid; Methadone; Mid-Atlantic Region; Middle Aged; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Rural Population; Sex Factors; Socioeconomic Factors; United States; Urban Population; Young Adult | 2012 |
Road traffic crashes and prescribed methadone and buprenorphine: a French registry-based case-control study.
Topics: Accidents, Traffic; Adult; Automobile Driving; Buprenorphine; Case-Control Studies; Databases, Factual; Female; France; Humans; Male; Methadone; Middle Aged; Narcotic Antagonists; Narcotics; Opiate Substitution Treatment; Police; Registries; Reproducibility of Results; Risk-Taking; Socioeconomic Factors; Wounds and Injuries | 2012 |
Receipt of opioid agonist treatment in the Veterans Health Administration: facility and patient factors.
Topics: Adult; Age Factors; Buprenorphine; Female; Hospitals, Veterans; Humans; Male; Methadone; Middle Aged; Opioid-Related Disorders; Sex Factors; Treatment Outcome; United States; United States Department of Veterans Affairs; Veterans Health | 2012 |
New approaches to dealing with opioid drug dependence.
Topics: Buprenorphine; General Practice; Humans; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Psychotherapy | 2011 |
Is maternal opioid use hazardous to breast-fed infants?
Topics: Age Factors; Analgesics, Opioid; Breast Feeding; Buprenorphine; Codeine; Female; Humans; Hydrocodone; Infant; Infant, Newborn; Meperidine; Methadone; Milk, Human; Morphine; Oxycodone | 2012 |
Actigraphic measurements in opioid detoxification with methadone or buprenorphine.
Topics: Actigraphy; Adult; Austria; Buprenorphine; Circadian Rhythm; Dose-Response Relationship, Drug; Female; Humans; Length of Stay; Male; Methadone; Opiate Substitution Treatment; Sleep | 2012 |
Use and misuse of opioid replacement therapies: a Queensland study.
Topics: Analgesics, Opioid; Buprenorphine; Drug Combinations; Harm Reduction; Humans; Methadone; Naloxone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Queensland; Retrospective Studies; Substance Abuse, Intravenous; Substance-Related Disorders | 2012 |
Personality differences between drug injectors and non-injectors among substance-dependent patients in substitution treatment.
Topics: Adult; Buprenorphine; Drug Users; Female; Humans; Male; Methadone; Middle Aged; Narcotics; Opiate Substitution Treatment; Opioid-Related Disorders; Personality; Personality Disorders; Personality Inventory; Substance Abuse Treatment Centers; Substance Abuse, Intravenous | 2012 |
A comparison of attitudes toward opioid agonist treatment among short-term buprenorphine patients.
Topics: Adult; Attitude to Health; Buprenorphine; Clinical Trials as Topic; Female; Humans; Male; Methadone; Narcotics; Opiate Substitution Treatment; Opioid-Related Disorders; Patient Preference | 2012 |
Medication-assisted treatment in criminal justice agencies affiliated with the criminal justice-drug abuse treatment studies (CJ-DATS): availability, barriers, and intentions.
Topics: Adult; Buprenorphine; Crime; Criminal Law; Data Collection; Female; Humans; Male; Methadone; Naltrexone; Narcotic Antagonists; Opiate Substitution Treatment; Pregnancy; Pregnancy Complications; Prisons; Substance-Related Disorders; Young Adult | 2012 |
Assessing need for medication-assisted treatment for opiate-dependent prison inmates.
Topics: Adult; Analgesics, Opioid; Buprenorphine; Cross-Sectional Studies; Female; Health Services Needs and Demand; Heroin Dependence; Humans; Male; Methadone; Needs Assessment; Opiate Substitution Treatment; Prisoners; Puerto Rico; Young Adult | 2012 |
Rate of community methadone treatment reporting at jail reentry following a methadone increased dose quality improvement effort.
Topics: Adult; Analgesics, Opioid; Buprenorphine; Female; Heroin Dependence; Humans; Male; Methadone; New York City; Opiate Substitution Treatment; Opioid-Related Disorders; Patient Compliance; Prisoners; Quality Improvement | 2012 |
Medication-assisted therapy for opioid-dependent incarcerated populations in New Mexico: statewide efforts to increase access.
Topics: Analgesics, Opioid; Buprenorphine; Harm Reduction; Health Services Accessibility; Humans; Methadone; New Mexico; Opiate Substitution Treatment; Opioid-Related Disorders; Prisoners | 2012 |
Simultaneous analysis of some club drugs in whole blood using solid phase extraction and gas chromatography-mass spectrometry.
Topics: Buprenorphine; Dextropropoxyphene; Flunitrazepam; Forensic Toxicology; Gas Chromatography-Mass Spectrometry; Humans; Illicit Drugs; Ketamine; Limit of Detection; Methadone; Narcotics; Phencyclidine; Solid Phase Extraction | 2012 |
Premorbid and current neuropsychological function in opiate abusers receiving treatment.
Topics: Aged; Buprenorphine; Cognition; Female; Frontal Lobe; Heroin; Humans; Male; Methadone; Middle Aged; Narcotics; Neuropsychological Tests; Opiate Substitution Treatment; Opioid-Related Disorders | 2012 |
Unplanned pregnancy and contraceptive use in women attending drug treatment services.
Topics: Adult; Buprenorphine; Contraception Behavior; Delivery of Health Care, Integrated; Drug Users; Female; Health Surveys; Humans; Methadone; Middle Aged; Opiate Substitution Treatment; Pregnancy; Pregnancy Outcome; Pregnancy, Unplanned; Surveys and Questionnaires; Women's Health Services; Young Adult | 2012 |
Opioid dependency in pregnancy and length of stay for neonatal abstinence syndrome.
Topics: Adult; Buprenorphine; Cohort Studies; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Gestational Age; Humans; Infant, Newborn; Length of Stay; Linear Models; Male; Methadone; Multivariate Analysis; Neonatal Abstinence Syndrome; Opiate Substitution Treatment; Opioid-Related Disorders; Pregnancy; Pregnancy Complications; Retrospective Studies; Risk Assessment; Time Factors; Treatment Outcome | 2012 |
In control?: Ukrainian opiate substitution treatment patients strive for a voice in their treatment.
Topics: Adult; Analgesics, Opioid; Buprenorphine; Drug Users; Female; Health Services Accessibility; HIV Infections; Humans; Interviews as Topic; Male; Methadone; Middle Aged; Opiate Substitution Treatment; Opioid-Related Disorders; Patient Advocacy; Patient Participation; Police; Self Efficacy; Ukraine; Urban Population | 2012 |
Development of a substance abuse program for opioid-dependent nonurban pregnant women improves outcome.
Topics: Buprenorphine; Cohort Studies; Combined Modality Therapy; Female; Health Services Accessibility; Humans; Infant, Newborn; Methadone; Narcotics; Opiate Substitution Treatment; Opioid-Related Disorders; Pregnancy; Pregnancy Complications; Prospective Studies; Retrospective Studies; Rural Health Services; Rural Population; Treatment Outcome; Vermont | 2012 |
Buprenorphine versus methadone use in opiate detoxification, are there other factors that should be considered?
Topics: Buprenorphine; Humans; Methadone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders | 2012 |
ACOG Committee Opinion No. 524: Opioid abuse, dependence, and addiction in pregnancy.
Topics: Analgesics, Opioid; Buprenorphine; Female; Humans; Infant, Newborn; Methadone; Neonatal Abstinence Syndrome; Opiate Substitution Treatment; Opioid-Related Disorders; Pregnancy; Pregnancy Complications; Pregnancy Outcome | 2012 |
Messages about methadone and buprenorphine in reality television: a content analysis of celebrity rehab with Dr. Drew.
Topics: Buprenorphine; Humans; Methadone; Narcotics; Opiate Substitution Treatment; Persuasive Communication; Public Opinion; Rehabilitation Centers; Stereotyping; Substance-Related Disorders; Television | 2012 |
Maintenance drugs to treat opioid dependence.
Topics: Adult; Buprenorphine; Female; Heroin Dependence; Humans; Methadone; Narcotic Antagonists; Opiate Substitution Treatment | 2012 |
Treatment of opioid dependence in the setting of pregnancy.
Topics: Adolescent; Alcohol-Related Disorders; Analgesics, Opioid; Buprenorphine; Child; Comorbidity; Delivery, Obstetric; Female; Humans; Infant, Newborn; Methadone; Neonatal Abstinence Syndrome; Opiate Substitution Treatment; Opioid-Related Disorders; Pain Management; Pregnancy; Pregnancy Complications; Prenatal Care; Prenatal Exposure Delayed Effects; Prescription Drugs; Self Medication; Substance Withdrawal Syndrome; United States | 2012 |
Tobacco addiction and smoking status in heroin addicts under methadone vs. buprenorphine therapy.
Topics: Adult; Buprenorphine; Female; Heroin Dependence; Humans; Italy; Male; Methadone; Narcotic Antagonists; Narcotics; Opiate Substitution Treatment; Smoking; Tobacco Use Disorder | 2012 |
The disparate treatment of medications and opiate pain medications under the law: permitting the proliferation of opiates and limiting access to treatment.
Topics: Analgesics, Opioid; Buprenorphine; Drug and Narcotic Control; Drug Approval; Health Services Accessibility; Healthcare Disparities; Humans; Legislation, Drug; Methadone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Oxycodone; Pain; Prescription Drugs; Substance-Related Disorders; United States; United States Food and Drug Administration | 2012 |
Neonatal abstinence syndrome can be a problem.
Topics: Buprenorphine; Female; Heroin Dependence; Humans; Methadone; Narcotic Antagonists; Opiate Substitution Treatment | 2012 |
Comparative patterns of cognitive performance amongst opioid maintenance patients, abstinent opioid users and non-opioid users.
Topics: Adult; Buprenorphine; Case-Control Studies; Cognition; Female; Humans; Male; Mental Recall; Methadone; Narcotics; Opiate Substitution Treatment; Opioid-Related Disorders; Psychological Tests | 2012 |
Methadone in combination with acepromazine as premedication prior to neutering in the cat.
Topics: Acepromazine; Analgesics, Opioid; Anesthesia, General; Animals; Behavior, Animal; Buprenorphine; Butorphanol; Cats; Dopamine Antagonists; Drug Therapy, Combination; Female; Hysterectomy; Male; Methadone; Orchiectomy; Ovariectomy; Pain | 2013 |
Neurodevelopmental investigation of the mirror neurone system in children of women receiving opioid maintenance therapy during pregnancy.
Topics: Adult; Analysis of Variance; Buprenorphine; Case-Control Studies; Child, Preschool; Developmental Disabilities; Eye Movement Measurements; Female; Humans; Male; Maternal Age; Methadone; Mirror Neurons; Narcotics; Neuropsychological Tests; Nystagmus, Pathologic; Opiate Substitution Treatment; Opioid-Related Disorders; Pregnancy; Pregnancy Complications; Prenatal Exposure Delayed Effects | 2013 |
Financial factors and the implementation of medications for treating opioid use disorders.
Topics: Buprenorphine; Community Mental Health Centers; Criminal Law; Financing, Government; Health Plan Implementation; Health Workforce; Humans; Insurance Coverage; Medicaid; Methadone; Naloxone; Opiate Substitution Treatment; Opioid-Related Disorders; Patient Care Team; Substance Abuse Treatment Centers; United States | 2012 |
Neonatal outcomes following in utero exposure to methadone or buprenorphine: a National Cohort Study of opioid-agonist treatment of Pregnant Women in Norway from 1996 to 2009.
Topics: Adult; Analgesics, Opioid; Buprenorphine; Cohort Studies; Female; Follow-Up Studies; Humans; Infant, Newborn; Methadone; Neonatal Abstinence Syndrome; Norway; Opiate Substitution Treatment; Opioid-Related Disorders; Pregnancy; Pregnancy Outcome; Prenatal Exposure Delayed Effects; Retrospective Studies; Treatment Outcome | 2013 |
[Lactic acidosis due to thiamine deficiency].
Topics: Acidosis, Lactic; Anorexia; Asthenia; Buprenorphine; Cachexia; Humans; Male; Methadone; Middle Aged; Neuralgia, Postherpetic; Opioid-Related Disorders; Substance Withdrawal Syndrome; Thiamine; Thiamine Deficiency | 2012 |
Criminal behavior in opioid-dependent patients before and during maintenance therapy: 6-year follow-up of a nationally representative cohort sample.
Topics: Adolescent; Adult; Analgesics, Opioid; Buprenorphine; Cohort Studies; Crime; Drug Users; Female; Germany; Humans; Longitudinal Studies; Male; Methadone; Middle Aged; Opiate Substitution Treatment; Opioid-Related Disorders; Sex Work; Violence; Young Adult | 2012 |
Reducing stigma through education to enhance Medication-Assisted Recovery.
Topics: Analgesics, Opioid; Attitude of Health Personnel; Buprenorphine; Humans; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Patient Advocacy; Patient Education as Topic; Patient Participation; Stereotyping | 2012 |
Comparison of fatal poisonings by prescription opioids.
Topics: Accidents; Adolescent; Adult; Analgesics, Opioid; Buprenorphine; Central Nervous System Depressants; Codeine; Dextropropoxyphene; Drug Overdose; Ethanol; Fentanyl; Finland; Forensic Toxicology; Humans; Hypnotics and Sedatives; Methadone; Morphine; Opioid-Related Disorders; Oxycodone; Poisoning; Prescription Drug Misuse; Suicide; Tramadol; Young Adult | 2012 |
[Reimbursement of opiate substitution drugs to militaries in 2007].
Topics: Buprenorphine; Cross-Sectional Studies; Drug Utilization; Female; France; Heroin Dependence; Humans; Insurance, Health, Reimbursement; Male; Methadone; Military Personnel; Narcotics; National Health Programs; Opiate Substitution Treatment; Retrospective Studies; Substance Abuse Detection; Young Adult | 2012 |
Opioid dependence.
Topics: Buprenorphine; Clonidine; Evidence-Based Medicine; Humans; Inactivation, Metabolic; Methadone; Naloxone; Naltrexone; Narcotic Antagonists; Narcotics; Opiate Substitution Treatment; Opioid-Related Disorders; Prognosis; Risk Factors; Substance Withdrawal Syndrome; Time Factors | 2012 |
Corrected QT interval during treatment with methadone and buprenorphine--relation to doses and serum concentrations.
Topics: Adult; Arrhythmias, Cardiac; Buprenorphine; Electrocardiography; Female; Humans; International Classification of Diseases; Linear Models; Long QT Syndrome; Longitudinal Studies; Male; Methadone; Middle Aged; Narcotics; Opioid-Related Disorders; Potassium; Risk; Sex Characteristics; Torsades de Pointes; Young Adult | 2013 |
Different patterns of administration modulate propensity of methadone and buprenorphine to promote locomotor sensitization in mice.
Topics: Animals; Behavior, Animal; Buprenorphine; Drug Administration Schedule; Methadone; Mice; Morphine; Motor Activity; Narcotics | 2013 |
Treatment of addicts in Bosnia and Herzegovina--constraints and opportunities.
Topics: Adult; Analgesics, Opioid; Bosnia and Herzegovina; Buprenorphine; Buprenorphine, Naloxone Drug Combination; Community Mental Health Centers; Humans; Mental Health Services; Methadone; Naloxone; Opiate Substitution Treatment; Opioid-Related Disorders; Treatment Outcome | 2012 |
Do drug treatment variables predict cognitive performance in multidrug-treated opioid-dependent patients? A regression analysis study.
Topics: Adult; Analgesics, Opioid; Attention; Buprenorphine; Cognition Disorders; Drug Therapy, Combination; Female; Humans; Male; Memory, Short-Term; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Reaction Time; Regression Analysis; United States; Young Adult | 2012 |
Patterns of symptom reporting during pregnancy comparing opioid maintained and control women.
Topics: Adult; Buprenorphine; Case-Control Studies; Female; Humans; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Pregnancy; Pregnancy Complications; Self Report; Substance Withdrawal Syndrome | 2012 |
Deficits in social perception in opioid maintenance patients, abstinent opioid users and non-opioid users.
Topics: Adult; Analysis of Variance; Buprenorphine; Case-Control Studies; Cognition Disorders; Emotions; Female; Humans; Male; Methadone; Narcotics; Opiate Substitution Treatment; Opioid-Related Disorders; Social Perception | 2013 |
Just call it "treatment".
Topics: Behavior, Addictive; Buprenorphine; Buprenorphine, Naloxone Drug Combination; Counseling; Humans; Methadone; Naloxone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Substance-Related Disorders | 2012 |
Comments on: Efficacy versus effectiveness of buprenorphine and methadone maintenance in pregnancy.
Topics: Buprenorphine; Female; Humans; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Pregnancy; Pregnancy Complications | 2012 |
Increased somatic morbidity in the first year after leaving opioid maintenance treatment: results from a Norwegian cohort study.
Topics: Adult; Buprenorphine; Cohort Studies; Female; Health Status; Humans; Male; Methadone; Norway; Opiate Substitution Treatment; Opioid-Related Disorders; Patient Compliance; Substance-Related Disorders; Time Factors | 2013 |
Evaluation of the quality of life (Whoqol-Bref) among methadone and suboxone substitution state program patients and healthy volunteers in Georgia.
Topics: Adult; Aged; Buprenorphine; Buprenorphine, Naloxone Drug Combination; Case-Control Studies; Female; Georgia (Republic); Government Programs; Humans; Male; Methadone; Middle Aged; Naloxone; Opiate Substitution Treatment; Quality of Life; Social Change; Surveys and Questionnaires; Young Adult | 2012 |
Dual dilemma-should naltrexone be used in the treatment of opioid-dependent pregnant women?
Topics: Buprenorphine; Female; Humans; Infant, Newborn; Methadone; Naltrexone; Narcotic Antagonists; Narcotics; Neonatal Abstinence Syndrome; Opiate Substitution Treatment; Opioid-Related Disorders; Pregnancy; Pregnancy Complications; Risk Assessment; Treatment Outcome | 2013 |
Blocking endogenous opioids during development--do we understand the consequences?
Topics: Animals; Brain; Buprenorphine; Female; Fetal Development; Humans; Methadone; Naltrexone; Narcotic Antagonists; Narcotics; Opiate Substitution Treatment; Opioid-Related Disorders; Pregnancy; Pregnancy Complications; Treatment Outcome | 2013 |
Needs assessment and treatment compliance at state opioid substitution treatment programes in Georgia.
Topics: Adult; Aged; Buprenorphine; Buprenorphine, Naloxone Drug Combination; Female; Georgia (Republic); Government Programs; Heroin Dependence; Humans; Hypnotics and Sedatives; Male; Marijuana Abuse; Methadone; Middle Aged; Naloxone; Needs Assessment; Opiate Substitution Treatment; Patient Compliance; Patient Satisfaction; Psychotherapy; Substance-Related Disorders; Surveys and Questionnaires; Young Adult | 2013 |
Social network support for individuals receiving opiate substitution treatment and its association with treatment progress.
Topics: Adult; Buprenorphine; Cross-Sectional Studies; England; Female; Heroin Dependence; Humans; Male; Methadone; Middle Aged; Opiate Substitution Treatment; Social Support; Substance-Related Disorders; Treatment Outcome | 2013 |
Impact of opioid pharmacotherapy on arterial stiffness and vascular ageing: cross-sectional and longitudinal studies.
Topics: Adult; Aging; Blood Vessels; Buprenorphine; Cross-Sectional Studies; Endothelium, Vascular; Female; Heroin Dependence; Humans; Longitudinal Studies; Male; Methadone; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders; Phenotype; Pulse Wave Analysis; Regression Analysis; Vascular Stiffness | 2013 |
Opioid agonist treatments and heroin overdose deaths in Baltimore, Maryland, 1995-2009.
Topics: Baltimore; Buprenorphine; Drug Overdose; Heroin Dependence; Humans; Linear Models; Longitudinal Studies; Methadone; Mortality; Narcotic Antagonists; Opiate Substitution Treatment | 2013 |
Simultaneous determination of opiates, methadone, buprenorphine and metabolites in human urine by superficially porous liquid chromatography tandem mass spectrometry.
Topics: Analgesics, Opioid; Buprenorphine; Chromatography, Liquid; Drug Monitoring; Drug Stability; Humans; Limit of Detection; Linear Models; Methadone; Opiate Substitution Treatment; Reproducibility of Results; Tandem Mass Spectrometry | 2013 |
Italy's electronic health record system for opioid agonist treatment.
Topics: Adult; Age Factors; Buprenorphine; Electronic Health Records; Female; Humans; Italy; Length of Stay; Male; Methadone; Middle Aged; Opiate Substitution Treatment; Opioid-Related Disorders; Sex Factors; Substance Abuse Detection; Substance Abuse Treatment Centers | 2013 |
Pain relief and opioid requirements in the first 24 hours after surgery in patients taking buprenorphine and methadone opioid substitution therapy.
Topics: Adult; Analgesia, Patient-Controlled; Analgesics, Opioid; Buprenorphine; Cohort Studies; Female; Humans; Male; Methadone; Middle Aged; Pain, Postoperative; Retrospective Studies | 2013 |
Development of sensitization to methamphetamine in offspring prenatally exposed to morphine, methadone and buprenorphine.
Topics: Analgesics, Opioid; Animals; Behavior, Animal; Buprenorphine; Central Nervous System Stimulants; Female; Male; Methadone; Methamphetamine; Models, Animal; Morphine; Motor Activity; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Sprague-Dawley; Reward; RNA, Messenger | 2014 |
Opioid treatment in Ukraine risks losing momentum.
Topics: Buprenorphine; HIV Infections; Humans; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Substance Abuse, Intravenous; Ukraine | 2013 |
Treating opioid use disorders during pregnancy: historical, current, and future directions.
Topics: Buprenorphine; Disease Management; Female; History, 19th Century; History, 20th Century; History, 21st Century; Humans; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Pregnancy; Pregnancy Complications | 2013 |
Comparison of the transcriptional responses induced by acute morphine, methadone and buprenorphine.
Topics: Analgesics, Opioid; Animals; Behavior, Animal; Buprenorphine; Enkephalins; Male; Methadone; Morphine; Neostriatum; Nociceptin Receptor; Nucleus Accumbens; Pro-Opiomelanocortin; Protein Precursors; Proto-Oncogene Proteins c-fos; Rats; Rats, Sprague-Dawley; Receptors, Opioid; RNA, Messenger; Thalamus; Transcription, Genetic | 2013 |
Abstinence versus agonist maintenance treatment: an outdated debate?
Topics: Buprenorphine; Humans; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Substance Abuse Treatment Centers | 2013 |
Medical outcomes associated with nonmedical use of methadone and buprenorphine.
Topics: Adolescent; Adult; Aged; Buprenorphine; Emergency Service, Hospital; Female; Hospitalization; Humans; Intensive Care Units; Male; Methadone; Middle Aged; Narcotic Antagonists; Narcotics; Poison Control Centers; Retrospective Studies; Young Adult | 2013 |
Variation in use of buprenorphine and methadone treatment by racial, ethnic, and income characteristics of residential social areas in New York City.
Topics: Buprenorphine; Drug Prescriptions; Female; Humans; Income; Male; Methadone; New York City; Opiate Substitution Treatment; Opioid-Related Disorders; Practice Patterns, Physicians'; Socioeconomic Factors | 2013 |
Deviant smooth pursuit in preschool children exposed prenatally to methadone or buprenorphine and tobacco affects integrative visuomotor capabilities.
Topics: Analysis of Variance; Buprenorphine; Child, Preschool; Cohort Studies; Female; Humans; Male; Methadone; Narcotic Antagonists; Ocular Motility Disorders; Opiate Substitution Treatment; Pregnancy; Prenatal Exposure Delayed Effects; Pursuit, Smooth; Saccades; Smoking | 2013 |
Engagement, retention, and abstinence for three types of opioid users in Florida.
Topics: Adult; Buprenorphine; Female; Heroin Dependence; Humans; Male; Medication Adherence; Methadone; Narcotics; Opiate Substitution Treatment; Opioid-Related Disorders; Patient Acceptance of Health Care; Prescription Drugs; Qualitative Research; Treatment Outcome | 2013 |
Schwartz et al. respond.
Topics: Buprenorphine; Drug Overdose; Heroin Dependence; Humans; Methadone; Opiate Substitution Treatment | 2013 |
Efforts to reduce overdose deaths.
Topics: Buprenorphine; Drug Overdose; Heroin Dependence; Humans; Methadone; Opiate Substitution Treatment | 2013 |
Driving under the influence (DUI) among patients in opioid maintenance treatment (OMT): a registry-based national cohort study.
Topics: Adult; Automobile Driving; Buprenorphine; Crime; Female; Humans; Male; Methadone; Narcotics; Norway; Opiate Substitution Treatment; Opioid-Related Disorders; Registries; Risk Factors | 2013 |
Investigating expectation and reward in human opioid addiction with [(11) C]raclopride PET.
Topics: Adult; Aged; Analgesics, Opioid; Anticipation, Psychological; Buprenorphine; Corpus Striatum; Dopamine; Dopamine Antagonists; Humans; Male; Methadone; Middle Aged; Opioid-Related Disorders; Positron-Emission Tomography; Raclopride; Reward; Young Adult | 2014 |
Time to initiation of treatment for neonatal abstinence syndrome in neonates exposed in utero to buprenorphine or methadone.
Topics: Birth Weight; Buprenorphine; Case-Control Studies; Female; Gestational Age; Humans; Infant, Newborn; Male; Methadone; Neonatal Abstinence Syndrome; Opiate Substitution Treatment; Retrospective Studies; Time Factors | 2013 |
Comparison of premedication with buprenorphine or methadone with meloxicam for postoperative analgesia in dogs undergoing orthopaedic surgery.
Topics: Acepromazine; Analgesia; Animals; Buprenorphine; Deep Sedation; Dogs; Female; Injections, Intramuscular; Male; Meloxicam; Methadone; Orthopedic Procedures; Postoperative Period; Preanesthetic Medication; Thiazines; Thiazoles; Tibia | 2013 |
Acute pain management for patients under opioid maintenance treatment: what physicians do in emergency departments?
Topics: Acetaminophen; Analgesics, Non-Narcotic; Analgesics, Opioid; Anti-Inflammatory Agents, Non-Steroidal; Buprenorphine; Cross-Sectional Studies; Drug Utilization; Emergency Service, Hospital; Health Care Surveys; Humans; Methadone; Opiate Substitution Treatment; Pain Management; Pain Threshold; Practice Patterns, Physicians' | 2014 |
Breastfeeding reduces the need for withdrawal treatment in opioid-exposed infants.
Topics: Adult; Breast Feeding; Buprenorphine; Cohort Studies; Female; Humans; Infant, Newborn; Methadone; Narcotics; Neonatal Abstinence Syndrome; Norway; Opioid-Related Disorders | 2013 |
Methadone as an additional opioid for a cancer patient with severe neuropathic and bone pain not responsive to other opioids and adjuvant analgesics.
Topics: Administration, Cutaneous; Administration, Oral; Analgesics, Opioid; Buprenorphine; Drug Therapy, Combination; Humans; Lung Neoplasms; Methadone; Middle Aged; Morphine; Musculoskeletal Pain; Neuralgia; Palliative Care | 2013 |
Differential effects of methadone and buprenorphine on the response of D2/D3 dopamine receptors in adolescent mice.
Topics: Age Factors; Analgesics, Opioid; Animals; Buprenorphine; Dopamine Agonists; Dose-Response Relationship, Drug; Male; Methadone; Mice; Mice, Inbred C57BL; Motor Activity; Receptors, Dopamine D2; Receptors, Dopamine D3 | 2013 |
Economic evaluation: a comparison of methadone versus buprenorphine for opiate substitution treatment.
Topics: Buprenorphine; Cost-Benefit Analysis; Costs and Cost Analysis; Drug Costs; Health Care Costs; Health Personnel; Heroin Dependence; Humans; Methadone; Narcotics; Opiate Substitution Treatment; Opioid-Related Disorders; Patient Compliance; Pharmacies; Substance Abuse Detection; Treatment Outcome | 2013 |
Maternal stress and behavioral adaptation in methadone- or buprenorphine-exposed toddlers.
Topics: Adult; Anxiety; Buprenorphine; Child; Child, Preschool; Depression; Family; Female; Humans; Longitudinal Studies; Male; Methadone; Mother-Child Relations; Mothers; Opiate Substitution Treatment; Parenting; Pregnancy; Prenatal Exposure Delayed Effects; Quality of Life; Social Adjustment; Stress, Psychological | 2013 |
Comparison of QTc interval prolongation for patients in methadone versus buprenorphine maintenance treatment: a 5-year follow-up.
Topics: Adult; Aged; Buprenorphine; Comorbidity; Dose-Response Relationship, Drug; Electrocardiography; Epidemiologic Methods; Female; Heart Failure; Humans; Long QT Syndrome; Male; Methadone; Middle Aged; Opiate Substitution Treatment; Opioid-Related Disorders; Outcome Assessment, Health Care; Time Factors | 2013 |
Prescribing of drugs for attention-deficit hyperactivity disorder in opioid maintenance treatment patients in Norway.
Topics: Adolescent; Adult; Analgesics, Opioid; Attention Deficit Disorder with Hyperactivity; Buprenorphine; Buprenorphine, Naloxone Drug Combination; Central Nervous System Stimulants; Databases, Factual; Female; Humans; Male; Methadone; Naloxone; Norway; Opiate Substitution Treatment; Opioid-Related Disorders; Prescription Drugs; Treatment Outcome; Young Adult | 2014 |
Clinical care for opioid-using pregnant and postpartum women: the role of obstetric providers.
Topics: Analgesics, Opioid; Buprenorphine; Confidentiality; Dose-Response Relationship, Drug; Emergency Service, Hospital; Female; Humans; Labor Pain; Labor, Obstetric; Mental Disorders; Methadone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Pain, Postoperative; Physician-Patient Relations; Postnatal Care; Pregnancy; Pregnancy Complications; Prenatal Care; Referral and Consultation; Triage | 2014 |
'Diversion' of methadone or buprenorphine: 'harm' versus 'helping'.
Topics: Adult; Buprenorphine; Crime; Female; Heroin Dependence; Humans; Illicit Drugs; Male; Methadone; Middle Aged; Narcotics; Norway; Opiate Substitution Treatment; Opioid-Related Disorders; Patient Compliance; Prescription Drug Diversion; Prisoners; Substance-Related Disorders; Young Adult | 2013 |
Illicit use of methadone and buprenorphine among adolescents and young adults in Sweden.
Topics: Adolescent; Adult; Attitude of Health Personnel; Buprenorphine; Data Interpretation, Statistical; Databases, Factual; Female; Health Surveys; Humans; Illicit Drugs; Male; Marijuana Abuse; Methadone; Narcotics; Opioid-Related Disorders; Prescription Drug Diversion; Schools; Substance-Related Disorders; Sweden; Telephone; Young Adult | 2013 |
Necrosis of the intranasal structures and soft palate as a result of heroin snorting: a case series.
Topics: Administration, Intranasal; Adult; Buprenorphine; Female; Heroin; Heroin Dependence; Humans; Male; Methadone; Necrosis; Nose; Opiate Substitution Treatment; Palate, Soft; Pharynx | 2013 |
Opioid substitution treatment in pretrial prison detention: a case study from Geneva, Switzerland.
Topics: Adult; Analgesics, Opioid; Buprenorphine; Continuity of Patient Care; Female; Health Services Accessibility; Humans; Male; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Prisoners; Prisons; Retrospective Studies; Substance Abuse, Intravenous; Switzerland; Vulnerable Populations; Young Adult | 2013 |
From methadone to buprenorphine: changes during a 10 year period within a national opioid maintenance treatment programme.
Topics: Adult; Analgesics, Opioid; Buprenorphine; Female; Humans; Male; Methadone; Opioid-Related Disorders | 2014 |
Datapoints: regional variation in benzodiazepine prescribing for patients on opioid agonist therapy.
Topics: Analgesics, Opioid; Benzodiazepines; Buprenorphine; Drug Prescriptions; Humans; Methadone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Practice Patterns, Physicians'; United States; United States Department of Veterans Affairs | 2014 |
Outcome evaluation of the opioid agonist maintenance treatment in Iran.
Topics: Adult; Analgesics, Opioid; Buprenorphine; Female; Health Status; Humans; Iran; Male; Mental Health; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Treatment Outcome | 2014 |
Commentary on Freelemyer et al. (2014): medication-assisted treatment in Africa-need is growing but response remains tepid.
Topics: Analgesics, Opioid; Buprenorphine; Developing Countries; Humans; Medication Adherence; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders | 2014 |
Commentary on Hser et al. (2014): to retain or not to retain-open questions in opioid maintenance therapy.
Topics: Analgesics, Opioid; Buprenorphine; Buprenorphine, Naloxone Drug Combination; Female; Humans; Male; Medication Adherence; Methadone; Naloxone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders | 2014 |
The diversion and injection of a buprenorphine-naloxone soluble film formulation.
Topics: Administration, Sublingual; Adult; Australia; Buprenorphine; Chemistry, Pharmaceutical; Drug Costs; Female; Humans; Injections, Intravenous; Male; Methadone; Motivation; Naloxone; Narcotic Antagonists; Opiate Substitution Treatment; Prescription Drug Diversion; Substance Abuse, Intravenous; Tablets; Treatment Outcome | 2014 |
Mobile opioid agonist treatment and public funding expands treatment for disenfranchised opioid-dependent individuals.
Topics: Adolescent; Adult; Black or African American; Buprenorphine; Databases, Factual; Female; Financing, Government; Health Services Accessibility; Humans; Ill-Housed Persons; Logistic Models; Male; Medically Uninsured; Methadone; Middle Aged; Mobile Health Units; New Jersey; Opiate Substitution Treatment; Opioid-Related Disorders; Substance Abuse, Intravenous; Young Adult | 2014 |
Access to treatment for opioid dependence in rural America: challenges and future directions.
Topics: Adult; Analgesics, Opioid; Buprenorphine; Cross-Sectional Studies; Delayed-Action Preparations; Drug Implants; Forecasting; Health Services Accessibility; Health Services Needs and Demand; Humans; Medication Adherence; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Patient Admission; Prescription Drugs; Rural Health Services; Telemedicine; United States; Waiting Lists | 2014 |
Confronting the stigma of opioid use disorder--and its treatment.
Topics: Buprenorphine; Chronic Disease; Criminal Law; Humans; Illicit Drugs; Methadone; Narcotic Antagonists; Opioid-Related Disorders; Social Stigma | 2014 |
Execution of control among 'non-compliant', imprisoned individuals in opioid maintenance treatment.
Topics: Adult; Buprenorphine; Data Collection; Female; Humans; Internal-External Control; Male; Medication Adherence; Methadone; Middle Aged; Opiate Substitution Treatment; Opioid-Related Disorders; Prescription Drug Diversion; Prisoners; Prisons; Young Adult | 2014 |
Commentary on Holland et al. (2014): Opioid maintenance treatment--how much supervision is helpful?
Topics: Buprenorphine; Female; Humans; Male; Medication Adherence; Methadone; Narcotics; Opiate Substitution Treatment; Opioid-Related Disorders | 2014 |
Comparison of toxicity associated with nonmedical use of benzodiazepines with buprenorphine or methadone.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Analgesics, Opioid; Benzodiazepines; Buprenorphine; Drug Interactions; Female; Hospitalization; Humans; Male; Methadone; Middle Aged; Retrospective Studies; Substance-Related Disorders; Treatment Outcome; Young Adult | 2014 |
A preliminary evaluation of the effects of opioids on innate and adaptive human in vitro immune function.
Topics: Adaptive Immunity; Adult; Analgesics, Opioid; Buprenorphine; Codeine; Fentanyl; Humans; Immunity, Innate; Interleukin-2; Interleukin-6; Leukocytes, Mononuclear; Methadone; Monocytes; Morphine; Neutrophils; Oxycodone; Phagocytosis; Respiratory Burst; Tramadol | 2014 |
Opioid maintenance therapy in Switzerland: an overview of the Swiss IMPROVE study.
Topics: Adult; Aged; Attitude of Health Personnel; Buprenorphine; Cross-Sectional Studies; Female; Humans; Language; Maintenance Chemotherapy; Male; Methadone; Middle Aged; Narcotics; Opiate Substitution Treatment; Opioid-Related Disorders; Patient Preference; Practice Patterns, Physicians'; Prescription Drug Misuse; Research Design; Surveys and Questionnaires; Switzerland; Young Adult | 2014 |
Opioid-related mortality and filled prescriptions for buprenorphine and methadone.
Topics: Adolescent; Adult; Aged; Buprenorphine; Databases, Factual; Female; Heroin Dependence; Humans; Male; Methadone; Middle Aged; Opiate Substitution Treatment; Opioid-Related Disorders; Registries; Sweden; Young Adult | 2014 |
A comparison of characteristics and outcomes of opioid-dependent patients initiating office-based buprenorphine or methadone maintenance treatment.
Topics: Adult; Buprenorphine; Female; Humans; Internal Medicine; Male; Methadone; Narcotic Antagonists; Narcotics; Opiate Substitution Treatment; Opioid-Related Disorders; Retrospective Studies; Socioeconomic Factors; Student Health Services; Time Factors; Treatment Outcome; Young Adult | 2014 |
Evaluation of state opioid substitution treatment program in Georgia.
Topics: Adult; Aged; Alcoholism; Buprenorphine; Female; Georgia (Republic); Government Programs; Hepatitis B; Hepatitis C; HIV Infections; Humans; Male; Methadone; Middle Aged; Naloxone; Opiate Substitution Treatment; Patient Compliance; Patient Satisfaction; Surveys and Questionnaires; Young Adult | 2014 |
[Opioid substitution treatment and risk reduction].
Topics: Buprenorphine; Humans; Methadone; Opiate Substitution Treatment; Practice Patterns, Physicians'; Risk Management | 2014 |
Prevalence of heroin markers in urine for pain management patients.
Topics: Analgesics, Opioid; Biomarkers; Buprenorphine; Chromatography, Liquid; Chronic Pain; Codeine; Heroin; Heroin Dependence; Humans; Illicit Drugs; Methadone; Morphine Derivatives; Pain Clinics; Tandem Mass Spectrometry | 2014 |
Intravenous methadone application as a serious risk factor for an overdose death: methadone-related fatalities in Hamburg from 2007 to 2012.
Topics: Adult; Buprenorphine; Drug Overdose; Female; Forensic Toxicology; Germany; Humans; Lactose; Male; Methadone; Middle Aged; Narcotics; Opiate Substitution Treatment; Risk Factors; Substance Abuse, Intravenous; Sucrose | 2014 |
Advertising representation, treatment menu and economic circulation of substance misuse treatment centers in Iran: a rapid survey based on newspaper advertisements.
Topics: Advertising; Buprenorphine; Data Collection; Humans; Iran; Methadone; Newspapers as Topic; Opioid-Related Disorders; Substance Abuse Treatment Centers; Substance-Related Disorders | 2014 |
Patterns of non-compliant buprenorphine, levomethadone, and methadone use among opioid dependent persons in treatment.
Topics: Adult; Analgesics, Opioid; Buprenorphine; Female; Humans; Male; Medication Adherence; Methadone; Narcotics; Opiate Substitution Treatment; Opioid-Related Disorders; Surveys and Questionnaires | 2014 |
A latent class analysis of self-reported clinical indicators of psychosocial stability and adherence among opioid substitution therapy patients: do stable patients receive more unsupervised doses?
Topics: Age Factors; Buprenorphine; Cross-Sectional Studies; Female; Humans; Male; Medication Adherence; Methadone; Models, Theoretical; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Self Report | 2014 |
Characteristics and quality of life of opioid-dependent pregnant women in Austria.
Topics: Administration, Oral; Adult; Austria; Buprenorphine; Delayed-Action Preparations; Female; Humans; Methadone; Morphine; Narcotics; Opiate Substitution Treatment; Opioid-Related Disorders; Pregnancy; Pregnancy Outcome; Pregnancy Trimester, Third; Pregnant Women; Quality of Life; Treatment Outcome | 2014 |
Laboratory and clinical evaluation of on-site urine drug testing.
Topics: Amphetamines; Analgesics, Opioid; Benzodiazepines; Buprenorphine; Cannabinoids; Evaluation Studies as Topic; False Negative Reactions; Humans; Methadone; Sensitivity and Specificity; Substance Abuse Detection; Tramadol | 2014 |
A naturalistic comparison of the effectiveness of methadone and two sublingual formulations of buprenorphine on maintenance treatment outcomes: findings from a retrospective multisite study.
Topics: Administration, Sublingual; Adolescent; Adult; Age Distribution; Analgesics, Opioid; Analysis of Variance; Buprenorphine; Chemistry, Pharmaceutical; Female; Humans; Male; Methadone; Middle Aged; Opioid-Related Disorders; Retrospective Studies; Treatment Outcome; United States; Urinalysis; Young Adult | 2014 |
Opioid selective antinociception following microinjection into the periaqueductal gray of the rat.
Topics: Analgesics, Opioid; Animals; Buprenorphine; Female; Injections, Intraventricular; Male; Methadone; Microinjections; Oxycodone; Periaqueductal Gray; Rats; Rats, Sprague-Dawley; Receptors, Opioid, mu | 2014 |
Exploring the Concepts of Abstinence and Recovery Through the Experiences of Long-Term Opiate Substitution Clients.
Topics: Analgesics, Opioid; Buprenorphine; Fear; Female; Humans; Male; Methadone; Middle Aged; Motivation; Opiate Substitution Treatment; Opioid-Related Disorders; Qualitative Research; Rural Population; Substance Withdrawal Syndrome | 2015 |
Risk reduction with buprenorphine-naloxone and methadone: patient's choice.
Topics: Buprenorphine; Female; HIV Infections; Humans; Male; Methadone; Naloxone; Narcotic Antagonists; Opioid-Related Disorders; Risk Reduction Behavior | 2014 |
Supply of buprenorphine waivered physicians: the influence of state policies.
Topics: Analgesics, Opioid; Buprenorphine; Drug Prescriptions; Humans; Medicaid; Methadone; Opiate Substitution Treatment; Physicians; Public Policy; United States | 2015 |
The effectiveness of opioid substitution treatments for patients with opioid dependence: a systematic review and multiple treatment comparison protocol.
Topics: Buprenorphine; Buprenorphine, Naloxone Drug Combination; Heroin; Humans; Methadone; Naloxone; Naltrexone; Narcotics; Opiate Substitution Treatment; Opioid-Related Disorders; Research Design; Systematic Reviews as Topic | 2014 |
Authors' reply: "Risk reduction with buprenorphine-naloxone and methadone: patient's choice".
Topics: Buprenorphine; Female; HIV Infections; Humans; Male; Methadone; Naloxone; Narcotic Antagonists; Opioid-Related Disorders; Risk Reduction Behavior | 2014 |
Challenges and opportunities in using wastewater analysis to measure drug use in a small prison facility.
Topics: Buprenorphine; Humans; Illicit Drugs; Male; Methadone; Prescription Drug Misuse; Prisoners; Prisons; Substance Abuse Detection; Substance-Related Disorders; Wastewater | 2016 |
Geographic variability in HIV and injection drug use in Ukraine: implications for integration and expansion of drug treatment and HIV care.
Topics: Adult; Buprenorphine; Female; HIV Infections; Humans; Male; Methadone; Opiate Substitution Treatment; Prevalence; Sexual Partners; Substance Abuse, Intravenous; Ukraine | 2015 |
[Treatment of chronic hepatitis C in drug users: ethic, successful and useful].
Topics: AIDS-Related Opportunistic Infections; Antiviral Agents; Buprenorphine; Comorbidity; Cooperative Behavior; Cross-Sectional Studies; Ethics, Medical; Follow-Up Studies; France; Health Services Accessibility; Hepatitis C, Chronic; Humans; Interdisciplinary Communication; Methadone; Patient Care Team; Prisoners; Recurrence; Substance Abuse Detection; Substance Abuse Treatment Centers; Substance Abuse, Intravenous; Utilization Review | 2014 |
Association of opioid agonist therapy with lower incidence of hepatitis C virus infection in young adult injection drug users.
Topics: Adolescent; Adult; Buprenorphine; Cohort Studies; Disease Transmission, Infectious; Drug Users; Female; Hepatitis C; Humans; Incidence; Injections, Intravenous; Male; Methadone; Narcotics; Opiate Substitution Treatment; Opioid-Related Disorders; Poisson Distribution; Proportional Hazards Models; Substance Abuse, Intravenous; Young Adult | 2014 |
Executive function in preschool children prenatally exposed to methadone or buprenorphine.
Topics: Analgesics, Opioid; Buprenorphine; Case-Control Studies; Child; Child Development; Child, Preschool; Executive Function; Female; Humans; Inhibition, Psychological; Male; Memory, Short-Term; Methadone; Neuropsychological Tests; Opiate Substitution Treatment; Opioid-Related Disorders; Pregnancy; Prenatal Exposure Delayed Effects; Time | 2015 |
Striatal dopamine D1 and D2 receptors are differentially regulated following buprenorphine or methadone treatment.
Topics: Analgesics, Opioid; Animals; Buprenorphine; Corpus Striatum; Dose-Response Relationship, Drug; Drug Administration Schedule; Male; Methadone; Mice; Receptors, Dopamine D1; Receptors, Dopamine D2 | 2015 |
Commentary on Nolan et al. (2014): Opiate substitution treatment and hepatitis C virus prevention: building an evidence base?
Topics: Buprenorphine; Hepacivirus; Humans; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders | 2014 |
Visual selective attention is impaired in children prenatally exposed to opioid agonist medication.
Topics: Analgesics, Opioid; Attention; Buprenorphine; Case-Control Studies; Child, Preschool; Female; Humans; Male; Methadone; Photic Stimulation; Pregnancy; Prenatal Exposure Delayed Effects; Saccades | 2015 |
Co-morbid pain and opioid addiction: long term effect of opioid maintenance on acute pain.
Topics: Acute Pain; Adult; Analgesics, Opioid; Behavior, Addictive; Buprenorphine; Comorbidity; Female; Humans; Male; Methadone; Middle Aged; Opiate Substitution Treatment; Opioid-Related Disorders; Pain Measurement; Pain Threshold; Time Factors; Treatment Outcome | 2014 |
Diversion of methadone and buprenorphine by patients in opioid substitution treatment in Sweden: prevalence estimates and risk factors.
Topics: Adult; Buprenorphine; Female; Humans; Logistic Models; Male; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Prescription Drug Diversion; Prevalence; Risk Factors; Surveys and Questionnaires; Sweden; Young Adult | 2015 |
The impact of recent cocaine use on plasma levels of methadone and buprenorphine in patients with and without HIV-infection.
Topics: Adult; Anti-HIV Agents; Buprenorphine; Cocaine; Cocaine-Related Disorders; Drug Interactions; Female; HIV Infections; Humans; Male; Methadone; Middle Aged; Opiate Substitution Treatment; Opioid-Related Disorders; Stereoisomerism; Time Factors | 2015 |
Hyperalgesia and increased sevoflurane minimum alveolar concentration induced by opioids in the rat: a randomised experimental study.
Topics: Analgesics, Opioid; Anesthetics, Inhalation; Animals; Behavior, Animal; Buprenorphine; Hyperalgesia; Ketamine; Male; Methadone; Methyl Ethers; Morphine; Nociception; Pain Threshold; Piperidines; Pulmonary Alveoli; Random Allocation; Rats, Wistar; Remifentanil; Sevoflurane | 2015 |
Diversion of methadone and buprenorphine from opioid substitution treatment: patients who regularly sell or share their medication.
Topics: Analgesics, Opioid; Buprenorphine; Commerce; Female; Humans; Interviews as Topic; Male; Methadone; Motivation; Opiate Substitution Treatment; Opioid-Related Disorders; Prescription Drug Diversion; Risk Factors; Sweden | 2015 |
Reversal of opioid overdose syndrome in morphine-dependent rats using buprenorphine.
Topics: Animals; Buprenorphine; Drug Overdose; Male; Methadone; Morphine Dependence; Naloxone; Narcotic Antagonists; Rats; Rats, Wistar | 2015 |
A longitudinal comparison of retention in buprenorphine and methadone treatment for opioid dependence in New South Wales, Australia.
Topics: Adult; Analgesics, Opioid; Buprenorphine; Crime; Female; Humans; Longitudinal Studies; Male; Medication Adherence; Methadone; Middle Aged; Multivariate Analysis; New South Wales; Opiate Substitution Treatment; Opioid-Related Disorders; Patient Dropouts; Proportional Hazards Models; Retrospective Studies; Young Adult | 2015 |
Failure to identify or effectively manage prescription opioid dependence acted as a gateway to heroin use-buprenorphine/naloxone treatment and recovery in a surgical patient.
Topics: Adult; Analgesics, Opioid; Buprenorphine; Codeine; Disease Management; Female; Heroin; Heroin Dependence; Humans; Methadone; Naloxone; Opiate Substitution Treatment; Opioid-Related Disorders; Pain, Postoperative; Substance Withdrawal Syndrome; Young Adult | 2014 |
Illicit use of opioid substitution drugs: prevalence, user characteristics, and the association with non-fatal overdoses.
Topics: Adult; Buprenorphine; Cross-Sectional Studies; Drug Overdose; Drug Users; Female; Heroin; Humans; Illicit Drugs; Male; Methadone; Middle Aged; Norway; Opiate Substitution Treatment; Opioid-Related Disorders; Prevalence; Risk Factors; Young Adult | 2015 |
Application of drug testing using exhaled breath for compliance monitoring of drug addicts in treatment.
Topics: Adolescent; Adult; Aged; Amphetamines; Breath Tests; Buprenorphine; Cocaine; Drug Users; Exhalation; Female; Humans; Male; Methadone; Methamphetamine; Middle Aged; Morphine; Morphine Derivatives; Patient Compliance; Substance Abuse Detection; Young Adult | 2015 |
Buprenorphine and naloxone compared with methadone treatment in pregnancy.
Topics: Adult; Buprenorphine; Female; Humans; Infant, Newborn; Methadone; Naloxone; Narcotic Antagonists; Narcotics; Neonatal Abstinence Syndrome; Opiate Substitution Treatment; Opioid-Related Disorders; Pregnancy; Pregnancy Complications; Retrospective Studies; Young Adult | 2015 |
Factors associated with work and taking prescribed methadone or buprenorphine among Swedish opiate addicts.
Topics: Adult; Buprenorphine; Educational Status; Employment; Female; Humans; Male; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Sweden; Unemployment | 2015 |
Past-year gambling behaviour among patients receiving opioid substitution treatment.
Topics: Adult; Age Factors; Buprenorphine; Buprenorphine, Naloxone Drug Combination; Cross-Sectional Studies; Drug Combinations; Female; Finland; Gambling; Humans; Male; Methadone; Middle Aged; Narcotic Antagonists; Narcotics; Opiate Substitution Treatment; Opioid-Related Disorders; Sex Factors | 2015 |
Diversion of methadone and buprenorphine from opioid substitution treatment: the importance of patients' attitudes and norms.
Topics: Adult; Attitude; Buprenorphine; Female; Humans; Individuality; Male; Methadone; Morals; Motivation; Narcotics; Opiate Substitution Treatment; Opioid-Related Disorders; Patient Satisfaction; Prescription Drug Diversion; Reference Values; Risk-Taking; Social Behavior; Socioeconomic Factors | 2015 |
First Dutch national guidelines--pharmacological care for detained opioid addicts.
Topics: Buprenorphine; Communicable Diseases; Comorbidity; Continuity of Patient Care; Female; Health Policy; Health Services Accessibility; Humans; Male; Mental Disorders; Methadone; Netherlands; Opiate Substitution Treatment; Opioid-Related Disorders; Practice Guidelines as Topic; Pregnancy; Pregnancy Complications; Prisoners | 2009 |
Opiate addiction therapies and HIV-1 Tat: interactive effects on glial [Ca²⁺]i, oxyradical and neuroinflammatory chemokine production and correlative neurotoxicity.
Topics: Buprenorphine; Calcium; Cell Survival; Cells, Cultured; Chemokines; Humans; Methadone; Morphine; Narcotic Antagonists; Narcotics; Neuroglia; Neurons; Reactive Oxygen Species; tat Gene Products, Human Immunodeficiency Virus | 2014 |
HIV-gp120 and physical dependence to buprenorphine.
Topics: Animals; Buprenorphine; HIV Envelope Protein gp120; HIV Infections; Male; Methadone; Opioid-Related Disorders; Pain; Periaqueductal Gray; Rats; Rats, Sprague-Dawley | 2015 |
Commentary on Burns et al. (2015): retention in buprenorphine treatment.
Topics: Buprenorphine; Burns; Humans; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders | 2015 |
Cost-Effectiveness of Injectable Extended-Release Naltrexone Compared With Methadone Maintenance and Buprenorphine Maintenance Treatment for Opioid Dependence.
Topics: Adolescent; Adult; Aged; Buprenorphine; Computer Simulation; Cost-Benefit Analysis; Delayed-Action Preparations; Drug Costs; Humans; Injections; Male; Markov Chains; Methadone; Middle Aged; Naltrexone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Young Adult | 2015 |
Quantification of morphine, morphine 6-glucuronide, buprenorphine, and the enantiomers of methadone by enantioselective mass spectrometric chromatography in whole blood.
Topics: Buprenorphine; Chromatography, Liquid; Forensic Toxicology; Humans; Mass Spectrometry; Methadone; Molecular Structure; Morphine; Morphine Derivatives; Narcotics; Solid Phase Extraction; Stereoisomerism; Substance-Related Disorders | 2015 |
UHPLC-MS/MS quantification of buprenorphine, norbuprenorphine, methadone, and glucuronide conjugates in umbilical cord plasma.
Topics: Blood Chemical Analysis; Blood Specimen Collection; Buprenorphine; Chromatography, High Pressure Liquid; Female; Fetal Blood; Glucuronides; Humans; Infant, Newborn; Methadone; Phospholipids; Pregnancy; Reproducibility of Results; Sensitivity and Specificity; Solid Phase Extraction; Tandem Mass Spectrometry | 2015 |
Buprenorphine Maintenance vs. Methadone Maintenance or Placebo for Opioid Use Disorder.
Topics: Buprenorphine; Humans; Methadone; Narcotic Antagonists; Opioid-Related Disorders | 2015 |
Growth and developmental outcome of infants with in-utero exposure to methadone vs buprenorphine.
Topics: Adult; Analgesics, Opioid; Buprenorphine; Female; Humans; Infant; Infant, Newborn; Infant, Premature; Male; Massachusetts; Methadone; Mother-Child Relations; Neonatal Abstinence Syndrome; Pregnancy; Prenatal Exposure Delayed Effects; Retrospective Studies; Young Adult | 2015 |
Treatment readiness, attitudes toward, and experiences with methadone and buprenorphine maintenance therapy among people who inject drugs in Malaysia.
Topics: Adult; Age Factors; Age of Onset; Aged; Attitude; Buprenorphine; Ethnicity; Female; Humans; Malaysia; Male; Methadone; Middle Aged; Narcotics; Needle Sharing; Needle-Exchange Programs; Opiate Substitution Treatment; Patient Acceptance of Health Care; Stress, Psychological; Substance Abuse Treatment Centers; Substance Abuse, Intravenous; Young Adult | 2015 |
Azole antifungal inhibition of buprenorphine, methadone and oxycodone in vitro metabolism.
Topics: Administration, Oral; Analgesics, Opioid; Antifungal Agents; Azoles; Biotransformation; Buprenorphine; Chromatography, Liquid; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Drug Interactions; Humans; Isoenzymes; Kinetics; Liver; Methadone; Microsomes, Liver; Models, Biological; Molecular Structure; Oxycodone; Recombinant Proteins; Risk Assessment; Spectrometry, Mass, Electrospray Ionization; Structure-Activity Relationship; Substrate Specificity; Tandem Mass Spectrometry | 2015 |
Vermont responds to its opioid crisis.
Topics: Buprenorphine; Cost-Benefit Analysis; Health Care Costs; Health Policy; Health Services Accessibility; Humans; Methadone; Narcotics; Opiate Substitution Treatment; Opioid-Related Disorders; Vermont | 2015 |
Long-term self-treatment with methadone or buprenorphine as a response to barriers to opioid substitution treatment: the case of Sweden.
Topics: Adult; Buprenorphine; Drug Users; Female; Health Services Accessibility; Humans; Interviews as Topic; Male; Methadone; Middle Aged; Narcotics; Opiate Substitution Treatment; Opioid-Related Disorders; Self Medication; Sweden; Young Adult | 2015 |
Interim treatment: Bridging delays to opioid treatment access.
Topics: Adult; Buprenorphine; Female; Health Services Accessibility; Humans; Male; Methadone; Narcotic Antagonists; Narcotics; Opioid-Related Disorders; Randomized Controlled Trials as Topic; United States; Waiting Lists | 2015 |
Tapering from Methadone or Buprenorphine during Pregnancy: Maternal and Neonatal Outcomes in Norway 1996-2009.
Topics: Adult; Birth Weight; Buprenorphine; Drug Administration Schedule; Female; Humans; Infant, Newborn; Male; Methadone; Narcotic Antagonists; Narcotics; Norway; Opiate Substitution Treatment; Pregnancy; Pregnancy Outcome; Prospective Studies; Retrospective Studies | 2015 |
Risk Factors for Relapse and Higher Costs Among Medicaid Members with Opioid Dependence or Abuse: Opioid Agonists, Comorbidities, and Treatment History.
Topics: Adult; Analgesics, Opioid; Behavior Therapy; Buprenorphine; Combined Modality Therapy; Comorbidity; Female; Health Care Costs; Humans; Male; Medicaid; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Recurrence; Risk Factors; United States | 2015 |
The relative risk of fatal poisoning by methadone or buprenorphine within the wider population of England and Wales.
Topics: Analgesics, Opioid; Buprenorphine; Databases, Factual; Drug Overdose; Drug Prescriptions; England; Humans; Methadone; Narcotics; Opiate Substitution Treatment; Retrospective Studies; Risk; Wales | 2015 |
The paradox of control: An ethnographic analysis of opiate maintenance treatment in a Norwegian prison.
Topics: Anthropology, Cultural; Buprenorphine; Humans; Methadone; Norway; Opiate Substitution Treatment; Opioid-Related Disorders; Prisoners | 2015 |
A Retrospective Evaluation of Inpatient Transfer from High-Dose Methadone to Buprenorphine Substitution Therapy.
Topics: Adult; Analgesics, Opioid; Buprenorphine; Female; Humans; Inpatients; Male; Methadone; Naloxone; Opiate Substitution Treatment; Opioid-Related Disorders; Outcome Assessment, Health Care | 2015 |
Hepatitis C virus infection and pain sensitivity in patients on methadone or buprenorphine maintenance therapy for opioid use disorders.
Topics: Adult; Buprenorphine; Case-Control Studies; Coinfection; Female; Hepatitis C; HIV Infections; Humans; Male; Methadone; Middle Aged; Opiate Substitution Treatment; Opioid-Related Disorders; Pain Threshold | 2015 |
Growth In Buprenorphine Waivers For Physicians Increased Potential Access To Opioid Agonist Treatment, 2002-11.
Topics: Analgesics, Opioid; Buprenorphine; Controlled Substances; Drug and Narcotic Control; Drug Prescriptions; Humans; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Physicians; Rural Population; United States | 2015 |
National and State Treatment Need and Capacity for Opioid Agonist Medication-Assisted Treatment.
Topics: Analgesics, Opioid; Buprenorphine; Capacity Building; Health Services Needs and Demand; Health Surveys; Humans; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; United States | 2015 |
Arrhythmia associated with buprenorphine and methadone reported to the Food and Drug Administration.
Topics: Adult; Arrhythmias, Cardiac; Buprenorphine; Female; Heart Arrest; Humans; Long QT Syndrome; Male; Methadone; Narcotic Antagonists; Retrospective Studies; Torsades de Pointes; United States; United States Food and Drug Administration | 2015 |
Stigma from the Viewpoint of the Patient.
Topics: Buprenorphine; Humans; Methadone; Narcotics; Opiate Substitution Treatment; Opioid-Related Disorders; Patients; Prejudice; Social Stigma | 2015 |
Addiction Treatment Within U.S. Correctional Facilities: Bridging the Gap Between Current Practice and Evidence-Based Care.
Topics: Buprenorphine; Humans; Methadone; Narcotics; Opiate Substitution Treatment; Prisoners; Prisons; United States | 2015 |
Heroin Use, HIV-Risk, and Criminal Behavior in Baltimore: Findings from Clinical Research.
Topics: Baltimore; Buprenorphine; Counseling; Criminal Behavior; Health Services Accessibility; Health Services Needs and Demand; Heroin Dependence; HIV Infections; Humans; Methadone; Narcotics; Opiate Substitution Treatment; Risk Factors; Substance Abuse Treatment Centers; United States | 2015 |
Harm Reduction: Front Line Public Health.
Topics: Buprenorphine; Drug Overdose; Harm Reduction; Humans; Methadone; Naloxone; Narcotic Antagonists; Narcotics; Needle-Exchange Programs; Public Health; Substance-Related Disorders | 2015 |
Challenges and Opportunities for the Use of Medications to Treat Opioid Addiction in the United States and Other Nations of the World.
Topics: Behavior, Addictive; Buprenorphine; Global Health; Health Services Accessibility; Humans; Methadone; Naltrexone; Narcotic Antagonists; Narcotics; Opiate Substitution Treatment; Opioid-Related Disorders; Prescription Drug Misuse; United States | 2015 |
Assessment of drug-drug interactions between daclatasvir and methadone or buprenorphine-naloxone.
Topics: Buprenorphine; Buprenorphine, Naloxone Drug Combination; Carbamates; Drug Interactions; Imidazoles; Methadone; Pyrrolidines; Valine | 2015 |
Methadone versus buprenorphine for the treatment of opioid abuse in pregnancy: science and stigma.
Topics: Buprenorphine; Female; Humans; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Pregnancy; Pregnancy Complications; Social Stigma | 2015 |
Counselor training and attitudes toward pharmacotherapies for opioid use disorder.
Topics: Buprenorphine; Counselors; Female; Health Knowledge, Attitudes, Practice; Humans; Information Dissemination; Male; Methadone; Narcotic Antagonists; Opioid-Related Disorders | 2016 |
Ethanol Reversal of Tolerance to the Respiratory Depressant Effects of Morphine.
Topics: Analgesics, Opioid; Animals; Brain; Buprenorphine; Central Nervous System Depressants; Corticosterone; Dose-Response Relationship, Drug; Drug Tolerance; Ethanol; Exploratory Behavior; Hot Temperature; Male; Methadone; Mice; Morphine; Motor Activity; Nociceptive Pain; Pain Threshold; Plethysmography; Respiration; Respiratory System Agents; Tidal Volume | 2016 |
Opioid use disorder during pregnancy in Tennessee: expediency vs. science.
Topics: Buprenorphine; Female; Humans; Insurance Coverage; Medicaid; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Politics; Pregnancy; Pregnancy Complications; Tennessee; United States | 2015 |
A cost-effectiveness analysis of opioid substitution therapy upon prison release in reducing mortality among people with a history of opioid dependence.
Topics: Adult; Age of Onset; Buprenorphine; Cost-Benefit Analysis; Deinstitutionalization; Female; Humans; Male; Methadone; Narcotic Antagonists; New South Wales; Opiate Substitution Treatment; Opioid-Related Disorders; Prisoners; Treatment Outcome | 2015 |
Caring for pregnant opioid abusers in Vermont: A potential model for non-urban areas.
Topics: Adult; Buprenorphine; Community Health Centers; Female; Health Services Accessibility; Humans; Infant; Infant, Newborn; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Pregnancy; Pregnancy Complications; Rural Health Services; Vermont | 2015 |
Opioid dependency rehabilitation with the opioid maintenance treatment programme - a qualitative study from the clients' perspective.
Topics: Adult; Buprenorphine; Female; Humans; Male; Methadone; Middle Aged; Norway; Opiate Substitution Treatment; Opioid-Related Disorders; Patient Participation; Patient Satisfaction; Qualitative Research | 2015 |
Mortality risk of opioid substitution therapy with methadone versus buprenorphine: a retrospective cohort study.
Topics: Adult; Buprenorphine; Cause of Death; Cohort Studies; Female; Humans; Kaplan-Meier Estimate; Male; Methadone; Middle Aged; Mortality; Opiate Substitution Treatment; Opioid-Related Disorders; Retrospective Studies; Young Adult | 2015 |
Comparative safety of methadone and buprenorphine.
Topics: Buprenorphine; Heroin Dependence; Humans; Methadone; Opioid-Related Disorders; Safety | 2015 |
Neonatal abstinence syndrome: use of clonazepam?
Topics: Analgesics, Opioid; Buprenorphine; Female; Humans; Male; Methadone; Morphine; Neonatal Abstinence Syndrome | 2015 |
Reply to 'Methadone versus morphine for treatment of neonatal abstinence syndrome: a prospective randomized clinical trial'.
Topics: Analgesics, Opioid; Buprenorphine; Female; Humans; Male; Methadone; Morphine; Neonatal Abstinence Syndrome | 2015 |
Management of opioid-dependent patients: comparison of the cost associated with use of buprenorphine/naloxone or methadone, and their interactions with concomitant treatments for infectious or psychiatric comorbidities.
Topics: Analgesics, Opioid; Buprenorphine; Drug Interactions; Health Care Costs; Humans; Infections; Mental Disorders; Methadone; Naloxone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders | 2015 |
Impact of treatment for opioid dependence on fatal drug-related poisoning: a national cohort study in England.
Topics: Adolescent; Adult; Analgesics, Opioid; Buprenorphine; Cohort Studies; Combined Modality Therapy; Drug Overdose; England; Female; Humans; Male; Methadone; Middle Aged; Narcotics; Opiate Substitution Treatment; Opioid-Related Disorders; Psychotherapy; Young Adult | 2016 |
Balancing access and safety in prescribing opioid agonist therapy to prevent HIV transmission.
Topics: Buprenorphine; Health Services Accessibility; HIV Infections; Humans; Methadone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Substance Abuse, Intravenous | 2015 |
Revision of Breastfeeding Guidelines in the Setting of Maternal Opioid Use Disorder: One Institution's Experience.
Topics: Analgesics, Opioid; Boston; Breast Feeding; Buprenorphine; Female; Health Promotion; Humans; Infant, Newborn; Methadone; Neonatal Abstinence Syndrome; Opiate Substitution Treatment; Opioid-Related Disorders; Postnatal Care; Practice Guidelines as Topic; Pregnancy; Pregnancy Complications | 2016 |
Characterizing pain and associated coping strategies in methadone and buprenorphine-maintained patients.
Topics: Adaptation, Psychological; Adult; Analgesics, Opioid; Buprenorphine; Chronic Pain; Female; Humans; Maintenance Chemotherapy; Male; Methadone; Middle Aged; Opioid-Related Disorders; Pain Management; Pain Threshold; Prevalence | 2015 |
Policies related to opioid agonist therapy for opioid use disorders: The evolution of state policies from 2004 to 2013.
Topics: Buprenorphine; Health Policy; Health Services Accessibility; Humans; Medicaid; Methadone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; United States | 2016 |
Risk factors for opioid overdose and awareness of overdose risk among veterans prescribed chronic opioids for addiction or pain.
Topics: Adult; Aged; Analgesics, Opioid; Behavior, Addictive; Buprenorphine; Chronic Pain; Drug Overdose; Female; Humans; Male; Methadone; Middle Aged; Midwestern United States; Opioid-Related Disorders; Pain Management; Prescription Drugs; Risk Factors; Veterans | 2016 |
Correlates of Skin and Soft Tissue Infections in Injection Drug Users in a Syringe-Exchange Program in Malmö, Sweden.
Topics: Adult; Amphetamine-Related Disorders; Buprenorphine; Buprenorphine, Naloxone Drug Combination; Drug Users; Female; Heroin Dependence; Housing; Humans; Ill-Housed Persons; Logistic Models; Male; Methadone; Methylphenidate; Middle Aged; Neck; Needle-Exchange Programs; Odds Ratio; Opioid-Related Disorders; Prescription Drugs; Prevalence; Sex Factors; Skin Diseases, Bacterial; Soft Tissue Infections; Substance Abuse, Intravenous; Surveys and Questionnaires; Sweden; Young Adult | 2015 |
Commentary on Cousins et al. (2016): Accumulating evidence on risk of mortality on and off opioid substitution treatment.
Topics: Analgesics, Opioid; Buprenorphine; Humans; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders | 2016 |
A Cohort Comparison of Buprenorphine versus Methadone Treatment for Neonatal Abstinence Syndrome.
Topics: Adult; Analgesics, Opioid; Buprenorphine; Clinical Protocols; Cohort Studies; Female; Humans; Infant, Newborn; Length of Stay; Linear Models; Male; Methadone; Neonatal Abstinence Syndrome; Ohio; Opioid-Related Disorders; Retrospective Studies | 2016 |
Community pharmacy services for people with drug problems over two decades in Scotland: Implications for future development.
Topics: Adult; Attitude of Health Personnel; Buprenorphine; Community Pharmacy Services; Cross-Sectional Studies; Female; Humans; Male; Methadone; Needle-Exchange Programs; Opioid-Related Disorders; Pharmacists; Professional Role; Scotland; Sex Factors; Substance-Related Disorders; Surveys and Questionnaires | 2016 |
Commentary on Pierce et al. (2016): Raising the bar of addiction treatment--first do no harm.
Topics: Buprenorphine; Humans; Methadone; Narcotics; Opioid-Related Disorders | 2016 |
Methadone, buprenorphine and preferences for opioid agonist treatment: A qualitative analysis.
Topics: Adult; Analgesics, Opioid; Buprenorphine; Female; Health Knowledge, Attitudes, Practice; Humans; Male; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Patient Preference; Qualitative Research; Social Stigma | 2016 |
Changes in psychological well-being among heroin-dependent adolescents during psychologically supported opiate substitution treatment.
Topics: Adolescent; Adolescent Behavior; Anger; Anxiety; Buprenorphine; Combined Modality Therapy; Depression; Female; Heroin Dependence; Humans; Male; Methadone; Opiate Substitution Treatment; Problem Behavior; Prospective Studies; Psychotherapy; Self Concept | 2018 |
Characteristics of veterans receiving buprenorphine vs. methadone for opioid use disorder nationally in the Veterans Health Administration.
Topics: Adult; Buprenorphine; Comorbidity; Demography; Female; Health Status; Humans; Male; Methadone; Middle Aged; Opiate Substitution Treatment; Opioid-Related Disorders; Patient Acceptance of Health Care; United States; United States Department of Veterans Affairs; Veterans | 2016 |
Non-prescribed use of opioid substitution medication: Patterns and trends in sub-populations of opioid users in Germany.
Topics: Buprenorphine; Cross-Sectional Studies; Drug Users; Germany; Health Status; Methadone; Motivation; Opioid-Related Disorders; Prescription Drug Diversion; Prevalence; Substance Abuse, Intravenous | 2016 |
Sexual Dysfunction in Heroin Dependents: A Comparison between Methadone and Buprenorphine Maintenance Treatment.
Topics: Adult; Buprenorphine; Cross-Sectional Studies; Erectile Dysfunction; Heroin Dependence; Humans; Maintenance Chemotherapy; Male; Methadone; Middle Aged; Opiate Substitution Treatment; Quality of Life | 2016 |
Receipt of pharmacotherapy for opioid use disorder by justice-involved U.S. Veterans Health Administration patients.
Topics: Adult; Analgesics, Opioid; Buprenorphine; Female; Humans; Logistic Models; Male; Methadone; Middle Aged; Naltrexone; Opiate Substitution Treatment; Opioid-Related Disorders; Prisons; Retrospective Studies; Social Justice; United States; United States Department of Veterans Affairs; Veterans | 2016 |
Differences in polysubstance use patterns and drug-related outcomes between people who inject drugs receiving and not receiving opioid substitution therapies.
Topics: Abscess; Adolescent; Adult; Alcoholism; Amphetamine-Related Disorders; Analgesics, Opioid; Australia; Buprenorphine; Buprenorphine, Naloxone Drug Combination; Cocaine-Related Disorders; Cross-Sectional Studies; Drug Overdose; Female; Heroin Dependence; Humans; Male; Marijuana Abuse; Methadone; Middle Aged; Needle Sharing; Odds Ratio; Opiate Substitution Treatment; Opioid-Related Disorders; Substance Abuse, Intravenous; Substance-Related Disorders; Thrombosis; Violence; Young Adult | 2016 |
Total Joint Arthroplasty in Patients Taking Methadone or Buprenorphine/Naloxone Preoperatively for Prior Heroin Addiction: A Prospective Matched Cohort Study.
Topics: Aged; Arthroplasty, Replacement; Buprenorphine; Cohort Studies; Female; Heroin Dependence; Humans; Male; Methadone; Middle Aged; Naloxone; Narcotic Antagonists; Narcotics; Pain Management; Pain, Postoperative; Prospective Studies; Registries; Retrospective Studies; Treatment Outcome | 2016 |
[Opiate substitution records success stories].
Topics: Buprenorphine; Cooperative Behavior; Dose-Response Relationship, Drug; General Practice; Germany; Humans; Interdisciplinary Communication; Methadone; Opiate Substitution Treatment; Placebo Effect; Treatment Outcome | 2015 |
Medication-assisted treatment for hospitalized patients with intravenous-drug-use related infective endocarditis.
Topics: Adult; Buprenorphine; Endocarditis; Female; Hospitalization; Humans; Inpatients; Male; Methadone; Middle Aged; Opiate Substitution Treatment; Opioid-Related Disorders; Patient Acceptance of Health Care; Referral and Consultation; Retrospective Studies; Substance Abuse, Intravenous; Young Adult | 2016 |
Incidence of high dosage buprenorphine and methadone shopping behavior in a retrospective cohort of opioid-maintained patients in France.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Buprenorphine; Commerce; Databases, Factual; Female; France; Humans; Incidence; Male; Methadone; Middle Aged; Opiate Substitution Treatment; Pharmacies; Physicians; Prescriptions; Retrospective Studies; Young Adult | 2016 |
Office-Based Buprenorphine Versus Clinic-Based Methadone: A Cost-Effectiveness Analysis.
Topics: Adult; Ambulatory Care Facilities; Buprenorphine; Cost-Benefit Analysis; Humans; Markov Chains; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Randomized Controlled Trials as Topic; United States | 2016 |
Simultaneous quantification of buprenorphine, naloxone and phase I and II metabolites in plasma and breastmilk by liquid chromatography-tandem mass spectrometry.
Topics: Buprenorphine; Chromatography, Liquid; Female; Glucuronides; Humans; Infant, Newborn; Metabolic Detoxication, Phase I; Metabolic Detoxication, Phase II; Methadone; Milk, Human; Naloxone; Narcotic Antagonists; Pregnancy; Solid Phase Extraction; Tandem Mass Spectrometry | 2016 |
Criminal Charges Prior to and After Enrollment in Opioid Agonist Treatment: A Comparison of Methadone Maintenance and Office-based Buprenorphine.
Topics: Buprenorphine; Criminals; Humans; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders | 2016 |
Buprenorphine and methadone treatment for opioid dependence by income, ethnicity and race of neighborhoods in New York City.
Topics: Analgesics, Opioid; Black or African American; Buprenorphine; Ethnicity; Female; Hispanic or Latino; Humans; Male; Methadone; New York City; Opioid-Related Disorders; Poverty; Racial Groups; Residence Characteristics | 2016 |
[Investigation of the medical and social situation of patients managed by opiate replacement regimens for over 10 years by their GP].
Topics: Adult; Analgesics, Opioid; Buprenorphine; Female; Follow-Up Studies; France; General Practitioners; Humans; Male; Methadone; Middle Aged; Opiate Substitution Treatment; Opioid-Related Disorders; Substance-Related Disorders; Surveys and Questionnaires; Unemployment | 2016 |
Patients' Beliefs About Medications are Associated with Stated Preference for Methadone, Buprenorphine, Naltrexone, or no Medication-Assisted Therapy Following Inpatient Opioid Detoxification.
Topics: Adult; Buprenorphine; Delayed-Action Preparations; Female; Humans; Interviews as Topic; Male; Methadone; Naltrexone; Opiate Substitution Treatment; Opioid-Related Disorders; Patient Preference; Substance Withdrawal Syndrome; Young Adult | 2016 |
[Characteristics of subjects under opiate maintenance treatment in primary care using the OPEMA data 2013].
Topics: Adolescent; Adult; Alcohol Drinking; Anxiety; Benzodiazepines; Buprenorphine; Depressive Disorder; Digestive System Diseases; Employment; Female; France; General Practice; Humans; Maintenance Chemotherapy; Male; Methadone; Middle Aged; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Respiration Disorders; Young Adult | 2016 |
Opioid agonist doses for oxycodone and morphine dependence: Findings from a retrospective case series.
Topics: Adult; Analgesics, Opioid; Buprenorphine; Dose-Response Relationship, Drug; Female; Humans; Male; Methadone; Middle Aged; Morphine Dependence; Opiate Substitution Treatment; Opioid-Related Disorders; Oxycodone; Retrospective Studies | 2017 |
Arrhythmia associated with buprenorphine and methadone reported to the Food and Drug Administration.
Topics: Analgesics, Opioid; Arrhythmias, Cardiac; Buprenorphine; Dose-Response Relationship, Drug; Humans; Long QT Syndrome; Methadone; Opioid-Related Disorders; United States Food and Drug Administration | 2016 |
Reply to Cataldo (2016): Arrhythmia associated with buprenorphine and methadone reported to the Food and Drug Administration.
Topics: Arrhythmias, Cardiac; Buprenorphine; Electrocardiography; Humans; Long QT Syndrome; Methadone; Torsades de Pointes; United States Food and Drug Administration | 2016 |
Determinants of willingness to enroll in opioid agonist treatment among opioid dependent people who inject drugs in Ukraine.
Topics: Adult; Analgesics, Opioid; Buprenorphine; Cross-Sectional Studies; Drug Overdose; Female; Humans; Male; Methadone; Opioid-Related Disorders; Patient Acceptance of Health Care; Substance Abuse, Intravenous; Ukraine | 2016 |
Chronic pain, craving, and illicit opioid use among patients receiving opioid agonist therapy.
Topics: Adult; Analgesics, Opioid; Buprenorphine; Chronic Pain; Craving; Cross-Sectional Studies; Depression; Female; Humans; Male; Methadone; Middle Aged; Opiate Substitution Treatment; Opioid-Related Disorders | 2016 |
Evaluation of the vaginal flora in pregnant women receiving opioid maintenance therapy: a matched case-control study.
Topics: Adult; Analgesics, Opioid; Asymptomatic Infections; Austria; Birth Weight; Buprenorphine; Candidiasis, Vulvovaginal; Case-Control Studies; Female; Gestational Age; Humans; Infant, Newborn; Maintenance Chemotherapy; Methadone; Morphine; Opioid-Related Disorders; Pregnancy; Pregnancy Complications, Infectious; Retrospective Studies; Trichomonas Vaginitis; Vagina; Vaginosis, Bacterial; Young Adult | 2016 |
Psychiatric Disorders Among Patients Seeking Treatment for Co-Occurring Chronic Pain and Opioid Use Disorder.
Topics: Adult; Buprenorphine; Chronic Pain; Comorbidity; Cross-Sectional Studies; Disability Evaluation; Female; Heroin Dependence; HIV Seropositivity; Humans; Illicit Drugs; Male; Mental Disorders; Methadone; Middle Aged; Naloxone; Opioid-Related Disorders; Pain Measurement; Prescription Drugs; Young Adult | 2016 |
High prevalence of constipation and reduced quality of life in opioid-dependent patients treated with opioid substitution treatments.
Topics: Adult; Analgesics, Opioid; Buprenorphine; Constipation; Female; Heroin Dependence; Humans; Italy; Male; Methadone; Middle Aged; Opiate Substitution Treatment; Opioid-Related Disorders; Prevalence; Quality of Life | 2016 |
Mother-child interaction and cognitive development in children prenatally exposed to methadone or buprenorphine.
Topics: Adult; Buprenorphine; Case-Control Studies; Child Development; Cognition; Female; Humans; Infant, Newborn; Language Development; Male; Memory; Methadone; Mother-Child Relations; Narcotic Antagonists; Opiate Substitution Treatment; Pregnancy; Prenatal Exposure Delayed Effects; Psychomotor Performance | 2016 |
Too much or never enough: a response to Treatment of opioid disorders in Canada: looking at the 'other epidemic'.
Topics: Analgesics, Opioid; Buprenorphine; Humans; Methadone; Ontario; Opioid-Related Disorders | 2016 |
Neonatal Abstinence Syndrome: Twelve Years of Experience at a Regional Referral Center.
Topics: Buprenorphine; Diseases in Twins; Female; Hospitalization; Humans; Infant, Newborn; Male; Methadone; Morphine; Neonatal Abstinence Syndrome; Opioid-Related Disorders; Phenobarbital; Pregnancy; Referral and Consultation; Retrospective Studies; Substance Abuse Treatment Centers; Treatment Outcome | 2017 |
Decrease in self-reported offences and incarceration rates during methadone treatment: A comparison between patients switching from buprenorphine to methadone and maintenance treatment incident users (ANRS-Methaville trial).
Topics: Adult; Buprenorphine; Crime; Drug Trafficking; Female; France; Humans; Male; Methadone; Opiate Substitution Treatment; Randomized Controlled Trials as Topic; Self Report; Young Adult | 2017 |
[Trend in buprenorphine and methadone shopping behavior in France from 2004 to 2014].
Topics: Adult; Aged; Aged, 80 and over; Analgesics, Opioid; Buprenorphine; Cross-Sectional Studies; Female; France; Humans; Male; Methadone; Middle Aged; Opiate Substitution Treatment; Opioid-Related Disorders; Practice Patterns, Physicians'; Time Factors; Young Adult | 2016 |
Neonatal abstinence syndrome and the gastrointestinal tract.
Topics: Analgesics, Opioid; Buprenorphine; Child; Child, Preschool; Dysbiosis; Female; Gastrointestinal Tract; Humans; Infant; Infant, Newborn; Maternal Exposure; Methadone; Microbiota; Models, Theoretical; Neonatal Abstinence Syndrome; Opioid-Related Disorders; Pregnancy; Pregnancy Complications; Prenatal Exposure Delayed Effects; Risk; Substance Withdrawal Syndrome | 2016 |
A polymorphism in the OPRM1 3'-untranslated region is associated with methadone efficacy in treating opioid dependence.
Topics: 3' Untranslated Regions; Adult; Alleles; Analgesics, Opioid; Australia; Buprenorphine; Buprenorphine, Naloxone Drug Combination; Female; Genotype; Humans; Male; Methadone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Polymorphism, Genetic; Receptors, Opioid, mu; White People | 2018 |
Buprenorphine, Norbuprenorphine, R-Methadone, and S-Methadone Upregulate BCRP/ABCG2 Expression by Activating Aryl Hydrocarbon Receptor in Human Placental Trophoblasts.
Topics: ATP Binding Cassette Transporter, Subfamily G, Member 2; Buprenorphine; Female; Gene Knockdown Techniques; Humans; Ligands; Methadone; Placenta; Pregnancy; Promoter Regions, Genetic; Receptors, Aryl Hydrocarbon; RNA, Messenger; Transcription, Genetic; Trophoblasts; Up-Regulation | 2017 |
Delayed villous maturation in term placentas exposed to opioid maintenance therapy: a retrospective cohort study.
Topics: Adult; Buprenorphine; Case-Control Studies; Chorionic Villi; Cohort Studies; Female; Humans; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Pennsylvania; Placenta Diseases; Pregnancy; Pregnancy Complications; Retrospective Studies | 2017 |
Response to Smith and Brogly et al. commentaries on Zedler et al.
Topics: Buprenorphine; Female; Humans; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Pregnancy; Pregnancy Complications | 2016 |
The comparative safety of buprenorphine versus methadone in pregnancy-what about confounding?
Topics: Buprenorphine; Female; Humans; Methadone; Neonatal Abstinence Syndrome; Opiate Substitution Treatment; Opioid-Related Disorders; Pregnancy; Pregnancy Complications | 2016 |
Monitoring Intravenous Abuse of Methadone or Buprenorphine in Opiate Maintenance Treatment (OMT): A Simple and Fast LC-MS-MS Method for the Detection of Disaccharides in Urine Samples.
Topics: Adult; Biomarkers; Buprenorphine; Carbonated Beverages; Case-Control Studies; Chocolate; Chromatography, Liquid; Female; Humans; Lactose; Limit of Detection; Male; Methadone; Middle Aged; Opiate Alkaloids; Reproducibility of Results; Substance Abuse Detection; Substance Abuse, Intravenous; Sucrose; Tandem Mass Spectrometry; Young Adult | 2017 |
Drug safety and adverse drug reaction reporting behavior related to outpatient opioid replacement therapy: Results from a survey among physicians.
Topics: Analgesics, Opioid; Buprenorphine; Drug-Related Side Effects and Adverse Reactions; Female; Germany; Health Care Surveys; Humans; Male; Methadone; Middle Aged; Opiate Substitution Treatment; Opioid-Related Disorders; Outpatients; Physicians | 2017 |
Are UK opioid substitution treatment agencies fit for purpose?
Topics: Buprenorphine; Methadone; Opiate Substitution Treatment; United Kingdom | 2017 |
Examination of the Hepatitis C Virus care continuum among individuals with an opioid use disorder in substance use treatment.
Topics: Adult; Buprenorphine; Continuity of Patient Care; Female; Hepatitis C; Humans; Male; Methadone; Middle Aged; Narcotics; Opiate Substitution Treatment; Opioid-Related Disorders; Self Report; Socioeconomic Factors; Substance Abuse, Intravenous | 2017 |
Commentary on Nikoo et al. (2017): The role of research.
Topics: Buprenorphine; Heroin Dependence; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders | 2017 |
Evaluation of an Automated Reader and Color Interpretation-Based Immunoassays for Multiplexed Drug-of-Abuse Testing in Urine.
Topics: Amphetamine; Automation; Buprenorphine; China; Cocaine; Dronabinol; Gas Chromatography-Mass Spectrometry; Illicit Drugs; Immunoassay; Mass Spectrometry; Methadone; Methamphetamine; Morphine; Sensitivity and Specificity; Substance Abuse Detection | 2017 |
Intravenous Buprenorphine: A Substitute for Naloxone in Methadone-Overdosed Patients?
Topics: Administration, Intravenous; Buprenorphine; Drug Overdose; Humans; Male; Methadone; Naloxone; Narcotic Antagonists; Respiratory Insufficiency; Treatment Outcome; Young Adult | 2017 |
Primary healthcare-based integrated care with opioid agonist treatment: First experience from Ukraine.
Topics: Adult; Buprenorphine; Cross-Sectional Studies; Delivery of Health Care, Integrated; Female; Health Services Research; HIV Infections; Humans; Male; Methadone; Middle Aged; Opiate Substitution Treatment; Opioid-Related Disorders; Patient Dropouts; Patient Satisfaction; Pilot Projects; Primary Health Care; Quality of Life; Substance Abuse, Intravenous; Ukraine | 2017 |
Medication-Assisted Treatment for Adolescents in Specialty Treatment for Opioid Use Disorder.
Topics: Adolescent; Analgesics, Opioid; Buprenorphine; Female; Humans; Male; Medication Adherence; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders | 2017 |
Changes in substance use in patients receiving opioid substitution therapy and resulting clinical challenges: a 17-year treatment case register analysis.
Topics: Adult; Alcoholism; Analgesics, Opioid; Buprenorphine; Female; Humans; Male; Methadone; Middle Aged; Opiate Substitution Treatment; Opioid-Related Disorders; Registries; Switzerland | 2017 |
Commentary on Gibson et al. (2017): Gestational age and the severity of neonatal abstinence syndrome.
Topics: Buprenorphine; Gestational Age; Humans; Infant, Newborn; Methadone; Morphine; Neonatal Abstinence Syndrome; Opiate Substitution Treatment; Opioid-Related Disorders; Pregnancy Complications | 2017 |
Opioid Agonist Treatment for Patients With Dependence on Prescription Opioids.
Topics: Buprenorphine; Humans; Methadone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Randomized Controlled Trials as Topic | 2017 |
Buprenorphine for Persons on Waiting Lists for Treatment for Opioid Dependence.
Topics: Analgesics, Opioid; Buprenorphine; Humans; Methadone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Treatment Outcome; Waiting Lists | 2017 |
Buprenorphine for Persons on Waiting Lists for Treatment for Opioid Dependence.
Topics: Analgesics, Opioid; Buprenorphine; Humans; Methadone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Treatment Outcome; Waiting Lists | 2017 |
Another Senseless Death - The Case for Supervised Injection Facilities.
Topics: Buprenorphine; Drug Overdose; Heroin Dependence; Humans; Methadone; Needle-Exchange Programs; Opiate Substitution Treatment; Substance Abuse, Intravenous; United States | 2017 |
Benzodiazepine, z-drug and pregabalin prescriptions and mortality among patients in opioid maintenance treatment-A nation-wide register-based open cohort study.
Topics: Adolescent; Adult; Benzodiazepines; Buprenorphine; Drug Overdose; Drug Prescriptions; Female; Humans; Hypnotics and Sedatives; Male; Methadone; Middle Aged; Opiate Substitution Treatment; Opioid-Related Disorders; Pregabalin; Registries; Retrospective Studies; Young Adult | 2017 |
Gender-related psychopathology in opioid use disorder: Results from a representative sample of Italian addiction services.
Topics: Adult; Buprenorphine; Comorbidity; Cross-Sectional Studies; Female; Humans; Italy; Male; Mental Disorders; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Psychometrics; Sex Factors | 2017 |
Infants Born to Opioid-Dependent Women in Ontario, 2002-2014.
Topics: Adult; Buprenorphine; Congenital Abnormalities; Databases, Factual; Female; Health Care Costs; Humans; Infant; Infant Mortality; Infant, Newborn; Length of Stay; Male; Methadone; Naloxone; Narcotic Antagonists; Narcotics; Neonatal Abstinence Syndrome; Ontario; Opiate Substitution Treatment; Opioid-Related Disorders; Pregnancy; Pregnancy Complications; Stillbirth; Young Adult | 2017 |
Six-Year Outcome of Opioid Maintenance Treatment in Heroin-Dependent Patients: Results from a Naturalistic Study in a Nationally Representative Sample.
Topics: Adult; Analgesics, Opioid; Buprenorphine; Female; Heroin Dependence; Humans; Longitudinal Studies; Male; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Prevalence; Prospective Studies; Surveys and Questionnaires; Treatment Outcome | 2017 |
Sex Differences in Regional Brain Glucose Metabolism Following Opioid Withdrawal and Replacement.
Topics: Analgesics, Opioid; Animals; Brain; Brain Mapping; Buprenorphine; Cross-Sectional Studies; Disease Models, Animal; Female; Fluorodeoxyglucose F18; Glucose; Longitudinal Studies; Male; Methadone; Morphine; Morphine Dependence; Positron-Emission Tomography; Radiopharmaceuticals; Rats, Sprague-Dawley; Sex Characteristics; Treatment Outcome | 2017 |
Co-occurring Attention Deficit Hyperactivity Disorder symptoms in adults affected by heroin dependence: Patients characteristics and treatment needs.
Topics: Adult; Attention Deficit Disorder with Hyperactivity; Behavior, Addictive; Buprenorphine; Comorbidity; Female; Heroin Dependence; Humans; Male; Mental Disorders; Methadone; Middle Aged; Opiate Substitution Treatment; Opioid-Related Disorders; Psychiatric Status Rating Scales; Quality of Life; Substance-Related Disorders; Surveys and Questionnaires; Young Adult | 2017 |
QT interval prolongation in opioid agonist treatment: analysis of continuous 12-lead electrocardiogram recordings.
Topics: Adult; Analgesics, Opioid; Buprenorphine; Dose-Response Relationship, Drug; Electrocardiography; Female; Humans; Long QT Syndrome; Male; Methadone; Middle Aged; Opiate Substitution Treatment; Opioid-Related Disorders; Prospective Studies; Torsades de Pointes; Young Adult | 2017 |
Use of opioid substitution therapies in the treatment of opioid use disorder: results of a UK cost-effectiveness modelling study.
Topics: Buprenorphine; Cost-Benefit Analysis; Crime; Health Services; Hepatitis C; HIV Infections; Humans; Markov Chains; Methadone; Models, Economic; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Quality-Adjusted Life Years; United Kingdom | 2017 |
A Retrospective Cohort Study of Birth Outcomes in Neonates Exposed to Naltrexone in Utero: A Comparison with Methadone-, Buprenorphine- and Non-opioid-Exposed Neonates.
Topics: Adult; Australia; Buprenorphine; Drug Administration Routes; Female; Humans; Incidence; Infant, Newborn; Male; Methadone; Naltrexone; Neonatal Abstinence Syndrome; Opiate Substitution Treatment; Opioid-Related Disorders; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Prenatal Exposure Delayed Effects; Retrospective Studies | 2017 |
Context and craving during stressful events in the daily lives of drug-dependent patients.
Topics: Adult; Affect; Buprenorphine; Craving; Female; Humans; Male; Methadone; Middle Aged; Narcotics; Opiate Substitution Treatment; Opioid-Related Disorders; Outpatients; Smartphone; Stress, Psychological | 2017 |
Fatal and non-fatal opioid overdose in opioid dependent patients treated with methadone, buprenorphine or implant naltrexone.
Topics: Adult; Buprenorphine; Cohort Studies; Drug Implants; Drug Overdose; Female; Humans; Male; Methadone; Multivariate Analysis; Naltrexone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Proportional Hazards Models; Prospective Studies; Retrospective Studies; Risk Factors; Western Australia; Young Adult | 2017 |
Hepatitis C in injection drug users: It is time to treat.
Topics: Antiviral Agents; Buprenorphine; Drug Users; Hepatitis C; Humans; Interdisciplinary Communication; Liver Diseases; Methadone; Patient Care Team; Practice Guidelines as Topic; Program Development; Substance Abuse, Intravenous; Substance-Related Disorders; Treatment Outcome | 2017 |
Polydrug abuse among opioid maintenance treatment patients is related to inadequate dose of maintenance treatment medicine.
Topics: Adult; Analgesics, Opioid; Benzodiazepines; Buprenorphine; Female; Finland; Humans; Male; Methadone; Middle Aged; Opiate Substitution Treatment; Opioid-Related Disorders; Psychotropic Drugs; Retrospective Studies; Substance-Related Disorders | 2017 |
Patterns of physician prescribing for opioid maintenance treatment in Ontario, Canada in 2014.
Topics: Adult; Analgesics, Opioid; Buprenorphine; Cross-Sectional Studies; Drug Prescriptions; Female; Humans; Male; Methadone; Middle Aged; Ontario; Opiate Substitution Treatment; Opioid-Related Disorders; Physicians | 2017 |
Frequency and correlates of sleep disturbance in methadone and buprenorphine-maintained patients.
Topics: Adult; Buprenorphine; Comorbidity; Female; Humans; Male; Methadone; Middle Aged; Opiate Substitution Treatment; Opioid-Related Disorders; Sleep Wake Disorders; Treatment Outcome; United States | 2018 |
Utilization of buprenorphine and methadone among opioid users who inject drugs.
Topics: Adult; Analgesics, Opioid; Buprenorphine; Case-Control Studies; Female; Humans; Male; Methadone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Patient Acceptance of Health Care; Substance Abuse, Intravenous; Young Adult | 2018 |
Retention in medication-assisted treatment programs in Ukraine-Identifying factors contributing to a continuing HIV epidemic.
Topics: Adult; Buprenorphine; Cohort Studies; Delivery of Health Care, Integrated; Dose-Response Relationship, Drug; Female; HIV Infections; Humans; Male; Methadone; Multivariate Analysis; Opiate Substitution Treatment; Opioid-Related Disorders; Patient Compliance; Patient Dropouts; Retrospective Studies; Tuberculosis; Ukraine | 2017 |
Transitioning from methadone to buprenorphine maintenance in management of opioid use disorder during pregnancy.
Topics: Adult; Analgesics, Opioid; Buprenorphine; Drug Substitution; Female; Humans; Infant, Newborn; Methadone; Neonatal Abstinence Syndrome; Opiate Substitution Treatment; Opioid-Related Disorders; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Treatment Outcome | 2018 |
Medication-Assisted Treatment for Opioid Addiction in the United States: Critique and Commentary.
Topics: Analgesics, Opioid; Buprenorphine; Buprenorphine, Naloxone Drug Combination; Health Services Accessibility; Humans; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Patient Compliance; Social Control, Formal; Social Stigma | 2018 |
Maternal buprenorphine treatment and infant outcome.
Topics: Buprenorphine; Female; Humans; Infant, Newborn; Methadone; Neonatal Abstinence Syndrome; Opiate Substitution Treatment; Opioid-Related Disorders; Pregnancy; Pregnancy Complications | 2017 |
Buprenorphine for the Neonatal Abstinence Syndrome.
Topics: Buprenorphine; Humans; Infant, Newborn; Methadone; Neonatal Abstinence Syndrome; Opiate Substitution Treatment; Opioid-Related Disorders; Pregnancy Complications | 2017 |
Buprenorphine for the Neonatal Abstinence Syndrome.
Topics: Buprenorphine; Humans; Infant, Newborn; Methadone; Neonatal Abstinence Syndrome; Opiate Substitution Treatment; Opioid-Related Disorders; Pregnancy Complications | 2017 |
Buprenorphine for the Neonatal Abstinence Syndrome.
Topics: Buprenorphine; Humans; Infant, Newborn; Methadone; Neonatal Abstinence Syndrome; Opiate Substitution Treatment; Opioid-Related Disorders; Pregnancy Complications | 2017 |
Buprenorphine for the Neonatal Abstinence Syndrome.
Topics: Buprenorphine; Humans; Infant, Newborn; Methadone; Neonatal Abstinence Syndrome; Opiate Substitution Treatment; Opioid-Related Disorders; Pregnancy Complications | 2017 |
Using nominal group technique among clinical providers to identify barriers and prioritize solutions to scaling up opioid agonist therapies in Ukraine.
Topics: Budgets; Buprenorphine; Drug Users; Health Policy; HIV Infections; Humans; Methadone; Narcotics; Opiate Substitution Treatment; Opioid-Related Disorders; Substance Abuse, Intravenous; Ukraine | 2017 |
Antenatal methadone vs buprenorphine exposure and length of hospital stay in infants admitted to the intensive care unit with neonatal abstinence syndrome.
Topics: Adult; Buprenorphine; Female; Gestational Age; Humans; Infant, Newborn; Intensive Care Units, Neonatal; Length of Stay; Male; Maternal Age; Methadone; Multivariate Analysis; Neonatal Abstinence Syndrome; Opiate Substitution Treatment; Opioid-Related Disorders; Pregnancy; Pregnancy Complications; Propensity Score; Proportional Hazards Models; Retrospective Studies; United States; Young Adult | 2018 |
Constipation and other common symptoms reported by women and men in methadone and buprenorphine maintenance treatment.
Topics: Adult; Analgesics, Opioid; Australia; Buprenorphine; Case-Control Studies; Constipation; Depression; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Male; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Prevalence; Sex Factors; Young Adult | 2017 |
[ACUTE PAIN MANAGEMENT IN PATIENT ON OPIOID SUBSTITUTION THERAPY WITH\
METHADONE OR BUPRENORPHINE].
Topics: Acute Disease; Buprenorphine; Humans; Methadone; Opiate Substitution Treatment; Pain; Pain Management; Quality of Life | 2016 |
Predictors of heroin abstinence in opiate substitution therapy in heroin-only users and dual users of heroin and crack.
Topics: Adult; Aged; Analgesics, Opioid; Buprenorphine; Cocaine-Related Disorders; Comorbidity; Female; Heroin Dependence; Humans; London; Male; Methadone; Middle Aged; Narcotic Antagonists; Opiate Substitution Treatment; Retrospective Studies; Treatment Outcome; Young Adult | 2018 |
Expanding Treatment Opportunities for Hospitalized Patients with Opioid Use Disorders.
Topics: Analgesics, Opioid; Buprenorphine; Hospitalization; Humans; Inpatients; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Practice Patterns, Physicians'; United States | 2018 |
Methadone Versus Buprenorphine for Opioid Use Dependence and Risk of Neonatal Abstinence Syndrome.
Topics: Adult; Analgesics, Opioid; Buprenorphine; Female; Humans; Infant, Newborn; Methadone; Neonatal Abstinence Syndrome; Opiate Substitution Treatment; Opioid-Related Disorders; Pennsylvania; Pregnancy | 2018 |
Comparison of Neonatal Abstinence Syndrome Treatment with Sublingual Buprenorphine versus Conventional Opioids.
Topics: Analgesics, Opioid; Buprenorphine; Drug Administration Schedule; Female; Humans; Infant, Newborn; Length of Stay; Male; Methadone; Morphine; Neonatal Abstinence Syndrome; Opiate Substitution Treatment; Retrospective Studies; Time Factors | 2018 |
A retrospective cohort study of the health of children prenatally exposed to methadone, buprenorphine or naltrexone compared with non-exposed control children.
Topics: Adult; Buprenorphine; Child; Child, Preschool; Female; Humans; Infant; Infant, Newborn; Longitudinal Studies; Male; Methadone; Naltrexone; Pregnancy; Prenatal Exposure Delayed Effects; Retrospective Studies; Western Australia | 2017 |
Invited Commentary: A Novel Strategy for Addressing Unmeasured Confounding When Comparing Opioid Agonist Therapies in Pregnancy.
Topics: Buprenorphine; Female; Humans; Infant, Newborn; Medicaid; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Pregnancy; Pregnancy Complications | 2018 |
Neonatal Outcomes in a Medicaid Population With Opioid Dependence.
Topics: Buprenorphine; Female; Humans; Infant, Newborn; Methadone; Narcotics; Opioid-Related Disorders; Pregnancy; Pregnancy Complications; Prenatal Exposure Delayed Effects | 2018 |
Excess overdose mortality immediately following transfer of patients and their care as well as after cessation of opioid substitution therapy.
Topics: Adult; Analgesics, Opioid; Buprenorphine; Cause of Death; Drug Overdose; Female; Humans; Male; Methadone; Middle Aged; Opiate Substitution Treatment; Opioid-Related Disorders; Patient Dropouts; Patient Transfer; United Kingdom; Withholding Treatment | 2018 |
Medication-assisted treatment for youth with opioid use disorder: Current dilemmas and remaining questions.
Topics: Adolescent; Adult; Analgesics, Opioid; Buprenorphine; Drug Therapy, Combination; Humans; Methadone; Naltrexone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Young Adult | 2018 |
Erectile dysfunction and quality of life in men receiving methadone or buprenorphine maintenance treatment. A cross-sectional multicentre study.
Topics: Adolescent; Adult; Aged; Buprenorphine; Cross-Sectional Studies; Erectile Dysfunction; Humans; Male; Methadone; Middle Aged; Opiate Substitution Treatment; Opioid-Related Disorders; Quality of Life; Young Adult | 2017 |
Only One In Twenty Justice-Referred Adults In Specialty Treatment For Opioid Use Receive Methadone Or Buprenorphine.
Topics: Adult; Buprenorphine; Criminal Law; Female; Humans; Male; Methadone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; United States; Young Adult | 2017 |
Medication-Assisted Treatment (MAT) for Opioid Addiction: Introduction to the Special Issue.
Topics: Analgesics, Opioid; Buprenorphine; Health Services Accessibility; History, 20th Century; Humans; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Patient Compliance; Social Stigma | 2018 |
A cross-national analysis of the association between years of implementation of opioid substitution treatments and drug-related deaths in Europe from 1995 to 2013.
Topics: Analgesics, Opioid; Buprenorphine; Drug Overdose; Europe; Heroin Dependence; Humans; Methadone; Opiate Substitution Treatment | 2018 |
Long-acting intramuscular naltrexone for opioid use disorder: Utilization and association with multi-morbidity nationally in the Veterans Health Administration.
Topics: Adult; Analgesics, Opioid; Buprenorphine; Comorbidity; Cross-Sectional Studies; Female; Humans; Injections, Intramuscular; Male; Methadone; Middle Aged; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders; Treatment Outcome; United States; United States Department of Veterans Affairs; Veterans; Veterans Health | 2018 |
Plasma Testosterone and Sexual Function in Southeast Asian Men Receiving Methadone and Buprenorphine Maintenance Treatment.
Topics: Adult; Analgesics, Opioid; Buprenorphine; Depression; Female; Humans; Hypogonadism; Male; Methadone; Middle Aged; Opiate Substitution Treatment; Opioid-Related Disorders; Prevalence; Prolactin; Sexual Dysfunction, Physiological; Testosterone | 2018 |
Prescribing Opioid Replacement Therapy in U.S. Correctional Settings.
Topics: Buprenorphine; Humans; Methadone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Prisoners; Prisons; United States | 2017 |
Oxford House Residents' Attitudes Toward Medication Assisted Treatment Use in Fellow Residents.
Topics: Analgesics, Opioid; Analysis of Variance; Attitude to Health; Buprenorphine; Cross-Sectional Studies; Drug Utilization; Female; Halfway Houses; Humans; Male; Methadone; Naloxone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Outpatients; Surveys and Questionnaires | 2018 |
Healthcare utilization and costs associated with treatment for opioid dependence.
Topics: Adult; Age Factors; Buprenorphine; Comorbidity; Counseling; Delayed-Action Preparations; Health Expenditures; Health Resources; Humans; Male; Methadone; Middle Aged; Models, Econometric; Naltrexone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Retrospective Studies | 2018 |
Improving recruitment to pharmacological trials for illicit opioid use: findings from a qualitative focus group study.
Topics: Adult; Aged; Attitude to Health; Buprenorphine; Clinical Trials as Topic; Female; Focus Groups; Heroin Dependence; Humans; Male; Methadone; Middle Aged; Narcotics; Opiate Substitution Treatment; Opioid-Related Disorders; Patient Selection; Qualitative Research | 2018 |
The Role of Preterm Birth in the Association Between Opioid Maintenance Therapy and Neonatal Abstinence Syndrome.
Topics: Adult; Buprenorphine; Female; Humans; Infant, Newborn; Maternal Age; Methadone; Neonatal Abstinence Syndrome; Opiate Substitution Treatment; Pennsylvania; Pregnancy; Premature Birth; Risk Factors | 2018 |
Tobacco withdrawal among opioid-dependent smokers.
Topics: Adult; Analgesics, Opioid; Buprenorphine; Cigarette Smoking; Comorbidity; Craving; Female; Humans; Male; Methadone; Middle Aged; Nicotiana; Nicotine; Opioid-Related Disorders; Prevalence; Substance Withdrawal Syndrome | 2018 |
Patterns of regional variation of opioid prescribing in primary care in England: a retrospective observational study.
Topics: Analgesics, Opioid; Buprenorphine; Chronic Pain; Crime; Databases, Factual; Education; Employment; England; Health Status; Housing; Humans; Income; Methadone; Morphine; Oxycodone; Practice Patterns, Physicians'; Primary Health Care; Residence Characteristics; Retrospective Studies; Socioeconomic Factors; Tramadol | 2018 |
Neonatal outcomes after fetal exposure to methadone and buprenorphine: national registry studies from the Czech Republic and Norway.
Topics: Abortion, Spontaneous; Adult; Analgesics, Opioid; Apgar Score; Buprenorphine; Czech Republic; Female; Gestational Age; Humans; Infant, Newborn; Infant, Small for Gestational Age; Linear Models; Logistic Models; Male; Methadone; Neonatal Abstinence Syndrome; Norway; Opiate Substitution Treatment; Opioid-Related Disorders; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Premature Birth; Registries; Stillbirth; Young Adult | 2018 |
Physician prescribing of opioid agonist treatments in provincial correctional facilities in Ontario, Canada: A survey.
Topics: Adult; Buprenorphine; Humans; Male; Methadone; Naloxone; Ontario; Opiate Substitution Treatment; Opioid-Related Disorders; Practice Patterns, Physicians'; Prisons; Surveys and Questionnaires | 2018 |
Postincarceration Fatal Overdoses After Implementing Medications for Addiction Treatment in a Statewide Correctional System.
Topics: Adolescent; Adult; Buprenorphine; Cause of Death; Drug Overdose; Female; Fentanyl; Health Plan Implementation; Humans; Male; Methadone; Middle Aged; Naltrexone; Odds Ratio; Opioid-Related Disorders; Patient Discharge; Prisoners; Prisons; Retrospective Studies; Rhode Island; Transitional Care; Young Adult | 2018 |
Concurrent drug injection during opioid agonist treatment among people who inject drugs in Ukraine.
Topics: Adult; Analgesics, Opioid; Buprenorphine; Cross-Sectional Studies; Female; Humans; Male; Methadone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Patient Dropouts; Substance Abuse, Intravenous; Ukraine | 2018 |
Inhibition of In Vitro Metabolism of Opioids by Skeletal Muscle Relaxants.
Topics: Analgesics, Opioid; Animals; Buprenorphine; Cytochrome P-450 Enzyme System; Drug Interactions; Female; Humans; In Vitro Techniques; Inhibitory Concentration 50; Insecta; Male; Methadone; Microsomes, Liver; Neuromuscular Agents; Oxycodone | 2018 |
Buprenorphine Maintenance Subjects Are Hyperalgesic and Have No Antinociceptive Response to a Very High Morphine Dose.
Topics: Adult; Analgesics, Opioid; Buprenorphine; Drug Tolerance; Female; Humans; Hyperalgesia; Injections, Intravenous; Male; Methadone; Morphine; Opiate Substitution Treatment; Pain Measurement; Pain Threshold; Young Adult | 2019 |
Addressing discordant quantitative urine buprenorphine and norbuprenorphine levels: Case examples in opioid use disorder.
Topics: Adult; Buprenorphine; Buprenorphine, Naloxone Drug Combination; Cocaine-Related Disorders; Drug Contamination; Female; Humans; Male; Methadone; Middle Aged; Opioid-Related Disorders; Substance Abuse Detection | 2018 |
Dissatisfaction with opioid maintenance treatment partly explains reported side effects of medications.
Topics: Adult; Analgesics, Opioid; Buprenorphine; Buprenorphine, Naloxone Drug Combination; Female; Humans; Maintenance Chemotherapy; Male; Methadone; Middle Aged; Norway; Opiate Substitution Treatment; Opioid-Related Disorders; Patient Dropouts; Patient Satisfaction; Surveys and Questionnaires | 2018 |
The impact of buprenorphine and methadone on mortality: a primary care cohort study in the United Kingdom.
Topics: Adult; Buprenorphine; Cause of Death; Cohort Studies; Drug Overdose; Female; Humans; Male; Methadone; Middle Aged; Mortality; Narcotics; Opiate Substitution Treatment; Opioid-Related Disorders; Primary Health Care; United Kingdom | 2018 |
Challenges in implementing opioid agonist therapy in Lebanon: a qualitative study from a user's perspective.
Topics: Adolescent; Adult; Buprenorphine; Drug Users; Health Knowledge, Attitudes, Practice; Health Services Accessibility; Humans; Lebanon; Male; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Qualitative Research; Young Adult | 2018 |
Re: Erectile Dysfunction and Quality of Life in Men Receiving Methadone or Buprenorphine Maintenance Treatment. A Cross-Sectional Multicentre Study.
Topics: Buprenorphine; Cross-Sectional Studies; Erectile Dysfunction; Humans; Male; Methadone; Quality of Life | 2018 |
Opioid Deaths in Milwaukee County, Wisconsin 2013-2017: The Primacy of Heroin and Fentanyl.
Topics: Analgesics, Opioid; Buprenorphine; Coroners and Medical Examiners; Fentanyl; Heroin; Humans; Hydrocodone; Illicit Drugs; Incidence; Methadone; Opioid-Related Disorders; Oxycodone; Substance-Related Disorders; Wisconsin | 2019 |
Neurobiology of Opioid Use Disorder and Comorbid Traumatic Brain Injury.
Topics: Analgesics, Opioid; Brain Injuries, Traumatic; Buprenorphine; Humans; Methadone; Naltrexone; Opioid-Related Disorders; Pain; Receptors, Opioid, mu | 2018 |
Opioid substitution treatment and heroin dependent adolescents: reductions in heroin use and treatment retention over twelve months.
Topics: Adolescent; Buprenorphine; Cocaine-Related Disorders; Female; Follow-Up Studies; Heroin Dependence; Humans; Male; Medication Adherence; Methadone; Opiate Substitution Treatment; Patient Dropouts | 2018 |
Medical, psychosocial, and treatment predictors of opioid overdose among high risk opioid users.
Topics: Adult; Analgesics, Opioid; Buprenorphine; Drug Overdose; Female; Friends; Hepatitis C, Chronic; Humans; Male; Methadone; Odds Ratio; Opiate Substitution Treatment; Opioid-Related Disorders; Risk Factors; United States | 2018 |
Medicines for Patients After an Opioid Overdose.
Topics: Analgesics, Opioid; Buprenorphine; Drug Overdose; Humans; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders | 2018 |
Medication for Opioid Use Disorder After Nonfatal Opioid Overdose and Association With Mortality: A Cohort Study.
Topics: Adolescent; Adult; Analgesics, Opioid; Buprenorphine; Drug Overdose; Female; Humans; Male; Massachusetts; Methadone; Middle Aged; Mortality; Naltrexone; Opiate Substitution Treatment; Opioid-Related Disorders; Proportional Hazards Models; Retrospective Studies; Young Adult | 2018 |
A population-based examination of trends and disparities in medication treatment for opioid use disorders among Medicaid enrollees.
Topics: Adolescent; Adult; Buprenorphine; Drug Utilization; Ethnicity; Female; Healthcare Disparities; Humans; Male; Medicaid; Methadone; Middle Aged; Opiate Substitution Treatment; Opioid-Related Disorders; Poverty Areas; United States; Young Adult | 2018 |
Barriers to accessing treatment for pregnant women with opioid use disorder in Appalachian states.
Topics: Analgesics, Opioid; Appalachian Region; Buprenorphine; Female; Health Expenditures; Health Personnel; Health Services Accessibility; Health Services Research; Humans; Insurance, Health; Kentucky; Medicaid; Methadone; North Carolina; Opiate Substitution Treatment; Opioid-Related Disorders; Pregnancy; Pregnancy Complications; Pregnant Women; Surveys and Questionnaires; Tennessee; Time-to-Treatment; United States; West Virginia | 2019 |
Topics: Buprenorphine; Drug Interactions; Germany; Humans; Loperamide; Methadone; Opiate Substitution Treatment; Substance-Related Disorders; Torsades de Pointes | 2016 |
Intent to Refer: Exploring Bias Toward Specific Medication-Assisted Treatments by Community Corrections Employees.
Topics: Adult; Buprenorphine; Female; Humans; Intention; Male; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Referral and Consultation; Treatment Outcome; United States | 2018 |
Profile, risk practices and needs of people who inject morphine sulfate: Results from the ANRS-AERLI study.
Topics: Adult; Buprenorphine; Female; France; Humans; Longitudinal Studies; Male; Methadone; Morphine; Narcotics; Needs Assessment; Opiate Substitution Treatment; Substance Abuse, Intravenous | 2018 |
Moving Addiction Care to the Mainstream - Improving the Quality of Buprenorphine Treatment.
Topics: Buprenorphine; Drug Approval; Drug Overdose; Humans; Methadone; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders; Primary Health Care; United States; United States Food and Drug Administration | 2018 |
ERP correlates of cognitive control in children prenatally exposed to methadone or buprenorphine.
Topics: Buprenorphine; Child; Cognition; Evoked Potentials; Female; Humans; Longitudinal Studies; Male; Methadone; Narcotics; Pregnancy; Prenatal Exposure Delayed Effects; Reaction Time | 2018 |
Fatal and Nonfatal Overdose Among Pregnant and Postpartum Women in Massachusetts.
Topics: Adult; Buprenorphine; Drug Overdose; Female; Humans; Massachusetts; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Pregnancy; Pregnancy Complications; Puerperal Disorders; Retrospective Studies | 2018 |
Readiness and recovery: Transferring between methadone and buprenorphine/naloxone for the treatment of opioid use disorder.
Topics: Adult; Aged; Buprenorphine; Drug Substitution; Female; Humans; Interviews as Topic; Male; Methadone; Middle Aged; Naloxone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Patient Preference | 2019 |
Overview of Drugs Used to Treat Opioid Use Disorder.
Topics: Analgesics, Opioid; Buprenorphine; Humans; Methadone; Naltrexone; Nurse's Role; Opiate Substitution Treatment; Opioid-Related Disorders; Patient Education as Topic | 2018 |
Medications for Alcohol and Opioid Use Disorders and Risk of Suicidal Behavior, Accidental Overdoses, and Crime.
Topics: Acamprosate; Adult; Aged; Alcohol Deterrents; Alcoholism; Buprenorphine; Cohort Studies; Crime; Drug Overdose; Female; Follow-Up Studies; Humans; Male; Methadone; Middle Aged; Naltrexone; Opiate Substitution Treatment; Opioid-Related Disorders; Risk Factors; Suicidal Ideation; Young Adult | 2018 |
Using routinely collected data to understand and predict adverse outcomes in opioid agonist treatment: Protocol for the Opioid Agonist Treatment Safety (OATS) Study.
Topics: Analgesics, Opioid; Buprenorphine; Drug Overdose; Emergency Service, Hospital; Hospitalization; Humans; Methadone; New South Wales; Opioid-Related Disorders; Patient Dropouts; Receptors, Opioid; Regression Analysis; Research Design; Retrospective Studies; Risk Factors | 2018 |
Telemedicine's Role in Addressing the Opioid Epidemic.
Topics: Analgesics, Opioid; Buprenorphine; Epidemics; Health Policy; Humans; Methadone; Naltrexone; Opiate Substitution Treatment; Opioid-Related Disorders; Telemedicine; United States | 2018 |
Management of opioid withdrawal symptoms.
Topics: Adrenergic alpha-2 Receptor Agonists; Buprenorphine; Clonidine; Humans; Methadone; Narcotic Antagonists; Narcotics; Opioid-Related Disorders; Substance Withdrawal Syndrome | 2018 |
Expanded table: Some drugs for management of opioid withdrawal symptoms.
Topics: Adrenergic alpha-2 Receptor Agonists; Buprenorphine; Clonidine; Humans; Methadone; Narcotic Antagonists; Narcotics; Opioid-Related Disorders; Substance Withdrawal Syndrome | 2018 |
Improving Rural Access to Opioid Treatment Programs.
Topics: Analgesics, Opioid; Buprenorphine; Drug Overdose; Health Services Accessibility; Health Services Needs and Demand; Humans; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Rural Health Services; Rural Population; United States | 2018 |
Trends and Outcomes Associated With Using Long-Acting Opioids During Delivery Hospitalizations.
Topics: Adolescent; Adult; Analgesics, Opioid; Buprenorphine; Delivery, Obstetric; Female; Guideline Adherence; Hospitalization; Humans; Methadone; Opiate Substitution Treatment; Pregnancy; Young Adult | 2018 |
Prenatal Treatment and Outcomes of Women With Opioid Use Disorder.
Topics: Adult; Buprenorphine; Female; Humans; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Pregnancy; Pregnancy Complications; Prospective Studies; Young Adult | 2018 |
Impact of psychiatric medication co-exposure on Neonatal Abstinence Syndrome severity.
Topics: Adult; Analgesics, Opioid; Benzodiazepines; Buprenorphine; Female; Gabapentin; Humans; Infant; Infant, Newborn; Length of Stay; Methadone; Neonatal Abstinence Syndrome; Opioid-Related Disorders; Pregnancy; Prenatal Exposure Delayed Effects; Retrospective Studies; Severity of Illness Index | 2018 |
The First Comprehensive Program for Opioid Use Disorder in a US Statewide Correctional System.
Topics: Buprenorphine; Female; Humans; Male; Mass Screening; Methadone; Naltrexone; Opiate Substitution Treatment; Opioid-Related Disorders; Prisons; Rhode Island; United States | 2018 |
Receipt of Timely Addiction Treatment and Association of Early Medication Treatment With Retention in Care Among Youths With Opioid Use Disorder.
Topics: Adolescent; Behavior Therapy; Buprenorphine; Female; Humans; Male; Methadone; Naltrexone; Narcotics; Opiate Substitution Treatment; Opioid-Related Disorders; Retention in Care; Retrospective Studies; Time Factors; United States; Young Adult | 2018 |
One size does not fit all-evolution of opioid agonist treatments in a naturalistic setting over 23 years.
Topics: Adult; Age Factors; Analgesics, Opioid; Buprenorphine; Employment; Family Relations; Female; Friends; Heroin; Housing; Humans; Male; Methadone; Middle Aged; Morphine; Opiate Substitution Treatment; Opioid-Related Disorders; Social Integration; Social Participation; Substance Abuse, Intravenous; Switzerland | 2019 |
Buprenorphine medication-assisted treatment during pregnancy: An exploratory factor analysis associated with adherence.
Topics: Adult; Buprenorphine; Factor Analysis, Statistical; Female; Humans; Infant, Newborn; Medication Adherence; Methadone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Pregnancy; Pregnancy Complications; Retrospective Studies; Substance Withdrawal Syndrome | 2018 |
Opioid Agonist Treatment and Improved Outcomes at Each Stage of the HIV Treatment Cascade in People Who Inject Drugs in Ukraine.
Topics: Adolescent; Adult; Aged; Analgesics, Opioid; Anti-HIV Agents; Buprenorphine; Cities; Cross-Sectional Studies; Female; HIV Infections; Humans; Male; Methadone; Middle Aged; Substance Abuse, Intravenous; Treatment Outcome; Ukraine; Young Adult | 2018 |
Facility-level changes in receipt of pharmacotherapy for opioid use disorder: Implications for implementation science.
Topics: Buprenorphine; Hospitals, Veterans; Humans; Implementation Science; Methadone; Naltrexone; Opiate Substitution Treatment; Opioid-Related Disorders; Quality Improvement; Quality Indicators, Health Care; United States; United States Department of Veterans Affairs; Veterans | 2018 |
Heroin Addiction in Serbian Patients With Tourette Syndrome.
Topics: Adult; Age of Onset; Attention Deficit Disorder with Hyperactivity; Buprenorphine; Heroin Dependence; Humans; Male; Methadone; Middle Aged; Narcotics; Opiate Substitution Treatment; Serbia; Tourette Syndrome; Young Adult | 2018 |
Could prenatal food insecurity influence neonatal abstinence syndrome severity?
Topics: Adult; Analgesics, Opioid; Buprenorphine; Female; Food Supply; Humans; Methadone; Neonatal Abstinence Syndrome; Opiate Substitution Treatment; Opioid-Related Disorders; Pregnancy; Pregnancy Complications; Prenatal Care; Prenatal Exposure Delayed Effects; Prospective Studies | 2019 |
Delivering information about medication assisted treatment to individuals who misuse opioids through a mobile app: a pilot study.
Topics: Adult; Analgesics, Opioid; Buprenorphine; Humans; Methadone; Mobile Applications; Opiate Substitution Treatment; Pilot Projects | 2020 |
Interrelationship of Opioid Dependence, Impaired Impulse Control, and Depressive Symptoms: An Open-Label Cross-Sectional Study of Patients in Maintenance Therapy.
Topics: Adult; Analgesics, Opioid; Buprenorphine; Comorbidity; Cross-Sectional Studies; Depression; Educational Status; Executive Function; Female; Humans; Impulsive Behavior; Male; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Psychiatric Status Rating Scales; Self-Control | 2019 |
Effect of three opioid-based analgesic protocols on the perioperative autonomic-mediated cardiovascular response in sheep.
Topics: Administration, Intravenous; Analgesia; Analgesics, Opioid; Animals; Arterial Pressure; Buprenorphine; Female; Fentanyl; Heart Rate; Methadone; Sheep, Domestic | 2019 |
Change in alcohol and other drug use during five years of continuous opioid substitution treatment.
Topics: Adult; Aged; Alcohol Drinking; Buprenorphine; Cohort Studies; Female; Hospitalization; Humans; Male; Marijuana Use; Methadone; Middle Aged; Opiate Substitution Treatment; Prevalence; Prospective Studies; Substance-Related Disorders; Young Adult | 2019 |
The complex relation between access to opioid agonist therapy and diversion of opioid medications: a case example of large-scale misuse of buprenorphine in the Czech Republic.
Topics: Adolescent; Adult; Analgesics, Opioid; Buprenorphine; Czech Republic; Female; Health Services Accessibility; Humans; Illicit Drugs; Male; Methadone; Middle Aged; Narcotics; Opiate Substitution Treatment; Opioid-Related Disorders; Substance-Related Disorders; Young Adult | 2018 |
Integrated Brief Intervention for PTSD and Substance Use in an Antepartum Unit.
Topics: Adaptation, Psychological; Adult; Alcoholism; Benzodiazepines; Buprenorphine; Female; Humans; Maternal Health Services; Methadone; Opiate Substitution Treatment; Pregnancy; Psychometrics; Stress Disorders, Post-Traumatic; Substance-Related Disorders; Surveys and Questionnaires | 2019 |
Evaluation of an on-site test device for the heroin metabolite 6-acetylmorphine in urine.
Topics: Buprenorphine; Codeine; Gas Chromatography-Mass Spectrometry; Heroin; Humans; Methadone; Morphine; Morphine Derivatives; Reagent Strips; Sensitivity and Specificity; Substance Abuse Detection | 2019 |
Barriers and Facilitators to Implementation of Pharmacotherapy for Opioid Use Disorders in VHA Residential Treatment Programs.
Topics: Analgesics, Opioid; Buprenorphine; Cohort Studies; Female; Hospitals, Veterans; Humans; Male; Methadone; Naltrexone; Opioid-Related Disorders; Residential Treatment; United States; United States Department of Veterans Affairs; Veterans | 2018 |
Medication-assisted treatment for opioid use disorder.
Topics: Buprenorphine; Humans; Methadone; Naltrexone; Narcotic Antagonists; Nurse Practitioners; Opiate Substitution Treatment; Opioid-Related Disorders; Practice Patterns, Nurses'; United States | 2019 |
Measurement-based care using DSM-5 for opioid use disorder: can we make opioid medication treatment more effective?
Topics: Analgesics, Opioid; Buprenorphine; Diagnostic and Statistical Manual of Mental Disorders; Evidence-Based Medicine; Humans; International Classification of Diseases; Methadone; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders; Patient Reported Outcome Measures; Remission Induction | 2019 |
Best Practices for Pregnant Incarcerated Women With Opioid Use Disorder.
Topics: Buprenorphine; Female; Humans; Methadone; Narcotics; Opiate Substitution Treatment; Opioid-Related Disorders; Pregnancy; Prisons | 2019 |
Intravenous Misuse of Methadone, Buprenorphine and Buprenorphine-Naloxone in Patients Under Opioid Maintenance Treatment: A Cross-Sectional Multicentre Study.
Topics: Administration, Intravenous; Adolescent; Adult; Analgesics, Opioid; Benzodiazepines; Buprenorphine; Buprenorphine, Naloxone Drug Combination; Cross-Sectional Studies; Drug Misuse; Female; Hospitalization; Humans; Italy; Male; Methadone; Middle Aged; Opiate Substitution Treatment; Opioid-Related Disorders; Risk Factors; Young Adult | 2019 |
Overdose mortality rates in Croatia and factors associated with self-reported drug overdose among persons who inject drugs in three Croatian cities.
Topics: Adult; Buprenorphine; Croatia; Cross-Sectional Studies; Drug Overdose; Female; Harm Reduction; Humans; Male; Methadone; Middle Aged; Mortality; Naloxone; Opiate Substitution Treatment; Self Report; Substance Abuse, Intravenous; Surveys and Questionnaires | 2019 |
Medical specialty of buprenorphine prescribers for pregnant women with opioid use disorder.
Topics: Analgesics, Opioid; Buprenorphine; Drug Prescriptions; Female; Humans; Medicaid; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Pennsylvania; Physician's Role; Pregnancy; Pregnancy Complications; Rural Health Services; Specialization; United States; Urban Health Services | 2019 |
Should Physicians Recommend Replacing Opioids With Cannabis?
Topics: Analgesics, Opioid; Buprenorphine; Chronic Pain; Evidence-Based Medicine; Government Regulation; Humans; Legislation, Drug; Medical Marijuana; Methadone; Opioid-Related Disorders; United States | 2019 |
Hospitalization of children after prenatal exposure to opioid maintenance therapy during pregnancy: a national registry study from the Czech Republic.
Topics: Adult; Analgesics, Opioid; Buprenorphine; Case-Control Studies; Child, Preschool; Czech Republic; Digestive System Diseases; Female; Hospitalization; Humans; Infant; Infant, Newborn; Infections; Length of Stay; Male; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Pregnancy; Pregnancy Complications; Prenatal Exposure Delayed Effects; Registries; Skin Diseases; Young Adult | 2019 |
Comparing Canadian and United States opioid agonist therapy policies.
Topics: Buprenorphine; Canada; Drug Overdose; Health Policy; Humans; Insurance Coverage; Methadone; Naloxone; Opiate Substitution Treatment; Opioid Epidemic; Opioid-Related Disorders; United States | 2019 |
Electronic cigarette and tobacco use in individuals entering methadone or buprenorphine treatment.
Topics: Adult; Buprenorphine; Electronic Nicotine Delivery Systems; Female; Humans; Male; Methadone; Middle Aged; Odds Ratio; Opiate Substitution Treatment; Opioid-Related Disorders; Prevalence; Surveys and Questionnaires; Tobacco Smoking; Tobacco Use Disorder; Vaping; White People | 2019 |
Opioid addiction: long-acting formulations for a long-term disorder.
Topics: Buprenorphine; Double-Blind Method; Drug Compounding; Humans; Methadone; Opioid-Related Disorders | 2019 |
Suppression of Human Natural Killer Cells by Different Classes of Opioids.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Analgesics, Opioid; Anesthesia; Buprenorphine; Enkephalin, D-Penicillamine (2,5)-; Fentanyl; Fluoresceins; Humans; Immunosuppression Therapy; K562 Cells; Killer Cells, Natural; Loperamide; Methadone; Morphinans; Morphine; Naloxone; Naltrexone; Succinimides; Toll-Like Receptor 4; Tramadol | 2019 |
Evaluation of the Effects of a Monthly Buprenorphine Depot Subcutaneous Injection on QT Interval During Treatment for Opioid Use Disorder.
Topics: Adult; Age Factors; Aged; Barbiturates; Buprenorphine; Delayed-Action Preparations; Dose-Response Relationship, Drug; Electrocardiography; Female; Humans; Injections, Subcutaneous; Long QT Syndrome; Male; Methadone; Middle Aged; Opiate Substitution Treatment; Opioid-Related Disorders; Sex Factors; Young Adult | 2019 |
Opioid Use Disorder and Incarceration - Hope for Ensuring the Continuity of Treatment.
Topics: Adult; Buprenorphine; Humans; Legislation, Medical; Male; Methadone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Prisoners; Prisons; Substance Withdrawal Syndrome; United States | 2019 |
Prescription Drug and Alcohol Use Disorders: Opioid Use Disorder.
Topics: Analgesics, Opioid; Buprenorphine; Female; Humans; Methadone; Naltrexone; Opiate Substitution Treatment; Opioid-Related Disorders; Pregnancy | 2019 |
A retrospective cohort study of mortality rates in patients with an opioid use disorder treated with implant naltrexone, oral methadone or sublingual buprenorphine.
Topics: Buprenorphine; Female; Humans; Male; Methadone; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders; Retrospective Studies | 2019 |
Non drug-related and opioid-specific causes of 3262 deaths in Scotland's methadone-prescription clients, 2009-2015.
Topics: Adult; Analgesics, Opioid; Buprenorphine; Cause of Death; Cohort Studies; Female; Heroin; Humans; Male; Mental Status and Dementia Tests; Methadone; Middle Aged; Neurocognitive Disorders; Opiate Substitution Treatment; Opioid-Related Disorders; Scotland; Young Adult | 2019 |
Role of agonist efficacy in exposure-induced enhancement of mu opioid reward in rats.
Topics: Analgesics, Opioid; Animals; Buprenorphine; Dose-Response Relationship, Drug; Fentanyl; Male; Methadone; Morphine; Nalbuphine; Rats; Rats, Sprague-Dawley; Receptors, Opioid, mu; Reward; Self Stimulation | 2019 |
Rapid transition from methadone to buprenorphine using naltrexone-induced withdrawal: A case report.
Topics: Adult; Antidiarrheals; Antiemetics; Antipruritics; Buprenorphine; Clonidine; Deprescriptions; Drug Substitution; Female; Humans; Loperamide; Methadone; Methocarbamol; Muscle Relaxants, Central; Naltrexone; Narcotic Antagonists; Ondansetron; Opiate Substitution Treatment; Opioid-Related Disorders; Promethazine; Substance Withdrawal Syndrome; Sympatholytics | 2019 |
Implications of perinatal buprenorphine exposure on infant head circumference at birth.
Topics: Buprenorphine; Female; Humans; Infant; Infant, Newborn; Male; Methadone; Neonatal Abstinence Syndrome; Opioid-Related Disorders; Pregnancy; Pregnancy Complications; Prenatal Exposure Delayed Effects; Retrospective Studies | 2021 |
Concurrent Use of Buprenorphine, Methadone, or Naltrexone Does Not Inhibit Ketamine's Antidepressant Activity.
Topics: Adult; Aged; Analgesics, Opioid; Antidepressive Agents; Buprenorphine; Depressive Disorder, Treatment-Resistant; Female; Humans; Ketamine; Male; Methadone; Middle Aged; Naltrexone; Treatment Outcome | 2019 |
News Media Reporting On Medication Treatment For Opioid Use Disorder Amid The Opioid Epidemic.
Topics: Analgesics, Opioid; Buprenorphine; Female; Health Education; Health Information Management; Humans; Information Dissemination; Male; Mass Media; Medical Informatics; Methadone; Naltrexone; Needs Assessment; Opiate Substitution Treatment; Opioid Epidemic; Opioid-Related Disorders; Public Health; Retrospective Studies; Risk Assessment; United States | 2019 |
Prolonged-release opioid agonist therapy: qualitative study exploring patients' views of 1-week, 1-month, and 6-month buprenorphine formulations.
Topics: Adult; Analgesics, Opioid; Attitude to Health; Buprenorphine; Delayed-Action Preparations; Drug Implants; Female; Heroin Dependence; Humans; London; Male; Methadone; Middle Aged; Opiate Substitution Treatment; Qualitative Research; Young Adult | 2019 |
Medication-Assisted Treatment Use Among Pregnant Women With Opioid Use Disorder.
Topics: Adolescent; Adult; Analgesics, Opioid; Buprenorphine; Cohort Studies; Databases, Factual; Female; Humans; Medicaid; Methadone; Middle Aged; Opiate Substitution Treatment; Opioid-Related Disorders; Pennsylvania; Pregnancy; Pregnancy Complications; Retrospective Studies; United States; Young Adult | 2019 |
Cigarette smoking in subjects maintained with methadone or buprenorphine: The role of psychiatric symptoms and psychological distress.
Topics: Adult; Buprenorphine; Cigarette Smoking; Female; Humans; Male; Methadone; Narcotics; Psychological Distress | 2019 |
Opioid agonist treatment dosage and patient-perceived dosage adequacy, and risk of hepatitis C infection among people who inject drugs.
Topics: Adult; Buprenorphine; Cohort Studies; Disease Transmission, Infectious; Drug Users; Female; Hepatitis C; Humans; Injections, Intravenous; Male; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders | 2019 |
Buprenorphine unobserved "home" induction: a survey of Ontario's addiction physicians.
Topics: Addiction Medicine; Attitude of Health Personnel; Buprenorphine; Cross-Sectional Studies; Female; Health Knowledge, Attitudes, Practice; Humans; Male; Methadone; Narcotics; Ontario; Opiate Substitution Treatment; Opioid-Related Disorders; Practice Guidelines as Topic; Practice Patterns, Physicians' | 2019 |
Medication-Based Treatment to Address Opioid Use Disorder.
Topics: Analgesics, Opioid; Buprenorphine; Humans; Methadone; Naltrexone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Stereotyping | 2019 |
Non-prescribed use of methadone and buprenorphine prior to opioid substitution treatment: lifetime prevalence, motives, and drug sources among people with opioid dependence in five Swedish cities.
Topics: Adult; Analgesics, Opioid; Buprenorphine; Buprenorphine, Naloxone Drug Combination; Cities; Drug Trafficking; Female; Humans; Male; Methadone; Motivation; Opiate Substitution Treatment; Opioid-Related Disorders; Prescription Drug Diversion; Prevalence; Self Medication; Substance Withdrawal Syndrome; Sweden | 2019 |
Concomitant Heroin and Cocaine Use among Opioid-Dependent Patients during Methadone, Buprenorphine or Morphine Opioid Agonist Therapy.
Topics: Adult; Analgesics, Opioid; Behavior, Addictive; Buprenorphine; Cocaine; Cross-Sectional Studies; Delayed-Action Preparations; Female; Heroin; Humans; Male; Methadone; Morphine; Opiate Substitution Treatment; Opioid-Related Disorders; Switzerland | 2019 |
The case for a medication first approach to the treatment of opioid use disorder.
Topics: Analgesics, Opioid; Buprenorphine; Certification; Health Plan Implementation; Health Services Accessibility; Humans; Methadone; Missouri; Naltrexone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Practice Guidelines as Topic; State Government | 2019 |
Quality of primary care among individuals receiving treatment for opioid use disorder.
Topics: Adult; Analgesics, Opioid; Buprenorphine; Female; Humans; Logistic Models; Male; Methadone; Middle Aged; Ontario; Opiate Substitution Treatment; Opioid-Related Disorders; Primary Health Care; Retrospective Studies | 2019 |
Methadone and buprenorphine treatments in patients with schizophrenia.
Topics: Adult; Analgesics, Opioid; Buprenorphine; Comorbidity; Female; Humans; Male; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Prevalence; Schizophrenia; Young Adult | 2019 |
Intervention stigma: How medication-assisted treatment marginalizes patients and providers.
Topics: Analgesics, Opioid; Buprenorphine; Grounded Theory; Health Services Accessibility; Humans; Methadone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Qualitative Research; Social Marginalization; Social Stigma | 2019 |
Depot buprenorphine injections for opioid use disorder: Patient information needs and preferences.
Topics: Adult; Buprenorphine; Female; Health Services Needs and Demand; Humans; Male; Methadone; Middle Aged; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Patient Preference; Young Adult | 2019 |
Insomnia and excessive daytime sleepiness in women and men receiving methadone and buprenorphine maintenance treatment.
Topics: Adult; Analgesics, Opioid; Anxiety; Buprenorphine; Comorbidity; Cross-Sectional Studies; Depression; Female; Humans; Male; Methadone; New South Wales; Opiate Substitution Treatment; Opioid-Related Disorders; Prevalence; Sleep Initiation and Maintenance Disorders; Sleepiness; Young Adult | 2019 |
Age related medication for addiction treatment (MAT) use for opioid use disorder among Medicaid-insured patients in New York.
Topics: Adolescent; Adult; Age Factors; Buprenorphine; Drug Utilization; Female; Humans; Male; Medicaid; Methadone; Middle Aged; Naltrexone; New York; Opiate Substitution Treatment; Opioid-Related Disorders; United States; Young Adult | 2019 |
Psycho-physiological response to pain among individuals with comorbid pain and opioid use disorder: Implications for patients with prolonged abstinence.
Topics: Adaptation, Psychological; Adult; Analgesics, Opioid; Buprenorphine; Chronic Pain; Female; Humans; Male; Methadone; Middle Aged; Opiate Substitution Treatment; Opioid-Related Disorders; Time Factors | 2019 |
Interventions for the Treatment of Neonatal Abstinence Syndrome.
Topics: Analgesics, Opioid; Buprenorphine; Female; Humans; Infant, Newborn; Male; Methadone; Morphine; Neonatal Abstinence Syndrome; Opiate Substitution Treatment; Pregnancy; Pregnancy Complications; Treatment Outcome | 2019 |
Mortality and causes of death among patients with opioid use disorder receiving opioid agonist treatment: a national register study.
Topics: Adult; Autopsy; Buprenorphine; Cause of Death; Female; Humans; Male; Methadone; Middle Aged; Opiate Substitution Treatment; Opioid-Related Disorders; Registries | 2019 |
A New Way Forward in the Emergency Department.
Topics: Adult; Aged; Aged, 80 and over; Buprenorphine; Emergency Service, Hospital; Female; Forecasting; Humans; Male; Methadone; Middle Aged; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Practice Guidelines as Topic; United States | 2019 |
Legal and policy changes urgently needed to increase access to opioid agonist therapy in the United States.
Topics: Buprenorphine; Drug Overdose; Health Policy; Health Services Accessibility; Humans; Methadone; Opiate Substitution Treatment; Opioid Epidemic; Opioid-Related Disorders; Social Determinants of Health; United States | 2019 |
Transitioning Hospitalized Patients with Opioid Use Disorder from Methadone to Buprenorphine without a Period of Opioid Abstinence Using a Microdosing Protocol.
Topics: Adult; Buprenorphine; Dose-Response Relationship, Drug; Drug Substitution; Female; Humans; Male; Methadone; Middle Aged; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Outcome and Process Assessment, Health Care; Substance Withdrawal Syndrome | 2019 |
A national survey of approaches to manage the ICU patient with opioid use disorder.
Topics: Analgesics, Opioid; Buprenorphine; Critical Care; Critical Illness; Hospitalization; Hospitals; Humans; Hypnotics and Sedatives; Intensive Care Units; Methadone; Naloxone; Opioid-Related Disorders; Outpatients; Practice Guidelines as Topic; Surveys and Questionnaires; United States | 2019 |
Opioid receptor-mediated changes in the NMDA receptor in developing rat and chicken.
Topics: Analgesics, Opioid; Animals; Buprenorphine; Cerebellum; Chickens; Female; Methadone; Morphine; Pregnancy; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Signal Transduction | 2019 |
Treating perinatal opioid use disorder in rural settings: Challenges and opportunities.
Topics: Adult; Analgesics, Opioid; Buprenorphine; Female; Humans; Methadone; New Hampshire; Opiate Substitution Treatment; Opioid-Related Disorders; Perinatal Care; Practice Guidelines as Topic; Pregnancy; Pregnancy Complications; Pregnant Women; Rural Population; Vermont | 2019 |
High Accumulation of Methadone Compared with Buprenorphine in Fetal Rat Brain after Maternal Exposure.
Topics: Analgesics, Opioid; Animals; Body Weight; Brain; Buprenorphine; Female; Fetus; Male; Maternal-Fetal Exchange; Methadone; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Sprague-Dawley | 2019 |
Patient perceptions of treatment with medication treatment for opioid use disorder (MOUD) in the Vermont hub-and-spoke system.
Topics: Adult; Aged; Aged, 80 and over; Buprenorphine; Female; Health Services Accessibility; Humans; Male; Methadone; Middle Aged; Naloxone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Patient Satisfaction; Vermont; Young Adult | 2019 |
A comparison of adherence, outcomes, and costs among opioid use disorder Medicaid patients treated with buprenorphine and methadone: A view from the payer perspective.
Topics: Adult; Buprenorphine; Emergency Service, Hospital; Female; Health Care Costs; Humans; Male; Medicaid; Methadone; Middle Aged; Narcotics; Opiate Substitution Treatment; Opioid-Related Disorders; Outcome Assessment, Health Care; Patient Compliance; United States | 2019 |
Evaluation of a Nurse-Led Program for Rural Pregnant Women With Opioid Use Disorder to Improve Maternal-Neonatal Outcomes.
Topics: Adult; Buprenorphine; Databases, Factual; Female; Hospitals, Community; Humans; Infant Health; Massachusetts; Maternal Health; Maternal Health Services; Methadone; Neonatal Abstinence Syndrome; Opiate Substitution Treatment; Opioid-Related Disorders; Practice Patterns, Nurses'; Pregnancy; Program Evaluation; Retrospective Studies; Rural Population; Treatment Outcome; Young Adult | 2019 |
Use of naltrexone in treating opioid use disorder in pregnancy.
Topics: Abortion, Spontaneous; Adult; Analgesics, Opioid; Buprenorphine; Case-Control Studies; Female; Humans; Infant, Newborn; Methadone; Naltrexone; Narcotic Antagonists; Neonatal Abstinence Syndrome; Opiate Substitution Treatment; Opioid-Related Disorders; Pregnancy; Pregnancy Complications; Prospective Studies; Stillbirth; Young Adult | 2020 |
Risk assessment of using off-label morphine sulfate in a population-based retrospective cohort of opioid-dependent patients.
Topics: Analgesics, Opioid; Buprenorphine; Delivery of Health Care; Humans; Male; Methadone; Morphine; Off-Label Use; Opiate Substitution Treatment; Opioid-Related Disorders; Retrospective Studies; Risk Assessment | 2020 |
Initiating opioid agonist treatment for opioid use disorder nationally in the Veterans Health Administration: Who gets what?
Topics: Adult; Age Factors; Analgesics, Opioid; Black People; Buprenorphine; Confidence Intervals; Correlation of Data; Cross-Sectional Studies; Female; Humans; Male; Methadone; Middle Aged; Odds Ratio; Opioid-Related Disorders; Patient Admission; Veterans Health Services | 2020 |
US ED Opioid-Related Visits Increase, While Use of Medication for Opioid Use Disorder Undetectable, 2011-2016.
Topics: Buprenorphine; Drug Overdose; Emergency Service, Hospital; Humans; Methadone; Naltrexone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Practice Patterns, Physicians'; Retrospective Studies; United States | 2020 |
Prenatal exposure to opioid maintenance treatment and neonatal outcomes: Nationwide registry studies from the Czech Republic and Norway.
Topics: Adult; Buprenorphine; Child Development; Czech Republic; Female; Humans; Infant, Newborn; Logistic Models; Methadone; Neonatal Abstinence Syndrome; Norway; Opiate Substitution Treatment; Opioid-Related Disorders; Pregnancy; Pregnancy Complications; Prenatal Exposure Delayed Effects; Registries; Young Adult | 2019 |
Patient Barriers and Facilitators to Medications for Opioid Use Disorder in Primary Care.
Topics: Adult; Analgesics, Opioid; Buprenorphine; Female; Health Services Accessibility; Humans; Male; Methadone; Middle Aged; Naltrexone; Opiate Substitution Treatment; Opioid-Related Disorders; Primary Health Care; Young Adult | 2019 |
Factors impeding switching from methadone to buprenorphine in heroin users receiving methadone maintenance therapy - A naturalistic cohort study.
Topics: Adult; Analgesics, Opioid; Buprenorphine; Buprenorphine, Naloxone Drug Combination; Comorbidity; Female; Heroin Dependence; Humans; Male; Methadone; Opiate Substitution Treatment; Retrospective Studies; Taiwan | 2019 |
Innovations in efforts to expand treatment for opioid use disorder.
Topics: Adult; Aged; Aged, 80 and over; Analgesics, Opioid; Buprenorphine; Female; Humans; Male; Methadone; Middle Aged; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Practice Guidelines as Topic; Therapies, Investigational; United States | 2019 |
Drug screening during pregnancy: Urine dip cups measure up.
Topics: Amphetamines; Analgesics, Opioid; Benzodiazepines; Buprenorphine; Cocaine; Female; Humans; Laboratories, Hospital; Methadone; Pregnancy; Pregnancy Complications; Substance Abuse Detection; Substance-Related Disorders; Urinalysis | 2019 |
Fentanyl exposure and preferences among individuals starting treatment for opioid use disorder.
Topics: Adult; Analgesics, Opioid; Buprenorphine; Drug Overdose; Female; Fentanyl; Heroin; Humans; Male; Methadone; Middle Aged; Narcotic Antagonists; Opioid-Related Disorders; Surveys and Questionnaires; Treatment Outcome | 2019 |
Comparison between methadone and buprenorphine within the QUAD protocol for perioperative analgesia in cats undergoing ovariohysterectomy.
Topics: Analgesia; Animals; Buprenorphine; Cat Diseases; Cats; Female; Humans; Hysterectomy; Methadone; Ovariectomy | 2019 |
Optimising opioid substitution therapy in the prison environment.
Topics: Age Factors; Buprenorphine; Comorbidity; Continuity of Patient Care; Delayed-Action Preparations; Drug Administration Schedule; England; Hepatitis C; HIV Infections; Humans; Mental Disorders; Methadone; Naltrexone; Narcotics; Needle Sharing; Opiate Substitution Treatment; Opioid-Related Disorders; Prisons; Quality Improvement; Social Work; Wales | 2019 |
Underutilization of medications to treat opioid use disorder: What role does stigma play?
Topics: Buprenorphine; Health Policy; Health Services Accessibility; Health Services Misuse; Humans; Methadone; Opiate Substitution Treatment; Patient Acceptance of Health Care; Social Stigma; Treatment Outcome; United States | 2019 |
Salivary cortisol levels relate to cognitive performance in children prenatally exposed to methadone or buprenorphine.
Topics: Analgesics, Opioid; Buprenorphine; Child; Child Development; Cohort Studies; Female; Humans; Hydrocortisone; Hypothalamo-Hypophyseal System; Intelligence; Male; Methadone; Opiate Substitution Treatment; Pregnancy; Prenatal Exposure Delayed Effects; Wechsler Scales | 2020 |
Perceptions of extended-release naltrexone, methadone, and buprenorphine treatments following release from jail.
Topics: Adult; Analgesics, Opioid; Buprenorphine; Continuity of Patient Care; Delayed-Action Preparations; Female; Health Services Accessibility; Humans; Interviews as Topic; Male; Methadone; Middle Aged; Naltrexone; Opiate Substitution Treatment; Opioid-Related Disorders; Patient Satisfaction; Prisoners; Qualitative Research; Socioeconomic Factors | 2019 |
Relationship of County Opioid Epidemic Severity to Changes in Access to Substance Use Disorder Treatment, 2009-2017.
Topics: Analgesics, Opioid; Buprenorphine; Health Services Accessibility; Humans; Logistic Models; Medicaid; Methadone; Multivariate Analysis; Opiate Substitution Treatment; Opioid Epidemic; Opioid-Related Disorders; Patient Protection and Affordable Care Act; United States | 2020 |
Reductions in emergency department presentations associated with opioid agonist treatment vary by geographic location: A retrospective study in New South Wales, Australia.
Topics: Adult; Analgesics, Opioid; Australia; Buprenorphine; Cohort Studies; Emergency Service, Hospital; Female; Humans; Male; Methadone; Middle Aged; New South Wales; Opiate Substitution Treatment; Opioid-Related Disorders; Retrospective Studies | 2019 |
Characteristics and Receipt of Medication Treatment Among Young Adults Who Experience a Nonfatal Opioid-Related Overdose.
Topics: Adolescent; Adult; Age Distribution; Analgesics, Opioid; Buprenorphine; Databases, Factual; Drug Overdose; Female; Humans; Male; Massachusetts; Methadone; Naltrexone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Proportional Hazards Models; Retrospective Studies; Time-to-Treatment; Young Adult | 2020 |
Methadone, Buprenorphine, or Detoxification for Management of Perinatal Opioid Use Disorder: A Cost-Effectiveness Analysis.
Topics: Buprenorphine; Cost-Benefit Analysis; Decision Support Techniques; Female; Humans; Methadone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Pregnancy; Pregnancy Complications; Prenatal Care | 2019 |
Harm reduction drug policy in Israel: what has been accomplished and what still needs to be done?
Topics: Age Factors; Buprenorphine; Cannabis; Harm Reduction; Health Policy; Humans; Israel; Methadone; Needle-Exchange Programs; Opiate Substitution Treatment; Substance Abuse, Intravenous | 2019 |
Comparison of pre-pulse inhibition, tactile discrimination learning and barrel cortical neural response in adult male rats following chronic exposure to morphine, methadone and buprenorphine.
Topics: Animals; Auditory Perception; Buprenorphine; Cerebral Cortex; Discrimination Learning; Male; Methadone; Morphine; Neurons; Prepulse Inhibition; Rats; Stereotyped Behavior; Touch Perception | 2019 |
Characteristics and current clinical practices of opioid treatment programs in the United States.
Topics: Analgesics, Opioid; Buprenorphine; Female; Humans; Male; Mass Screening; Methadone; Naltrexone; Opiate Substitution Treatment; Opioid-Related Disorders; Substance Abuse Treatment Centers; Surveys and Questionnaires; Telemedicine; United States | 2019 |
Medications for opioid use disorders: clinical and pharmacological considerations.
Topics: Buprenorphine; Humans; Methadone; Naltrexone; Opioid-Related Disorders | 2020 |
An ethical analysis of medication treatment for opioid use disorder (MOUD) for persons who are incarcerated.
Topics: Analgesics, Opioid; Beneficence; Buprenorphine; Correctional Facilities; Evidence-Based Practice; Health Services Accessibility; Humans; Mental Health Services; Methadone; Naltrexone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Personal Autonomy; Prisoners; Public Health; Social Justice | 2020 |
Buprenorphine compared with methadone in opioid-dependent pregnant women: How does it affect neonatal abstinence syndrome?
Topics: Adult; Buprenorphine; Female; Humans; Infant; Infant, Newborn; Length of Stay; Methadone; Narcotic Antagonists; Neonatal Abstinence Syndrome; Opiate Substitution Treatment; Opioid-Related Disorders; Pregnancy; Pregnant Women | 2019 |
Multimodal assessment of sleep in men and women during treatment for opioid use disorder.
Topics: Adult; Analgesics, Opioid; Buprenorphine; Cohort Studies; Ecological Momentary Assessment; Electroencephalography; Female; Humans; Male; Methadone; Middle Aged; Monitoring, Ambulatory; Opiate Substitution Treatment; Opioid-Related Disorders; Sleep Wake Disorders; Smartphone | 2020 |
Help Is on the Way: Medicare Coverage of Opioid Treatment Programs.
Topics: Aged; Analgesics, Opioid; Buprenorphine; Humans; Medicare; Methadone; Naltrexone; Opioid-Related Disorders; United States | 2020 |
Opioid use disorder in Germany: healthcare costs of patients in opioid maintenance treatment.
Topics: Adult; Buprenorphine; Cost of Illness; Female; Germany; Health Care Costs; Humans; Male; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders | 2019 |
Long-time effects of prenatal morphine, tramadol, methadone, and buprenorphine exposure on seizure and anxiety in immature rats.
Topics: Animals; Animals, Newborn; Anxiety; Behavior, Animal; Buprenorphine; Female; Locomotion; Male; Maze Learning; Methadone; Morphine; Narcotics; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Wistar; Seizures; Sex Factors; Tramadol | 2020 |
The cascade of care for opioid use disorder: a retrospective study in British Columbia, Canada.
Topics: Adult; Analgesics, Opioid; British Columbia; Buprenorphine; Female; Hepatitis C; Humans; Ill-Housed Persons; Male; Methadone; Middle Aged; Naloxone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Retrospective Studies; Young Adult | 2020 |
Investigating opioid-related fatalities in southern Sweden: contact with care-providing authorities and comparison of substances.
Topics: Adult; Aged; Analgesics, Opioid; Buprenorphine; Female; Fentanyl; Heroin; Humans; Male; Methadone; Middle Aged; Opiate Substitution Treatment; Opioid-Related Disorders; Registries; Retrospective Studies; Sweden | 2020 |
Impact of Medications for Opioid Use Disorder on Discharge Against Medical Advice Among People Who Inject Drugs Hospitalized for Infective Endocarditis.
Topics: Adult; Analgesics, Opioid; Buprenorphine; Endocarditis; Female; Humans; Injections; Male; Methadone; Middle Aged; Naltrexone; Narcotic Antagonists; Odds Ratio; Opiate Substitution Treatment; Opioid-Related Disorders; Patient Compliance; Patient Discharge; Retrospective Studies; Treatment Refusal | 2020 |
Predictors of Medication Utilization for Opioid Use Disorder Among Medicaid-Insured HIV Patients in New York.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Analgesics, Opioid; Buprenorphine; Drug Utilization; Female; HIV Infections; Humans; Logistic Models; Male; Medicaid; Methadone; Middle Aged; New York; Opiate Substitution Treatment; Opioid-Related Disorders; United States | 2020 |
Acute Pain Management for Patients Receiving Medication-Assisted Therapy.
Topics: Acute Pain; Adult; Aged; Aged, 80 and over; Analgesics; Buprenorphine; Female; Humans; Male; Methadone; Middle Aged; Opiate Substitution Treatment; Opioid-Related Disorders; Pain Management; Practice Guidelines as Topic; United States | 2019 |
Substance use disorder treatment services for pregnant and postpartum women in residential and outpatient settings.
Topics: Buprenorphine; Female; Health Services Accessibility; Humans; Methadone; Opioid-Related Disorders; Outpatients; Postpartum Period; Pregnancy; Substance Abuse Treatment Centers; United States | 2020 |
Initial Management of Incarcerated Pregnant Women With Opioid Use Disorder.
Topics: Buprenorphine; Female; Humans; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Pregnancy; Pregnant Women; Prevalence; Prisoners; Prisons; United States | 2020 |
Epidemiology of pediatric buprenorphine and methadone exposures reported to the poison centers.
Topics: Buprenorphine; Child; Child, Preschool; Databases, Factual; Environmental Exposure; Female; Humans; Infant; Male; Methadone; Narcotic Antagonists; Poison Control Centers; Poisoning; United States | 2020 |
Comparative Effectiveness of Different Treatment Pathways for Opioid Use Disorder.
Topics: Adolescent; Adult; Analgesics, Opioid; Behavior Therapy; Buprenorphine; Comparative Effectiveness Research; Critical Pathways; Female; Humans; Male; Methadone; Middle Aged; Opiate Substitution Treatment; Opioid-Related Disorders; Proportional Hazards Models; Retrospective Studies; Substance Abuse Treatment Centers; Treatment Outcome; United States; Young Adult | 2020 |
Differences in Availability and Use of Medications for Opioid Use Disorder in Residential Treatment Settings in the United States.
Topics: Analgesics, Opioid; Buprenorphine; Cross-Sectional Studies; Health Services Accessibility; Humans; Medicaid; Methadone; Naltrexone; Opiate Substitution Treatment; Opioid-Related Disorders; Residential Treatment; Substance Abuse Treatment Centers; United States | 2020 |
Opioid agonist treatment and fatal overdose risk in a state-wide US population receiving opioid use disorder services.
Topics: Adolescent; Adult; Analgesics, Opioid; Buprenorphine; Cause of Death; Cohort Studies; Drug Overdose; Female; Humans; Male; Maryland; Methadone; Middle Aged; Naltrexone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Proportional Hazards Models; Retrospective Studies; Time Factors; United States; Young Adult | 2020 |
Association between mortality rates and medication and residential treatment after in-patient medically managed opioid withdrawal: a cohort analysis.
Topics: Adolescent; Adult; Buprenorphine; Cohort Studies; Drug Overdose; Female; Humans; Male; Massachusetts; Methadone; Middle Aged; Naltrexone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Proportional Hazards Models; Residential Treatment; Retrospective Studies; Substance Withdrawal Syndrome; Young Adult | 2020 |
Responses among substance abuse treatment providers to the opioid epidemic in the USA: Variations in buprenorphine and methadone treatment by geography, operational, and payment characteristics, 2007-16.
Topics: Analgesics, Opioid; Buprenorphine; Cost of Illness; Geography; Healthcare Disparities; Humans; Medicaid; Methadone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid Epidemic; Opioid-Related Disorders; Substance Abuse Treatment Centers; Surveys and Questionnaires; United States | 2020 |
Opioid use disorder incidence and treatment among incarcerated pregnant women in the United States: results from a national surveillance study.
Topics: Analgesics, Opioid; Buprenorphine; Cross-Sectional Studies; Female; Humans; Incidence; Methadone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Population Surveillance; Pregnancy; Prisoners; Prisons; United States | 2020 |
Emerging therapies for the treatment of neonatal abstinence syndrome.
Topics: Analgesics, Opioid; Buprenorphine; Female; Humans; Infant, Newborn; Methadone; Morphine; Neonatal Abstinence Syndrome; Opiate Substitution Treatment; Opioid-Related Disorders; Pregnancy | 2022 |
A mixed-methods analysis of patient safety incidents involving opioid substitution treatment with methadone or buprenorphine in community-based care in England and Wales.
Topics: Analgesics, Opioid; Buprenorphine; England; Humans; Medication Errors; Methadone; Narcotic Antagonists; Opiate Substitution Treatment; Patient Safety; Safety Management; Wales | 2020 |
The effect of Medicaid expansion on use of opioid agonist treatment and the role of provider capacity constraints.
Topics: Analgesics, Opioid; Buprenorphine; Health Services Accessibility; Humans; Medicaid; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Patient Protection and Affordable Care Act; Physicians; Socioeconomic Factors; United States | 2020 |
Dual mental health diagnoses predict the receipt of medication-assisted opioid treatment: Associations moderated by state Medicaid expansion status, race/ethnicity and gender, and year.
Topics: Adolescent; Adult; Analgesics, Opioid; Buprenorphine; Diagnosis, Dual (Psychiatry); Ethnicity; Female; Forecasting; Humans; Male; Medicaid; Mental Disorders; Methadone; Middle Aged; Opiate Substitution Treatment; Opioid-Related Disorders; Racial Groups; Sex Factors; United States; Young Adult | 2020 |
The impact of the prescription opioid epidemic on young children: Trends and mortality.
Topics: Analgesics, Opioid; Buprenorphine; Child, Preschool; Epidemics; Female; Fentanyl; Humans; Infant; Male; Methadone; Morphine; Opioid Epidemic; Oxycodone; Poison Control Centers; Prescription Drugs | 2020 |
Methadone, Buprenorphine, or Detoxification for Management of Perinatal Opioid Use Disorder: A Cost-Effectiveness Analysis.
Topics: Buprenorphine; Cost-Benefit Analysis; Female; Humans; Infant, Newborn; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Pregnancy | 2020 |
In Reply.
Topics: Buprenorphine; Cost-Benefit Analysis; Humans; Methadone; Opioid-Related Disorders | 2020 |
HIV care continuum characteristics among people with opioid use disorder and HIV in Vietnam: baseline results from the BRAVO study.
Topics: Adult; Analgesics, Opioid; Anti-Retroviral Agents; Buprenorphine; Continuity of Patient Care; Female; HIV Infections; Humans; Logistic Models; Male; Methadone; Middle Aged; Opiate Substitution Treatment; Opioid-Related Disorders; Patient Acceptance of Health Care; Randomized Controlled Trials as Topic; Vietnam; Viral Load | 2020 |
Opioid agonist treatment and risk of mortality during opioid overdose public health emergency: population based retrospective cohort study.
Topics: Adolescent; Adult; British Columbia; Buprenorphine; Cause of Death; Cohort Studies; Emergencies; Female; Fentanyl; Humans; Illicit Drugs; Male; Methadone; Middle Aged; Mortality; Naloxone; Narcotic Antagonists; Opioid-Related Disorders; Public Health; Retrospective Studies; Risk Assessment; Young Adult | 2020 |
Necrotizing enterocolitis and its association with the neonatal abstinence syndrome.
Topics: Analgesics, Opioid; Buprenorphine; Cohort Studies; Enterocolitis, Necrotizing; Female; Fetal Blood; Gestational Age; Heroin; Humans; Infant, Newborn; Infant, Premature; Male; Methadone; Neonatal Abstinence Syndrome; Opioid-Related Disorders; Pregnancy; Pregnancy Complications; Retrospective Studies | 2020 |
Methadone does not potentiate the effect of doxorubicin in canine tumour cell lines.
Topics: Animals; Antineoplastic Agents; Buprenorphine; Cell Line, Tumor; Cell Proliferation; Dogs; Doxorubicin; Methadone | 2020 |
Opioid use disorder and the COVID 19 pandemic: A call to sustain regulatory easements and further expand access to treatment.
Topics: Betacoronavirus; Buprenorphine; Continuity of Patient Care; Coronavirus Infections; COVID-19; Humans; Methadone; Opioid-Related Disorders; Pandemics; Pharmacists; Pneumonia, Viral; SARS-CoV-2; United States | 2020 |
Association of Racial/Ethnic Segregation With Treatment Capacity for Opioid Use Disorder in Counties in the United States.
Topics: Adult; Buprenorphine; Cross-Sectional Studies; Health Services Accessibility; Humans; Male; Methadone; Narcotic Antagonists; Opioid-Related Disorders; Race Factors; Social Segregation; Spatial Analysis; Surveys and Questionnaires; United States | 2020 |
Diagnosis and Treatment of Opioid Use Disorder in 2020.
Topics: Adult; Buprenorphine; Delayed-Action Preparations; Diagnostic and Statistical Manual of Mental Disorders; Drug and Narcotic Control; Harm Reduction; Humans; Methadone; Naltrexone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Psychotherapy; Sensitivity and Specificity | 2020 |
Non-Opioid Substances Acute Poisonings with Suicidal Intent in Patients with Opioid Use Disorder.
Topics: Adolescent; Adult; Analgesics, Opioid; Antidepressive Agents; Antipsychotic Agents; Benzodiazepines; Buprenorphine; Caustics; Cross-Sectional Studies; Drug Overdose; Female; Heroin Dependence; Humans; Male; Methadone; Middle Aged; Opiate Substitution Treatment; Opioid-Related Disorders; Poisoning; Republic of North Macedonia; Substance Abuse, Intravenous; Suicide, Attempted; Tramadol; Young Adult | 2020 |
Naloxone should remain the appropriate antidote to treat opioid overdose.
Topics: Analgesics, Opioid; Antidotes; Buprenorphine; Drug Overdose; Humans; Methadone; Naloxone; Prospective Studies; Respiratory Insufficiency | 2020 |
Living a normal life? Follow-up study of women who had been in opioid maintenance treatment during pregnancy.
Topics: Buprenorphine; Child; Female; Follow-Up Studies; Humans; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Pregnancy | 2020 |
Self-Help Groups And Medication Use In Opioid Addiction Treatment: A National Analysis.
Topics: Adult; Analgesics, Opioid; Buprenorphine; Humans; Methadone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Self-Help Groups | 2020 |
Receipt of training about medication for opioid use disorder from pharmaceutical manufacturers: A preliminary study of Florida criminal problem-solving and dependency court staff.
Topics: Analgesics, Opioid; Buprenorphine; Criminals; Cross-Sectional Studies; Drug Industry; Florida; Humans; Judicial Role; Methadone; Naltrexone; Opiate Substitution Treatment; Opioid-Related Disorders; Problem Solving | 2020 |
Prenatal exposure to methadone or buprenorphine impairs cognitive performance in young adult rats.
Topics: Animals; Animals, Newborn; Buprenorphine; Cognition; Female; Infusion Pumps, Implantable; Male; Memory; Methadone; Opiate Substitution Treatment; Pregnancy; Prenatal Exposure Delayed Effects; Random Allocation; Rats; Rats, Sprague-Dawley | 2020 |
The real-world impact of dosing of methadone and buprenorphine in retention on opioid agonist therapies in Ukraine.
Topics: Adult; Analgesics, Opioid; Buprenorphine; Cohort Studies; Female; Humans; Longitudinal Studies; Male; Methadone; Middle Aged; Opiate Substitution Treatment; Opioid-Related Disorders; Patient Dropouts; Time Factors; Ukraine | 2021 |
Polysubstance use and association with opioid use disorder treatment in the US Veterans Health Administration.
Topics: Adult; Ambulatory Care; Buprenorphine; Cohort Studies; Female; Humans; Male; Methadone; Middle Aged; Opiate Substitution Treatment; Opioid-Related Disorders; Retrospective Studies; Substance-Related Disorders; United States; United States Department of Veterans Affairs; Veterans | 2021 |
TIME TO REVISIT UNEVEN POLICY IN THE UNITED STATES FOR MEDICATION FOR OPIOID USE DISORDER DURING COVID-19.
Topics: Analgesics, Opioid; Betacoronavirus; Buprenorphine; Coronavirus Infections; COVID-19; Humans; Methadone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Pandemics; Physical Examination; Pneumonia, Viral; Practice Guidelines as Topic; SARS-CoV-2; United States | 2020 |
Assessment of Racial and Ethnic Disparities in the Use of Medication to Treat Opioid Use Disorder Among Pregnant Women in Massachusetts.
Topics: Adult; Black or African American; Buprenorphine; Female; Healthcare Disparities; Hispanic or Latino; Humans; Massachusetts; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Pregnancy; Pregnancy Complications; Racial Groups; White People | 2020 |
Commentary on Gibson et al. (2020): Medications for opioid use disorder- access, retention, and safety.
Topics: Buprenorphine; England; Humans; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Patient Safety; Wales | 2020 |
Pain outcomes among patients after cesarean consuming buprenorphine or methadone and opioid-naïve patients.
Topics: Analgesics, Opioid; Buprenorphine; Female; Humans; Methadone; Opioid-Related Disorders; Pain; Pregnancy | 2020 |
[Opioid Agonist Therapy (OAT) for opioid dependency].
Topics: Analgesics, Opioid; Buprenorphine; Europe; Humans; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders | 2020 |
Scotland's 2009-2015 methadone-prescription cohort: Quintiles for daily dose of prescribed methadone and risk of methadone-specific death.
Topics: Buprenorphine; Female; Humans; Methadone; Middle Aged; Opiate Substitution Treatment; Opioid-Related Disorders; Prescriptions; Scotland | 2021 |
Incidence and factors associated with discontinuation of opioid agonist therapy among people who inject drugs in Australia.
Topics: Analgesics, Opioid; Buprenorphine; Buprenorphine, Naloxone Drug Combination; Cross-Sectional Studies; Humans; Incidence; Infant, Newborn; Male; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Substance Abuse, Intravenous | 2021 |
Switching opioid-dependent patients in substitution treatment from racemic methadone, levomethadone and buprenorphine to slow-release oral morphine: Analysis of the switching process in routine care.
Topics: Administration, Oral; Adult; Buprenorphine; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Substitution; Female; Humans; Male; Methadone; Middle Aged; Morphine; Opiate Substitution Treatment; Opioid-Related Disorders; Treatment Outcome; Young Adult | 2020 |
Lessons from COVID 19: Are we finally ready to make opioid treatment accessible?
Topics: Analgesics, Opioid; Buprenorphine; Coronavirus Infections; COVID-19; Humans; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Pandemics; Pneumonia, Viral; Telemedicine; Vulnerable Populations | 2020 |
Comparison of buprenorphine and methadone in the management of maternal opioid use disorder in full term pregnancies.
Topics: Birth Weight; Buprenorphine; Delivery, Obstetric; Female; Humans; Infant, Newborn; Length of Stay; Male; Maternal Age; Methadone; Narcotic Antagonists; Neonatal Abstinence Syndrome; Opioid-Related Disorders; Pregnancy; Pregnancy Complications; Pregnancy Outcome; United States | 2020 |
Medications for opioid use disorder in pregnancy in a state women's prison facility.
Topics: Adult; Analgesics, Opioid; Buprenorphine; Female; Humans; Methadone; North Carolina; Opioid-Related Disorders; Pregnancy; Prisons; Retrospective Studies; Young Adult | 2020 |
Stepped Care for Opioid Use Disorder Train the Trainer (SCOUTT) initiative: Expanding access to medication treatment for opioid use disorder within Veterans Health Administration facilities.
Topics: Ambulatory Care Facilities; Analgesics, Opioid; Buprenorphine; Delivery of Health Care; Health Services Accessibility; Hospitals, Veterans; Humans; Implementation Science; Mental Health Services; Methadone; Naltrexone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Pain Clinics; Primary Health Care; Teacher Training; United States; United States Department of Veterans Affairs; Veterans Health Services | 2020 |
Medication treatment for opioid use disorder and community pharmacy: Expanding care during a national epidemic and global pandemic.
Topics: Analgesics, Opioid; Australia; Betacoronavirus; Buprenorphine; Canada; Community Pharmacy Services; Coronavirus Infections; COVID-19; Delivery of Health Care; Health Services Accessibility; Humans; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Pandemics; Pharmacists; Pneumonia, Viral; SARS-CoV-2; Scope of Practice; United Kingdom; United States | 2020 |
Primary Care Providers And Specialists Deliver Comparable Buprenorphine Treatment Quality.
Topics: Analgesics, Opioid; Buprenorphine; Humans; Methadone; North Carolina; Opiate Substitution Treatment; Opioid-Related Disorders; Primary Health Care; Specialization; United States | 2020 |
Adverse neonatal outcomes associated with maternal severe mental health diagnoses and opioid use.
Topics: Analgesics, Opioid; Buprenorphine; Female; Humans; Infant, Newborn; Mental Health; Methadone; Neonatal Abstinence Syndrome; Opioid-Related Disorders; Pregnancy; Pregnancy Complications; Retrospective Studies | 2020 |
Comparing perspectives on medication treatment for opioid use disorder between national samples of primary care trainee physicians and attending physicians.
Topics: Buprenorphine; Drug Prescriptions; Female; Humans; Male; Methadone; Naltrexone; Opiate Substitution Treatment; Opioid-Related Disorders; Physicians, Primary Care; Primary Health Care; Surveys and Questionnaires; United States | 2020 |
Relative Cost Differences of Initial Treatment Strategies for Newly Diagnosed Opioid Use Disorder: A Cohort Study.
Topics: Adolescent; Adult; Aged; Ambulatory Care; Behavior Therapy; Buprenorphine; Cohort Studies; Female; Health Care Costs; Hospitalization; Humans; Male; Medicare; Methadone; Middle Aged; Naltrexone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Retrospective Studies; United States | 2020 |
Integration of a contraception clinic into an opioid treatment setting to improve contraception knowledge, accessibility and uptake: a pilot study.
Topics: Adolescent; Adult; Analgesics, Opioid; Buprenorphine; Contraception; Delivery of Health Care, Integrated; Family Planning Services; Female; Health Knowledge, Attitudes, Practice; Health Services Accessibility; Humans; Long-Acting Reversible Contraception; Methadone; Middle Aged; Opiate Substitution Treatment; Opioid-Related Disorders; Outcome and Process Assessment, Health Care; Patient Acceptance of Health Care; Pilot Projects; Pregnancy; Young Adult | 2020 |
A Comparison of Medication for Opioid Use Disorder Treatment Strategies for Persons Who Inject Drugs With Invasive Bacterial and Fungal Infections.
Topics: Adult; Aged; Anti-Bacterial Agents; Antifungal Agents; Bacterial Infections; Buprenorphine; Continuity of Patient Care; Drug Users; Female; Humans; Invasive Fungal Infections; Male; Medication Adherence; Methadone; Middle Aged; Opiate Substitution Treatment; Opioid-Related Disorders; Patient Readmission; Retrospective Studies; Substance Abuse, Intravenous; Tertiary Care Centers; Time Factors; Treatment Outcome; Young Adult | 2020 |
Comparative effectiveness of buprenorphine-naloxone versus methadone for treatment of opioid use disorder: a population-based observational study protocol in British Columbia, Canada.
Topics: Adult; Analgesics, Opioid; British Columbia; Buprenorphine; Buprenorphine, Naloxone Drug Combination; Humans; Methadone; Observational Studies as Topic; Opiate Substitution Treatment; Opioid-Related Disorders; Retrospective Studies | 2020 |
A mixed-method comparison of physician-reported beliefs about and barriers to treatment with medications for opioid use disorder.
Topics: Analgesics, Opioid; Attitude of Health Personnel; Buprenorphine; Delayed-Action Preparations; Drug and Narcotic Control; Female; Humans; Insurance Coverage; Insurance, Health; Male; Mental Disorders; Methadone; Naltrexone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Practice Patterns, Physicians'; Specialization; United States | 2020 |
Beliefs about medications for opioid use disorder among Florida criminal problem-solving court & dependency court staff.
Topics: Analgesics, Opioid; Buprenorphine; Case Managers; Counselors; Criminal Law; Criminals; Cross-Sectional Studies; Female; Florida; Health Knowledge, Attitudes, Practice; Humans; Male; Methadone; Naltrexone; Opiate Substitution Treatment; Opioid-Related Disorders | 2020 |
Retention and outcomes for clients attending a methadone clinic in a resource-constrained setting: a mixed methods prospective cohort study in Imphal, Northeast India.
Topics: Adolescent; Adult; Buprenorphine; Cohort Studies; Female; Humans; India; Male; Methadone; Middle Aged; Opiate Substitution Treatment; Opioid-Related Disorders; Prospective Studies; Retention in Care; Treatment Outcome; Young Adult | 2020 |
Perspectives of clients and providers on factors influencing opioid agonist treatment uptake among HIV-positive people who use drugs in Indonesia, Ukraine, and Vietnam: HPTN 074 study.
Topics: Adult; Analgesics, Opioid; Anti-HIV Agents; Buprenorphine; Drug Overdose; Female; Health Services Accessibility; HIV Infections; Humans; Indonesia; Interviews as Topic; Male; Methadone; Opioid-Related Disorders; Patient Acceptance of Health Care; Substance Abuse, Intravenous; Ukraine; Vietnam | 2020 |
Commentary on Farnum et al.: Agonist maintenance in Ukraine-ambivalence, success and moving forward.
Topics: Analgesics, Opioid; Buprenorphine; Humans; Maintenance; Methadone; Ukraine | 2021 |
Revising our attitudes towards agonist medications and their diversion in a time of pandemic.
Topics: Analgesics, Opioid; Buprenorphine; Coronavirus Infections; COVID-19; Drug Overdose; Humans; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Pandemics; Pneumonia, Viral; Practice Patterns, Physicians'; Prescription Drug Diversion | 2020 |
Implementation of a Medication for Addiction Treatment (MAT) and Linkage Program by Leveraging Community Partnerships and Medical Toxicology Expertise.
Topics: Adult; Buprenorphine; Female; Humans; Interprofessional Relations; Male; Methadone; Middle Aged; Naltrexone; Opiate Substitution Treatment; Opioid-Related Disorders; Patient Care Team; United States | 2021 |
Mechanisms of QT prolongation by buprenorphine cannot be explained by direct hERG channel block.
Topics: Buprenorphine; Electrocardiography; Ether-A-Go-Go Potassium Channels; HEK293 Cells; Humans; Induced Pluripotent Stem Cells; Ion Channel Gating; Methadone; Myocytes, Cardiac; Naloxone; Naltrexone; Potassium Channel Blockers; Receptors, Opioid; Time Factors | 2020 |
Rapid transitional response to the COVID-19 pandemic by opioid agonist treatment programs in Ukraine.
Topics: Analgesics, Opioid; Buprenorphine; COVID-19; Drug Overdose; Humans; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Patient Dropouts; Telemedicine; Ukraine | 2021 |
Depression Disorders in Patients with Chronic Hepatitis C.
Topics: Antiviral Agents; Bosnia and Herzegovina; Buprenorphine; Depression; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Methadone; Ribavirin | 2020 |
Medication treatment for opioid use disorder in the age of COVID-19: Can new regulations modify the opioid cascade?
Topics: Black or African American; Buprenorphine; COVID-19; Health Services Accessibility; Healthcare Disparities; Hispanic or Latino; Humans; Legislation, Drug; Methadone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Pandemics; Telemedicine; United States | 2021 |
System-level factors shaping the implementation of "hub and spoke" systems to expand MOUD in rural areas.
Topics: Analgesics, Opioid; Buprenorphine; Humans; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders | 2021 |
COVID-19 and treating incarcerated populations for opioid use disorder.
Topics: Buprenorphine; COVID-19; Humans; Massachusetts; Methadone; Naltrexone; Opiate Substitution Treatment; Opioid-Related Disorders; Prisoners; Prisons; Public Health; Telemedicine | 2021 |
The provision of counseling to patients receiving medications for opioid use disorder: Telehealth innovations and challenges in the age of COVID-19.
Topics: Buprenorphine; Continuity of Patient Care; Counseling; COVID-19; Delivery of Health Care; Humans; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Rhode Island; Telemedicine | 2021 |
Unprecedented need and recommendations for harnessing data to guide future policy and practice for opioid use disorder treatment following COVID-19.
Topics: Big Data; Buprenorphine; COVID-19; Drug Overdose; Health Policy; Humans; Methadone; Narcotic Antagonists; Narcotics; Opiate Substitution Treatment; Opioid-Related Disorders; Pandemics; United States | 2021 |
Prevalence and Geographic Distribution of Obstetrician-Gynecologists Who Treat Medicaid Enrollees and Are Trained to Prescribe Buprenorphine.
Topics: Adult; Buprenorphine; Cross-Sectional Studies; Female; Humans; Infant, Newborn; Male; Medicaid; Methadone; Narcotic Antagonists; Neonatal Abstinence Syndrome; Obstetrics; Opioid-Related Disorders; Physicians; Pregnancy; Pregnancy Complications; Prevalence; Rural Health; Staff Development; United States | 2020 |
Hepatitis C Virus Screening among Medicaid-Insured Individuals with Opioid Use Disorder across Substance Use Disorder Treatment Settings.
Topics: Analgesics, Opioid; Buprenorphine; Hepacivirus; Humans; Medicaid; Methadone; New York; Opiate Substitution Treatment; Opioid-Related Disorders; United States | 2021 |
Delivery dose of methadone, but not buprenorphine, is associated with the risk and severity of neonatal opiate withdrawal syndrome.
Topics: Buprenorphine; Female; Humans; Infant, Newborn; Methadone; Pregnancy; Pregnancy Complications; Prospective Studies; Retrospective Studies | 2020 |
Reimagining patient-centered care in opioid treatment programs: Lessons from the Bronx during COVID-19.
Topics: Appointments and Schedules; Buprenorphine; Clinical Decision-Making; COVID-19; Drug Overdose; Health Services Accessibility; Humans; Methadone; Narcotic Antagonists; Narcotic-Related Disorders; New York City; Opiate Substitution Treatment; Pandemics; Patient-Centered Care; Physical Distancing; Substance Abuse Detection | 2021 |
The relationship between dissociative symptoms and the medications used in the treatment of opioid use disorder.
Topics: Buprenorphine; Female; Humans; Male; Methadone; Naltrexone; Ohio; Opiate Substitution Treatment; Opioid-Related Disorders; Patient Health Questionnaire | 2021 |
Shortages of Medication-Assisted Treatment for Opioid Use Disorder in Underserved Michigan Counties: Examining the Influence of Urbanicity and Income Level.
Topics: Buprenorphine; Humans; Methadone; Michigan; Opioid-Related Disorders; Rural Population | 2020 |
Are point-of-care urine drug testing devices suitable for antenatal drug screening? A study verifying the Alere® Drug Screen Test Cup for the detection of six classes of drug in a pregnant population.
Topics: Amphetamine; Benzodiazepines; Buprenorphine; Chromatography, Liquid; Cocaine; Female; Gas Chromatography-Mass Spectrometry; Humans; Illicit Drugs; Methadone; Narcotics; Opiate Alkaloids; Point-of-Care Testing; Pregnancy; Substance Abuse Detection; Substance-Related Disorders; Tandem Mass Spectrometry; Urinalysis | 2021 |
Methadone dose at delivery is not an accurate proxy for fetal exposure.
Topics: Buprenorphine; Humans; Infant, Newborn; Methadone; Opioid-Related Disorders; Substance Withdrawal Syndrome | 2021 |
Reply.
Topics: Buprenorphine; Methadone | 2021 |
Cost effectiveness of buprenorphine vs. methadone for pregnant people with opioid use disorder.
Topics: Analgesics, Opioid; Buprenorphine; Cerebral Palsy; Cost-Benefit Analysis; Female; Fetal Growth Retardation; Humans; Infant, Newborn; Methadone; Neonatal Abstinence Syndrome; Opiate Substitution Treatment; Opioid-Related Disorders; Pregnancy; Premature Birth | 2022 |
Managing opioid withdrawal precipitated by buprenorphine with buprenorphine.
Topics: Analgesics, Opioid; Buprenorphine; Humans; Methadone; Narcotic Antagonists; Opioid-Related Disorders; Substance Withdrawal Syndrome | 2021 |
Determinants of interest in extended-released buprenorphine: A survey among 366 French patients treated with buprenorphine or methadone.
Topics: Adolescent; Adult; Analgesics, Opioid; Buprenorphine; Delayed-Action Preparations; Female; France; Humans; Injections; Male; Methadone; Middle Aged; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Patient Preference; Surveys and Questionnaires; Young Adult | 2021 |
An anesthesiologist-led inpatient buprenorphine initiative.
Topics: Analgesics, Opioid; Anesthesiologists; Buprenorphine; Humans; Inpatients; Methadone; Naltrexone; Opioid-Related Disorders | 2021 |
Medication for Adolescents and Young Adults With Opioid Use Disorder.
Topics: Adolescent; Analgesics, Opioid; Buprenorphine; Humans; Methadone; Naltrexone; Opioid-Related Disorders; Young Adult | 2021 |
Medications for opioid use disorder among American Indians and Alaska natives: Availability and use across a national sample.
Topics: Adolescent; Adult; Alaskan Natives; American Indian or Alaska Native; Buprenorphine; Databases, Factual; Facilities and Services Utilization; Female; Health Services Accessibility; Humans; Male; Methadone; Middle Aged; Opiate Substitution Treatment; Opioid-Related Disorders; United States; Young Adult | 2021 |
Imperfect progress: treatment options for opioid dependence.
Topics: Buprenorphine; HIV Infections; Humans; Maintenance; Methadone; Naloxone; Nitriles; Opioid-Related Disorders; Referral and Consultation; Vietnam | 2021 |
What Differs between Patients under Methadone and under Buprenorphine for Opioid Use Disorder (OUD) in Daily Clinical Practice in France? A Short Report.
Topics: Analgesics, Opioid; Buprenorphine; Cross-Sectional Studies; Female; France; Humans; Male; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders | 2021 |
Beyond abstinence and relapse II: momentary relationships between stress, craving, and lapse within clusters of patients with similar patterns of drug use.
Topics: Affect; Buprenorphine; Cocaine-Related Disorders; Craving; Ecological Momentary Assessment; Female; Humans; Male; Methadone; Middle Aged; Opiate Substitution Treatment; Opioid-Related Disorders; Recurrence; Smartphone; Stress, Psychological | 2021 |
Changes in opioid-related deaths following increased access to opioid substitution treatment.
Topics: Analgesics, Opioid; Buprenorphine; Humans; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders | 2021 |
Leveraging COVID-19 to sustain regulatory flexibility in the treatment of opioid use disorder.
Topics: Buprenorphine; COVID-19; Health Services Needs and Demand; Humans; Methadone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; SARS-CoV-2; United States | 2021 |
Comparison of psychological symptoms and cognitive functions in patients under maintenance treatment with methadone or buprenorphine, current opioid users and healthy subjects.
Topics: Analgesics, Opioid; Buprenorphine; Cognition; Healthy Volunteers; Humans; Methadone; Opioid-Related Disorders | 2021 |
Association of Opioid Use Disorder Treatment With Alcohol-Related Acute Events.
Topics: Accidental Falls; Adult; Alcohol-Related Disorders; Alcoholism; Analgesics, Opioid; Buprenorphine; Central Nervous System Depressants; Drug Overdose; Ethanol; Female; Humans; Male; Methadone; Middle Aged; Naltrexone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Protective Factors; Wounds and Injuries; Young Adult | 2021 |
Familial perceptions of appropriate treatment types and goals for a family member who has opioid use disorder.
Topics: Adult; Analgesics, Opioid; Buprenorphine; Family; Female; Goals; Humans; Male; Methadone; Middle Aged; Naltrexone; Opiate Substitution Treatment; Opioid-Related Disorders; Perception; Professional-Family Relations; Treatment Outcome | 2021 |
Impacts of the COVID-19 pandemic on healthcare access among patients receiving medication for opioid use disorder.
Topics: Adult; Buprenorphine; Clinical Trials as Topic; COVID-19; Cross-Sectional Studies; Female; Harm Reduction; Health Services Accessibility; Humans; Latent Class Analysis; Male; Methadone; Naloxone; New England; Opiate Substitution Treatment; Substance-Related Disorders | 2021 |
Perceived social support in patients with chronic pain with and without opioid use disorder and role of medication for opioid use disorder.
Topics: Adult; Analgesics, Opioid; Buprenorphine; Chronic Pain; Female; Humans; Male; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Social Support; Treatment Outcome; White People | 2021 |
COVID-19: A catalyst for change in telehealth service delivery for opioid use disorder management.
Topics: Adult; Alcoholism; Analgesics, Opioid; Buprenorphine; COVID-19; Delivery of Health Care; Feasibility Studies; Female; Health Services Accessibility; Humans; Ill-Housed Persons; Male; Marijuana Abuse; Methadone; Middle Aged; Opiate Substitution Treatment; Opioid-Related Disorders; Public Health; Quarantine; San Francisco; SARS-CoV-2; Sodium Oxybate; Substance-Related Disorders; Telemedicine; Telephone | 2021 |
Payer strategies to ensure access to care for individuals with opioid use disorder during COVID-19.
Topics: Ambulatory Care; Buprenorphine; COVID-19; Health Services Accessibility; Humans; Insurance, Health, Reimbursement; Methadone; Naltrexone; Opiate Substitution Treatment; Opioid-Related Disorders; Telemedicine; United States | 2021 |
Chronic Pain Among Patients With an Opioid Use Disorder.
Topics: Adolescent; Adult; Buprenorphine; Chronic Pain; Cross-Sectional Studies; Female; Humans; Male; Methadone; Middle Aged; Norway; Opiate Substitution Treatment; Opioid-Related Disorders; Prevalence; Young Adult | 2021 |
Trends in Urine Drug Monitoring Among Persons Receiving Long-Term Opioids and Persons with Opioid Use Disorder in the United States.
Topics: Adult; Analgesics, Opioid; Buprenorphine; Chronic Pain; Cross-Sectional Studies; Drug Monitoring; Female; Humans; Male; Methadone; Middle Aged; Naltrexone; Opioid-Related Disorders; United States; Young Adult | 2021 |
Using telehealth to improve buprenorphine access during and after COVID-19: A rapid response initiative in Rhode Island.
Topics: Buprenorphine; COVID-19; Emergency Service, Hospital; Health Services Accessibility; Humans; Methadone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Rhode Island; Telemedicine | 2021 |
Association between methadone or buprenorphine use during medically supervised opioid withdrawal and extended-release injectable naltrexone induction failure.
Topics: Analgesics, Opioid; Buprenorphine; Delayed-Action Preparations; Humans; Injections, Intramuscular; Methadone; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders | 2021 |
Conceptualizing stigma in contexts of pregnancy and opioid misuse: A qualitative study with women and healthcare providers in Ohio.
Topics: Adult; Buprenorphine; Female; Health Personnel; Humans; Infant, Newborn; Methadone; Neonatal Abstinence Syndrome; Ohio; Opiate Substitution Treatment; Opioid-Related Disorders; Pregnancy; Pregnancy Complications | 2021 |
Quality of Life in Opioid Replacement Therapy: A Naturalistic Cross-Sectional Comparison of Methadone/Levomethadone, Buprenorphine, and Diamorphine Patients.
Topics: Buprenorphine; Cross-Sectional Studies; Heroin; Humans; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Quality of Life | 2021 |
Cost-effectiveness of Treatments for Opioid Use Disorder.
Topics: Adult; Buprenorphine; Combined Modality Therapy; Cost-Benefit Analysis; Delayed-Action Preparations; Female; Humans; Male; Methadone; Middle Aged; Naloxone; Opiate Overdose; Opiate Substitution Treatment; Opioid-Related Disorders; Psychotherapy; Treatment Outcome | 2021 |
Leveraging Telehealth in the United States to Increase Access to Opioid Use Disorder Treatment in Pregnancy and Postpartum During the COVID-19 Pandemic.
Topics: Adult; Buprenorphine; Comorbidity; Comprehensive Health Care; COVID-19; Delivery of Health Care; Evidence-Based Medicine; Female; Follow-Up Studies; Guideline Adherence; Health Services Accessibility; Humans; Infant, Newborn; Methadone; Opioid-Related Disorders; Pregnancy; Pregnancy Complications; Puerperal Disorders; Referral and Consultation; Risk Assessment; Telemedicine; User-Computer Interface | 2021 |
Medication Treatment of Active Opioid Use Disorder in Veterans With Cirrhosis.
Topics: Age Factors; Alcoholism; Analgesics, Opioid; Buprenorphine; Cohort Studies; Female; Hepatitis C, Chronic; Humans; Liver Cirrhosis; Liver Cirrhosis, Alcoholic; Male; Methadone; Middle Aged; Mortality; Multivariate Analysis; Opiate Substitution Treatment; Opioid-Related Disorders; Proportional Hazards Models; United States; United States Department of Veterans Affairs; Veterans | 2021 |
Impact of opioid maintenance treatment during pregnancy on neonatal birth weight and head circumference.
Topics: Analgesics, Opioid; Birth Weight; Buprenorphine; Female; Humans; Infant; Infant, Newborn; Male; Methadone; Opiate Substitution Treatment; Pregnancy; Pregnancy Complications; Retrospective Studies | 2021 |
Methadone and buprenorphine discontinuation among postpartum women with opioid use disorder.
Topics: Adult; Analgesics, Opioid; Black or African American; Buprenorphine; Correctional Facilities; Ethnicity; Female; Hispanic or Latino; Humans; Kaplan-Meier Estimate; Medication Adherence; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Postpartum Period; Pregnancy; Pregnancy Complications; Proportional Hazards Models; White People; Young Adult | 2021 |
Evaluation of functional status among patients undergoing maintenance treatments for opioid use disorders.
Topics: Buprenorphine; Functional Status; Humans; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Seroepidemiologic Studies | 2021 |
The effect of buprenorphine vs methadone on sleep breathing disorders.
Topics: Adult; Buprenorphine; Dose-Response Relationship, Drug; Female; Humans; Male; Methadone; Middle Aged; Opiate Substitution Treatment; Opioid-Related Disorders; Sleep Apnea Syndromes | 2021 |
European Court of Human Rights.
Topics: Adult; Buprenorphine; Europe; Female; Hospitals, State; Human Rights; Humans; Male; Methadone; Middle Aged; Opiate Substitution Treatment; Opioid-Related Disorders; Russia; Substance Withdrawal Syndrome | 2020 |
[Methadone and buprenorphine maintenance therapy of opioid dependence - 10 years of experience].
Topics: Buprenorphine; Humans; Methadone; Opioid-Related Disorders; Patient Discharge; Treatment Outcome | 2021 |
Incarceration and compulsory rehabilitation impede use of medication for opioid use disorder and HIV care engagement in Vietnam.
Topics: Analgesics, Opioid; Buprenorphine; HIV Infections; Humans; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Vietnam | 2022 |
Benzodiazepine Use in Opioid Maintenance Treatment Programme: Risks and Clinical Outcomes.
Topics: Adult; Analgesics, Opioid; Anxiety; Benzodiazepines; Buprenorphine; Cross-Sectional Studies; Diazepam; Female; Humans; Male; Mental Disorders; Methadone; Middle Aged; Narcotics; Opiate Substitution Treatment; Opioid-Related Disorders; Portugal; Prevalence; Sleep Initiation and Maintenance Disorders; Surveys and Questionnaires; Treatment Outcome | 2021 |
Methadone and buprenorphine treatment in United States jails and prisons: lessons from early adopters.
Topics: Analgesics, Opioid; Buprenorphine; Humans; Jails; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Prisons; United States | 2021 |
Impact of treatment duration on mortality among Veterans with opioid use disorder in the United States Veterans Health Administration.
Topics: Analgesics, Opioid; Buprenorphine; Duration of Therapy; Humans; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; United States; Veterans; Veterans Health | 2021 |
Outcomes associated with the use of medications for opioid use disorder during pregnancy.
Topics: Analgesics, Opioid; Buprenorphine; Female; Humans; Infant; Infant, Newborn; Methadone; Neonatal Abstinence Syndrome; Opioid-Related Disorders; Pregnancy; Pregnancy Complications; Premature Birth; Retrospective Studies | 2021 |
Affective decision-making in children prenatally exposed to opioids.
Topics: Analgesics, Opioid; Buprenorphine; Child; Child Development; Cognition; Decision Making; Female; Humans; Male; Methadone; Norway; Pregnancy; Prenatal Exposure Delayed Effects; Prospective Studies | 2021 |
The Abuse Characteristics of Amphetamine-Type Stimulants in Patients Receiving Methadone Maintenance Treatment and Buprenorphine Maintenance Treatment.
Topics: Adult; Amphetamine; Amphetamine-Related Disorders; Buprenorphine; Female; Humans; Male; Methadone; Retrospective Studies; Surveys and Questionnaires | 2021 |
Characterizing initiation, use, and discontinuation of extended-release buprenorphine in a nationally representative United States commercially insured cohort.
Topics: Analgesics, Opioid; Buprenorphine; Delayed-Action Preparations; Humans; Methadone; Naltrexone; Opiate Substitution Treatment; Opioid-Related Disorders; United States | 2021 |
Increased utilization of buprenorphine and methadone in 2018 compared to 2015 among Seattle-area persons who inject drugs.
Topics: Buprenorphine; Drug Users; Humans; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Pharmaceutical Preparations; Substance Abuse, Intravenous | 2021 |
Transporting to treatment: Evaluating the effectiveness of a mobile engagement unit.
Topics: Buprenorphine; Humans; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Retrospective Studies; United States | 2021 |
Characterizing opioid agonist treatment discontinuation trends in British Columbia, Canada, 2012-2018.
Topics: Analgesics, Opioid; British Columbia; Buprenorphine; Humans; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Retrospective Studies | 2021 |
Addressing Racial And Ethnic Disparities In The Use Of Medications For Opioid Use Disorder.
Topics: Analgesics, Opioid; Buprenorphine; Humans; Methadone; Opiate Substitution Treatment; Opioid Epidemic; Opioid-Related Disorders; United States | 2021 |
"It could potentially be dangerous... but nothing else has seemed to help me.": Patient and clinician perspectives on benzodiazepine use in opioid agonist treatment.
Topics: Analgesics, Opioid; Benzodiazepines; Buprenorphine; Humans; Methadone; Opioid-Related Disorders | 2021 |
Racial inequity in methadone dose at delivery in pregnant women with opioid use disorder.
Topics: Analgesics, Opioid; Buprenorphine; Female; Humans; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Pregnancy; Pregnancy Complications; Pregnant Women | 2021 |
Methadone, Buprenorphine, Oxycodone, Fentanyl and Tramadol in Multiple Postmortem Matrices.
Topics: Analgesics, Opioid; Autopsy; Buprenorphine; Fentanyl; Methadone; Oxycodone; Tramadol | 2022 |
A retrospective cohort study of medication dispensing at pharmacies: Administration matters!
Topics: Buprenorphine; Humans; Methadone; Opiate Substitution Treatment; Pharmacies; Retrospective Studies | 2021 |
Impact of intensity of behavioral treatment, with or without medication treatment, for opioid use disorder on HIV outcomes in persons with HIV.
Topics: Buprenorphine; Cohort Studies; HIV Infections; Humans; Methadone; Opioid-Related Disorders | 2022 |
Gender disparities in opioid treatment progress in methadone versus counseling.
Topics: Analgesics, Opioid; Buprenorphine; Counseling; Female; Humans; Male; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; United States | 2021 |
Pronounced Regional Disparities in United States Methadone Distribution.
Topics: Analgesics, Opioid; Buprenorphine; Humans; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Pain; Telemedicine; United States | 2022 |
Treatment of opioid dependence with depot buprenorphine (CAM2038) in custodial settings.
Topics: Analgesics, Opioid; Buprenorphine; Female; Humans; Male; Methadone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders | 2022 |
Plausibility of patient-centred care in high-intensity methadone treatment: reflections of providers and patients.
Topics: Buprenorphine; Humans; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Patient-Centered Care | 2021 |
Stigmatization of medications for opioid use disorder in 12-step support groups and participant responses.
Topics: Analgesics, Opioid; Buprenorphine; Humans; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Self-Help Groups; Stereotyping | 2022 |
Structural and organizational factors shaping access to medication treatment for opioid use disorder in community supervision.
Topics: Analgesics, Opioid; Buprenorphine; Health Services Accessibility; Humans; Methadone; Naltrexone; Opiate Substitution Treatment; Opioid-Related Disorders | 2021 |
Criminal problem-solving and civil dependency court policies regarding medications for opioid use disorder.
Topics: Analgesics, Opioid; Buprenorphine; Child; Criminals; Humans; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Policy | 2022 |
An examination between treatment type and treatment retention in persons with opioid and co-occurring alcohol use disorders.
Topics: Alcoholism; Analgesics, Opioid; Buprenorphine; Humans; Methadone; Naltrexone; Opiate Substitution Treatment; Opioid-Related Disorders | 2021 |
Hydromorphone and codeine concentrations in oral fluid specimens from patients receiving substitution therapy with Substitol™ (morphine sulfate).
Topics: Adult; Aged; Aged, 80 and over; Buprenorphine; Codeine; Female; Humans; Hydromorphone; Male; Methadone; Middle Aged; Morphine; Opiate Substitution Treatment; Opioid-Related Disorders; Saliva; Substance Abuse Detection | 2021 |
Acute Pain Management for Patients with Substance Use Disorder Receiving Buprenorphine or Methadone Compared to Patients without Opioid-Dependence Disorder.
Topics: Analgesics, Opioid; Buprenorphine; Humans; Methadone; Opioid-Related Disorders; Pain Management; Pain, Postoperative; Retrospective Studies | 2021 |
Nasal Opioid Agonist Treatment in Patients with Severe Opioid Dependence: A Case Series.
Topics: Analgesics, Opioid; Buprenorphine; Heroin; Humans; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders | 2022 |
Can buprenorphine be used for opioid use disorder during pregnancy?
Topics: Buprenorphine; Female; Humans; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Pregnancy; Pregnancy Complications | 2021 |
Uptake of slow-release oral morphine as opioid agonist treatment among hospitalised patients with opioid use disorder.
Topics: Analgesics, Opioid; Buprenorphine; Humans; Methadone; Morphine; Opiate Substitution Treatment; Opioid-Related Disorders | 2022 |
Relationship between choice of opioid agonist therapy and distance from patients' residences in Taiwan, 2012-2014.
Topics: Adult; Analgesics, Opioid; Buprenorphine; Female; Health Services Accessibility; Humans; Male; Methadone; Middle Aged; Odds Ratio; Opiate Substitution Treatment; Opioid-Related Disorders; Patient Preference; Taiwan | 2021 |
Transition from methadone to subcutaneous buprenorphine depot in patients with opioid use disorder in custodial setting - a case series.
Topics: Administration, Sublingual; Adult; Analgesics, Opioid; Buprenorphine; Delayed-Action Preparations; Germany; Humans; Injections, Subcutaneous; Male; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Prisons; Retrospective Studies | 2021 |
History of Methadone and Buprenorphine Opioid Agonist Therapy Among People Who Died of an Accidental Opioid-Involved Overdose: Rhode Island, January 1, 2018-June 30, 2020.
Topics: Analgesics, Opioid; Buprenorphine; Humans; Methadone; Opiate Overdose; Opiate Substitution Treatment; Opioid-Related Disorders; Risk Factors | 2021 |
Tracing the affordances of long-acting injectable depot buprenorphine: A qualitative study of patients' experiences in Australia.
Topics: Analgesics, Opioid; Buprenorphine; Female; Humans; Male; Methadone; Middle Aged; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Victoria | 2021 |
Buprenorphine Increases HIV-1 Infection In Vitro but Does Not Reactivate HIV-1 from Latency.
Topics: Buprenorphine; HIV Infections; HIV-1; Humans; Leukocytes, Mononuclear; Methadone; Morphine; Nociceptin Receptor; Receptors, Opioid; Virus Activation; Virus Latency; Virus Replication | 2021 |
Treatment of Neonatal Opioid Withdrawal.
Topics: Analgesics, Opioid; Buprenorphine; Humans; Infant, Newborn; Methadone | 2021 |
Opioid Use Disorder and Perinatal Outcomes.
Topics: Adult; Analgesics, Opioid; British Columbia; Buprenorphine; Female; Humans; Incidence; Infant, Newborn; Logistic Models; Longitudinal Studies; Methadone; Naloxone; Neonatal Abstinence Syndrome; Opiate Substitution Treatment; Opioid-Related Disorders; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Premature Birth; Retrospective Studies | 2021 |
Qualitative characterizations of misinformed disclosure reactions to medications for opioid use disorders and their consequences.
Topics: Analgesics, Opioid; Buprenorphine; Disclosure; Humans; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders | 2022 |
Declines and regional variation in opioid distribution by U.S. hospitals.
Topics: Analgesics, Opioid; Buprenorphine; Codeine; Hospitals; Humans; Hydromorphone; Meperidine; Methadone; Morphine; Oxymorphone; United States | 2022 |
A history of opioid abuse: Why buprenorphine is superior for the management of opioid use disorder and pain.
Topics: Analgesics, Opioid; Buprenorphine; Humans; Methadone; Naltrexone; Opiate Substitution Treatment; Opioid-Related Disorders; Pain | 2021 |
Rapid microinduction of sublingual buprenorphine from methadone in an outpatient setting: "A case series".
Topics: Analgesics, Opioid; Buprenorphine; Humans; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Outpatients | 2021 |
Health professionals' attitudes toward medications for opioid use disorder.
Topics: Analgesics, Opioid; Attitude of Health Personnel; Buprenorphine; Humans; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders | 2022 |
A retrospective, observational study on medication for opioid use disorder during pregnancy and risk for neonatal abstinence syndrome.
Topics: Analgesics, Opioid; Buprenorphine; Female; Humans; Infant; Infant, Newborn; Methadone; Neonatal Abstinence Syndrome; Opiate Substitution Treatment; Opioid-Related Disorders; Pregnancy; Pregnancy Complications; Retrospective Studies | 2022 |
Perioperative Management of Buprenorphine/Naloxone in a Large, National Health Care System: a Retrospective Cohort Study.
Topics: Analgesics, Opioid; Buprenorphine; Delivery of Health Care; Humans; Male; Methadone; Naloxone; Opiate Substitution Treatment; Opioid-Related Disorders; Retrospective Studies | 2022 |
Methadone vs. Buprenorphine for In-Hospital Initiation: Which Is Better for Outpatient Care Retention in Patients with Opioid Use Disorder?
Topics: Ambulatory Care; Buprenorphine; Hospitals; Humans; Methadone; Opioid-Related Disorders; Outpatients; Retrospective Studies | 2022 |
A national survey of barriers and facilitators to medications for opioid use disorder among legal-involved veterans in the Veterans Health Administration.
Topics: Buprenorphine; Humans; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Veterans; Veterans Health | 2022 |
Using administrative data to predict cessation risk and identify novel predictors among new entrants to opioid agonist treatment.
Topics: Analgesics, Opioid; Buprenorphine; Humans; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Retrospective Studies | 2021 |
A Descriptive analysis of urine drug screen results in patients with opioid use disorder managed in a primary care setting.
Topics: Analgesics, Opioid; Buprenorphine; Buprenorphine, Naloxone Drug Combination; Humans; Methadone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Primary Health Care | 2021 |
Research priorities for expanding access to methadone treatment for opioid use disorder in the United States: A National Institute on Drug Abuse Center for Clinical Trials Network Task Force report.
Topics: Analgesics, Opioid; Buprenorphine; Humans; Methadone; National Institute on Drug Abuse (U.S.); Opiate Substitution Treatment; Opioid-Related Disorders; Research; United States | 2021 |
Spatial proximity and access to buprenorphine or methadone treatment for opioid use disorder in a sample of people misusing opioids in Southern California.
Topics: Analgesics, Opioid; Buprenorphine; Humans; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; United States | 2022 |
Economic analysis of out-of-pocket costs among people in opioid agonist treatment: A cross-sectional survey in three Australian jurisdictions.
Topics: Analgesics, Opioid; Buprenorphine; Cross-Sectional Studies; Health Expenditures; Humans; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Victoria | 2022 |
Comparing characteristics and outcomes of different opioid agonist treatment modalities among opioid-dependent federal men correctional populations in Canada.
Topics: Analgesics, Opioid; Buprenorphine; Buprenorphine, Naloxone Drug Combination; Canada; Humans; Male; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Retrospective Studies | 2022 |
Histological Changes Observed in Placentas Exposed to Medication-Assisted Treatment.
Topics: Buprenorphine; Female; Humans; Infant, Newborn; Methadone; Opiate Substitution Treatment; Placenta; Pregnancy; Pregnancy Complications | 2021 |
Compulsivity and impulsivity in opioid dependence.
Topics: Buprenorphine; Cross-Sectional Studies; Heroin Dependence; Humans; Impulsive Behavior; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders | 2021 |
Perception of a New Prolonged-Release Buprenorphine Formulation in Patients with Opioid Use Disorder: The PREDEPO Study.
Topics: Adult; Analgesics, Opioid; Buprenorphine; Buprenorphine, Naloxone Drug Combination; Cross-Sectional Studies; Humans; Male; Methadone; Middle Aged; Opiate Substitution Treatment; Opioid-Related Disorders; Perception; Retrospective Studies | 2022 |
Prior use of medications for opioid use disorder in ED patients with opioid overdose: prevalence, misuse and overdose severity.
Topics: Adult; Analgesics, Opioid; Buprenorphine; Female; Hospital Mortality; Humans; Length of Stay; Logistic Models; Male; Methadone; Middle Aged; Naltrexone; Opiate Overdose; Opiate Substitution Treatment; Opioid-Related Disorders; Prevalence; Prospective Studies | 2022 |
Assessing the determinants of completing OAT induction and long-term retention: A population-based study in British Columbia, Canada.
Topics: Analgesics, Opioid; Avena; British Columbia; Buprenorphine; Humans; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Retrospective Studies | 2022 |
Rates of opioid agonist treatment prescribing in provincial prisons in Ontario, Canada, 2015-2018: a repeated cross-sectional analysis.
Topics: Adolescent; Adult; Analgesics, Opioid; Buprenorphine; Cross-Sectional Studies; Humans; Methadone; Ontario; Opiate Substitution Treatment; Opioid-Related Disorders; Prisons | 2021 |
Self-harm and suicide during and after opioid agonist treatment among primary care patients in England: a cohort study.
Topics: Adolescent; Adult; Buprenorphine; England; Female; Follow-Up Studies; Hospitalization; Humans; Male; Methadone; Middle Aged; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Primary Health Care; Retrospective Studies; Self-Injurious Behavior; Suicide; Young Adult | 2022 |
Examining differences in retention on medication for opioid use disorder: An analysis of Ohio Medicaid data.
Topics: Adolescent; Analgesics, Opioid; Buprenorphine; Female; Humans; Medicaid; Methadone; Naltrexone; Ohio; Opiate Substitution Treatment; Opioid-Related Disorders; Pregnancy; Quality of Life; United States; Young Adult | 2022 |
Methadone initiation in a bridge clinic for opioid withdrawal and opioid treatment program linkage: a case report applying the 72-hour rule.
Topics: Analgesics, Opioid; Buprenorphine; Female; Humans; Methadone; Middle Aged; Opiate Substitution Treatment; Opioid-Related Disorders; United States | 2021 |
Opioid Use Disorder Treatment Initiation and Continuation: a Qualitative Study of Patients Who Received Addiction Consultation and Hospital-Based Providers.
Topics: Analgesics, Opioid; Buprenorphine; Hospitals; Humans; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Referral and Consultation | 2022 |
Variation in Initiation, Engagement, and Retention on Medications for Opioid Use Disorder Based on Health Insurance Plan Design.
Topics: Adolescent; Adult; Aged; Analgesics, Opioid; Buprenorphine; Cohort Studies; Cost Sharing; Female; Health Expenditures; Humans; Insurance, Health; Male; Medication Adherence; Methadone; Middle Aged; Naltrexone; Opiate Substitution Treatment; Opioid-Related Disorders; United States; Young Adult | 2022 |
Harm Reduction for Patients With Substance Use Disorders.
Topics: Adult; Buprenorphine; Contraception; Drug Overdose; Female; Harm Reduction; Heroin; Humans; Male; Methadone; Methamphetamine; Naloxone; Opioid-Related Disorders; Pregnancy; Quality of Life; Referral and Consultation; Substance-Related Disorders | 2022 |
Real-world effectiveness of pharmacological treatments of opioid use disorder in a national cohort.
Topics: Analgesics, Opioid; Buprenorphine; Cohort Studies; Female; Humans; Male; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders | 2022 |
Perioperative Management of Patients on Maintenance Medication for Addiction Treatment: The Development of an Institutional Guideline.
Topics: Analgesics, Opioid; Buprenorphine; Humans; Methadone; Naltrexone; Opiate Substitution Treatment; Opioid-Related Disorders | 2022 |
"
Topics: Analgesics, Opioid; Buprenorphine; Humans; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Patient Preference; Safety-net Providers; United States | 2022 |
Risk factors for preterm birth among gravid individuals receiving buprenorphine for opioid use disorder.
Topics: Buprenorphine; Female; Humans; Infant, Newborn; Methadone; Opioid-Related Disorders; Placenta; Pregnancy; Premature Birth; Retrospective Studies; Risk Factors | 2022 |
Evaluating how has care been affected by the Ontario COVID-19 Opioid Agonist Treatment Guidance: Patients' and prescribers' experiences with changes in unsupervised dosing.
Topics: Analgesics, Opioid; Buprenorphine; COVID-19; Humans; Methadone; Ontario; Opiate Substitution Treatment; Opioid-Related Disorders; Pandemics | 2022 |
Examining the cost and impact of dosing fees among clients in opioid agonist treatment: Results from a cross-sectional survey of Australian treatment clients.
Topics: Analgesics, Opioid; Australia; Buprenorphine; Cross-Sectional Studies; Humans; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders | 2022 |
Comparison Between Preoperative Methadone and Buprenorphine Use on Postoperative Opioid Requirement: A Retrospective Cohort Study.
Topics: Analgesics, Opioid; Buprenorphine; Humans; Methadone; Opioid-Related Disorders; Pain, Postoperative; Retrospective Studies | 2022 |
Understanding and co-managing medication treatment options for opioid use disorder.
Topics: Analgesics, Opioid; Buprenorphine; Humans; Methadone; Naltrexone; Opiate Substitution Treatment; Opioid-Related Disorders | 2022 |
Association of Medication-Assisted Therapy with New Onset of Cardiac Arrhythmia in Patients Diagnosed with Opioid Use Disorders.
Topics: Analgesics, Opioid; Arrhythmias, Cardiac; Buprenorphine; Humans; Methadone; Naltrexone; Opiate Substitution Treatment; Opioid-Related Disorders; Retrospective Studies | 2022 |
Methadone and buprenorphine: The search for a non-addictive opioid.
Topics: Analgesics, Opioid; Buprenorphine; Humans; Methadone; Opioid-Related Disorders | 2022 |
Pharmacological Management of Heroin Withdrawal Syndrome: A Century of Expert Opinions in Cecil Textbook of Medicine.
Topics: Analgesics, Opioid; Buprenorphine; Clonidine; Expert Testimony; Heroin; Humans; Methadone; Narcotics; Opioid-Related Disorders; Substance Withdrawal Syndrome | 2022 |
Opioid use disorder in anaesthesia and intensive care: Prevention, diagnosis and management.
Topics: Analgesics, Opioid; Anesthesia; Australia; Buprenorphine; Critical Care; Drug Tolerance; Humans; Methadone; Opioid-Related Disorders | 2022 |
Trends in the severity of opioid use disorder during pregnancy over time.
Topics: Analgesics, Opioid; Buprenorphine; Female; Humans; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Pregnancy; Pregnancy Complications; Retrospective Studies | 2022 |
Association Between Increased Dispensing of Opioid Agonist Therapy Take-Home Doses and Opioid Overdose and Treatment Interruption and Discontinuation.
Topics: Adult; Analgesics, Opioid; Buprenorphine; COVID-19; Female; Humans; Male; Medication Adherence; Methadone; Naloxone; Narcotic Antagonists; Ontario; Opiate Overdose; Opiate Substitution Treatment; Practice Patterns, Physicians'; Propensity Score; Retrospective Studies | 2022 |
Developing a cascade of care for opioid use disorder among individuals in jail.
Topics: Analgesics, Opioid; Buprenorphine; Drug Overdose; Humans; Jails; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; United States | 2022 |
Acceptance of medications for opioid use disorder in recovery housing programs in Missouri.
Topics: Analgesics, Opioid; Buprenorphine; Housing; Humans; Methadone; Missouri; Naltrexone; Opiate Substitution Treatment; Opioid-Related Disorders | 2022 |
Factors associated with retention on medications for opioid use disorder among a cohort of adults seeking treatment in the community.
Topics: Adult; Analgesics, Opioid; Buprenorphine; Drug Overdose; Female; Humans; Male; Methadone; Naltrexone; Opiate Substitution Treatment; Opioid-Related Disorders; Pain; Prospective Studies | 2022 |
Duration of use and outcomes among people with opioid use disorder initiating methadone and buprenorphine in Ontario: a population-based propensity-score matched cohort study.
Topics: Analgesics, Opioid; Buprenorphine; Buprenorphine, Naloxone Drug Combination; Cohort Studies; Drug Overdose; Humans; Methadone; Ontario; Opiate Overdose; Opiate Substitution Treatment; Opioid-Related Disorders | 2022 |
Impact of the COVID-19 pandemic on the provision of take-home doses of opioid agonist therapy in Ontario, Canada: A population-based time-series analysis.
Topics: Analgesics, Opioid; Buprenorphine; Buprenorphine, Naloxone Drug Combination; COVID-19; Humans; Methadone; Ontario; Opiate Substitution Treatment; Opioid-Related Disorders; Pandemics | 2022 |
Microinduction to Buprenorphine from Methadone for Chronic Pain: Outpatient Protocol with Case Examples.
Topics: Analgesics, Opioid; Buprenorphine; Chronic Pain; Humans; Methadone; Opioid-Related Disorders; Outpatients | 2022 |
Nonmedical use of gabapentin and opioid agonist medications in treatment-seeking individuals with opioid use disorder.
Topics: Analgesics, Opioid; Buprenorphine; Cross-Sectional Studies; Gabapentin; Humans; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders | 2022 |
Undetected Respiratory Depression in People with Opioid Use Disorder.
Topics: Analgesics, Opioid; Buprenorphine; Carbon Dioxide; Drug Overdose; Humans; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Pulmonary Disease, Chronic Obstructive; Respiratory Insufficiency | 2022 |
"You have to take this medication, but then you get punished for taking it:" lack of agency, choice, and fear of medications to treat opioid use disorder across the perinatal period.
Topics: Analgesics, Opioid; Buprenorphine; Child; Fear; Female; Humans; Infant, Newborn; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Pregnancy | 2022 |
How do people who use drugs receiving Opioid Medication Therapy perceive their treatment ? A multicentre study.
Topics: Analgesics, Opioid; Buprenorphine; Cross-Sectional Studies; Female; Humans; Male; Methadone; Opiate Substitution Treatment | 2022 |
Attitudes and beliefs among Georgia addiction treatment staff about medication for opioid use disorder in adolescents, young adults, and adults: a multi-mixed methods study.
Topics: Adolescent; Adult; Aged; Analgesics, Opioid; Buprenorphine; Female; Georgia; Humans; Male; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Reproducibility of Results; Retrospective Studies; Young Adult | 2022 |
"Just give them a choice": Patients' perspectives on starting medications for opioid use disorder in the ED.
Topics: Analgesics, Opioid; Buprenorphine; Emergency Service, Hospital; Humans; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders | 2022 |
Familial support in integrated treatment with antiretroviral therapy and medications for opioid use disorder in Vietnam: A qualitative study.
Topics: Analgesics, Opioid; Buprenorphine; HIV Infections; Humans; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Vietnam | 2022 |
Assessment of Community-Level Vulnerability and Access to Medications for Opioid Use Disorder.
Topics: Analgesics, Opioid; Buprenorphine; COVID-19 Drug Treatment; Cross-Sectional Studies; Health Services Accessibility; Humans; Methadone; Naltrexone; Opiate Substitution Treatment; Opioid-Related Disorders; United States | 2022 |
Association of Duration of Methadone or Buprenorphine Use During Pregnancy With Risk of Nonfatal Drug Overdose Among Pregnant Persons With Opioid Use Disorder in the US.
Topics: Buprenorphine; Drug Overdose; Female; Humans; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Pregnancy | 2022 |
Lessons from the First Wave of COVID-19 for Improved Medications for Opioid Use Disorder (MOUD) Treatment: Benefits of Easier Access, Extended Take Homes, and New Delivery Modalities.
Topics: Analgesics, Opioid; Buprenorphine; COVID-19 Drug Treatment; Humans; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Pharmaceutical Preparations; United States | 2022 |
Long-acting depot buprenorphine in people who are homeless: Views and experiences.
Topics: Analgesics, Opioid; Buprenorphine; Female; Humans; Ill-Housed Persons; Male; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders | 2022 |
Impact of the COVID-19 pandemic on the prevalence of opioid agonist therapy discontinuation in Ontario, Canada: A population-based time series analysis.
Topics: Analgesics, Opioid; Buprenorphine; Buprenorphine, Naloxone Drug Combination; COVID-19; Humans; Methadone; Ontario; Opiate Substitution Treatment; Opioid-Related Disorders; Pandemics; Prevalence; Time Factors | 2022 |
Inflammatory, oxidative stress and cognitive functions in patients under maintenance treatment with methadone or buprenorphine and healthy subjects.
Topics: Analgesics, Opioid; Antioxidants; Buprenorphine; C-Reactive Protein; Cognition; Ferritins; Healthy Volunteers; Humans; Methadone; Oxidative Stress | 2022 |
Consumer access to buprenorphine and methadone in certified community behavioral health centers: A secret shopper study.
Topics: Analgesics, Opioid; Buprenorphine; Humans; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders | 2022 |
Kamini, a little recognised source of illicit opioid: A case series of 12 patients.
Topics: Analgesics, Opioid; Buprenorphine; COVID-19; Humans; Methadone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Pandemics | 2022 |
Impact of prenatal substance use policies on commercially insured pregnant females with opioid use disorder.
Topics: Analgesics, Opioid; Buprenorphine; Female; Humans; Methadone; Opiate Overdose; Opiate Substitution Treatment; Opioid-Related Disorders; Policy; Pregnancy | 2022 |
County-level sociodemographic differences in availability of two medications for opioid use disorder: United States, 2019.
Topics: Analgesics, Opioid; Buprenorphine; Drug Overdose; Humans; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; United States | 2022 |
Buprenorphine uptake during pregnancy following the 2017 guidelines update on prenatal opioid use disorder.
Topics: Analgesics, Opioid; Buprenorphine; Female; Humans; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Pregnancy; Pregnancy Complications | 2022 |
Individual, interpersonal, and neighborhood measures associated with opioid use stigma: Evidence from a nationally representative survey.
Topics: Analgesics, Opioid; Buprenorphine; Humans; Methadone; Naltrexone; Opiate Substitution Treatment; Opioid-Related Disorders; Surveys and Questionnaires | 2022 |
Rapid Extraction and Qualitative Screening of 30 Drugs in Oral Fluid at Concentrations Recommended for the Investigation of DUID Cases.
Topics: 2-Propanol; 3,4-Methylenedioxyamphetamine; Alprazolam; Amphetamines; Buprenorphine; Carisoprodol; Clonazepam; Cocaine; Codeine; Dronabinol; Fentanyl; Hexanes; Hydrocodone; Hydromorphone; Lorazepam; Meprobamate; Methadone; Methamphetamine; Morphine Derivatives; N-Methyl-3,4-methylenedioxyamphetamine; Nordazepam; Oxazepam; Oxycodone; Oxymorphone; Pharmaceutical Preparations; Phencyclidine; Tandem Mass Spectrometry; Temazepam; Tramadol; Zolpidem | 2022 |
Identifying key risk factors for premature discontinuation of opioid use disorder treatment in the United States: A predictive modeling study.
Topics: Analgesics, Opioid; Buprenorphine; Cross-Sectional Studies; Humans; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Risk Factors; United States | 2022 |
Intra-individual variability and stability of affect and craving among individuals receiving medication treatment for opioid use disorder.
Topics: Adult; Analgesics, Opioid; Buprenorphine; Craving; Humans; Methadone; Opioid-Related Disorders | 2022 |
Differences in the delivery of medications for opioid use disorder during hospitalization by racial categories: A retrospective cohort analysis.
Topics: Adult; Aged; Aged, 80 and over; Analgesics, Opioid; Buprenorphine; COVID-19; Drug Overdose; Female; Hospitalization; Humans; Male; Methadone; Middle Aged; Opiate Substitution Treatment; Opioid-Related Disorders; Pandemics; Retrospective Studies; Young Adult | 2022 |
Attitudes on Methadone Utilization in the Emergency Department: A Physician Cross-sectional Study.
Topics: Analgesics, Opioid; Attitude; Buprenorphine; Cross-Sectional Studies; Emergency Service, Hospital; Humans; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Physicians | 2022 |
Association between clinically recognized suicidality and subsequent initiation or continuation of medications for opioid use disorder.
Topics: Analgesics, Opioid; Buprenorphine; Humans; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Suicidal Ideation; Suicide | 2022 |
Development of an intravenous low-dose buprenorphine initiation protocol.
Topics: Acute Pain; Analgesics, Opioid; Buprenorphine; Fentanyl; Humans; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Retrospective Studies | 2022 |
Association of Bupropion, Naltrexone, and Opioid Agonist Treatment With Stimulant-Related Admissions Among People With Opioid Use Disorder: A Case-Crossover Analysis.
Topics: Analgesics, Opioid; Buprenorphine; Bupropion; Central Nervous System Stimulants; Cross-Over Studies; Humans; Methadone; Naltrexone; Opiate Substitution Treatment; Opioid-Related Disorders | 2022 |
Opioid Use Disorder and Older Adults: Navigating Treatment Options.
Topics: Aged; Analgesics, Opioid; Buprenorphine; Humans; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders | 2022 |
Consensus-Based Guidance on Opioid Management in Individuals With Advanced Cancer-Related Pain and Opioid Misuse or Use Disorder.
Topics: Analgesics, Opioid; Benzodiazepines; Buprenorphine; Cancer Pain; Consensus; Female; Humans; Male; Methadone; Naloxone; Neoplasms; Opioid-Related Disorders | 2022 |
Laws for expanding access to medications for opioid use disorder: a legal analysis of 16 states & Washington D.C.
Topics: Analgesics, Opioid; Buprenorphine; Health Services Accessibility; Humans; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Washington | 2022 |
Verbal and nonverbal memory in school-aged children born to opioid-dependent mothers.
Topics: Analgesics, Opioid; Buprenorphine; Child; Female; Humans; Longitudinal Studies; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Pregnancy; Prenatal Exposure Delayed Effects; Prospective Studies | 2022 |
A comparison of mortality rates for buprenorphine versus methadone treatments for opioid use disorder.
Topics: Buprenorphine; Drug Overdose; Female; Humans; Male; Methadone; Middle Aged; Opiate Substitution Treatment; Opioid-Related Disorders; United States | 2023 |
Emergency department utilization by individuals with opioid use disorder who were recently incarcerated.
Topics: Analgesics, Opioid; Buprenorphine; Emergency Service, Hospital; Humans; Infant, Newborn; Methadone; Naltrexone; Opiate Substitution Treatment; Opioid-Related Disorders; Prisoners; Retrospective Studies | 2022 |
Changes in Buprenorphine and Methadone Supplies in the US During the COVID-19 Pandemic.
Topics: Buprenorphine; COVID-19 Drug Treatment; Cross-Sectional Studies; Humans; Methadone; Opiate Substitution Treatment; Pandemics | 2022 |
Identifying Clinically Relevant Drug-Drug Interactions With Methadone and Buprenorphine: A Translational Approach to Signal Detection.
Topics: Baclofen; Bayes Theorem; Benzodiazepines; Buprenorphine; Clonidine; Drug Interactions; Fluconazole; Humans; Methadone; Methocarbamol; Opiate Overdose; Opiate Substitution Treatment; Opioid-Related Disorders; Quetiapine Fumarate; Simvastatin | 2022 |
Effects of methadone, buprenorphine, and naltrexone on actigraphy-based sleep-like parameters in male rhesus monkeys.
Topics: Actigraphy; Analgesics, Opioid; Animals; Buprenorphine; Humans; Macaca mulatta; Male; Methadone; Naltrexone; Opiate Substitution Treatment; Opioid-Related Disorders; Sleep | 2022 |
Perspectives Regarding Medications for Opioid Use Disorder Among Individuals with Mental Illness.
Topics: Adult; Analgesics, Opioid; Buprenorphine; Humans; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders | 2023 |
Effect of TRV130 and methadone on fentanyl-vs.-food choice and somatic withdrawal signs in opioid-dependent and post-opioid-dependent rats.
Topics: Analgesics, Opioid; Animals; Buprenorphine; Fentanyl; Male; Methadone; Narcotics; Opioid-Related Disorders; Rats; Receptors, Opioid; Spiro Compounds; Substance Withdrawal Syndrome; Thiophenes | 2022 |
Treatment retention in opioid agonist therapy: comparison of methadone versus buprenorphine/naloxone by analysis of daily-witnessed dispensed medication in a Canadian Province.
Topics: Adolescent; Adult; Analgesics, Opioid; Buprenorphine; Buprenorphine, Naloxone Drug Combination; Canada; Humans; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Retrospective Studies | 2022 |
Analysis of methamphetamine, methadone, tramadol, and buprenorphine in biological samples by ion mobility spectrometry after electromembrane extraction in tandem with slug flow microextraction.
Topics: Buprenorphine; Ion Mobility Spectrometry; Liquid Phase Microextraction; Membranes, Artificial; Methadone; Methamphetamine; Tramadol | 2022 |
Commentary on Savinkina et al.: Reforming drug 'detox' centers-what will it entail and where do we begin?
Topics: Buprenorphine; Humans; Methadone | 2022 |
[Opioid Substitution Treatment in Prisons: Comparison of Cost of Buprenorphine Depot with other Medications - a Health-Economic Calculation].
Topics: Analgesics, Opioid; Buprenorphine; Germany; Humans; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Prisons | 2023 |
Perceptions of buprenorphine barriers and efficacy among nurse practitioners and physician assistants.
Topics: Buprenorphine; Humans; Methadone; Naltrexone; Nurse Practitioners; Opiate Substitution Treatment; Opioid-Related Disorders; Physician Assistants | 2022 |
Differences in orexin-A level in the functional brain network of HUD patients undergoing harm reduction therapy.
Topics: Brain; Buprenorphine; Harm Reduction; Heroin; Heroin Dependence; Humans; Methadone; Orexins | 2022 |
Attitudes toward Medication for Opioid Use Disorder among Substance Use Treatment Providers.
Topics: Analgesics, Opioid; Buprenorphine; Child; Female; Humans; Methadone; Naltrexone; Opiate Substitution Treatment; Opioid-Related Disorders; Pregnancy; Treatment Outcome | 2022 |
Receipt of Telehealth Services, Receipt and Retention of Medications for Opioid Use Disorder, and Medically Treated Overdose Among Medicare Beneficiaries Before and During the COVID-19 Pandemic.
Topics: Aged; Analgesics, Opioid; Buprenorphine; COVID-19; Drug Overdose; Female; Humans; Longitudinal Studies; Male; Medicare; Methadone; Naltrexone; Opiate Substitution Treatment; Opioid-Related Disorders; Pandemics; Telemedicine; United States | 2022 |
Buprenorphine & methadone dosing strategies to reduce risk of relapse in the treatment of opioid use disorder.
Topics: Analgesics, Opioid; Buprenorphine; Buprenorphine, Naloxone Drug Combination; Humans; Methadone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Recurrence | 2022 |
Administration and patient-incurred costs associated with opioid agonist treatment in Norway.
Topics: Analgesics, Opioid; Buprenorphine; Humans; Methadone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders | 2022 |
Flexible Buprenorphine/Naloxone Treatment Models: Safe and Effective in Reducing Opioid Use Among Persons With Prescription Opioid Use Disorder.
Topics: Analgesics, Opioid; Buprenorphine; Buprenorphine, Naloxone Drug Combination; Humans; Methadone; Naloxone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Prescriptions | 2022 |
Diagnosis and treatment of opioid-related disorders in a South African private sector medical insurance scheme: A cohort study.
Topics: Analgesics, Opioid; Buprenorphine; Cohort Studies; Humans; Insurance; Male; Methadone; Opioid-Related Disorders; Private Sector; South Africa; Young Adult | 2022 |
OUD MEETS: A novel program to increase initiation of medications for opioid use disorder and improve outcomes for hospitalized patients being discharged to skilled nursing facilities.
Topics: Analgesics, Opioid; Buprenorphine; Humans; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Patient Discharge; Skilled Nursing Facilities | 2022 |
[Substitution treatments for opiate-dependent users. An experience of the Integrated Addiction Treatment Center in Dakar].
Topics: Analgesics, Opioid; Buprenorphine; Heroin; Heroin Dependence; Humans; Methadone; Opiate Alkaloids; Senegal | 2022 |
Spatial and Nonspatial Factors Associated with Access to Medication for Opioid Use Disorder among Pregnant Women in Massachusetts.
Topics: Analgesics, Opioid; Buprenorphine; Female; Health Services Accessibility; Humans; Massachusetts; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Pregnancy; Pregnant Women | 2022 |
Health care use and spending for Medicaid patients diagnosed with opioid use disorder receiving primary care in Federally Qualified Health Centers and other primary care settings.
Topics: Analgesics, Opioid; Benzodiazepines; Buprenorphine; Buprenorphine, Naloxone Drug Combination; Cross-Sectional Studies; Delivery of Health Care; Humans; Medicaid; Methadone; Naltrexone; Opioid-Related Disorders; Primary Health Care; United States | 2022 |
Methadone and buprenorphine-related deaths among people prescribed and not prescribed Opioid Agonist Therapy during the COVID-19 pandemic in England.
Topics: Analgesics, Opioid; Buprenorphine; Communicable Disease Control; COVID-19; Humans; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Pandemics; Retrospective Studies | 2022 |
Nothing really changed: Arizona patient experience of methadone and buprenorphine access during COVID.
Topics: Analgesics, Opioid; Arizona; Buprenorphine; COVID-19; COVID-19 Drug Treatment; Humans; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Pandemics; Patient Outcome Assessment | 2022 |
Association between jail-based methadone or buprenorphine treatment for opioid use disorder and overdose mortality after release from New York City jails 2011-17.
Topics: Adult; Analgesics, Opioid; Buprenorphine; Drug Overdose; Female; Humans; Jails; Male; Methadone; New York City; Opiate Substitution Treatment; Opioid-Related Disorders; Retrospective Studies; United States | 2023 |
Depot buprenorphine as an opioid agonist therapy in New South Wales correctional centres: a costing model.
Topics: Analgesics, Opioid; Australia; Buprenorphine; Humans; Methadone; New South Wales; Opioid-Related Disorders | 2022 |
The impact of COVID-19 and rapid policy exemptions expanding on access to medication for opioid use disorder (MOUD): A nationwide Veterans Health Administration cohort study.
Topics: Analgesics, Opioid; Buprenorphine; Cohort Studies; COVID-19; COVID-19 Drug Treatment; Health Services Accessibility; Humans; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Veterans Health | 2022 |
Opioid replacement therapy with methadone or buprenorphine effects on male mice reproduction.
Topics: Analgesics, Opioid; Animals; Buprenorphine; Chromatin; Male; Methadone; Mice; Morphine; Morphine Dependence; Opiate Substitution Treatment; Opioid-Related Disorders; Reproduction; Semen; Semen Analysis | 2023 |
Evaluation of the gap in delivery of opioid agonist therapy among individuals with opioid-related health problems: a population-based retrospective cohort study.
Topics: Analgesics, Opioid; Buprenorphine; Humans; Male; Methadone; Ontario; Opiate Substitution Treatment; Opioid-Related Disorders; Retrospective Studies | 2023 |
Buprenorphine versus Methadone for Opioid Use Disorder in Pregnancy.
Topics: Buprenorphine; Cesarean Section; Cohort Studies; Female; Humans; Infant; Infant, Low Birth Weight; Infant, Newborn; Infant, Small for Gestational Age; Live Birth; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Premature Birth; United States | 2022 |
Understanding motivations and use typologies of gabapentin with opioid agonist medications.
Topics: Analgesics, Opioid; Buprenorphine; Cross-Sectional Studies; Gabapentin; Humans; Methadone; Motivation; Opiate Substitution Treatment; Opioid-Related Disorders; Pain | 2023 |
GC-MS Analysis of Methadone and EDDP in Addicted Patients under Methadone Substitution Treatment: Comparison of Urine and Plasma as Biological Samples.
Topics: Buprenorphine; Gas Chromatography-Mass Spectrometry; Humans; Methadone; Opioid-Related Disorders; Pyrrolidines | 2022 |
Association of medication-assisted treatment and short acting opioids with newborn head circumference and birth weight.
Topics: Analgesics, Opioid; Birth Weight; Buprenorphine; Cesarean Section; Female; Humans; Infant, Newborn; Methadone; Pregnancy; United States | 2023 |
Exploring the question of financial incentives for training amongst non-adopters of MOUD in rural primary care.
Topics: Analgesics, Opioid; Buprenorphine; Humans; Methadone; Motivation; Opiate Substitution Treatment; Opioid-Related Disorders; Primary Health Care | 2022 |
Resource utilization and convalescent care cost in neonatal opioid withdrawal syndrome.
Topics: Analgesics, Opioid; Buprenorphine; Child; Hospitalization; Humans; Infant; Infant, Newborn; Length of Stay; Methadone; Neonatal Abstinence Syndrome; Retrospective Studies | 2023 |
The Case for Medication for Opioid Use Disorder during Incarceration as Standard of Care.
Topics: Buprenorphine; Humans; Methadone; Opioid-Related Disorders; Prisoners; Prisons; Standard of Care | 2022 |
Optimally Choosing Medication Type for Patients With Opioid Use Disorder.
Topics: Analgesics, Opioid; Buprenorphine; Buprenorphine, Naloxone Drug Combination; Humans; Methadone; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders | 2023 |
Buprenorphine-naloxone, buprenorphine, and methadone throughout pregnancy in maternal opioid use disorder.
Topics: Analgesics, Opioid; Buprenorphine; Buprenorphine, Naloxone Drug Combination; Female; Humans; Illicit Drugs; Infant, Newborn; Methadone; Mothers; Opioid-Related Disorders; Parturition; Pregnancy; Pregnancy Complications | 2023 |
Outpatient Rapid Microinduction of Sublingual Buprenorphine in 3 Days From Methadone for Opioid Use Disorder.
Topics: Administration, Sublingual; Analgesics, Opioid; Buprenorphine; Humans; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Outpatients | 2022 |
Exploring potential moderators of depressive symptoms and treatment outcomes among patients with opioid use disorder.
Topics: Analgesics, Opioid; Buprenorphine; Depression; Humans; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Quality of Life; Treatment Outcome | 2023 |
How does a clinician approach the pharmacological management of opioid use disorders in pregnant women and pregnant people?
Topics: Analgesics, Opioid; Buprenorphine; Female; Humans; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Pregnancy; Pregnancy Complications; Pregnant Women | 2023 |
Comparative Safety Analysis of Opioid Agonist Treatment in Pregnant Women with Opioid Use Disorder: A Population-Based Study.
Topics: Analgesics, Opioid; Buprenorphine; Female; Humans; Infant, Newborn; Methadone; Neonatal Abstinence Syndrome; Opiate Substitution Treatment; Opioid-Related Disorders; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Pregnant Women; Premature Birth; Retrospective Studies | 2023 |
Access to Medications for Opioid Use Disorder in Rural Versus Urban Veterans Health Administration Facilities.
Topics: Analgesics, Opioid; Buprenorphine; Health Services Accessibility; Humans; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Veterans Health | 2023 |
Changes and trends in medication-assisted treatment in Israel.
Topics: Analgesics, Opioid; Buprenorphine; Humans; Israel; Methadone; Naloxone; Opioid-Related Disorders; Pharmaceutical Preparations | 2023 |
[Buprenorphine depot in opiate use disorder].
Topics: Buprenorphine; Humans; Methadone; Narcotic Antagonists; Opiate Alkaloids; Opioid-Related Disorders | 2023 |
Incremental expenditures attributable to daily dispensation and witnessed ingestion for opioid agonist treatment in British Columbia: 2014-20.
Topics: Analgesics, Opioid; British Columbia; Buprenorphine; COVID-19; Eating; Health Expenditures; Humans; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Pandemics; Retrospective Studies | 2023 |
Exploring patient experience and satisfaction with depot buprenorphine formulations: A mixed-methods study.
Topics: Analgesics, Opioid; Australia; Buprenorphine; Buprenorphine, Naloxone Drug Combination; Humans; Methadone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Patient Outcome Assessment; Patient Satisfaction | 2023 |
Safety and preliminary outcomes of short-acting opioid agonist treatment (sOAT) for hospitalized patients with opioid use disorder.
Topics: Analgesics, Opioid; Buprenorphine; Buprenorphine, Naloxone Drug Combination; Female; Humans; Hydromorphone; Male; Methadone; Naloxone; Opiate Substitution Treatment; Opioid-Related Disorders; Pain | 2023 |
Does opioid agonist treatment reduce overdose mortality risk in people who are older or have physical comorbidities? Cohort study using linked administrative health data in New South Wales, Australia, 2002-17.
Topics: Aged; Analgesics, Opioid; Australia; Buprenorphine; Cohort Studies; Drug Overdose; Humans; Methadone; Middle Aged; New South Wales; Opiate Overdose; Opiate Substitution Treatment; Opioid-Related Disorders; Retrospective Studies | 2023 |
Buprenorphine versus Methadone in Pregnancy.
Topics: Analgesics, Opioid; Buprenorphine; Female; Humans; Methadone; Opioid-Related Disorders; Pregnancy | 2023 |
Buprenorphine versus Methadone in Pregnancy. Reply.
Topics: Analgesics, Opioid; Buprenorphine; Female; Humans; Methadone; Opioid-Related Disorders; Pregnancy | 2023 |
Risk of Experiencing an Overdose Event for Patients Undergoing Treatment With Medication for Opioid Use Disorder.
Topics: Buprenorphine; Drug Overdose; Humans; Methadone; Naltrexone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders | 2023 |
[Opioid substitution therapy and harm reduction].
Topics: Analgesics, Opioid; Buprenorphine; Harm Reduction; Humans; Methadone; Opiate Substitution Treatment | 2022 |
Initiation and Treatment Discontinuation of Medications for Opioid Use Disorder in Pregnant People Compared With Nonpregnant People.
Topics: Adult; Analgesics, Opioid; Buprenorphine; Female; Humans; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Pregnancy; Retrospective Studies; United States | 2023 |
Measurement Approaches to Estimating Methadone Continuity in Opioid Use Disorder Care.
Topics: Analgesics, Opioid; Buprenorphine; Humans; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders | 2023 |
Patients' perceptions of self-administered dosing to opioid agonist treatment and other changes during the COVID-19 pandemic: a qualitative study.
Topics: Adolescent; Adult; Analgesics, Opioid; Buprenorphine; COVID-19; Humans; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Pandemics | 2023 |
Phenobarbital for alcohol withdrawal in the context of the opioid epidemic: a neglected caveat.
Topics: Alcoholism; Analgesics, Opioid; Buprenorphine; Humans; Methadone; Opiate Substitution Treatment; Opioid Epidemic; Opioid-Related Disorders; Phenobarbital; Substance Withdrawal Syndrome | 2023 |
Treatment access for opioid use disorder among women with medicaid in Florida.
Topics: Analgesics, Opioid; Buprenorphine; Female; Florida; Humans; Medicaid; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Pregnancy; United States | 2023 |
METHADONE INITIATION IN THE EMERGENCY DEPARTMENT FOR OPIOID USE DISORDER: A CASE SERIES.
Topics: Analgesics, Opioid; Buprenorphine; Emergency Service, Hospital; Humans; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders | 2023 |
A Comparative Effectiveness Study on Opioid Use Disorder Prediction Using Artificial Intelligence and Existing Risk Models.
Topics: Analgesics, Opioid; Artificial Intelligence; Buprenorphine; Female; Humans; Male; Methadone; Middle Aged; Opiate Substitution Treatment; Opioid-Related Disorders; Retrospective Studies; United States | 2023 |
United States county jail treatment and care of pregnant incarcerated persons with opioid use disorder.
Topics: Analgesics, Opioid; Buprenorphine; Cross-Sectional Studies; Female; Humans; Jails; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Pregnancy; Prisoners; United States | 2023 |
Barriers and facilitators to the use of medication for opioid use disorder within the criminal justice system: Perspectives from clinicians.
Topics: Buprenorphine; Criminal Law; Humans; Methadone; Naltrexone; Opioid-Related Disorders | 2023 |
Transitioning off methadone: A qualitative study exploring why patients discontinue methadone treatment for opioid use disorder.
Topics: Analgesics, Opioid; Buprenorphine; Cocaine; Humans; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders | 2023 |
Treating Opioid Use Disorder in Patients Who Are Incarcerated: Quandaries of a Hospitalist.
Topics: Analgesics, Opioid; Buprenorphine; Hospitalists; Humans; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Prisoners | 2023 |
Augmenting project ECHO for opioid use disorder with data-informed quality improvement.
Topics: Buprenorphine; Humans; Methadone; Naltrexone; Opiate Overdose; Opiate Substitution Treatment; Opioid-Related Disorders; Quality Improvement; Surveys and Questionnaires | 2023 |
Trends in Methadone Dispensing for Opioid Use Disorder After Medicare Payment Policy Changes.
Topics: Aged; Buprenorphine; COVID-19; Cross-Sectional Studies; Female; Humans; Male; Medicare Part C; Methadone; Middle Aged; Opiate Substitution Treatment; Opioid-Related Disorders; Pandemics; Policy; United States | 2023 |
A comparison of postpartum opioid consumption and opioid discharge prescriptions among opioid-naïve patients and those with opioid use disorder.
Topics: Analgesics, Opioid; Buprenorphine; Drug Prescriptions; Female; Humans; Methadone; Morphine Derivatives; Opioid-Related Disorders; Pain, Postoperative; Patient Discharge; Postpartum Period; Pregnancy; Retrospective Studies | 2023 |
Drug use patterns and factors related to the use and discontinuation of medications for opioid use disorder in the age of fentanyl: findings from a mixed-methods study of people who use drugs.
Topics: Analgesics, Opioid; Benzodiazepines; Buprenorphine; Crack Cocaine; Drug Overdose; Fentanyl; Heroin; Humans; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Pain; Pharmaceutical Preparations | 2023 |
Impacts of the COVID-19 pandemic on enrollment in medications for opioid use disorder (MOUD) in Vancouver, Canada: An interrupted time series analysis.
Topics: Analgesics, Opioid; British Columbia; Buprenorphine; Buprenorphine, Naloxone Drug Combination; COVID-19; Humans; Interrupted Time Series Analysis; Methadone; Morphine Derivatives; Opiate Substitution Treatment; Opioid-Related Disorders; Pandemics | 2023 |
Ventricular Arrhythmias Associated With Over-the-Counter and Recreational Opioids.
Topics: Analgesics, Opioid; Arrhythmias, Cardiac; Buprenorphine; Diphenoxylate; Humans; Loperamide; Methadone; Naltrexone; Nonprescription Drugs | 2023 |
Trends in smoking during pregnancy stratified by the use of opioid agonist therapy and the contribution of smoking to poor outcome in neonates prenatally exposed to opioid agonist treatment.
Topics: Analgesics, Opioid; Buprenorphine; Female; Humans; Infant, Newborn; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Parturition; Pregnancy; Pregnancy Complications | 2023 |
Changes In County-Level Access To Medications For Opioid Use Disorder After Medicare Coverage Of Methadone Treatment Began.
Topics: Aged; Analgesics, Opioid; Buprenorphine; Health Services Accessibility; Humans; Medicare; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; United States | 2023 |
Trajectories of drug treatment and illicit opioid use in the AIDS Linked to the IntraVenous Experience cohort, 2014-2019.
Topics: Acquired Immunodeficiency Syndrome; Aged; Analgesics, Opioid; Buprenorphine; Humans; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders | 2023 |
A truly patient-centred evaluation of opioid agonist treatment.
Topics: Analgesics, Opioid; Buprenorphine; Humans; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders | 2023 |
Comparing presumptive with direct-to-definitive drug testing in oral fluid vs. urine for a U.S. national sample of individuals misusing drugs.
Topics: Buprenorphine; Cocaine; Humans; Illicit Drugs; Methadone; Saliva; Substance Abuse Detection; Tramadol | 2023 |
Buprenorphine and methadone differentially alter early brain development in human cortical organoids.
Topics: Analgesics, Opioid; Brain; Buprenorphine; Humans; Infant, Newborn; Methadone; N-Methylaspartate; Narcotic Antagonists; Opioid-Related Disorders; Organoids; Receptors, Opioid, kappa | 2023 |
Methamphetamine use and utilization of medications for opioid use disorder among rural people who use drugs.
Topics: Analgesics, Opioid; Buprenorphine; Humans; Methadone; Methamphetamine; Opiate Substitution Treatment; Opioid-Related Disorders; Rural Population | 2023 |
Changes in Opioid Agonist Treatment Practice in Germany during the COVID-19 Pandemic: What Have Physicians Done, and What Would They Like to Keep Doing?
Topics: Analgesics, Opioid; Buprenorphine; COVID-19; Female; Humans; Male; Methadone; Middle Aged; Opiate Substitution Treatment; Opioid-Related Disorders; Pandemics; Physicians; SARS-CoV-2 | 2023 |
Re-Purposing FDA-Approved Drugs for Opioid Use Disorder.
Topics: Adolescent; Adult; Aged; Analgesics, Opioid; Buprenorphine; Comorbidity; Humans; Methadone; Middle Aged; Opiate Substitution Treatment; Opioid-Related Disorders; Young Adult | 2023 |
Cardiac and mortality outcome differences between methadone, buprenorphine and naltrexone prescriptions in patients with an opioid use disorder.
Topics: Buprenorphine; Humans; Long QT Syndrome; Methadone; Naltrexone; Opiate Substitution Treatment; Opioid-Related Disorders; Prescriptions; Retrospective Studies; United States | 2023 |
Risk and Protective Factors Affecting Drug Craving among Patients with Substance Use Disorders Undergoing Opioid Agonists Maintenance Therapy.
Topics: Analgesics, Opioid; Buprenorphine; Craving; Family Health; Humans; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Protective Factors; Resilience, Psychological | 2023 |
Risks of returning to opioid use at treatment entry and early in opioid use disorder treatment: Role of non-opioid substances.
Topics: Analgesics, Opioid; Buprenorphine; Cocaine; Humans; Methadone; Naltrexone; Opiate Substitution Treatment; Opioid-Related Disorders | 2023 |
Barriers to initiate buprenorphine and methadone for opioid use disorder treatment with postdischarge treatment linkage.
Topics: Aftercare; Analgesics, Opioid; Buprenorphine; Humans; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Patient Discharge | 2023 |
Flexible delivery of opioid agonist treatment during COVID-19 in Norway: qualitative and quantitative findings from an online survey of provider experiences.
Topics: Analgesics, Opioid; Buprenorphine; COVID-19; Cross-Sectional Studies; Female; General Practitioners; Humans; Methadone; Norway; Pandemics; Surveys and Questionnaires | 2023 |
"Get in and get out, get on with life": Patient and provider perspectives on methadone van implementation for opioid use disorder treatment.
Topics: Analgesics, Opioid; Buprenorphine; Health Services Accessibility; Humans; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders | 2023 |
Large variations in all-cause and overdose mortality among >13,000 patients in and out of opioid maintenance treatment in different settings: a comparative registry linkage study.
Topics: Buprenorphine; Drug Overdose; Female; Humans; Male; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Registries | 2023 |
Medications for Opioid Use Disorder and Mortality and Hospitalization Among People With Opioid Use-related Infections.
Topics: Adult; Analgesics, Opioid; Buprenorphine; Female; Hospitalization; Humans; Male; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Soft Tissue Infections | 2024 |
Research Priorities for Expansion of Opioid Use Disorder Treatment in the Community Pharmacy.
Topics: Analgesics, Opioid; Buprenorphine; Educational Status; Humans; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; Pharmacies; Pharmacy; Research | 2023 |
Weight change in a national cohort of U.S. Military Veterans engaged in medication treatment for opioid use disorder.
Topics: Analgesics, Opioid; Buprenorphine; Humans; Methadone; Opiate Substitution Treatment; Opioid-Related Disorders; United States; United States Department of Veterans Affairs; Veterans; Weight Gain | 2023 |